<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Toxicol Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Toxicol Rep</journal-id>
      <journal-title-group>
        <journal-title>Toxicology Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2214-7500</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">5615787</article-id>
      <article-id pub-id-type="publisher-id">S2214-7500(16)30008-7</article-id>
      <article-id pub-id-type="doi">10.1016/j.toxrep.2016.01.008</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Omega-3 and alpha-tocopherol provide more protection against contaminants in novel feeds for Atlantic salmon (<italic>Salmo salar</italic> L.) than omega-6 and gamma tocopherol</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>S&#xF8;fteland</surname>
            <given-names>Liv</given-names>
          </name>
          <email>lso@nifes.no</email>
          <xref rid="aff0005" ref-type="aff">a</xref>
          <xref rid="cor0005" ref-type="corresp">&#x204E;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Berntssen</surname>
            <given-names>Marc H.G.</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kirwan</surname>
            <given-names>Jennifer A.</given-names>
          </name>
          <xref rid="aff0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>St&#xF8;rseth</surname>
            <given-names>Trond R.</given-names>
          </name>
          <xref rid="aff0015" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Viant</surname>
            <given-names>Mark R.</given-names>
          </name>
          <xref rid="aff0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Torstensen</surname>
            <given-names>Bente E.</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Waagb&#xF8;</surname>
            <given-names>Rune</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Olsvik</surname>
            <given-names>P&#xE5;l A.</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
      </contrib-group>
      <aff id="aff0005"><label>a</label>National Institute of Nutrition and Seafood Research, Norway</aff>
      <aff id="aff0010"><label>b</label>School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK</aff>
      <aff id="aff0015"><label>c</label>SINTEF Fisheries and Aquaculture, Norway</aff>
      <author-notes>
        <corresp id="cor0005"><label>&#x204E;</label>Corresponding author. <email>lso@nifes.no</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>14</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>1</month>
        <year>2016</year>
      </pub-date>
      <volume>3</volume>
      <fpage>211</fpage>
      <lpage>224</lpage>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>23</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 The Authors</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="abs0005">
        <p>Extended use of plant ingredients in Atlantic salmon farming has increased the need for knowledge on the effects of new nutrients and contaminants in plant based feeds on fish health and nutrient-contaminant interactions. Primary Atlantic salmon hepatocytes were exposed to a mixture of PAHs and pesticides alone or in combination with the nutrients ARA, EPA, &#x3B1;-tocopherol, and &#x3B3;-tocopherol according to a factorial design. Cells were screened for effects using xCELLigence cytotoxicity screening, NMR spectroscopy metabolomics, mass spectrometry lipidomics and RT-qPCR transcriptomics. The cytotoxicity results suggest that adverse effects of the contaminants can be counteracted by the nutrients. The lipidomics suggested effects on cell membrane stability and vitamin D metabolism after contaminant and fatty acid exposure. Co-exposure of the contaminants with EPA or &#x3B1;-tocopherol contributed to an antagonistic effect in exposed cells, with reduced effects on the VTG and FABP4 transcripts. ARA and &#x3B3;-tocopherol strengthened the contaminant-induced response, ARA by contributing to an additive and synergistic induction of CYP1A, CYP3A and CPT2, and &#x3B3;-tocopherol by synergistically increasing ACOX1. Individually EPA and &#x3B1;-tocopherol seemed more beneficial than ARA and &#x3B3;-tocopherol in preventing the adverse effects induced by the contaminant mixture, though a combination of all nutrients showed the greatest ameliorating effect.</p>
      </abstract>
      <kwd-group id="kwd0005">
        <title>Chemical compounds studied in this article</title>
        <kwd>Chlorpyrifos</kwd>
        <kwd>Endosulfan</kwd>
        <kwd>Phenanthrene</kwd>
        <kwd>Benzo(a) pyrene</kwd>
        <kwd>Arachidonic acid</kwd>
        <kwd>Eicosapentaenoic acid</kwd>
        <kwd>&#x3B1;-tocopherol</kwd>
        <kwd>&#x3B3;-tocopherol</kwd>
      </kwd-group>
      <kwd-group id="kwd0010">
        <title>Keywords</title>
        <kwd>Interactions</kwd>
        <kwd>Nutrients</kwd>
        <kwd>PAH</kwd>
        <kwd>Pesticides</kwd>
        <kwd>Lipidomics</kwd>
        <kwd>Metabolomics</kwd>
        <kwd>RT-qPCR transcriptomics</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec0005">
      <label>1</label>
      <title>Introduction</title>
      <p>Increased use of plant feed ingredients has introduced a new cocktail of plant-oil derived contaminants, such as polycyclic aromatic hydrocarbons (PAHs) and pesticides, formerly not related with farming of salmonids <xref rid="bib0025" ref-type="bibr">[5]</xref>, <xref rid="bib0115" ref-type="bibr">[23]</xref>. Plant oils intended for animal feed production can be contaminated with PAH like phenanthrene and benzo(a) pyrene <xref rid="bib0390" ref-type="bibr">[81]</xref>, <xref rid="bib0060" ref-type="bibr">[12]</xref> due to atmospheric deposition of particles on crops before harvesting or later during the thermal processing of the oil seeds <xref rid="bib0100" ref-type="bibr">[20]</xref>, <xref rid="bib0305" ref-type="bibr">[64]</xref>. Residue levels of pesticides like endosulfan and chlorpyrifos have been reported in products from plants such as soya or maize <xref rid="bib0160" ref-type="bibr">[33]</xref>, <xref rid="bib0240" ref-type="bibr">[49]</xref> which are commonly used as ingredients in salmon feeds <xref rid="bib0020" ref-type="bibr">[4]</xref>. Both PAH and pesticides have been shown in several <italic>in vitro</italic> and <italic>in vivo</italic> experiments to cause lipid and endocrine disturbances and to induce cytochrome P450 enzymes in teleost fish <xref rid="bib0210" ref-type="bibr">[43]</xref>, <xref rid="bib0255" ref-type="bibr">[53]</xref>, <xref rid="bib0325" ref-type="bibr">[68]</xref>, <xref rid="bib0380" ref-type="bibr">[79]</xref>, <xref rid="bib0485" ref-type="bibr">[100]</xref>, <xref rid="bib0495" ref-type="bibr">[102]</xref>. PAHs are genotoxic <xref rid="bib0080" ref-type="bibr">[16]</xref>, <xref rid="bib0415" ref-type="bibr">[86]</xref>, <xref rid="bib0170" ref-type="bibr">[35]</xref> and exposure has been suggested to cause vitamin D signalling disruption <xref rid="bib0380" ref-type="bibr">[79]</xref> as well as an effect on cell membrane integrity <xref rid="bib0310" ref-type="bibr">[65]</xref>, <xref rid="bib0335" ref-type="bibr">[70]</xref>. The pesticides endosulfan and chlorpyrifos have been shown to induce lipid accumulation in Atlantic salmon liver cells both <italic>in vitro</italic> and <italic>in vivo</italic>
<xref rid="bib0210" ref-type="bibr">[43]</xref>, <xref rid="bib0115" ref-type="bibr">[23]</xref>, <xref rid="bib0380" ref-type="bibr">[79]</xref>.</p>
      <p>In addition to an altered contaminant profile, the plant-based feed ingredients also change the nutrient profile of the fish. Marine oils contain high levels of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) <xref rid="bib0175" ref-type="bibr">[36]</xref> while common plant oils can contain high levels of n-6 PUFA like linoleic acid (LA, 18:2n-6) <xref rid="bib0445" ref-type="bibr">[92]</xref>. Since the fatty acid composition of oily fish reflects the fatty acid composition of their feed <xref rid="bib0410" ref-type="bibr">[85]</xref>, replacing fish oil with vegetable oil in fish feed typically reduces the concentration in Atlantic salmon fillet of the n-3 PUFAs EPA and DHA and increases concentrations of the n-6 PUFAs LA and arachidonic acid (ARA, 20:4n-6) <xref rid="bib0125" ref-type="bibr">[25]</xref>, <xref rid="bib0295" ref-type="bibr">[62]</xref>, <xref rid="bib0405" ref-type="bibr">[84]</xref>, <xref rid="bib0410" ref-type="bibr">[85]</xref>. The liver is a central organ for lipid metabolism <xref rid="bib0035" ref-type="bibr">[7]</xref> and the synthesis of cholesterol and bile <xref rid="bib0205" ref-type="bibr">[42]</xref>. Immediately after uptake in the liver, the PUFA can be converted to energy by &#x3B2;-oxidation <xref rid="bib0355" ref-type="bibr">[74]</xref>, stored in adipocytes and in intracellular lipid droplets in different tissues <xref rid="bib0265" ref-type="bibr">[55]</xref> or incorporated into phospholipid membranes <xref rid="bib0445" ref-type="bibr">[92]</xref>. The n-3 and n-6 PUFAs can be converted to their respective group of eicosanoids or lipid mediators by the lipoxygenase (LOX), cyclooxygenase (COX) and cytochrome P450 (CYP) enzyme pathways <xref rid="bib0445" ref-type="bibr">[92]</xref>. The n-6 eicosanoids are a general group of pro-inflammatory eicosanoids <xref rid="bib0445" ref-type="bibr">[92]</xref>. By contrast, the n-3 PUFA can be converted to n-3 eicosanoids that have anti-inflammatory abilities <xref rid="bib0445" ref-type="bibr">[92]</xref>. Several studies have reported increase in liver lipid when fish oil was replaced with plant oils indicating that nutrients in fish oil such as EPA and DHA, n-6, saturated fatty acids, cholesterol and phytosterols play a role (Torstensen et al., 2011) <xref rid="bib0220" ref-type="bibr">[45]</xref>, <xref rid="bib0230" ref-type="bibr">[47]</xref>, <xref rid="bib0295" ref-type="bibr">[62]</xref>. High levels of the n-3 PUFAs DHA and EPA in fish feed can protect against induction of liver steatosis in Atlantic salmon <xref rid="bib0220" ref-type="bibr">[45]</xref>, <xref rid="bib0230" ref-type="bibr">[47]</xref>. &#x3B1;-tocopherol is an essential nutrient for fish <xref rid="bib0135" ref-type="bibr">[28]</xref> and is also the main form of vitamin E in fish fillet <xref rid="bib0365" ref-type="bibr">[76]</xref>. Dietary &#x3B1;-tocopherol is taken up more rapidly than &#x3B3;-tocopherol <xref rid="bib0450" ref-type="bibr">[93]</xref>, which is the main vitamin E congener in most plant seeds <xref rid="bib0165" ref-type="bibr">[34]</xref> and maize, rapeseed and soya oils <xref rid="bib0370" ref-type="bibr">[77]</xref>. &#x3B3;-tocopherol seems to be a more effective trap for lipophilic electrophiles than &#x3B1;-tocopherol <xref rid="bib0165" ref-type="bibr">[34]</xref> and in contrast to &#x3B1;-tocopherol, &#x3B3;-tocopherol possesses anti-inflammatory properties <xref rid="bib0165" ref-type="bibr">[34]</xref>. Similar to the n-3 PUFAs, high levels of tocopherol can inhibit induction of liver steatosis <xref rid="bib0440" ref-type="bibr">[91]</xref> and protect organisms against lipid oxidation <xref rid="bib0135" ref-type="bibr">[28]</xref>.</p>
      <p>The aim of this study was to examine how relevant nutrients can modulate the toxicological outcome of a contaminant mixture associated with plant feed ingredients using metabolomic, lipidomic and transcriptomic methods to search for novel biomarkers and possible interaction effects. The study utilised Atlantic salmon primary hepatocytes as a biological model system.</p>
    </sec>
    <sec id="sec0010">
      <label>2</label>
      <title>Materials and methods</title>
      <sec id="sec0015">
        <label>2.1</label>
        <title>Chemicals</title>
        <p>Endosulfan (6,7,8,9,10-hexachloro-1,5,5a,6,9,9,a-hexahydro-6,9-metano-2,4,3-benza-dioxathiepin-3-oxide, &#x3B1;&#xA0;+&#xA0;&#x3B2;&#x2013;2&#xA0;+&#xA0;1; PESTANAL<sup>&#xAE;</sup>, analytical standard), chlorpyrifos (<italic>O</italic>,<italic>O</italic>-diethyl-<italic>O</italic>-3,5,6-trichlor-2-pyridyl phosphorothioate, PESTANAL<sup>&#xAE;</sup>, analytical standard), phenanthrene (&#x2265;98% pure), benzo(a) pyrene (&#x2265;96% pure), arachidonic acid (ARA &#x2265;99%), eicosapentaenoic acid (EPA, &#x2265;99% pure), potassium hydroxide, &#x3B1;-tocopherol (&#x3B1;T, &gt;95.5% pure) and &#x3B3;-tocopherol (&#x3B3;T, &#x2265;96% pure) were all purchased from Sigma&#x2013;Aldrich (Oslo, Norway). Dimethyl stock solution was purchased from Scientific and Chemical Supplies Ltd. (Bilston, UK), chloroform (HPLC grade) was purchased from Fisher Scientific (Loughborough, UK) and ammonium acetate was purchased from Sigma&#x2013;Aldrich Co., Ltd. (Dorset, UK). The fatty acid free-BSA (FAF&#x2013;BSA) was purchased from PAA (Parching, Austria).</p>
        <sec id="sec0020">
          <label>2.1.1</label>
          <title>Bovine Serum Albumin (BSA) coupling of fatty acids</title>
          <p>Binding of fatty acids (FA) to fatty acid free-BSA (FAF&#x2013;BSA) was performed as per Ghioni et al. <xref rid="bib0110" ref-type="bibr">[22]</xref>. To summarize, FA dissolved in 0.04&#xA0;ml chloroform per mg FA was added to a glass sample tube and N<sub>2</sub> was used to evaporate the chloroform. Potassium hydroxide (KOH) was applied to the FA in a 1:3 ratio and the solution was shaken for 10&#xA0;min using a vortex mixer. FAF&#x2013;BSA was employed in a 2.5:1 relationship to the FA and the solution was mixed for 45&#xA0;min before it was sterile-filtered and preserved at &#x2212;80&#xA0;&#xB0;C in anoxic conditions.</p>
        </sec>
      </sec>
      <sec id="sec0025">
        <label>2.2</label>
        <title>Isolation of primary cultures of hepatocytes</title>
        <p>Juvenile Atlantic salmon were obtained and kept at the animal holding facility at Ilab, University of Bergen (UiB), Bergen, Norway. The fish were fed once daily with a special feed produced without addition of synthetic antioxidants and with low levels of contaminants, supplied by EWOS, Norway (Harmony Nature Transfer 75). All glassware, instruments and solutions were autoclaved prior to liver perfusion. Hepatocytes were isolated from eight Atlantic salmon (278&#x2013;381&#xA0;g) with a two-step perfusion method previously described in Ref. <xref rid="bib0375" ref-type="bibr">[78]</xref>. The final cell pellet was resuspended in L-15 medium containing 10% fish serum (FS) from salmon (Nordic BioSite, Oslo, Norway), 1% glutamax (Invitrogen, Norway) and 1% penicillin&#x2013;streptomycin&#x2013;amphotericin (10,000 units/ml potassium penicillin, 10000&#xA0;&#x3BC;g/ml streptomycin sulphate and 25&#xA0;&#x3BC;g/ml amphotericin B) (Lonzo, Medprobe, Oslo, Norway). The Trypan Blue exclusion method, performed in accordance with the manufacturer&#x2019;s protocol (Lonzo, Medprobe, Oslo, Norway), was used to determine cell viability. The different cell suspensions used in this study had cell viability between 85&#x2013;90%. The cell suspensions were plated on 5&#xA0;&#x3BC;g/cm<sup>2</sup> laminin (Sigma&#x2013;Aldrich, Oslo, Norway) coated culture plates (TPP, Trasadingen, Switzerland), and the hepatocytes were kept at 10&#xA0;&#xB0;C in a sterile incubator without additional O<sub>2</sub>/CO<sub>2</sub> (Sanyo, CFC FREE, Etten Leur, The Netherlands). The following cell concentrations were used; 7.2&#xA0;&#xD7;&#xA0;10<sup>6</sup> cells per well in 6-well plates (in 3&#xA0;ml complete L-15 medium), 2.6&#xA0;&#xD7;&#xA0;10<sup>6</sup> cells per well in 12-well plates (in 2&#xA0;ml complete L-15 medium), 0.2&#xA0;&#xD7;&#xA0;10<sup>6</sup> cells per well in xCELLigence 96-well plates (in 0.2&#xA0;ml complete L-15 medium).</p>
      </sec>
      <sec id="sec0030">
        <label>2.3</label>
        <title>Chemical and nutrient exposure</title>
        <p>The primary cells were cultured for 36&#x2013;40&#xA0;h prior to chemical exposure with one change of medium (containing 10% FS) after 18&#x2013;20&#xA0;h. The cells were exposed for 48&#xA0;h to single nutrients to establish cytotoxic dose-response curves and to nutrients and a contaminant mixture according to a factorial experimental design for interaction evaluation. Cytotoxicity dose-response curves were established for &#x3B1;-tocopherol (1, 10, 100, 1000 and 10,000&#xA0;&#x3BC;M) and EPA (100, 200, 4000 and 600&#xA0;&#x3BC;M) and cells from three fish (<italic>n</italic>&#xA0;=&#xA0;3) were used to make the dose-response curves. Based on individual cytotoxicity dose-response curves for the nutrients, non-cytotoxic concentrations of the &#x3B1;-tocopherol (100&#xA0;&#x3BC;M) and the fatty acid EPA (200&#xA0;&#x3BC;M) were used (data not shown). To be able to assess the effect of both marine and plant derived nutrients on the toxicity of a mixture of PAHs and pesticides, comparable concentrations were used for the plant derived nutrients &#x3B3;-tocopherol (100&#xA0;&#x3BC;M) and ARA (200&#xA0;&#x3BC;M) in a factorial design. The contaminant mixture used here was selected based on a previous study by S&#xF8;fteland et al. <xref rid="bib0380" ref-type="bibr">[79]</xref> and was composed of 100&#xA0;&#x3BC;M of the PAHs benzo(a) pyrene and phenanthrene and 1&#xA0;&#x3BC;M of the two pesticides chlorpyrifos and endosulfan. These concentrations were chosen after earlier individual assessment of the four contaminants aiming for levels just below the onset of cytotoxicity, and the contaminant mixture used in the present study was a potent combination <xref rid="bib0380" ref-type="bibr">[79]</xref>. A full factorial design was used with two levels (low and high concentrations), a zero point (control, 0.4% DMSO), and one centre point in order to evaluate linearity (<xref rid="tbl0005" ref-type="table">Table 1</xref>). In addition a BSA control was included. Cells from five fish were employed for the factorial design experiment. The exposure medium contained 1% FS. The chemical exposure medium was substituted with new medium after 18&#x2013;20&#xA0;h.<table-wrap id="tbl0005" position="float"><label>Table 1</label><caption><p>Overview of the different concentration (&#x3BC;M) combinations used for the various nutrients (eicosapentaenoic acid (EPA), arachidonic acid (ARA), &#x3B1;-tocopherol (&#x3B1;T) and &#x3B3;-tocopherol (&#x3B3;T)) and contaminant mixture (CM) used in the factorial design for lipidomic and RT-qPCR evaluation. CM contained 100&#xA0;&#x3BC;M of benzo(a) pyrene and phenanthrene and 1&#xA0;&#x3BC;M of chlorpyrifos and endosulfan.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Exp. no.</th><th align="left">EPA</th><th align="left">ARA</th><th align="left">&#x3B1;T</th><th align="left">&#x3B3;T</th><th align="left">CM</th></tr></thead><tbody><tr><td align="char"><bold>1</bold></td><td align="char">0</td><td align="char">0</td><td align="char">0</td><td align="char">0</td><td align="char">0</td></tr><tr><td align="char"><bold>2</bold></td><td align="char">200</td><td align="char">0</td><td align="char">0</td><td align="char">0</td><td align="char">0</td></tr><tr><td align="char"><bold>3</bold></td><td align="char">0</td><td align="char">200</td><td align="char">0</td><td align="char">0</td><td align="char">0</td></tr><tr><td align="char"><bold>4</bold></td><td align="char">200</td><td align="char">200</td><td align="char">0</td><td align="char">0</td><td align="char">0</td></tr><tr><td align="char"><bold>5</bold></td><td align="char">0</td><td align="char">0</td><td align="char">100</td><td align="char">0</td><td align="char">0</td></tr><tr><td align="char"><bold>6</bold></td><td align="char">200</td><td align="char">0</td><td align="char">100</td><td align="char">0</td><td align="char">0</td></tr><tr><td align="char"><bold>7</bold></td><td align="char">0</td><td align="char">200</td><td align="char">100</td><td align="char">0</td><td align="char">0</td></tr><tr><td align="char"><bold>8</bold></td><td align="char">200</td><td align="char">200</td><td align="char">100</td><td align="char">0</td><td align="char">0</td></tr><tr><td align="char"><bold>9</bold></td><td align="char">0</td><td align="char">0</td><td align="char">0</td><td align="char">100</td><td align="char">0</td></tr><tr><td align="char"><bold>10</bold></td><td align="char">200</td><td align="char">0</td><td align="char">0</td><td align="char">100</td><td align="char">0</td></tr><tr><td align="char"><bold>11</bold></td><td align="char">0</td><td align="char">200</td><td align="char">0</td><td align="char">100</td><td align="char">0</td></tr><tr><td align="char"><bold>12</bold></td><td align="char">200</td><td align="char">200</td><td align="char">0</td><td align="char">100</td><td align="char">0</td></tr><tr><td align="char"><bold>13</bold></td><td align="char">0</td><td align="char">0</td><td align="char">100</td><td align="char">100</td><td align="char">0</td></tr><tr><td align="char"><bold>14</bold></td><td align="char">200</td><td align="char">0</td><td align="char">100</td><td align="char">100</td><td align="char">0</td></tr><tr><td align="char"><bold>15</bold></td><td align="char">0</td><td align="char">200</td><td align="char">100</td><td align="char">100</td><td align="char">0</td></tr><tr><td align="char"><bold>16</bold></td><td align="char">200</td><td align="char">200</td><td align="char">100</td><td align="char">100</td><td align="char">0</td></tr><tr><td align="char"><bold>17</bold></td><td align="char">0</td><td align="char">0</td><td align="char">0</td><td align="char">0</td><td align="char">100</td></tr><tr><td align="char"><bold>18</bold></td><td align="char">200</td><td align="char">0</td><td align="char">0</td><td align="char">0</td><td align="char">100</td></tr><tr><td align="char"><bold>19</bold></td><td align="char">0</td><td align="char">200</td><td align="char">0</td><td align="char">0</td><td align="char">100</td></tr><tr><td align="char"><bold>20</bold></td><td align="char">200</td><td align="char">200</td><td align="char">0</td><td align="char">0</td><td align="char">100</td></tr><tr><td align="char"><bold>21</bold></td><td align="char">0</td><td align="char">0</td><td align="char">100</td><td align="char">0</td><td align="char">100</td></tr><tr><td align="char"><bold>22</bold></td><td align="char">200</td><td align="char">0</td><td align="char">100</td><td align="char">0</td><td align="char">100</td></tr><tr><td align="char"><bold>23</bold></td><td align="char">0</td><td align="char">200</td><td align="char">100</td><td align="char">0</td><td align="char">100</td></tr><tr><td align="char"><bold>24</bold></td><td align="char">200</td><td align="char">200</td><td align="char">100</td><td align="char">0</td><td align="char">100</td></tr><tr><td align="char"><bold>25</bold></td><td align="char">0</td><td align="char">0</td><td align="char">0</td><td align="char">100</td><td align="char">100</td></tr><tr><td align="char"><bold>26</bold></td><td align="char">200</td><td align="char">0</td><td align="char">0</td><td align="char">100</td><td align="char">100</td></tr><tr><td align="char"><bold>27</bold></td><td align="char">0</td><td align="char">200</td><td align="char">0</td><td align="char">100</td><td align="char">100</td></tr><tr><td align="char"><bold>28</bold></td><td align="char">200</td><td align="char">200</td><td align="char">0</td><td align="char">100</td><td align="char">100</td></tr><tr><td align="char"><bold>29</bold></td><td align="char">0</td><td align="char">0</td><td align="char">100</td><td align="char">100</td><td align="char">100</td></tr><tr><td align="char"><bold>30</bold></td><td align="char">200</td><td align="char">0</td><td align="char">100</td><td align="char">100</td><td align="char">100</td></tr><tr><td align="char"><bold>31</bold></td><td align="char">0</td><td align="char">200</td><td align="char">100</td><td align="char">100</td><td align="char">100</td></tr><tr><td align="char"><bold>32</bold></td><td align="char">200</td><td align="char">200</td><td align="char">100</td><td align="char">100</td><td align="char">100</td></tr><tr><td align="char"><bold>33</bold></td><td align="char">100</td><td align="char">100</td><td align="char">50</td><td align="char">50</td><td align="char">50</td></tr></tbody></table></table-wrap></p>
      </sec>
      <sec id="sec0035">
        <label>2.4</label>
        <title>Cytotoxicity testing of chemicals</title>
        <p>For the cytotoxicity assessment of the nutrients and contaminant mixtures, real time impedance data obtained by the xCELLigence systems (ACEA Biosciences, Inc. (ACEA), Aarhus, Denmark) was used. The xCELLigence system quantifies electrical impedance across electrodes in 96-well cell culture E-Plates. The impedance measurement gives quantitative information about the cells&#x2019; health status including morphology, cell number and viability and is indicated with the parameter Cell index (CI) or the normalized CI (NCI). The xCELLigence instrument was used to establish dose-response relationship for EPA and &#x3B1;-tocopherol exposed singly to the primary hepatocytes and interaction evaluation using cells exposed according to a factorial design, as mentioned above. The real time cell monitoring was conducted at 10&#xA0;&#xB0;C in an incubator without additional O<sub>2</sub>/CO<sub>2</sub> (Sanyo, CFC FREE, Etten Leur, Netherland), using the RTCA single plate xCELLigence platform. The data was collected according to S&#xF8;fteland et al. <xref rid="bib0380" ref-type="bibr">[79]</xref>. Briefly, the data was collected with intervals of 2&#xA0;min after contaminant exposure for 12&#xA0;h, and then every 15&#xA0;min for 120&#xA0;h. The last time point before compound exposure was used for the normalization, allowing a more precise comparison of the effect of the different contaminant concentrations tested. The CI values presented here were calculated from three to five replicate values. Determination of cytotoxic effects was done according to the International standardised test for <italic>in vitro</italic> cytotoxicity, ISO 10993-5:2009 <xref rid="bib0155" ref-type="bibr">[32]</xref>. Contaminants will be deemed cytotoxic when cells viability exceeds 30% reduction compared to the control.</p>
      </sec>
      <sec id="sec0040">
        <label>2.5</label>
        <title>Metabolomics and lipidomics</title>
        <p>Based on the factorial design cytotoxicity screening, a selection of mixtures were analysed with lipidomic and metabolomic methods to determine how nutrients modify the toxic effect of the contaminant mixtures. The exposure groups analysed were EPA, ARA, &#x3B1;T, &#x3B3;T, CM, C-EPA, C-ARA, C-&#x3B1;T, C-&#x3B3;T, C-All high, and C-All low, and these groups corresponded to following mixtures 2, 3, 5, 9, 17, 18, 19, 21, 25, 32 and 33, respectively, in <xref rid="tbl0005" ref-type="table">Table 1</xref>.</p>
        <sec id="sec0045">
          <label>2.5.1</label>
          <title>Metabolite extraction</title>
          <p>Lyophilized samples were extracted using a 1145&#xA0;&#x3BC;l mixture of chloroform:methanol:water (2:2:1.8) and vortexed in 2&#xA0;ml glass vials. The polar and non-polar phases of this bi-phasic mixture were separated, and the polar phase (500&#xA0;&#x3BC;l) was vacuum centrifuged (30&#xA0;min at 300&#xA0;K), frozen and freeze dried for nuclear magnetic resonance spectroscopy (NMR) analysis. For the non-polar phase, 300&#xA0;&#x3BC;l were evaporated under N<sub>2</sub> and stored at &#x2212;80&#xA0;&#xB0;C before MS analysis.</p>
        </sec>
        <sec id="sec0050">
          <label>2.5.2</label>
          <title>FT-ICR mass spectrometry based lipidomics</title>
          <p>All dried lipid samples were resuspended in an equal volume of 2:1 methanol:chloroform with 5&#xA0;mM ammonium acetate. Lipidomic analyses were conducted in negative ion mode using a hybrid 7-T FT-ICR mass spectrometer (LTQ FT Ultra, Thermo Fisher Scientific, Bremen, Germany) with a chip-based direct infusion nanoelectrospray ionisation assembly (Triversa, Advion Biosciences, Ithaca, NY). Nanoelectrospray conditions comprised of a 200&#xA0;nl/min flow rate, 0.4&#xA0;psi backing pressure and -1.2&#xA0;kV electrospray voltage controlled by ChipSoft software (version 8.1.0). Mass spectrometry conditions included an automatic gain control setting of 5&#xA0;&#xD7;&#xA0;10<sup>5</sup> and a mass resolution of 100,000. Analysis time was 4.25&#xA0;min (per technical replicate), controlled using Xcalibur software (version 2.0, Thermo Fisher Scientific). Spectra were collected using the &#x201C;SIM stitching&#x201D; method, <italic>i</italic>.<italic>e</italic>., fourteen overlapping selected ion monitoring (SIM) mass ranges, ranging from <italic>m</italic>/<italic>z</italic> 70 to 2000, were acquired and subsequently fused together, <xref rid="bib0345" ref-type="bibr">[72]</xref>, <xref rid="bib0460" ref-type="bibr">[95]</xref>. Duplicate analyses were averaged for each sample. A quality control (QC) sample consisting of a pooled aliquot of the samples was analysed before during and after the analysis.</p>
        </sec>
        <sec id="sec0055">
          <label>2.5.3</label>
          <title>NMR spectroscopy based metabolomics</title>
          <p>Subsequently the dried polar metabolite fraction was resuspended in 200&#xA0;&#x3BC;l D<sub>2</sub>O with 1&#xA0;mM TMSP and transferred to NMR tubes. All samples were maintained at 277&#xA0;K and analysed within 48&#xA0;h of resuspension. NMR was performed on a Bruker DRU 600 NMR spectrometer (600.23&#xA0;MHz for <sup>1</sup>H) fitted with a 5&#xA0;mm CPQCI cryogenic probe (Bruker Corporation). Three mm NMR tubes were used with the Bruker Sampletrack autosampler in which the samples were kept at 279&#xA0;K before (and after) analysis. The spectra were recorded at 300&#xA0;K with suppression of the residual water resonance using the noesygppr1d pulse sequence from the Bruker pulse sequence library. A pulse width of 7.91&#xA0;&#x3BC;s was used to collect 128 free induction decays with 32&#xA0;K data points with a spectral window of 12,019&#xA0;Hz (20&#xA0;ppm). The acquisition time was 2.73&#xA0;s and the interscan delay was 3&#xA0;s. The noesy mixing time was 10&#xA0;ms, the data were zero filled to 64&#xA0;K and exponential line broadening of 0.3&#xA0;Hz applied before Fourier transformation and the spectra were phased and baseline corrected.</p>
        </sec>
      </sec>
      <sec id="sec0060">
        <label>2.6</label>
        <title>Quantitative real-time RT-PCR</title>
        <sec id="sec0065">
          <label>2.6.1</label>
          <title>RNA extraction</title>
          <p>The RNeasy Plus mini kit (Qiagen, Crawley, UK) was used to extract total RNA according to the manufacturer&#x2019;s protocol. RNA was eluted in 30&#xA0;&#x3BC;l RNase-free MilliQ H<sub>2</sub>O and stored at &#x2212;80&#xA0;&#xB0;C. The RNA quantity and quality were assessed with the NanoDrop<sup>&#xAE;</sup> ND-1000 UV&#x2013;vis Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) and the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA) pursuant to the manufacturer&#x2019;s instructions. The integrity of the RNA was evaluated with the RNA 6000 Nano LabChip<sup>&#xAE;</sup> kit (Agilent Technologies). The samples used in this experiment had 260/280&#xA0;nm absorbance ratios and a 260/230&#xA0;nm ratios above 2 and RNA integrity number (RIN) values above 9, which indicate pure RNA and intact samples <xref rid="bib0315" ref-type="bibr">[66]</xref>.</p>
        </sec>
        <sec id="sec0070">
          <label>2.6.2</label>
          <title>Quantitative real-time RT-PCR</title>
          <p>The transcriptional levels of selected target genes were quantified with a two-step real-time RT-PCR protocol. A serial dilution curve of total RNA with six points in triplicates between 1000&#x2013;31&#xA0;ng were made for PCR efficiency calculations. 500&#xA0;ng of total RNA was added to the reaction for each sample, and reverse transcription (RT) reactions were run in duplicates using 96-well reaction plates. No-template control (ntc) and no-amplification control (nac) reactions were run for quality assessment for every gene assay. The 50&#xA0;&#x3BC;l RT reactions were performed at 48&#xA0;&#xB0;C for 60&#xA0;min utilizing a GeneAmp PCR 9700 thermocycler (Applied Biosystems, Foster City, CA, USA). Individual RT reactions contained 1X TaqMan RT buffer (10&#xD7;), 5.5&#xA0;mM MgCl<sub>2</sub>, 500&#xA0;mM dNTP (of each), oligo dT primers (2.5&#xA0;&#x3BC;M), 0.4&#xA0;U/&#x3BC;l RNase inhibitor and 1.67&#xA0;U/&#x3BC;l Multiscribe Reverse Transcriptase (Applied Biosystems) and RNase-free water.</p>
          <p>For every gene analysed, real-time qPCR was run in 10&#xA0;&#x3BC;l reactions on a LightCycler<sup>&#xAE;</sup> 480 Real-Time PCR System (Roche Applied Sciences, Basel, Switzerland) containing 2.0&#xA0;&#x3BC;l cDNA (diluted twofold). The real-time qPCR was carried out in two 384-well reaction plates using SYBR Green Master Mix (LightCycler 480 SYBR Green master mix kit, Roche Applied Sciences, Basel, Switzerland) containing gene-specific primers and FastStart DNA polymerase. PCR runs were performed with a 5&#xA0;min activation and denaturing step at 95&#xA0;&#xB0;C, followed by 45 cycles with each cycle consisting of a 10&#xA0;s denaturing step at 95&#xA0;&#xB0;C, a 10&#xA0;s annealing step (60&#xA0;&#xB0;C) and finally a 10&#xA0;s extension step at 72&#xA0;&#xB0;C. The primer pairs had an annealing temperature of 60&#xA0;&#xB0;C; see <xref rid="tbl0010" ref-type="table">Table 2</xref> for primer sequences, amplicon sizes and GenBank accession numbers. Final primer concentrations of 500&#xA0;nM were used. For confirmation of amplification of gene-specific products, a melting curve analysis was carried out and the second derivative maximum method <xref rid="bib0395" ref-type="bibr">[82]</xref> was used to determine crossing point (CT) values using the Lightcycler 480 Software. To calculate the mean normalized expression (MNE) of the target genes, the geNorm VBA applet for Microsoft Excel version 3.4 was used to calculate a normalization factor based on three reference genes. By using gene-specific efficiencies calculated from the standard curves, the CT values are converted into quantities <xref rid="bib0430" ref-type="bibr">[89]</xref>. Elongation factor 1 AB (EF1AB), acidic ribosomal protein (ARP) and &#x3B2;-actin were the selected reference genes for this experiment. The reference genes were stable with gene expression stability (<italic>M</italic>) values of 0.304.<table-wrap id="tbl0010" position="float"><label>Table 2</label><caption><p>PCR primers, GenBank accession numbers, amplicon sizes and efficiency.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Gene</th><th align="left">Accession no.</th><th align="left">Forward primer (5&#x2032; - 3&#x2032;)</th><th align="left">Reverse primer (5&#x2032; - 3&#x2032;)</th><th align="left">Product size (bp)</th><th align="left">Efficiency</th></tr></thead><tbody><tr><td align="left">CYP1A</td><td align="left">AF364076</td><td align="left">TGGAGATCTTCCGGCACTCT</td><td align="left">CAGGTGTCCTTGGGAATGGA</td><td align="left">101</td><td align="char">1.93</td></tr><tr><td align="left">PPARA</td><td align="left">NM001123560</td><td align="left">TCTCCAGCCTGGACCTGAAC</td><td align="left">GCCTCGTAGACGCCGTACTT</td><td align="left">58</td><td align="char">2.00</td></tr><tr><td align="left">CYP3A</td><td align="left">DQ361036</td><td align="left">ACTAGAGAGGGTCGCCAAGA</td><td align="left">TACTGAACCGCTCTGGTTTG</td><td align="left">146</td><td align="char">1.90</td></tr><tr><td align="left">ACOX1</td><td align="left">DY733173</td><td align="left">CACTGCCAGGTGTGGTGGTA</td><td align="left">GGAATTCGTACGTTCTCCAATTTCA</td><td align="left">94</td><td align="char">2.04</td></tr><tr><td align="left">FBP4</td><td align="left">BT125322</td><td align="left">CCGCCGACGACAGAAAAA</td><td align="left">TTTTGCACAAGGTTGCCATTT</td><td align="left">61</td><td align="char">1.99</td></tr><tr><td align="left">CPT2</td><td align="left">BG934647</td><td align="left">TGCTCAGCTAGCGTTCCATATG</td><td align="left">AGTGCTGCAGGACTCGTATGTG</td><td align="left">49</td><td align="char">2.07</td></tr><tr><td align="left">VTG</td><td align="left">AY049952</td><td align="left">GACTTCGCCATCAGCCTTTC</td><td align="left">GCCACGGTCTCCAAGAAGTCT</td><td align="left">110</td><td align="char">2.11</td></tr><tr><td align="left">EF1AB</td><td align="left">AF321836</td><td align="left">TGCCCCTCCAGGATGTCTAC</td><td align="left">CACGGCCCACAGGTACT</td><td align="left">59</td><td align="char">2.04</td></tr><tr><td align="left">UBA52</td><td align="left">GO050814</td><td align="left">TCAAGGCCAAGATCCAGGAT</td><td align="left">CGCAGCACAAGATGCAGAGT</td><td align="left">139</td><td align="char">2.01</td></tr><tr><td align="left">&#x392;-ACTIN</td><td align="left">BG933897</td><td align="left">CCAAAGCCAACAGGGAGAA</td><td align="left">AGGGACAACACTGCCTGGAT</td><td align="left">92</td><td align="char">1.96</td></tr></tbody></table></table-wrap></p>
        </sec>
      </sec>
      <sec id="sec0075">
        <label>2.7</label>
        <title>Data analysis</title>
        <sec id="sec0080">
          <label>2.7.1</label>
          <title>xCELLigence</title>
          <p>GraphPad Prism 6.0 software (GraphPad Software Inc., Palo Alto, CA, USA) was used for the statistical analyses of the xCELLigence dose-response evaluation using one-way ANOVA followed by a Dunnett&#x2019;s post hoc test (<italic>p</italic>&#xA0;&lt;&#xA0;0.05) to detect treatment variation in nutrient exposed hepatocytes. Mean&#xA0;&#xB1;&#xA0;SE were calculated for three replicates.</p>
        </sec>
        <sec id="sec0085">
          <label>2.7.2</label>
          <title>Metabolomics</title>
          <p>The processed NMR spectra were imported into Matlab (The Mathworks, Inc.) using ProMetab v3.3 software <xref rid="bib0435" ref-type="bibr">[90]</xref>. The region from 10 to 0.5&#xA0;ppm was imported with a resolution of 0.02&#xA0;ppm which resulted in 4750 data points, and transformed using a generalized log transformation. PCA and PLS-DA analysis was performed in PLS-toolbox v7.0.1 (Eigenvector Research, Inc.) on normalized and mean centred data prior to multivariate statistical analyses. The quantitative data from NMR were first subjected to the Shapiro&#x2013;Wilk test for normality and the metabolites were subjected to the Kruskal&#x2013;Wallis analysis of variance followed by Games&#x2013;Howell post hoc testing <xref rid="bib0105" ref-type="bibr">[21]</xref> in order to assess the comparisons of statistically significant changes between groups compared to the control.</p>
        </sec>
        <sec id="sec0090">
          <label>2.7.3</label>
          <title>Lipidomics</title>
          <p>All analyses were performed in Matlab 7.8.0 with PCA and PLS-DA analysis performed in PLS-toolbox v.6.7.1. Mass spectra were processed using a three-stage filtering algorithm as described in Ref. <xref rid="bib0280" ref-type="bibr">[59]</xref>. Samples were subsequently normalised using probabilistic quotient normalization <xref rid="bib0070" ref-type="bibr">[14]</xref>. Processing the raw mass spectra yielded a dataset that was further optimised using a QC based method as described in Ref. <xref rid="bib0190" ref-type="bibr">[39]</xref>. Mass features with over 20% missing values across all samples were removed and the resulting intensity matrix was submitted for univariate statistical analysis as described below. A k-nearest neighbor approach <xref rid="bib0150" ref-type="bibr">[31]</xref> was applied to impute missing values to the same dataset and it was transformed using a generalized log transformation (glog) prior to multivariate statistical analysis <xref rid="bib0070" ref-type="bibr">[14]</xref>. The final lipidomics dataset was comprised of 901 mass features upon which statistical analyses were conducted. PCA and PLSDA were performed to assess the overall effect (three outliers which were outside the Hotellings t2 plot were first removed). All supervised models were validated using cross validation and permutation testing to avoid over-fitting. Univariate statistical analyses were also conducted on the lipidomics dataset. A Kruskal&#x2013;Wallis analysis of variance followed by Games&#x2013;Howell post hoc testing <xref rid="bib0105" ref-type="bibr">[21]</xref> was conducted in order to assess the comparisons of statistically significant changes between groups compared to the control. A Benjamini&#x2013;Hochberg correction of 10% was applied to the KW results to control for false discovery <xref rid="bib0015" ref-type="bibr">[3]</xref>. The eigenvalues for the different groups in the different PCA plots are presented in the Supplementary Table A3.1-A3.5.</p>
          <p>For putative annotation of the detected mass features, the KEGG database and MI-Pack software (&#x2018;single peak search&#x2019; approach) were first used to assign one or more empirical formula(e), <italic>e</italic>.<italic>g</italic>., C<sub>c</sub>H<sub>h</sub>N<sub>n</sub>O<sub>o</sub>P<sub>p</sub>S<sub>s</sub>, as well as putative metabolite names to each mass feature <xref rid="bib0455" ref-type="bibr">[94]</xref>, assuming a maximum mass error of &#xB1;2&#xA0;ppm. This assignment equates to MSI level 2 <xref rid="bib0360" ref-type="bibr">[75]</xref>.</p>
        </sec>
        <sec id="sec0095">
          <label>2.7.4</label>
          <title>RT-qPCR</title>
          <p>Regression was performed with PLS <xref rid="bib0475" ref-type="bibr">[98]</xref> to correlate the design matrix to the responses of different transcripts. MODDE 9.0 (Umetrics, Ume&#xE5;, Sweden) was used for the experimental design and the PLS analysis. Before the PLS analysis the blend matrix was augmented with interaction terms, the data were scaled to unit variance and mean centred. The PLS models were validated with respect to explained variance and goodness of prediction (shown as <italic>Q</italic><sup>2</sup>), obtained after cross validation <xref rid="bib0470" ref-type="bibr">[97]</xref>. In addition, the PLS models were evaluated with respect to goodness of fit (<italic>R</italic><sup>2</sup>).</p>
        </sec>
      </sec>
    </sec>
    <sec id="sec0100">
      <label>3</label>
      <title>Results</title>
      <sec id="sec0105">
        <label>3.1</label>
        <title>xCELLigence cytotoxicity screening</title>
        <p>A multivariate model was used to analyse the cytotoxicity data. The PLS model, based on the xCELLigence normalized cell index (NCI), contained three significant positive nutrient&#x2013;contaminant interactions. Of the nutrient&#x2013;contaminant interactions, the interaction of the contaminant mixture (CM) and &#x3B3;T, the C-&#x3B3;T (<italic>p</italic>&#xA0;=&#xA0;0.005), displayed increased cell viability (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>A). In addition, the PLS plot contained two significant nutrient&#x2013;nutrient interactions of the lipids (EPA&#x2013;ARA) and the tocopherols (&#x3B1;T&#x2013;&#x3B3;T) with the EPA&#x2013;ARA (<italic>p</italic>&#xA0;=&#xA0;0.000078) interaction showing the strongest positive effect on the response, increasing the cell viability. The contour plot analysis of all the nutrients and the CM showed that the cell viability reduction caused by the CM was almost completely counteracted when cells were exposed to the CM in combination with all the nutrients due to a synergistic effect (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>B). The individual nutrients only moderately reduced cell viability. Only co-exposure to all nutrients provided sufficient protection against CM induced cytotoxicity.<fig id="fig0005"><label>Fig. 1</label><caption><p>A Simplified scaled and centered PLS regression coefficients with 95% confidence intervals for Normalized cell index (NCI) levels measured in primary Atlantic salmon hepatocytes exposed to eicosapentaenoic acid (EPA), arachidonic acid (ARA) and &#x3B1;-tocopherol (&#x3B1;T), &#x3B3;-tocopherol (&#x3B3;T) and contaminant mixture (CM) accordingly to the factorial design (<italic>N</italic>&#xA0;=&#xA0;5). The CM was composed of 100&#xA0;&#x3BC;M of benzo(a) pyrene and phenanthrene and 1&#xA0;&#x3BC;M of chlorpyrifos and endosulfan. The model is based on 33 experimental objects, and had one PLS component. The model containing five linear terms and eight interaction terms (<italic>R</italic><sup>2</sup>&#xA0;=&#xA0;0.85 and <italic>Q</italic><sup>2</sup>&#xA0;=&#xA0;0.55). Only linear (CM) and interaction terms representing contaminant-nutrient interactions (C-EPA, C-ARA, C-&#x3B3;T) and important nutrient-nutrient interaction (EPA-ARA, &#x3B1;T-&#x3B3;T) were included in the figure (confidence level&#xA0;=&#xA0;0.95). Significant PLS regression coefficients are indicated with a *(<italic>p&#xA0;</italic>&lt;&#xA0;0.05). The complete PLS regression model equation is described in the supplementary A1. The regression coefficients reflecting the impact of the factors on the PLS model. B 4D contour plot of xCELLigence cytotoxicity NCI levels as a function of EPA and ARA with increasing levels of CM and &#x3B3;T on the <italic>X</italic>- and <italic>Y</italic>-axis, respectively, keeping &#x3B1;T constant at 100&#xA0;&#x3BC;M. The highlighted values in the plot represent NCI levels for the different stratification beddings (isoboles).</p></caption><graphic xlink:href="gr1"/></fig></p>
      </sec>
      <sec id="sec0110">
        <label>3.2</label>
        <title>Metabolomics and lipidomics</title>
        <sec id="sec0115">
          <label>3.2.1</label>
          <title>FT-ICR mass spectrometry lipidomics</title>
          <p>A selection of the different mixtures were analysed with lipidomics and metabolomics to examine the mechanism of how nutrients affect the toxic effects of the CM. The exposure groups analysed were; cells exposed to a single nutrient (EPA, ARA and &#x3B1;T and &#x3B3;T) or CM, one nutrient in combination with the CM (C-EPA, C-ARA, C-&#x3B1;T and C-&#x3B3;T) and either a low or high concentration of the CM and all nutrients (C-All low and C-All high). Initially each of the four nutrients along with the CM was investigated with PCA and PLSDA to reveal the individual effects of the treatments. In the lipidomics PCA plots, the cells treated with the CM, ARA and EPA showed clear separation from each other and the control along PC1 (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>A and B). ARA was the nutrient that showed the greatest global effect on the lipidome. The PLSDA analysis displayed similar effects with <italic>p&#xA0;</italic>&#x2264;&#xA0;0.05 (from permutation testing) and classification error rate &#x2264;5% for these particular compounds (data not shown). Cells treated with the other nutrients (tocopherols) could not be reliably separated from the control cells (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>C (<italic>p</italic>&#xA0;=&#xA0;0.104, Table A4.4) and 2D (<italic>p</italic>&#xA0;=&#xA0;0.004, Table A4.5)). In contrast to &#x3B1;T, the &#x3B3;T was significant different from the other groups, however, due to small sample size and large number of latent variables, &#x3B3;T were therefore together with &#x3B1;T excluded from further analysis.<fig id="fig0010"><label>Fig. 2</label><caption><p>PCA scores plots from lipidomics data of salmon hepatocytes treated with different nutrients combined with a contaminant mixture (CM) versus control DMSO and the CM alone. A Effect of eicosapentaenoic acid (EPA) compared to the C-EPA, B arachidonic acid (ARA) compared to C-ARA, C &#x3B1;-tocopherol (&#x3B1;T) compared to C-&#x3B1;T, D &#x3B3;-tocopherol (&#x3B3;T) compared to C-&#x3B3;T. E The dose related effect on the lipidomic profile when a low dose (C-All low) or a high dose (C-All high) of combination of CM and all nutrients were used.</p></caption><graphic xlink:href="gr2"/></fig></p>
          <p>PCA scores plots for cells treated with either control DMSO, CM or a fatty acid plus CM showed that the addition of the fatty acids to the CM (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>A and B) shifted the lipidome back towards the normal (untreated) state. A similar but dose related effect on the lipidome was observed when all nutrients were combined together and administered alongside the CM at either a high or a low dose (<xref rid="fig0010" ref-type="fig">Fig. 2</xref>E).</p>
          <p>To assess if the fatty acids had an ameliorating effect on the CM toxicity, mass features that had been shown to be significantly changing between CM treated cells and the control DMSO treated cells were used as a proxy indicator of toxicity. The list of significantly different mass features was checked to see whether these features remained significantly different from the control class in the combined nutrient and CM treatment group. Analysis was conducted using Kruskal&#x2013;Wallis analysis of variance (level of significance set at <italic>q&#xA0;</italic>&lt;&#xA0;0.1) followed by Games Howell post hoc testing (level of significance defined as <italic>p&#xA0;</italic>&lt;&#xA0;0.05). In total, 88 mass features were deemed significant across the different treatment groups (Tables A2.1 and A2.2 in Supplementary), however, only 13 metabolites were annotated with individual putative identities and are presented in <xref rid="tbl0015" ref-type="table">Table 3</xref>. The C-EPA group had the largest number of 41 affected metabolites, <italic>e</italic>.<italic>g</italic>., four different adducts of dihydroxy norvitamin D3 (hydroxypropyl) with a mean fold change of between 6.84 and 11.34 in addition to xeniasterol, phosphatidylinositol (PI 42:5) and cholesterol sulphate with mean fold changes of 2.26, 1.96, and &#x2212;1.52, respectively. The CM was the second most affected group with 31 individual metabolites that changed significantly compared to the control. Four features, all putatively annotated as different adduct forms of dihydroxy norvitamin D3, had a mean fold change of between 10.11 and 15.39 and the phosphatidylglycerol (P-33:2) and phosphatidylserine (P-32:1) levels were both significantly reduced in the CM. In the ARA exposed group, 27 metabolites were affected overall, and of the individual putatively annotated metabolites, three metabolites were elevated compared to the control; two phosphatidylglycerols (PG 22:4) with fold changes of 13.44 and 13.42, and phosphatidylethanolamine (PE 42:10) with a fold change of 2.60. Eighteen metabolites were affected in C-ARA group, <italic>e</italic>.<italic>g</italic>., phosphatidylethanolamine (PE 42:10) and phosphatidylethanolamine (PE 42:9) were both elevated compared to the control with a fold change of 2.43 and 1.52, respectively. In the EPA group, 6 metabolites changed significantly compared to the control, however no putative identifications could be ascribed to these. Both EPA and ARA effected the CM lipidomic response in cells, however cells exposed to all nutrients showed globally a stronger protective effect against the lipidomic disturbances caused by the CM.<table-wrap id="tbl0015" position="float"><label>Table 3</label><caption><p>Table of putatively annotated mass features significantly different between hepatocytes treated with control DMSO and those treated with either a contaminant mixture (CM), eicosapentaenoic acid (EPA), arachidonic acid (ARA), or CM and ARA (C-ARA) or CM and EPA (C-EPA). Fold changes in bold indicate results that were significantly different with respect to the control. Mass features are represented more than once if they were significantly different with respect to the control for more than one class. Analysis was conducted using Kruskal Wallis analysis of variance (level of significance set at <italic>q</italic>&#xA0;&lt;&#xA0;0.1) followed by Games Howell post hoc testing (level of significance defined as <italic>p</italic>&#xA0;&lt;&#xA0;0.05).</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="9" align="left">Mean fold change (compared to the control)<hr/></th></tr><tr><th align="left"><italic>m</italic>/<italic>z</italic></th><th align="left">EPA</th><th align="left">C-EPA</th><th align="left">CM</th><th align="left">ARA</th><th align="left">C-ARA</th><th align="left">Empirical formula</th><th align="left">Putative Annotation</th><th align="left">Adducts</th></tr></thead><tbody><tr><td align="char"><bold>461.3636</bold></td><td align="left">1.39</td><td align="left"><bold>6.91</bold></td><td align="char"><bold>10.11</bold></td><td align="left">1.26</td><td align="left">8.95</td><td align="left">C29H50O4</td><td align="left">(Hydroxypropyl) Dihydroxy norvitamin D3</td><td align="left">[M&#xA0;&#x2212;&#xA0;H]-</td></tr><tr><td align="char"><bold>462.3671</bold></td><td align="left">1.38</td><td align="left"><bold>6.84</bold></td><td align="char"><bold>10.12</bold></td><td align="left">1.29</td><td align="left">8.86</td><td align="left">C29H50O4</td><td align="left">(Hydroxypropyl) Dihydroxy norvitamin D3</td><td align="left">[M&#xA0;&#x2212;&#xA0;H]- C13</td></tr><tr><td align="char"><bold>521.3846</bold></td><td align="left">1.51</td><td align="left"><bold>11.24</bold></td><td align="char"><bold>15.26</bold></td><td align="left">1.08</td><td align="left">12.35</td><td align="left">C29H50O4</td><td align="left">(Hydroxypropyl) Dihydroxy norvitamin D3</td><td align="left">[M&#xA0;+&#xA0;Hac-H]-</td></tr><tr><td align="char"><bold>522.3882</bold></td><td align="left">1.51</td><td align="left"><bold>11.34</bold></td><td align="char"><bold>15.39</bold></td><td align="left">1.04</td><td align="left">12.40</td><td align="left">C29H50O4</td><td align="left">(Hydroxypropyl) dihydroxy norvitamin D3</td><td align="left">[M&#xA0;+&#xA0;Hac-H]- C13</td></tr><tr><td align="char"><bold>559.3044</bold></td><td align="left"><bold>&#x2013;</bold></td><td align="left"><bold>&#x2013;</bold></td><td align="char">-1.89</td><td align="left"><bold>13.42</bold></td><td align="left">7.40</td><td align="left">C28H49O9P</td><td align="left">PG(22:4)</td><td align="left">[M&#xA0;&#x2212;&#xA0;H]-</td></tr><tr><td align="char"><bold>560.3077</bold></td><td align="left"><bold>&#x2013;</bold></td><td align="left"><bold>&#x2013;</bold></td><td align="char">-1.61</td><td align="left"><bold>13.44</bold></td><td align="left">7.68</td><td align="left">C28H49O9P</td><td align="left">PG(22:4)</td><td align="left">[M&#xA0;&#x2212;&#xA0;H]-</td></tr><tr><td align="char"><bold>810.5082</bold></td><td align="left"><bold>&#x2013;</bold></td><td align="left"><bold>&#x2013;</bold></td><td align="char">1.01</td><td align="left"><bold>2.60</bold></td><td align="left"><bold>2.43</bold></td><td align="left">C47H74NO8P</td><td align="left">PE(42:10)</td><td align="left">[M&#xA0;&#x2212;&#xA0;H]-</td></tr><tr><td align="char"><bold>812.5241</bold></td><td align="left">&#x2013;</td><td align="left">&#x2013;</td><td align="char">1.02</td><td align="left">1.66</td><td align="left"><bold>1.52</bold></td><td align="left">C47H76NO8P</td><td align="left">PE(42:9)</td><td align="left">[M&#xA0;&#x2212;&#xA0;H]-</td></tr><tr><td align="char"><bold>501.28166</bold></td><td align="left">&#x2212;1.53</td><td align="left"><bold>&#x2212;1.52</bold></td><td align="char">1.2</td><td align="left">&#x2013;</td><td align="left"><bold>&#x2013;</bold></td><td align="left">C27H46O4S</td><td align="left">Cholesterol sulphate</td><td align="left">[M&#xA0;+&#xA0;Cl]-</td></tr><tr><td align="char"><bold>551.39556</bold></td><td align="left">1.32</td><td align="left"><bold>2.26</bold></td><td align="char">2.36</td><td align="left">&#x2013;</td><td align="left"><bold>&#x2013;</bold></td><td align="left">C30H52O5</td><td align="left">Xeniasterol B</td><td align="left">[M&#xA0;+&#xA0;Hac-H]-</td></tr><tr><td align="char"><bold>775.51214</bold></td><td align="left">&#x2212;1.04</td><td align="left">&#x2212;1.18</td><td align="char"><bold>&#x2212;1.27</bold></td><td align="left">&#x2013;</td><td align="left"><bold>&#x2013;</bold></td><td align="left">C39H73O9P</td><td align="left">PG(P-33:2)</td><td align="left">[M&#xA0;+&#xA0;Hac-H]-</td></tr><tr><td align="char"><bold>776.50978</bold></td><td align="left">&#x2212;1.05</td><td align="left">&#x2212;1.18</td><td align="char"><bold>&#x2212;1.26</bold></td><td align="left">&#x2013;</td><td align="left"><bold>&#x2013;</bold></td><td align="left">C38H72NO9P</td><td align="left">PS(P-32:1)</td><td align="left">[M&#xA0;+&#xA0;Hac-H]-</td></tr><tr><td align="char"><bold>939.59786</bold></td><td align="left">2.25</td><td align="left"><bold>1.96</bold></td><td align="char">1.20</td><td align="left">&#x2013;</td><td align="left"><bold>&#x2013;</bold></td><td align="left">C51H89O13P</td><td align="left">PI(42:5)</td><td align="left">[M&#xA0;&#x2212;&#xA0;H]-</td></tr></tbody></table></table-wrap></p>
        </sec>
        <sec id="sec0120">
          <label>3.2.2</label>
          <title>NMR spectroscopy metabolomics</title>
          <p>The PCA and PLSDA analyses of the water-soluble metabolites showed a larger effect globally than at the individual metabolite level. The variations in the entire metabolic fingerprints from NMR represented by PCA and PLS scores plots showed shifts in some of the groups compared to the control. The CM group was separated from the control along PC2 (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>A), thus indicating metabolic shifts due to the exposure. The addition of the two fatty acids in combination with the CM treatment (C-EPA and C-ARA) shifted the metabolic status observed by NMR towards the control samples compared to the CM group alone (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>B and C). As can be observed, the direction of change in the scores plots was the same for the C-EPA and C-ARA, indicating similar shifts in the NMR observable metabolome, but with different magnitudes. The alleviating effect was more expressed for ARA where the C-ARA group was better separated from the CM group (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>C). For the EPA and C-EPA groups, both clustered between the control and the CM group (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>B). No apparent clustering was observed to support any alleviating effect from the C-&#x3B1;T and C-&#x3B3;T groups (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>D and E). The control and both C-All groups were separated from the CM group along PC2, but there was no observable differences between C-All high and C-All low groups (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>F). The low and high levels of the CM in combination with all nutrients reduced the toxicity more than individual fatty acids exposed in combination with CM, by shifting the metabolic response to almost overlapping the metabolic response observed in the control treatment. At the individual metabolite level, statistical analysis with a Kruskal&#x2013;Wallis test followed by the Games Howell post hoc test resulted in no significant metabolites (data not presented) which may be reflective of the small sample size combined with the lower statistical power inherent in all non-parametric tests. Cells exposed to all nutrients in combination with the CM showed a stronger ameliorating effect than individual fatty acids exposed in combination with CM.<fig id="fig0015"><label>Fig. 3</label><caption><p>Multivariate analyses of NMR metabolic fingerprints for Atlantic salmon hepatocyte responses to exposure shown by A PCA analysis of the response of the contaminant mixture (CM) exposure versus control (DMSO). B The effects of eicosapentaenoic acid (EPA) and C-EPA, C arachidonic acid (ARA) and C-ARA, D &#x3B1;-tocopherol (&#x3B1;T) and C-&#x3B1;T, E &#x3B3;-tocopherol (&#x3B3;T) and C-&#x3B3;T, and F C-All low and C-All high (low or high concentration of the CM and all nutrients) compared to the effect of CM.</p></caption><graphic xlink:href="gr3"/></fig></p>
        </sec>
      </sec>
      <sec id="sec0125">
        <label>3.3</label>
        <title>RT-qPCR</title>
        <p>PLS interaction evaluation was performed on candidate biomarkers that belong to well-known toxicological pathways; cytochrome P450 1A (CYP1A, <xref rid="fig0020" ref-type="fig">Fig. 4</xref>A), CYP3A (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>B), vitellogenin (VTG, <xref rid="fig0020" ref-type="fig">Fig. 4</xref>G), and four lipid metabolism candidate markers; fatty acid-binding protein 4 (FABP4, <xref rid="fig0020" ref-type="fig">Fig. 4</xref>F); peroxisome proliferator-activated receptors (PPARa, <xref rid="fig0020" ref-type="fig">Fig. 4</xref>C), carnitine palmitoyltransferase 2 (CPT2, <xref rid="fig0020" ref-type="fig">Fig. 4</xref>D) and peroxisomal acyl-coenzyme A oxidase 1 (ACOX1, <xref rid="fig0020" ref-type="fig">Fig. 4</xref>E). PLS models were based on the mean normalized expression levels (MNE) obtained from cells exposed to nutrients and contaminant mixture using a factorial design in order to determine possible contaminant- nutrient interactions.<fig id="fig0020"><label>Fig. 4</label><caption><p>Simplified scaled and centered PLS regression coefficient models for different transcripts measured in primary Atlantic salmon hepatocytes exposed to eicosapentaenoic acid (EPA), arachidonic acid (ARA), &#x3B1;-tocopherol (&#x3B1;T), &#x3B3;-tocopherol (&#x3B3;T) and contaminant mixture (CM) using mean normalized expression (MNE) and a factorial design (<italic>N</italic>&#xA0;=&#xA0;5). CM contained 100&#xA0;&#x3BC;M of benzo(a) pyrene and phenanthrene and 1&#xA0;&#x3BC;M of chlorpyrifos and endosulfan. The combined effects identified with contour plot analysis like additivity, synergism or antagonism are presented in the different PLS regression coefficient models (confidence level&#xA0;=&#xA0;0.95). Significant PLS regression coefficients are indicated with a *(<italic>p&#xA0;</italic>&lt;&#xA0;0.05). A Cytochrome P450 1A (CYP1A), <italic>R</italic><sup>2</sup>&#xA0;=&#xA0;0.90, <italic>Q</italic><sup>2</sup>&#xA0;=&#xA0;0.76. B Cytochrome P450 3A (CYP3A), <italic>R</italic><sup>2</sup>&#xA0;=&#xA0;0.84, <italic>Q</italic><sup>2</sup>&#xA0;=&#xA0;0.62. C Peroxisome proliferator-activated receptors (PPAR&#x3B1;), <italic>R</italic><sup>2</sup>&#xA0;=&#xA0;0.76, <italic>Q</italic><sup>2</sup>&#xA0;=&#xA0;0.53. D Carnitine palmitoyltransferase 2 (CPT2), <italic>R</italic><sup>2</sup>&#xA0;=&#xA0;0.78, <italic>Q</italic><sup>2</sup>&#xA0;=&#xA0;0.52. E Peroxisomal acyl-coenzyme A oxidase 1 (ACOX1), <italic>R</italic><sup>2</sup>&#xA0;=&#xA0;0.79, <italic>Q</italic><sup>2</sup>&#xA0;=&#xA0;0.55. F Fatty acid-binding protein 4 (FABP4), <italic>R</italic><sup>2</sup>&#xA0;=&#xA0;0.74, <italic>Q</italic><sup>2</sup>&#xA0;=&#xA0;0.47. G Vitellogenin (VTG), <italic>R</italic><sup>2</sup>&#xA0;=&#xA0;0.77, <italic>Q</italic><sup>2</sup>&#xA0;=&#xA0;0.58. The complete PLS regression model equations are described in the supplementary A1. Only important liner and interaction terms representing contaminant-nutrient and nutrient&#x2013;nutrient interactions were presented in the figures. The regression coefficients reflecting the impact of the factors on the PLS model.</p></caption><graphic xlink:href="gr4"/></fig></p>
        <p>In all PLS models, except for ACOX1, the CM had the strongest effect on the transcriptional levels compared to the other treatments. The PLS analysis of the transcripts CYP1A and PPAR&#x3B1; showed that ARA was the only nutrient that had a significant contribution to the transcription levels; having an additive combined effect together with the CM. For CYP1A (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>A), the additive response (<italic>p</italic>&#xA0;=&#xA0;0.044) caused increased transcription while the PPAR&#x3B1; additivity (<italic>p</italic>&#xA0;=&#xA0;0.002) gave a reduced transcription (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>C). The other nutrients, EPA, &#x3B1;T and &#x3B3;T did not have any significant contribution on CYP1A and PPARa transcription.</p>
        <p>A synergistic interaction effect between ARA and the CM was predicted by the PLS models for CYP3A (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>B, <italic>p</italic>&#xA0;=&#xA0;0.013) and CPT2 (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>D, <italic>p</italic>&#xA0;=&#xA0;0.001), resulting in increased transcription. The PLS model for ACOX1 (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>E) showed a similar synergistic interaction effect between yT and the CM (<italic>p</italic>&#xA0;=&#xA0;0.0008). For FABP4 (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>F), the negative interaction term for C-&#x3B1;T predicted an antagonistic effect between &#x3B1;T and the CM (<italic>p</italic>&#xA0;=&#xA0;0.044), reducing the transcription levels. Lastly, the VTG PLS model (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>G) revealed an antagonistic effect between EPA and the CM (<italic>p</italic>&#xA0;=&#xA0;0.014). Based on the effects on toxicological important markers, EPA and &#x3B1;-tocopherol seemed more beneficial than ARA and &#x3B3;-T in preventing the adverse effects induced by the CM.</p>
      </sec>
    </sec>
    <sec id="sec0130">
      <label>4</label>
      <title>Discussion</title>
      <p>Today&#x2019;s Atlantic salmon feed with high inclusion levels of plant ingredients contain a reduced amount of EPA, &#x3B1;T and contaminants such as persistent organic pollutants (PCBs, dioxins etc.) and heavy metals (Cd, Hg). At the same time, higher levels of plant-derived contaminants are found in plant based feeds like PAH and pesticides, and nutrients such as &#x3B3;T and ARA derived from linoleic acid (LA). The levels of feed nutrients and contaminants will vary with which type of feed ingredients used and actual feed composition of the feed ingredients <xref rid="bib0025" ref-type="bibr">[5]</xref>, <xref rid="bib0125" ref-type="bibr">[25]</xref>, <xref rid="bib0135" ref-type="bibr">[28]</xref>, <xref rid="bib0165" ref-type="bibr">[34]</xref>, <xref rid="bib0295" ref-type="bibr">[62]</xref>, <xref rid="bib0370" ref-type="bibr">[77]</xref>, <xref rid="bib0405" ref-type="bibr">[84]</xref>, <xref rid="bib0410" ref-type="bibr">[85]</xref>. To assure that the feed contain sufficient levels of tocopherol, synthetic &#x3B1;T is supplemented as a-tocopheryl acetate to Atlantic salmon feeds <xref rid="bib0135" ref-type="bibr">[28]</xref>. These tocopherols and fatty acids EPA and ARA have different kinetics and biological roles in cultured salmon <xref rid="bib0010" ref-type="bibr">[2]</xref>, <xref rid="bib0135" ref-type="bibr">[28]</xref>, <xref rid="bib0285" ref-type="bibr">[60]</xref>, with the possibility to affect the toxicity of contaminants differently. This study show that the nutrients EPA, ARA and &#x3B1;T, &#x3B3;T affect, individually and together, the toxicity of a CM composed of two PAHs and two pesticides. The addition of nutrients to the contaminant mix (CM) significantly increased the viability of Atlantic salmon hepatocyte cells compared to exposure to CM alone. PAHs and particularly lighter PAHs, like phenanthrene, are able to reduce cell viability <xref rid="bib0310" ref-type="bibr">[65]</xref>, <xref rid="bib0380" ref-type="bibr">[79]</xref> in teleost <italic>in vitro</italic> systems, used at the same concentration range as in this study <xref rid="bib0380" ref-type="bibr">[79]</xref>. Of the pesticides, only endosulfan has previously been shown to negatively affect cell viability of Atlantic salmon hepatocytes, however the reduction was observed at higher exposure concentration <xref rid="bib0380" ref-type="bibr">[79]</xref> than used in the present study. Therefore, it is most likely that it is the PAHs that are driving the negative effect observed in cell viability. The cytotoxicity of PAHs has been suggested to be caused by their ability to embed in and disrupt cellular membranes <xref rid="bib0310" ref-type="bibr">[65]</xref> by increasing their fluidity <xref rid="bib0225" ref-type="bibr">[46]</xref>. The cytotoxicity data obtained from the current contaminant-nutrient interaction evaluation suggest that the negative effects of the CM might be counteracted by the nutrients. Of the individual nutrients, &#x3B3;T had the strongest positive effect on the cell viability. Evaluation of the C-&#x3B3;T interaction term showed that &#x3B3;T seems to ameliorate the toxicity of the CM. &#x3B1;T is known to be the most important antioxidant that resides within cell membranes, protecting the lipids from peroxidation <xref rid="bib0005" ref-type="bibr">[1]</xref>, and maintaining the integrity of membranes by preventing the initiation of cell lysis <xref rid="bib0135" ref-type="bibr">[28]</xref>. Mammalian endothelial cells enriched with the n-6 PUFA LA showed a weakened endothelial barrier for PCB owing to a discrepancy in cellular status of antioxidant/oxidative stress <xref rid="bib0490" ref-type="bibr">[101]</xref>. In addition, PCB caused an increased uptake of LA. However, the dysfunction of the endothelial barrier caused by the PCB was completely restored by &#x3B1;T owing to reduced oxidative stress and production of inflammatory cytokines <xref rid="bib0490" ref-type="bibr">[101]</xref>. In a study where rats were exposed to iron-dextran in combination with &#x3B1;T or &#x3B3;T, it was shown that &#x3B3;T similar to &#x3B1;T is able to inhibit lipid oxidation <xref rid="bib0140" ref-type="bibr">[29]</xref>. This suggests that &#x3B3;Ts, by preventing lipid oxidation, are able to ameliorate the effect on the cell viability caused by the CM.</p>
      <p>To generate hypotheses about the potential modes of action of the studied CM, nutrients and nutrient&#x2013;contaminant combinations, lipidomic and metabolomic profiling were employed. ARA was the nutrient that showed the greatest global effect on the lipidome, having a stronger effect than the CM and EPA. Both forms of vitamin E had the least effect on the lipidomic and metabolomic responses, even though previous research suggest vitamin E has low effect on hepatocytes cell viability <xref rid="bib0245" ref-type="bibr">[50]</xref>. In total, 13 putative annotated metabolites were significantly affected. The C-EPA combination induced the most significant perturbed mass feature changes followed by the CM, ARA and C-ARA. EPA did not induce any significant mass feature changes. Both C-EPA and the CM significantly altered four mass features, identified as the vitamin D analogue 19 nor-2&#x3B1;-(3-hydroxypropyl)-1&#x3B1;,25(OH) 2D3 (dihydroxy norvitamin D3). The lipidomic data showed that 19 nor-2&#x3B1;-(3-hydroxypropyl)-1&#x3B1;,25(OH) 2D3 was significant increased 10.11&#x2013;15.39 fold in the CM group and 6.84&#x2013;11.34 fold in the C-EPA group compared to the control. 19 nor-2&#x3B1;-(3-hydroxypropyl)-1&#x3B1;,25(OH) 2D3 is an analog of the active vitamin D form 1&#x3B1;,25(OH) 2D3 <xref rid="bib0045" ref-type="bibr">[9]</xref>. This confirms previous results where benzo(a) pyrene and a similar contaminant mixture of PAH and pesticides induced an effect on the steroid synthesis pathway and vitamin D3 metabolism in primary Atlantic salmon hepatocytes <xref rid="bib0380" ref-type="bibr">[79]</xref>. The 19 nor-2&#x3B1;-(3-hydroxypropyl)-1&#x3B1;,25(OH) 2D3 has been shown to be effective in inhibiting cell proliferation in HepG2 cells <xref rid="bib0045" ref-type="bibr">[9]</xref> and in preventing cell growth in MCF-7 cells, and BxPC-3 tumor development in mouse <xref rid="bib0040" ref-type="bibr">[8]</xref>. The increased synthesis of the 19 nor-2&#x3B1;-(3-hydroxypropyl)-1&#x3B1;,25(OH) 2D3 in exposed Atlantic salmon hepatocytes might therefore prevent potential genotoxic effects induced by PAHs, like benzo(a) pyren <xref rid="bib0080" ref-type="bibr">[16]</xref>, <xref rid="bib0415" ref-type="bibr">[86]</xref>, <xref rid="bib0170" ref-type="bibr">[35]</xref>.</p>
      <p>Perturbed lipid and cholesterol homeostasis by contaminants has been demonstrated in numerous mammalian <xref rid="bib0095" ref-type="bibr">[19]</xref> and teleostean <xref rid="bib0095" ref-type="bibr">[19]</xref>, <xref rid="bib0380" ref-type="bibr">[79]</xref> studies. Contaminants affecting the lipid composition of membranes can significantly influence membrane transport, bioenergetics and cell signalling, as well as membrane function and integrity <xref rid="bib0095" ref-type="bibr">[19]</xref>. ARA and C-ARA treatments gave the strongest effect on cell membrane lipids in exposed cells; phosphatidylglycerol (PG 22:4) was 13-fold upregulated in ARA exposed cell and phosphatidylethanolamine, (PE 42:10) was 2.6- and 2.43-fold upregulated in the ARA and C-ARA exposed cells, respectively. The lipid phosphatidylglycerol is synthesized in the mitochondria and is used for production of cardiolipin, a mitochondrial inner membrane lipid stabilizing the electron transfer complex <xref rid="bib0250" ref-type="bibr">[51]</xref>, <xref rid="bib0425" ref-type="bibr">[88]</xref>, <xref rid="bib0420" ref-type="bibr">[87]</xref>. Phosphatidylethanolamine, phosphatidylserine and phosphatidylinositol, key structural lipids in eukaryotic membranes <xref rid="bib0425" ref-type="bibr">[88]</xref> and particularly enriched in the inner cytoplasmic leaflet <xref rid="bib0185" ref-type="bibr">[38]</xref>, were all found to be affected in this study. The physical properties of the membrane depends on the n-3 and n-6 PUFA acyl chains which affect the lateral organization, curvature etc. <xref rid="bib0330" ref-type="bibr">[69]</xref>. Bilayers becomes more deformable and disordered with ARA than those containing more double bonds like DHA. In PAH and PCB contaminated mussels, an increase in the non-polar/polar lipid ratio in the mussels has been observed, suggesting that the contaminants affected the lipid homoestasis by reducing the conversion of storage lipid to membrane lipids <xref rid="bib0095" ref-type="bibr">[19]</xref>. A similar reasoning can be used to explain the downregulation of the membrane lipids phosphatidylglycerol and phosphatidylserine by the CM treatment in the present study. Both excessive and deficient amount of fatty acids can induce mitochondrial and ER-stress responses, production of free radicals and steatosis in hepatocytes <xref rid="bib0055" ref-type="bibr">[11]</xref>, <xref rid="bib0120" ref-type="bibr">[24]</xref>, <xref rid="bib0480" ref-type="bibr">[99]</xref>. Only hepatocytes treated with C-EPA showed an effect on the cholesterol analogue cholesterol sulphate that was &#x2212;1.52-fold down regulated. The homeostasis of cholesterol is tightly regulated in animals, <italic>i</italic>.<italic>e</italic>., the amount absorbed via the diet, produced via de novo cholesterol synthesis, and excreted as bile salts or biliary cholesterol <xref rid="bib0050" ref-type="bibr">[10]</xref>, <xref rid="bib0180" ref-type="bibr">[37]</xref>, <xref rid="bib0235" ref-type="bibr">[48]</xref>. In mammals, cholesterol sulphate is an important component of cell membranes where it function as a stabilizing agent in a similar way as cholesterol <xref rid="bib0350" ref-type="bibr">[73]</xref>. This suggests that the C-EPA treatment reduced the stability of the cell membrane, though this effect was minor.</p>
      <p>To further identify nutrient&#x2013;contaminant interactions, genes encoding selected targeted biotransformation enzymes, lipid metabolism and endocrine effect markers were analysed with qPCR and PLS. Similar to the lipidomics data, ARA gave the strongest effect on gene transcription. Cells exposed to the CM in combination with ARA showed an additive and synergistic induction of the CYP1A and CYP3A transcripts, respectively. The other nutrients, EPA, &#x3B1;T and &#x3B3;T did not significantly alter the CM-induced response. Several CYP transcripts like CYP1A and CYP3A are not only involved in biotransformation of contaminants like benzo(a) pyrene and chlorpyrifos <xref rid="bib0380" ref-type="bibr">[79]</xref> but also play a critical role in degradation and synthesis of endogenous compounds like lipids <xref rid="bib0030" ref-type="bibr">[6]</xref>. Several CYP enzymes like CYP1A and CYP3A have previously been found to be involved in the CYP-dependent metabolising of ARA or LA into eicosanoids in mammals both <italic>in vivo</italic> and <italic>in vitro</italic>
<xref rid="bib0030" ref-type="bibr">[6]</xref>, <xref rid="bib0065" ref-type="bibr">[13]</xref>, <xref rid="bib0200" ref-type="bibr">[41]</xref> CYP1A, which has been seen as the primarily biotransformation enzyme and activator of toxic and carcinogenic contaminants <xref rid="bib0270" ref-type="bibr">[56]</xref>, is important in the bioactivation of benzo(a) pyrene, into the ultimate carcinogen, the diol epoxide <xref rid="bib0195" ref-type="bibr">[40]</xref>. In mammals, CYP1A and CYP3A have been shown to bioactivate chlorpyrifos to a chlorpyrifos&#x2013;oxon, which is a potent anticholinesterase <xref rid="bib0385" ref-type="bibr">[80]</xref>, and CYP3A to convert &#x3B2;-endosulfan to endoulfan sulphate which is as toxic as the mother compound <xref rid="bib0215" ref-type="bibr">[44]</xref>. CYP1A biotransformation of poorly metabolised inducers can cause production of ROS, lipid peroxidation and ultimately can change the membrane function <xref rid="bib0095" ref-type="bibr">[19]</xref>. Thus, the additive and synergistic increased expression of CYP1A and CYP3A by ARA can increase the toxicity of the CM when exposed in combination.</p>
      <p>Peroxisome proliferator-activated receptor &#x3B1; (PPAR&#x3B1;) regulates the expression of several target genes linked to mitochondrial and peroxisomal &#x3B2;-oxidation of lipids <xref rid="bib0290" ref-type="bibr">[61]</xref>. ARA exposure gave an additive effect on the CM induced downregulation of PPAR&#x3B1;. Though, despite the downregulation of PPAR&#x3B1;, the C-ARA caused a weak synergistic increase of carnitine palmitoyltransferase 2 (CPT2). The CPT2 transcript is an inner mitochondrial enzyme that takes part in the oxidising of long-chain fatty acids <xref rid="bib0105" ref-type="bibr">[21]</xref>, and is used as a marker for mitochondrial &#x3B2;-oxidation. &#x3B3;T contributed synergisticly to the CM induced increase of the transcription of peroxisomal &#x3B2;-oxidation enzyme peroxisomal acyl-coenzyme A oxidase 1 (ACOX1). ACOX1 is the first enzyme in peroxisomal &#x3B2;-oxidation and is in charge of the desaturation of acyl-CoAs to 2-<italic>trans</italic>-enoyl-CoAs <xref rid="bib0105" ref-type="bibr">[21]</xref>. This finding is in contrast to a study with rats where the mitochondria were found to have the main role in &#x3B2;-oxidation of &#x3B1;T <xref rid="bib0260" ref-type="bibr">[54]</xref>. The synergistic effect of the plant nutrients ARA and &#x3B3;T on the CM effect on mitochondrial and peroxisomal &#x3B2;-oxidation might cause the Atlantic salmon to lose weight. Pesticides like endosulfan have previously been shown to cause lipid metabolism disturbances such as steatosis in Atlantic salmon, both in exposed hepatocytes <xref rid="bib0210" ref-type="bibr">[43]</xref> and in <italic>in vivo</italic> studies <xref rid="bib0115" ref-type="bibr">[23]</xref>. However, an unbalanced diet can produce a similar effect in Atlantic salmon fed diets with high inclusion levels of plant ingredients in addition to low levels of EPA and DHA <xref rid="bib0220" ref-type="bibr">[45]</xref>. The fatty acid binding proteins (FABPs) are a family of proteins involved in lipid flux in cells <xref rid="bib0340" ref-type="bibr">[71]</xref>. In human hepatocytes and trophoblasts, increased lipid accumulation has been linked to elevated transcription of FABP4 <xref rid="bib0085" ref-type="bibr">[17]</xref>, <xref rid="bib0320" ref-type="bibr">[67]</xref>, <xref rid="bib0465" ref-type="bibr">[96]</xref>. An orthologue to mammalian FABP4 that may represent the adipose tissue type FABP (h6FABP or FABP11) in fish <xref rid="bib0400" ref-type="bibr">[83]</xref>, was induced by both chlorpyrifos <xref rid="bib0275" ref-type="bibr">[58]</xref>, <xref rid="bib0380" ref-type="bibr">[79]</xref> and endosulfan <xref rid="bib0380" ref-type="bibr">[79]</xref> in previous Atlantic salmon hepatocytes studies. In the present study, FABP4 was significantly upregulated in cells exposed to the CM. In cells co-treated with &#x3B1;T, however, the FABP4 transcript level was downregulated, possibly due to an antagonistic interaction between the CM and the antioxidant. A similar downregulation has been observed in Atlantic salmon hepatocytes co-treated with chlorpyrifos and &#x3B1;T <xref rid="bib0275" ref-type="bibr">[58]</xref>. The present finding thus confirms that &#x3B1;T can reduce FABP4 transcription and possible protect against chemical-induced steatosis in Atlantic salmon.</p>
      <p>Further, an antagonistic effect was also detected for the VTG transcript where EPA in combination with the CM induced a weak antagonistic effect on the VTG expression level. The egg yolk precursor protein VTG is generally produced in the female liver cells by estrogenic stimulation, originating from the developing ovarian follicles <xref rid="bib0090" ref-type="bibr">[18]</xref>, <xref rid="bib0145" ref-type="bibr">[30]</xref>. All four contaminants in the CM have the ability to interfere with the estrogen receptor (ER) pathway in fish <xref rid="bib0210" ref-type="bibr">[43]</xref>, <xref rid="bib0130" ref-type="bibr">[27]</xref>, <xref rid="bib0380" ref-type="bibr">[79]</xref>. In accordance with S&#xF8;fteland et al. <xref rid="bib0380" ref-type="bibr">[79]</xref>, exposure to the CM significantly increased VTG transcription, however, in combination with EPA, VTG upregulation was substantially reduced due to an antagonistic interaction. These results suggest that EPA can ameliorate the negative effect induced by the CM on the endocrine system. The mechanism behind EPA&#x2019;s ameliorating effect is however not known.</p>
      <p>The PCA analysis of both the lipidomics and metabolomics data showed that all nutrients, in combination with the CM, gave a shifted response closer to the control compared to the CM alone, and the lipidomics data indicated that the fatty acids had the strongest ameliorating effect. The cytotoxicity analysis showed a similar effect. From all the individual CM-nutrient combinations, only &#x3B3;T showed ameliorating effect on the CM treatment. However, the cell viability reduction caused by the contaminants was only completely restored when the hepatocytes were co-exposed with all the nutrients. It is not surprising that the lipids EPA and ARA can affect the PAHs impact on cell viability because both lipids are dietary essentials for marine fish due to their limited ability to elongate and/or desaturate 18-carbon PUFA <xref rid="bib0300" ref-type="bibr">[63]</xref>. In teleosts, the composition of the neutral lipids (<italic>e.g</italic>., storage lipids (TAG) and cholesterol) reflects the diet, and the polar lipids (<italic>e.g</italic>., membrane phospholipids) the requirements of the membranes <xref rid="bib0300" ref-type="bibr">[63]</xref>. Fish membrane phospholipids hold a large surplus of EPA relative to ARA <xref rid="bib0010" ref-type="bibr">[2]</xref>. Whereas ARA has a more even distribution between the neutral and polar lipids, as seen in haddock larvae <xref rid="bib0285" ref-type="bibr">[60]</xref>. Lipophilic, non-polar contaminants like PCBs are more closely linked with neutral lipids, than the polar membrane phospholipids <xref rid="bib0095" ref-type="bibr">[19]</xref>. Non-polar contaminants with non-specific mode of action, like narcotics compounds and PAHs, are able to embed into membranes and disturb their function. Sequestration of the contaminants into neutral storage lipids will therefore protect the cells by preventing the contaminants to interact with the target, the polar membrane lipids <xref rid="bib0095" ref-type="bibr">[19]</xref>. Further, co-exposure of EPA and ARA might have reduced the uptake of contaminants into the primary hepatocytes. In a previous study it was found that the bioavailability of PCB in the intestine of Channel catfish (<italic>Ictalurus punctatus</italic>) was reduced when micelle carriers composed of different lipids like myristic, palmitic, stearic acids and LA were used while the bioavailability was increased when micelles were comprised of only LA <xref rid="bib0075" ref-type="bibr">[15]</xref>. This suggests that lipids and tocopherols in combination can have ameliorating effects on the contaminants ability to disrupt the integrity of cell membranes; the tocopherols are likely to prevent lipid peroxidation and the lipids prevent sequestration of the contaminants into polar lipids and possibly by reducing the bioavailability of contaminants.</p>
    </sec>
    <sec id="sec0135">
      <label>5</label>
      <title>Conclusion</title>
      <p>The cytotoxicity results suggest that the negative effects of contaminants that can be found in plant-based salmon feed might be counteracted by nutrients. Of the nutrients, the fatty acids ARA and EPA showed the strongest perturbation effect on the lipidome, in contrast to the tocopherols that showed no effect. Responses most affected were cell membrane stability and vitamin D metabolism. The transcriptomic analysis identified nutrient-contaminant interaction effects on biotransformation, lipid metabolism and endocrine effects. Co-exposed with the contaminants, the n-3 PUFA EPA and &#x3B1;T showed ameliorating effects by antagonising the contaminants negative effect while the n-6 PUFA ARA and &#x3B3;T the toxicity of the contaminants due to an additive and synergistic interaction. Individually, at the selected concentrations the nutrients EPA and &#x3B1;T seem more beneficial than ARA and &#x3B3;T, nevertheless, a combination of all nutrients gave the strongest ameliorating effect on the toxicity of the contaminant mixture composed of PAH and pesticides.</p>
    </sec>
    <sec id="sec0140">
      <title>Transparency document</title>
      <p>
        <supplementary-material content-type="local-data" id="upi0005">
          <caption>
            <title>Transparency Document</title>
          </caption>
          <media xlink:href="mmc2.zip"/>
        </supplementary-material>
      </p>
    </sec>
  </body>
  <back>
    <ref-list id="bibl0005">
      <title>References</title>
      <ref id="bib0005">
        <label>1</label>
        <element-citation publication-type="journal" id="sbref0005">
          <person-group person-group-type="author">
            <name>
              <surname>Atkinson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Harroun</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Wassall</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Stillwell</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Katsaras</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>The location and behavior of alpha-tocopherol in membranes</article-title>
          <source>Mol. Nutr. Food Res.</source>
          <volume>54</volume>
          <issue>5</issue>
          <year>2010</year>
          <fpage>641</fpage>
          <lpage>651</lpage>
          <pub-id pub-id-type="pmid">20166146</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0010">
        <label>2</label>
        <element-citation publication-type="journal" id="sbref0010">
          <person-group person-group-type="author">
            <name>
              <surname>Bell</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Sargent</surname>
              <given-names>J.R.</given-names>
            </name>
          </person-group>
          <article-title>Arachidonic acid in aquaculture feeds: current status and future opportunities</article-title>
          <source>Aquaculture</source>
          <volume>218</volume>
          <year>2003</year>
          <fpage>491</fpage>
          <lpage>499</lpage>
        </element-citation>
      </ref>
      <ref id="bib0015">
        <label>3</label>
        <element-citation publication-type="journal" id="sbref0015">
          <person-group person-group-type="author">
            <name>
              <surname>Benjamini</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hochberg</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>
          <source>J. Roy. Stat. Soc. B</source>
          <volume>57</volume>
          <issue>1</issue>
          <year>1995</year>
          <fpage>289</fpage>
          <lpage>300</lpage>
        </element-citation>
      </ref>
      <ref id="bib0020">
        <label>4</label>
        <element-citation publication-type="journal" id="sbref0020">
          <person-group person-group-type="author">
            <name>
              <surname>Berntssen</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Giskegjerde</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Rosenlund</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Lundebye</surname>
              <given-names>A.K.</given-names>
            </name>
          </person-group>
          <article-title>Predicting World Health Organization toxic equivalency factor dioxin and dioxin-like polychlorinated biphenyl levels in farmed Atlantic salmon (<italic>Salmo salar</italic>) based on known levels in feed</article-title>
          <source>Environ. Toxicol. Chem.</source>
          <volume>26</volume>
          <issue>1</issue>
          <year>2007</year>
          <fpage>13</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">17269455</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0025">
        <label>5</label>
        <element-citation publication-type="journal" id="sbref0025">
          <person-group person-group-type="author">
            <name>
              <surname>Berntssen</surname>
              <given-names>M.H.G.</given-names>
            </name>
            <name>
              <surname>Julshamn</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lundebye</surname>
              <given-names>A.K.</given-names>
            </name>
          </person-group>
          <article-title>Chemical contaminants in aquafeeds and Atlantic salmon (<italic>Salmo salar</italic>) following the use of traditional versus alternative feed ingredients</article-title>
          <source>Chemosphere</source>
          <volume>78</volume>
          <year>2010</year>
          <fpage>637</fpage>
          <lpage>646</lpage>
          <pub-id pub-id-type="pmid">20045551</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0030">
        <label>6</label>
        <element-citation publication-type="journal" id="sbref0030">
          <person-group person-group-type="author">
            <name>
              <surname>Bishop-Bailey</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Askari</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Faulkner</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wheeler-Jones</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism</article-title>
          <source>Annu. Rev. Nutr.</source>
          <volume>34</volume>
          <year>2014</year>
          <fpage>261</fpage>
          <lpage>279</lpage>
          <pub-id pub-id-type="pmid">24819323</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0035">
        <label>7</label>
        <element-citation publication-type="journal" id="sbref0035">
          <person-group person-group-type="author">
            <name>
              <surname>Bratberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Olsvik</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Edvardsen</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Brekken</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Vadla</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Meier</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Effects of oil pollution and persistent organic pollutants (POPs) on glycerophospholipids in liver and brain of male Atlantic cod (<italic>Gadus morhua</italic>)</article-title>
          <source>Chemosphere</source>
          <volume>90</volume>
          <issue>7</issue>
          <year>2013</year>
          <fpage>2157</fpage>
          <lpage>2171</lpage>
          <pub-id pub-id-type="pmid">23266412</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0040">
        <label>8</label>
        <element-citation publication-type="journal" id="sbref0040">
          <person-group person-group-type="author">
            <name>
              <surname>Chiang</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>C.N.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>T.S.</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>Y.Y.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Jwo</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Takano</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kittaka</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Juang</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>T.C.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo</article-title>
          <source>Cell Cycle</source>
          <volume>12</volume>
          <issue>8</issue>
          <year>2013</year>
          <fpage>1316</fpage>
          <lpage>1325</lpage>
          <pub-id pub-id-type="pmid">23549173</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0045">
        <label>9</label>
        <element-citation publication-type="journal" id="sbref0045">
          <person-group person-group-type="author">
            <name>
              <surname>Chiang</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>C.N.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Juang</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M.F.</given-names>
            </name>
          </person-group>
          <article-title>19-Nor-2&#x3B1;-(3-hydroxypropyl)-1&#x3B1;,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells</article-title>
          <source>Steroids</source>
          <volume>76</volume>
          <year>2011</year>
          <fpage>1513</fpage>
          <lpage>1519</lpage>
          <pub-id pub-id-type="pmid">21888924</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0050">
        <label>10</label>
        <element-citation publication-type="journal" id="sbref0050">
          <person-group person-group-type="author">
            <name>
              <surname>Chiang</surname>
              <given-names>J.Y.</given-names>
            </name>
          </person-group>
          <article-title>Bile acid regulation of gene expression: roles of nuclear hormone receptors</article-title>
          <source>Endocr. Rev.</source>
          <volume>23</volume>
          <year>2002</year>
          <fpage>443</fpage>
          <lpage>463</lpage>
          <pub-id pub-id-type="pmid">12202460</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0055">
        <label>11</label>
        <element-citation publication-type="journal" id="sbref0055">
          <person-group person-group-type="author">
            <name>
              <surname>Cnop</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Foufelle</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Velloso</surname>
              <given-names>L.A.</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum stress, obesity and diabetes</article-title>
          <source>Trends Mol. Med.</source>
          <volume>18</volume>
          <issue>1</issue>
          <year>2012</year>
          <fpage>59</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="pmid">21889406</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0060">
        <label>12</label>
        <element-citation publication-type="journal" id="sbref0060">
          <person-group person-group-type="author">
            <name>
              <surname>Dennis</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Massey</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Cripps</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Venn</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Howarth</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Factors affecting the polycyclic aromatic hydrocarbon content of cereals: fats and other food products</article-title>
          <source>Food Addit. Contam.</source>
          <volume>8</volume>
          <year>1991</year>
          <fpage>517</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="pmid">1806403</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0065">
        <label>13</label>
        <element-citation publication-type="journal" id="sbref0065">
          <person-group person-group-type="author">
            <name>
              <surname>Diani-Moore</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Papachristou</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Labitzke</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rifkind</surname>
              <given-names>A.B.</given-names>
            </name>
          </person-group>
          <article-title>Induction of CYP1A and cyp2-mediated arachidonic acid epoxygenation and suppression of 20 hydroxyeicosatetraenoic acid by imidazole derivatives including the aromatase inhibitor vorozole</article-title>
          <source>Drug Metab. Dispos.</source>
          <volume>34</volume>
          <issue>8</issue>
          <year>2006</year>
          <fpage>1376</fpage>
          <lpage>1385</lpage>
          <pub-id pub-id-type="pmid">16714371</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0070">
        <label>14</label>
        <element-citation publication-type="journal" id="sbref0070">
          <person-group person-group-type="author">
            <name>
              <surname>Dieterle</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Schlotterbeck</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Senn</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Metabolite projection analysis for fast identification of metabolites in metabonomics: application in an amiodarone study</article-title>
          <source>Anal. Chem.</source>
          <volume>78</volume>
          <issue>11</issue>
          <year>2006</year>
          <fpage>3551</fpage>
          <lpage>3561</lpage>
          <pub-id pub-id-type="pmid">16737207</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0075">
        <label>15</label>
        <element-citation publication-type="journal" id="sbref0075">
          <person-group person-group-type="author">
            <name>
              <surname>Doi</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Lou</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Venugopal</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>M.O.</given-names>
            </name>
            <name>
              <surname>Kleinow</surname>
              <given-names>K.M.</given-names>
            </name>
          </person-group>
          <article-title>Effect of micelle fatty acid composition and 3,4,3&#x2032;, 4&#x2032;-tetrachlorobiphenyl (TCB) exposure on intestinal [(14)C]-TCB bioavailability and biotransformation in channel catfish in situ preparations</article-title>
          <source>Toxicol. Sci.</source>
          <volume>55</volume>
          <issue>1</issue>
          <year>2000</year>
          <fpage>85</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">10788563</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0080">
        <label>16</label>
        <mixed-citation publication-type="other" id="oref0080">K.C. Donnelly, Z.S. Naufal, Toxic and genotoxic effects of mixtures of polycyclic aromatic hydrocarbon. In: Mumtaz, M. (Ed.), Principles and practice of mixtures toxicology (2010), <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/9783527630196" id="intr0015">http://dx.doi.org/10.1002/9783527630196</ext-link>, ch20.</mixed-citation>
      </ref>
      <ref id="bib0085">
        <label>17</label>
        <element-citation publication-type="journal" id="sbref0085">
          <person-group person-group-type="author">
            <name>
              <surname>Duttaroy</surname>
              <given-names>A.K.</given-names>
            </name>
          </person-group>
          <article-title>Transport of fatty acids across the human placenta: a review</article-title>
          <source>Prog. Lipid Res.</source>
          <volume>48</volume>
          <issue>1</issue>
          <year>2009</year>
          <fpage>52</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">19041341</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0090">
        <label>18</label>
        <element-citation publication-type="journal" id="sbref0090">
          <person-group person-group-type="author">
            <name>
              <surname>Ekman</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Teng</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Villeneuve</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Kahl</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Durhan</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Ankley</surname>
              <given-names>G.T.</given-names>
            </name>
            <name>
              <surname>Collette</surname>
              <given-names>T.W.</given-names>
            </name>
          </person-group>
          <article-title>Investigating compensation and recovery of fathead minnow (<italic>Pimephales promelas</italic>) exposed to 17alpha-ethynylestradiol with metabolite profiling</article-title>
          <source>Environ. Sci. Technol.</source>
          <volume>42</volume>
          <issue>11</issue>
          <year>2008</year>
          <fpage>4188</fpage>
          <lpage>4194</lpage>
          <pub-id pub-id-type="pmid">18589986</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0095">
        <label>19</label>
        <element-citation publication-type="book" id="sbref0095">
          <person-group person-group-type="author">
            <name>
              <surname>Elskus</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Collier</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Monosson</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <chapter-title>Interactions between lipids and persistent organic pollutions in fish</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Mommsen</surname>
              <given-names>T.P.</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>T.W.</given-names>
            </name>
          </person-group>
          <series>Biochemistry and Molecular Biology of Fishes</series>
          <volume>vol. 6</volume>
          <year>2005</year>
          <publisher-name>Elsevier</publisher-name>
          <publisher-loc>The Netherlands, Amsterdam</publisher-loc>
          <fpage>119</fpage>
          <lpage>152</lpage>
          <comment>Environmental toxicology</comment>
        </element-citation>
      </ref>
      <ref id="bib0100">
        <label>20</label>
        <element-citation publication-type="journal" id="sbref0100">
          <person-group person-group-type="author">
            <name>
              <surname>Fromberg</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hojgard</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Duedahl-Olesen</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of polycyclic aromatic hydrocarbons in vegetable oils combining gel permeation chromatography with solid-phase extraction clean-up</article-title>
          <source>Food Addit. Contam.</source>
          <volume>24</volume>
          <year>2007</year>
          <fpage>758</fpage>
          <lpage>767</lpage>
          <pub-id pub-id-type="pmid">17613061</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0105">
        <label>21</label>
        <mixed-citation publication-type="other" id="oref0105">P.A. Games, J.F. Howell, 1976. Pairwise multiple comparison procedures with unequal N's and/or variances: a monte carlo study, J. Edu. Stat., 1, 113&#x2013;125. GeneCards database. Available: <ext-link ext-link-type="uri" xlink:href="http://www.genecards.org" id="intr0020">http://www.genecards.org</ext-link>. (assessed 01.05.2015.).</mixed-citation>
      </ref>
      <ref id="bib0110">
        <label>22</label>
        <element-citation publication-type="journal" id="sbref0110">
          <person-group person-group-type="author">
            <name>
              <surname>Ghioni</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tocher</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Sargent</surname>
              <given-names>J.R.</given-names>
            </name>
          </person-group>
          <article-title>The effect of culture on morphology, lipid and fatty acid composition, and polyunsaturated fatty acid metabolism of rainbow trout (<italic>Oncorhynchus mykiss</italic>) skin cells</article-title>
          <source>Fish Physiol. Biochem.</source>
          <volume>16</volume>
          <year>1997</year>
          <fpage>499</fpage>
          <lpage>513</lpage>
        </element-citation>
      </ref>
      <ref id="bib0115">
        <label>23</label>
        <element-citation publication-type="journal" id="sbref0115">
          <person-group person-group-type="author">
            <name>
              <surname>Glover</surname>
              <given-names>C.N.</given-names>
            </name>
            <name>
              <surname>Petri</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Tollefsen</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Jorum</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Handy</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Berntssen</surname>
              <given-names>M.H.G.</given-names>
            </name>
          </person-group>
          <article-title>Assessing the sensitivity of Atlantic salmon (<italic>Salmo salar</italic>) to dietary endosulfan exposure using tissue biochemistry and histology</article-title>
          <source>Aquat. Toxicol.</source>
          <volume>84</volume>
          <year>2007</year>
          <fpage>346</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="pmid">17675176</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0120">
        <label>24</label>
        <element-citation publication-type="journal" id="sbref0120">
          <person-group person-group-type="author">
            <name>
              <surname>Greenberg</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Kraemer</surname>
              <given-names>F.B.</given-names>
            </name>
            <name>
              <surname>McManaman</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Obin</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Puri</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>Q.W.</given-names>
            </name>
            <name>
              <surname>Miyoshi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mashek</surname>
              <given-names>D.G.</given-names>
            </name>
          </person-group>
          <article-title>The role of lipid droplets in metabolic disease in rodents and humans</article-title>
          <source>J. Clin. Invest.</source>
          <volume>121</volume>
          <issue>6</issue>
          <year>2011</year>
          <fpage>2102</fpage>
          <lpage>2110</lpage>
          <pub-id pub-id-type="pmid">21633178</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0125">
        <label>25</label>
        <element-citation publication-type="journal" id="sbref0125">
          <person-group person-group-type="author">
            <name>
              <surname>Grisdale-Helland</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ruyter</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Rosenlund</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Obach</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Helland</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Sandberg</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Standal</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>R&#xF8;sj&#xF8;</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Influence of high contents of dietary soybean oil on growth, feed utilization, tissue fatty acid composition, heart histology and standard oxygen consumption of Atlantic salmon (<italic>Salmo salar</italic>) raised at two temperatures</article-title>
          <source>Aquaculture</source>
          <volume>207</volume>
          <issue>3-4</issue>
          <year>2002</year>
          <fpage>311</fpage>
          <lpage>329</lpage>
        </element-citation>
      </ref>
      <ref id="bib0130">
        <label>27</label>
        <element-citation publication-type="journal" id="sbref0130">
          <person-group person-group-type="author">
            <name>
              <surname>Gr&#xFC;nfeld</surname>
              <given-names>H.T.</given-names>
            </name>
            <name>
              <surname>Bonefeld-Jorgensen</surname>
              <given-names>E.C.</given-names>
            </name>
          </person-group>
          <article-title>Effect of in vitro estrogenic pesticides on human oestrogen receptor a and b mRNA levels</article-title>
          <source>Toxicol. Lett.</source>
          <volume>151</volume>
          <year>2004</year>
          <fpage>467</fpage>
          <lpage>480</lpage>
          <pub-id pub-id-type="pmid">15261991</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0135">
        <label>28</label>
        <element-citation publication-type="journal" id="sbref0135">
          <person-group person-group-type="author">
            <name>
              <surname>Hamre</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Metabolism, interactions, requirements and functions of vitamin E in fish</article-title>
          <source>Aquacult. Nutr.</source>
          <volume>17</volume>
          <issue>1</issue>
          <year>2011</year>
          <fpage>98</fpage>
          <lpage>115</lpage>
        </element-citation>
      </ref>
      <ref id="bib0140">
        <label>29</label>
        <element-citation publication-type="journal" id="sbref0140">
          <person-group person-group-type="author">
            <name>
              <surname>Hensley</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Benaksas</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Bolli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Comp</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Grammas</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hamdheydari</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Mou</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pye</surname>
              <given-names>Q.N.</given-names>
            </name>
            <name>
              <surname>Stoddard</surname>
              <given-names>M.F.</given-names>
            </name>
            <name>
              <surname>Wallis</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wechter</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Floyd</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>36</volume>
          <issue>1</issue>
          <year>2004</year>
          <fpage>1</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">14732286</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0145">
        <label>30</label>
        <element-citation publication-type="book" id="sbref0145">
          <person-group person-group-type="author">
            <name>
              <surname>Hinton</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Segner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Au</surname>
              <given-names>D.W.T.</given-names>
            </name>
            <name>
              <surname>Kullman</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Hardman</surname>
              <given-names>R.C.</given-names>
            </name>
          </person-group>
          <chapter-title>Liver toxicity</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Di</surname>
              <given-names>Giulio</given-names>
            </name>
            <name>
              <surname>Hinton</surname>
              <given-names>D.E.</given-names>
            </name>
          </person-group>
          <source>The Toxicology of Fishes</source>
          <year>2008</year>
          <publisher-name>Taylor and Francis Group</publisher-name>
          <publisher-loc>USA, Florida</publisher-loc>
          <fpage>327</fpage>
          <lpage>400</lpage>
        </element-citation>
      </ref>
      <ref id="bib0150">
        <label>31</label>
        <element-citation publication-type="journal" id="sbref0150">
          <person-group person-group-type="author">
            <name>
              <surname>Hrydziuszko</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Viant</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Missing values in mass spectrometry based metabolomics: an undervalued step in the data processing pipeline</article-title>
          <source>Metabolomics</source>
          <year>2012</year>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11306-011-0366-4" id="intr0025">http://dx.doi.org/10.1007/s11306-011-0366-4</ext-link>
        </element-citation>
      </ref>
      <ref id="bib0155">
        <label>32</label>
        <mixed-citation publication-type="other" id="oref0155">ISO, Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity. International standard, 10993&#x2013;5 (2009), 1&#x2013;34.</mixed-citation>
      </ref>
      <ref id="bib0160">
        <label>33</label>
        <element-citation publication-type="journal" id="sbref0160">
          <person-group person-group-type="author">
            <name>
              <surname>Jergentz</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mugni</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bonetto</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Assessment of insecticide contamination in runoff and stream water of small agricultural streams in the main soybean area of Argentina</article-title>
          <source>Chemosphere</source>
          <volume>61</volume>
          <year>2005</year>
          <fpage>817</fpage>
          <lpage>826</lpage>
          <pub-id pub-id-type="pmid">15963551</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0165">
        <label>34</label>
        <element-citation publication-type="journal" id="sbref0165">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Christen</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shigenaga</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Ames</surname>
              <given-names>B.N.</given-names>
            </name>
          </person-group>
          <article-title>Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention</article-title>
          <source>Am. J. Clin. Nutr.</source>
          <volume>74</volume>
          <issue>6</issue>
          <year>2001</year>
          <fpage>714</fpage>
          <lpage>722</lpage>
          <pub-id pub-id-type="pmid">11722951</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0170">
        <label>35</label>
        <element-citation publication-type="book" id="sbref0170">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>L.L.</given-names>
            </name>
            <name>
              <surname>Arkoosh</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Bravo</surname>
              <given-names>C.F.</given-names>
            </name>
            <name>
              <surname>Collier</surname>
              <given-names>T.K.</given-names>
            </name>
            <name>
              <surname>Krahn</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Meador</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Reichert</surname>
              <given-names>W.L.</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <chapter-title>The effects of polycyclic aromatic hydrocarbons in fish from Puget sound Washington</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Di Giulio</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Hinton</surname>
              <given-names>D.E.</given-names>
            </name>
          </person-group>
          <source>The Toxicology of Fishes</source>
          <year>2008</year>
          <publisher-name>Taylor and Francis Group</publisher-name>
          <publisher-loc>USA, Florida</publisher-loc>
          <fpage>877</fpage>
          <lpage>923</lpage>
        </element-citation>
      </ref>
      <ref id="bib0175">
        <label>36</label>
        <element-citation publication-type="journal" id="sbref0175">
          <person-group person-group-type="author">
            <name>
              <surname>Kaul</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kreml</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Austria</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Richard</surname>
              <given-names>M.N.</given-names>
            </name>
            <name>
              <surname>Edel</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Dibrov</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Hirono</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zettler</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Pierce</surname>
              <given-names>G.N.</given-names>
            </name>
          </person-group>
          <article-title>A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers</article-title>
          <source>J. Am. Coll. Nutr.</source>
          <volume>27</volume>
          <issue>1</issue>
          <year>2008</year>
          <fpage>51</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">18460481</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0180">
        <label>37</label>
        <element-citation publication-type="journal" id="sbref0180">
          <person-group person-group-type="author">
            <name>
              <surname>Kidambi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>S.B.</given-names>
            </name>
          </person-group>
          <article-title>Cholesterol and non-cholesterol sterol transporters: ABCG5, ABCG8 and NPC1L1: a review</article-title>
          <source>Xenobiotica</source>
          <volume>38</volume>
          <year>2008</year>
          <fpage>1119</fpage>
          <lpage>1139</lpage>
          <pub-id pub-id-type="pmid">18668442</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0185">
        <label>38</label>
        <element-citation publication-type="journal" id="sbref0185">
          <person-group person-group-type="author">
            <name>
              <surname>Kiessling</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tamm</surname>
              <given-names>L.K.</given-names>
            </name>
          </person-group>
          <article-title>Domain coupling in asymmetric lipid bilayers</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1788</volume>
          <issue>1</issue>
          <year>2009</year>
          <fpage>64</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">18848518</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0190">
        <label>39</label>
        <element-citation publication-type="journal" id="sbref0190">
          <person-group person-group-type="author">
            <name>
              <surname>Kirwan</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Broadhurst</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Viant</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow</article-title>
          <source>Anal. Bioanal. Chem.</source>
          <volume>405</volume>
          <issue>15</issue>
          <year>2013</year>
          <fpage>5147</fpage>
          <lpage>5157</lpage>
          <pub-id pub-id-type="pmid">23455646</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0195">
        <label>40</label>
        <element-citation publication-type="book" id="sbref0195">
          <person-group person-group-type="author">
            <name>
              <surname>Klauning</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Kamendulis</surname>
              <given-names>L.M.</given-names>
            </name>
          </person-group>
          <chapter-title>Chemical carcinogenesis</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Klaassen</surname>
              <given-names>C.D.</given-names>
            </name>
          </person-group>
          <source>Casarett and Doull's Toxicology: The Basic Science of Poisons</source>
          <edition>7th ed.</edition>
          <year>2008</year>
          <publisher-name>The McGraw-Hill companies</publisher-name>
          <publisher-loc>USA, New York</publisher-loc>
          <fpage>329</fpage>
          <lpage>379</lpage>
        </element-citation>
      </ref>
      <ref id="bib0200">
        <label>41</label>
        <element-citation publication-type="journal" id="sbref0200">
          <person-group person-group-type="author">
            <name>
              <surname>Konkel</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Schunck</surname>
              <given-names>W.H.</given-names>
            </name>
          </person-group>
          <article-title>Review: role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1814</volume>
          <year>2011</year>
          <fpage>210</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">20869469</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0205">
        <label>42</label>
        <element-citation publication-type="journal" id="sbref0205">
          <person-group person-group-type="author">
            <name>
              <surname>Kortner</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Bj&#xF6;rkhem</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Krasnov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Timmerhaus</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Krogdahl</surname>
              <given-names>&#xC5;.</given-names>
            </name>
          </person-group>
          <article-title>Dietary cholesterol supplementation to a plant-based diet suppresses the complete pathway of cholesterol synthesis and induces bile acid production in Atlantic salmon (<italic>Salmo salar</italic> L.)</article-title>
          <source>Br. J. Nutr.</source>
          <volume>111</volume>
          <issue>12</issue>
          <year>2014</year>
          <fpage>2089</fpage>
          <lpage>2103</lpage>
          <pub-id pub-id-type="pmid">24635969</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0210">
        <label>43</label>
        <element-citation publication-type="journal" id="sbref0210">
          <person-group person-group-type="author">
            <name>
              <surname>Kr&#xF8;vel</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>S&#xF8;fteland</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Olsvik</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Endosulfan in vitro toxicity in Atlantic salmon hepatocytes obtained from fish fed either fish oil or vegetable oil</article-title>
          <source>Comp. Biochem. Physiol. C Toxicol. Pharmacol.</source>
          <volume>151</volume>
          <issue>2</issue>
          <year>2010</year>
          <fpage>175</fpage>
          <lpage>186</lpage>
          <pub-id pub-id-type="pmid">19874912</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0215">
        <label>44</label>
        <element-citation publication-type="journal" id="sbref0215">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>H.-K.</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>J.-K.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>C.-H.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>H.-W.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>B.-S.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>H.-S.</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>E.-C.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>Y.-D.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>K.-H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J.-H.</given-names>
            </name>
          </person-group>
          <article-title>Stereoselective Metabolism of Endosulfan by Human Liver Microsomes and Human Cytochrome P450 Isoforms</article-title>
          <source>Drug Metab. Dispos.</source>
          <volume>34</volume>
          <issue>7</issue>
          <year>2006</year>
          <fpage>1090</fpage>
          <lpage>1095</lpage>
          <pub-id pub-id-type="pmid">16581944</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0220">
        <label>45</label>
        <element-citation publication-type="journal" id="sbref0220">
          <person-group person-group-type="author">
            <name>
              <surname>Liland</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Hatlen</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Takle</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Venegas</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Espe</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
          </person-group>
          <article-title>Including processed poultry and porcine by-products in diets high in plant ingredients reduced liver TAG in Atlantic salmon, <italic>Salmo salar</italic> L</article-title>
          <source>Aquacult. Nutr.</source>
          <year>2014</year>
        </element-citation>
      </ref>
      <ref id="bib0225">
        <label>46</label>
        <element-citation publication-type="journal" id="sbref0225">
          <person-group person-group-type="author">
            <name>
              <surname>Liland</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Simonsen</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Duelund</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Berntssen</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Mouritsen</surname>
              <given-names>O.G.</given-names>
            </name>
          </person-group>
          <article-title>Polyaromatic hydrocarbons do not disturb liquid-liquid phase coexistence, but increase the fluidity of model membranes</article-title>
          <source>Chem. Phys. Lipids</source>
          <volume>184</volume>
          <year>2014</year>
          <fpage>18</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="pmid">25181555</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0230">
        <label>47</label>
        <element-citation publication-type="journal" id="sbref0230">
          <person-group person-group-type="author">
            <name>
              <surname>Liland</surname>
              <given-names>N.S.</given-names>
            </name>
            <name>
              <surname>Rosenlund</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Espe</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hjelle</surname>
              <given-names>J.I.</given-names>
            </name>
            <name>
              <surname>Lie</surname>
              <given-names>&#xD8;.</given-names>
            </name>
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
          </person-group>
          <article-title>Diets high in plant protein and phytosterols affect cholesterol metabolism in Atlantic salmon <italic>Salmo Salar</italic> L</article-title>
          <source>Br. J. Nutr.</source>
          <volume>10</volume>
          <year>2013</year>
          <fpage>258</fpage>
          <lpage>272</lpage>
        </element-citation>
      </ref>
      <ref id="bib0235">
        <label>48</label>
        <element-citation publication-type="journal" id="sbref0235">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>S.B.</given-names>
            </name>
          </person-group>
          <article-title>Dietary cholesterol absorption; more than just bile</article-title>
          <source>Trends Endocrinol. Metab.</source>
          <volume>12</volume>
          <year>2001</year>
          <fpage>314</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">11504671</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0240">
        <label>49</label>
        <element-citation publication-type="journal" id="sbref0240">
          <person-group person-group-type="author">
            <name>
              <surname>Marchis</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ferro</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Brizio</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Squadrone</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Abete</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>Detection of pesticides in crops: a modified QuEChERS approach</article-title>
          <source>Food Control</source>
          <volume>25</volume>
          <year>2012</year>
          <fpage>270</fpage>
          <lpage>273</lpage>
        </element-citation>
      </ref>
      <ref id="bib0245">
        <label>50</label>
        <element-citation publication-type="journal" id="sbref0245">
          <person-group person-group-type="author">
            <name>
              <surname>McCormick</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>R.S.</given-names>
            </name>
          </person-group>
          <article-title>The cytotoxicity of vitamin E is both vitamer- and cell-specific and involves a selectable trait</article-title>
          <source>J. Nutr.</source>
          <volume>134</volume>
          <issue>12</issue>
          <year>2004</year>
          <fpage>3335</fpage>
          <lpage>3342</lpage>
          <pub-id pub-id-type="pmid">15570034</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0250">
        <label>51</label>
        <element-citation publication-type="journal" id="sbref0250">
          <person-group person-group-type="author">
            <name>
              <surname>McMaster</surname>
              <given-names>C.R.</given-names>
            </name>
          </person-group>
          <article-title>Lipid metabolism and vesicle trafficking: more than just greasing the transport machinery</article-title>
          <source>Biochem. Cell Biol.</source>
          <volume>79</volume>
          <year>2001</year>
          <fpage>681</fpage>
          <lpage>692</lpage>
          <pub-id pub-id-type="pmid">11800009</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0255">
        <label>53</label>
        <element-citation publication-type="journal" id="sbref0255">
          <person-group person-group-type="author">
            <name>
              <surname>Monteiro</surname>
              <given-names>P.R.R.</given-names>
            </name>
            <name>
              <surname>Reis-Henriques</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Coimbra</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Polycyclic aromatic hydrocarbons inhibit in vitro ovarian steroidogenesis in the flounder (<italic>Platichthys flesus</italic> L.)</article-title>
          <source>Aquat. Toxicol.</source>
          <volume>48</volume>
          <year>2000</year>
          <fpage>549</fpage>
          <lpage>559</lpage>
          <pub-id pub-id-type="pmid">10794836</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0260">
        <label>54</label>
        <element-citation publication-type="journal" id="sbref0260">
          <person-group person-group-type="author">
            <name>
              <surname>Mustacich</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Leonard</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>N.K.</given-names>
            </name>
            <name>
              <surname>Traber</surname>
              <given-names>M.G.</given-names>
            </name>
          </person-group>
          <article-title>Alpha-tocopherol beta-oxidation localized to rat liver mitochondria</article-title>
          <source>Free Radic. Biol. Med.</source>
          <volume>48</volume>
          <issue>1</issue>
          <year>2010</year>
          <fpage>73</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">19819327</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0265">
        <label>55</label>
        <element-citation publication-type="journal" id="sbref0265">
          <person-group person-group-type="author">
            <name>
              <surname>Nanton</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Vegusdal</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bencze R&#xF8;r&#xE5;</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Ruyter</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Baeverfjord</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
          </person-group>
          <article-title>Muscle lipid storage pattern, composition, and adipocyte distribution in different parts of Atlantic salmon (<italic>Salmo salar</italic>) fed fish oil and vegetable oil</article-title>
          <source>Aquaculture</source>
          <volume>265</volume>
          <issue>1-4</issue>
          <year>2007</year>
          <fpage>230</fpage>
          <lpage>243</lpage>
        </element-citation>
      </ref>
      <ref id="bib0270">
        <label>56</label>
        <element-citation publication-type="journal" id="sbref0270">
          <person-group person-group-type="author">
            <name>
              <surname>Nebert</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Dalton</surname>
              <given-names>T.P.</given-names>
            </name>
            <name>
              <surname>Okey</surname>
              <given-names>A.B.</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>F.J.</given-names>
            </name>
          </person-group>
          <article-title>Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer</article-title>
          <source>J. Biol. Chem.</source>
          <volume>279</volume>
          <issue>23</issue>
          <year>2004</year>
          <fpage>23847</fpage>
          <lpage>23850</lpage>
          <pub-id pub-id-type="pmid">15028720</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0275">
        <label>58</label>
        <element-citation publication-type="journal" id="sbref0275">
          <person-group person-group-type="author">
            <name>
              <surname>Olsvik</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Berntssen</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>S&#xF8;fteland</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Modifying effects of vitamin e on chlorpyrifos toxicity in Atlantic salmon</article-title>
          <source>PLoS One</source>
          <volume>10</volume>
          <issue>3</issue>
          <year>2015</year>
          <fpage>e0119250</fpage>
          <comment>Mar 16</comment>
          <pub-id pub-id-type="pmid">25774794</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0280">
        <label>59</label>
        <element-citation publication-type="journal" id="sbref0280">
          <person-group person-group-type="author">
            <name>
              <surname>Payne</surname>
              <given-names>T.G.</given-names>
            </name>
            <name>
              <surname>Southam</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Arvanitis</surname>
              <given-names>T.N.</given-names>
            </name>
            <name>
              <surname>Viant</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>A signal filtering method for improved quantification and noise discrimination in fourier transform ion cyclotron resonance mass spectrometry-based metabolomics data</article-title>
          <source>J. Am. Soc. Mass Spectrom.</source>
          <volume>20</volume>
          <issue>6</issue>
          <year>2009</year>
          <fpage>1087</fpage>
          <lpage>1095</lpage>
          <pub-id pub-id-type="pmid">19269189</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0285">
        <label>60</label>
        <element-citation publication-type="journal" id="sbref0285">
          <person-group person-group-type="author">
            <name>
              <surname>Plante</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pernet</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Hach&#xE9;</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Ritchie</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>McIntosh</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Ontogenetic variations in lipid class and fatty acid composition of haddock larvae Melanogrammus aeglefinus in relation to changes in diet and microbial environment</article-title>
          <source>Aquaculture</source>
          <volume>263</volume>
          <issue>1-4</issue>
          <year>2007</year>
          <fpage>107</fpage>
          <lpage>121</lpage>
        </element-citation>
      </ref>
      <ref id="bib0290">
        <label>61</label>
        <mixed-citation publication-type="other" id="oref0290">M. Rakhhandehroo, B. Knoch, M. M&#xFC;ller, S. Kersten, Peroxisome Proliferator-Activated Receptor Alpha Target Genes PPAR Research, Article ID 612089 (2010), doi: 10.1155/2010/612089.</mixed-citation>
      </ref>
      <ref id="bib0295">
        <label>62</label>
        <element-citation publication-type="journal" id="sbref0295">
          <person-group person-group-type="author">
            <name>
              <surname>Ruyter</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Moya-Falc&#xF3;n</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Rosenlund</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Vegusdal</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Fat content and morphology of liver and intestine of Atlantic salmon (<italic>Salmo salar</italic>): effects of temperature and dietary soybean oil</article-title>
          <source>Aquaculture</source>
          <volume>252</volume>
          <issue>2-4</issue>
          <year>2006</year>
          <fpage>441</fpage>
          <lpage>452</lpage>
        </element-citation>
      </ref>
      <ref id="bib0300">
        <label>63</label>
        <element-citation publication-type="book" id="sbref0300">
          <person-group person-group-type="author">
            <name>
              <surname>Sargent</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Tocher</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>J.G.</given-names>
            </name>
          </person-group>
          <chapter-title>The lipids</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Halver</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>R.W.</given-names>
            </name>
          </person-group>
          <source>Fish Nutrition</source>
          <year>2002</year>
          <publisher-name>Academic Press</publisher-name>
          <publisher-loc>The Netherlands, Amsterdam</publisher-loc>
          <fpage>181</fpage>
          <lpage>255</lpage>
        </element-citation>
      </ref>
      <ref id="bib0305">
        <label>64</label>
        <mixed-citation publication-type="other" id="oref0305">SCF, Opinion of the Scientific Committee on Food on the risks to human health of Polycyclic Aromatic Hydrocarbons in food SCF/CS/CNTM/PAH/29 (2002), <ext-link ext-link-type="uri" xlink:href="http://europa.eu.int/comm/food/fs/sc/scf/index_en.html" id="intr0030">http://europa.eu.int/comm/food/fs/sc/scf/index_en.html</ext-link>.</mixed-citation>
      </ref>
      <ref id="bib0310">
        <label>65</label>
        <element-citation publication-type="journal" id="sbref0310">
          <person-group person-group-type="author">
            <name>
              <surname>Schirmer</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Bols</surname>
              <given-names>N.C.</given-names>
            </name>
          </person-group>
          <article-title>Ability of 16 priority PAHs to be directly cytotoxic to a cell line from the rainbow trout gill</article-title>
          <source>Toxicology</source>
          <volume>127</volume>
          <issue>1-3</issue>
          <year>1998</year>
          <fpage>129</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="pmid">9699800</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0315">
        <label>66</label>
        <element-citation publication-type="journal" id="sbref0315">
          <person-group person-group-type="author">
            <name>
              <surname>Schroeder</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Stocker</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Salowsky</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Leiber</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gassmann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lightfoot</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Menzel</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Granzow</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ragg</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>The RIN: an RNA integrity number for assigning integrity values to RNA measurements</article-title>
          <source>BMC Mol. Biol.</source>
          <volume>7</volume>
          <year>2006</year>
          <fpage>3</fpage>
          <pub-id pub-id-type="pmid">16448564</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0320">
        <label>67</label>
        <element-citation publication-type="journal" id="sbref0320">
          <person-group person-group-type="author">
            <name>
              <surname>Scifres</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Sadovsky</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts</article-title>
          <source>J. Clin. Endocrinol. Metab.</source>
          <volume>96</volume>
          <issue>7</issue>
          <year>2011</year>
          <fpage>E1083</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">21525163</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0325">
        <label>68</label>
        <element-citation publication-type="journal" id="sbref0325">
          <person-group person-group-type="author">
            <name>
              <surname>Seruto</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sapozhnikova</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Schlenk</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the relationships between biochemical endpoints of PAH exposure and physiological endpoints of reproduction in male California Halibut (<italic>Paralichthys californicus</italic>) exposed to sediments from a natural oil seep</article-title>
          <source>Mar. Environ. Res.</source>
          <volume>60</volume>
          <issue>4</issue>
          <year>2005</year>
          <fpage>454</fpage>
          <lpage>465</lpage>
          <pub-id pub-id-type="pmid">15924994</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0330">
        <label>69</label>
        <element-citation publication-type="journal" id="sbref0330">
          <person-group person-group-type="author">
            <name>
              <surname>Shaikh</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Edidin</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation</article-title>
          <source>Am. J. Clin. Nutr.</source>
          <volume>84</volume>
          <issue>6</issue>
          <year>2006</year>
          <fpage>1277</fpage>
          <lpage>1289</lpage>
          <pub-id pub-id-type="pmid">17158407</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0335">
        <label>70</label>
        <element-citation publication-type="journal" id="sbref0335">
          <person-group person-group-type="author">
            <name>
              <surname>Schirmer</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dixon</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Bols</surname>
              <given-names>N.C.</given-names>
            </name>
          </person-group>
          <article-title>Ability of 16 priority PAHs to be directly cytotoxic to a cell line from the rainbow trout gill</article-title>
          <source>Toxicology</source>
          <volume>127</volume>
          <issue>1-3</issue>
          <year>1998</year>
          <fpage>129</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="pmid">9699800</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0340">
        <label>71</label>
        <element-citation publication-type="journal" id="sbref0340">
          <person-group person-group-type="author">
            <name>
              <surname>Smathers</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>D.R.</given-names>
            </name>
          </person-group>
          <article-title>The human fatty acid-binding protein family: evolutionary divergences and functions</article-title>
          <source>Hum. Genomics</source>
          <volume>5</volume>
          <issue>3</issue>
          <year>2011</year>
          <fpage>170</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="pmid">21504868</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0345">
        <label>72</label>
        <element-citation publication-type="journal" id="sbref0345">
          <person-group person-group-type="author">
            <name>
              <surname>Southam</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Payne</surname>
              <given-names>T.G.</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Arvanitis</surname>
              <given-names>T.N.</given-names>
            </name>
            <name>
              <surname>Viant</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Dynamic range and mass accuracy of wide-scan direct infusion nanoelectrospray fourier transform ion cyclotron resonance mass spectrometry-based metabolomics increased by the spectral stitching method</article-title>
          <source>Anal. Chem.</source>
          <volume>79</volume>
          <issue>12</issue>
          <year>2007</year>
          <fpage>4595</fpage>
          <lpage>4602</lpage>
          <pub-id pub-id-type="pmid">17511421</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0350">
        <label>73</label>
        <element-citation publication-type="journal" id="sbref0350">
          <person-group person-group-type="author">
            <name>
              <surname>Strott</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Higashi</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Cholesterol sulfate in human physiology: what&#x2019;s it all about?</article-title>
          <source>J. Lipid Res.</source>
          <volume>44</volume>
          <issue>7</issue>
          <year>2003</year>
          <fpage>1268</fpage>
          <lpage>1278</lpage>
          <pub-id pub-id-type="pmid">12730293</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0355">
        <label>74</label>
        <element-citation publication-type="journal" id="sbref0355">
          <person-group person-group-type="author">
            <name>
              <surname>Stubhaug</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Lie</surname>
              <given-names>&#xD8;.</given-names>
            </name>
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
          </person-group>
          <article-title>Fatty acid productive value and b-oxidation capacity in Atlantic salmon (<italic>Salmo salar</italic> L.) fed on different lipid sources along the whole growth period</article-title>
          <source>Aquacult. Nutr.</source>
          <volume>13</volume>
          <year>2007</year>
          <fpage>145</fpage>
          <lpage>155</lpage>
        </element-citation>
      </ref>
      <ref id="bib0360">
        <label>75</label>
        <element-citation publication-type="journal" id="sbref0360">
          <person-group person-group-type="author">
            <name>
              <surname>Sumner</surname>
              <given-names>L.W.</given-names>
            </name>
            <name>
              <surname>Amberg</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Barrett</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Beale</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Beger</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Daykin</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>T.W.M.</given-names>
            </name>
            <name>
              <surname>Fiehn</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Goodacre</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Hankemeier</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Harnly</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Higashi</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kopka</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lane</surname>
              <given-names>A.N.</given-names>
            </name>
            <name>
              <surname>Lindon</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Marriott</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nicholls</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Reily</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Thaden</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Viant</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Proposed minimum reporting standards for chemical analysis</article-title>
          <source>Metabolomics</source>
          <volume>3</volume>
          <issue>3</issue>
          <year>2007</year>
          <fpage>211</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="pmid">24039616</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0365">
        <label>76</label>
        <element-citation publication-type="journal" id="sbref0365">
          <person-group person-group-type="author">
            <name>
              <surname>Syv&#xE4;oja</surname>
              <given-names>E.-L.</given-names>
            </name>
            <name>
              <surname>Salminen</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Tocopherols and tocotrienols in finnish foods: fish and fish products</article-title>
          <source>J. Am. Oil Chem. Soc.</source>
          <volume>62</volume>
          <issue>8</issue>
          <year>1985</year>
          <fpage>1245</fpage>
          <lpage>1248</lpage>
        </element-citation>
      </ref>
      <ref id="bib0370">
        <label>77</label>
        <element-citation publication-type="journal" id="sbref0370">
          <person-group person-group-type="author">
            <name>
              <surname>Syv&#xE4;oja</surname>
              <given-names>E.-L.</given-names>
            </name>
            <name>
              <surname>Pilronen</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Varo</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Koivistoinen</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Salminen</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Tocopherols and tocotrienols in Finnish foods: oils and fats</article-title>
          <source>J. Am. Oil Chem. Soc.</source>
          <volume>63</volume>
          <issue>3</issue>
          <year>1986</year>
          <fpage>328</fpage>
          <lpage>329</lpage>
        </element-citation>
      </ref>
      <ref id="bib0375">
        <label>78</label>
        <element-citation publication-type="journal" id="sbref0375">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xF8;fteland</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Eide</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Olsvik</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Factorial design applied for multiple endpoint toxicity evaluation in Atlantic salmon (<italic>Salmo salar</italic> L.) hepatocytes</article-title>
          <source>Toxicol. In Vitro</source>
          <volume>23</volume>
          <year>2009</year>
          <fpage>1455</fpage>
          <lpage>1464</lpage>
          <pub-id pub-id-type="pmid">19607907</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0380">
        <label>79</label>
        <element-citation publication-type="journal" id="sbref0380">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xF8;fteland</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kirwan</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>T.S.</given-names>
            </name>
            <name>
              <surname>St&#xF8;rseth</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Berntssen</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Viant</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Rise</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Waagb&#xF8;</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Booman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Olsvik</surname>
              <given-names>P.A.</given-names>
            </name>
          </person-group>
          <article-title>Toxicological effect of single contaminants and contaminant mixtures associated with plant ingredients in novel salmon feeds</article-title>
          <source>Food Chem. Toxicol.</source>
          <volume>73</volume>
          <year>2014</year>
          <fpage>157</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="pmid">25193261</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0385">
        <label>80</label>
        <element-citation publication-type="journal" id="sbref0385">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>J.1</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Rose</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Brimfield</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Hodgson</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes</article-title>
          <source>Drug Metab. Dispos.</source>
          <volume>29</volume>
          <issue>9</issue>
          <year>2001</year>
          <fpage>1201</fpage>
          <lpage>1204</lpage>
          <pub-id pub-id-type="pmid">11502728</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0390">
        <label>81</label>
        <element-citation publication-type="journal" id="sbref0390">
          <person-group person-group-type="author">
            <name>
              <surname>Teixeira</surname>
              <given-names>V.H.</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>PAHs content in sunflower, soybean and virgin olive oils: evaluation in commercial samples and during refining process</article-title>
          <source>Food Chem.</source>
          <volume>104</volume>
          <year>2007</year>
          <fpage>106</fpage>
          <lpage>112</lpage>
        </element-citation>
      </ref>
      <ref id="bib0395">
        <label>82</label>
        <element-citation publication-type="journal" id="sbref0395">
          <person-group person-group-type="author">
            <name>
              <surname>Tellmann</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The E-method: a highly accurate technique for gene-expression analysis</article-title>
          <source>Nat. Methods</source>
          <year>2006</year>
          <fpage>3</fpage>
          <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nmeth894" id="intr0035">http://dx.doi.org/10.1038/nmeth894</ext-link>
        </element-citation>
      </ref>
      <ref id="bib0400">
        <label>83</label>
        <element-citation publication-type="journal" id="sbref0400">
          <person-group person-group-type="author">
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Nanton</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Olsvik</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Sundvold</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Stubhaug</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Gene expression of fatty acid binding proteins (FABPs), fatty acid transport proteins (cd36 and FATP) and b-oxidation related genes in Atlantic salmon (<italic>Salmo salar</italic> L.) fed fish oil or vegetable oil</article-title>
          <source>Aquacult. Nutr.</source>
          <volume>15</volume>
          <issue>4</issue>
          <year>2009</year>
          <fpage>440</fpage>
          <lpage>451</lpage>
        </element-citation>
      </ref>
      <ref id="bib0405">
        <label>84</label>
        <element-citation publication-type="journal" id="sbref0405">
          <person-group person-group-type="author">
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>J.G.</given-names>
            </name>
            <name>
              <surname>Rosenlund</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Graff</surname>
              <given-names>I.E.</given-names>
            </name>
            <name>
              <surname>Tocher</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Lie</surname>
              <given-names>&#xD8;.</given-names>
            </name>
            <name>
              <surname>Sargent</surname>
              <given-names>J.R.</given-names>
            </name>
          </person-group>
          <article-title>Tailoring of Atlantic salmon (<italic>Salmo salar</italic> L.) flesh lipid composition and sensory quality by replacing fish oil with a vegetable oil blend</article-title>
          <source>J. Agric. Food Chem.</source>
          <volume>53</volume>
          <issue>26</issue>
          <year>2005</year>
          <fpage>10166</fpage>
          <lpage>10178</lpage>
          <pub-id pub-id-type="pmid">16366711</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0410">
        <label>85</label>
        <element-citation publication-type="journal" id="sbref0410">
          <person-group person-group-type="author">
            <name>
              <surname>Turchini</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Torstensen</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>W.K.</given-names>
            </name>
          </person-group>
          <article-title>Fish oil replacement in finfish nutrition</article-title>
          <source>Rev. Aquacult.</source>
          <volume>1</volume>
          <issue>1</issue>
          <year>2009</year>
          <fpage>10</fpage>
          <lpage>57</lpage>
        </element-citation>
      </ref>
      <ref id="bib0415">
        <label>86</label>
        <element-citation publication-type="journal" id="sbref0415">
          <person-group person-group-type="author">
            <name>
              <surname>van der Oost</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Beyer</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Vermeulen</surname>
              <given-names>N.P.E.</given-names>
            </name>
          </person-group>
          <article-title>Fish bioaccumulation and biomarkers in environmental risk assessment: a review</article-title>
          <source>Environ. Toxicol. Pharmacol.</source>
          <volume>13</volume>
          <year>2003</year>
          <fpage>57</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="pmid">21782649</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0420">
        <label>87</label>
        <element-citation publication-type="journal" id="sbref0420">
          <person-group person-group-type="author">
            <name>
              <surname>van Meer</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sprong</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Membrane lipids and vesicular traffic</article-title>
          <source>Curr. Opin. Cell Biol.</source>
          <volume>16</volume>
          <issue>4</issue>
          <year>2004</year>
          <fpage>373</fpage>
          <lpage>378</lpage>
          <pub-id pub-id-type="pmid">15261669</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0425">
        <label>88</label>
        <element-citation publication-type="journal" id="sbref0425">
          <person-group person-group-type="author">
            <name>
              <surname>van Meer</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Voelker</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Feigenson</surname>
              <given-names>G.W.</given-names>
            </name>
          </person-group>
          <article-title>Membrane lipids: where they are and how they behave</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>9</volume>
          <issue>2</issue>
          <year>2008</year>
          <fpage>112</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">18216768</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0430">
        <label>89</label>
        <element-citation publication-type="journal" id="sbref0430">
          <person-group person-group-type="author">
            <name>
              <surname>Vandesompele</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Preter</surname>
              <given-names>K.D.</given-names>
            </name>
            <name>
              <surname>Pattyn</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Poppe</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>N.V.</given-names>
            </name>
            <name>
              <surname>Paepe</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Speleman</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Accurate normalization of real-time quantiative RT-PCR data by geometric averaging of multiple internal control genes</article-title>
          <source>Genome Biol.</source>
          <volume>3</volume>
          <issue>7</issue>
          <year>2002</year>
          <fpage>1</fpage>
          <lpage>0034</lpage>
          <comment>11, Research0034</comment>
        </element-citation>
      </ref>
      <ref id="bib0435">
        <label>90</label>
        <element-citation publication-type="journal" id="sbref0435">
          <person-group person-group-type="author">
            <name>
              <surname>Viant</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Rosenblum</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Tieerdema</surname>
              <given-names>R.S.</given-names>
            </name>
          </person-group>
          <article-title>NMR-based metabolomics: a powerful approach for characterizing the effects of environmental stressors on organism health</article-title>
          <source>Environ. Sci. Technol.</source>
          <volume>37</volume>
          <issue>21</issue>
          <year>2003</year>
          <fpage>4982</fpage>
          <lpage>4989</lpage>
          <pub-id pub-id-type="pmid">14620827</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0440">
        <label>91</label>
        <element-citation publication-type="book" id="sbref0440">
          <person-group person-group-type="author">
            <name>
              <surname>Waagb&#xF8;</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <chapter-title>Feeding and disease resistance in fish</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Mosenthin</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zebrowska</surname>
              <given-names>T.E.</given-names>
            </name>
          </person-group>
          <series>Biology of Growing Animals</series>
          <volume>vol. 4</volume>
          <year>2006</year>
          <publisher-name>Elsevier</publisher-name>
          <publisher-loc>Netherlands Amsterdam</publisher-loc>
          <fpage>387</fpage>
          <lpage>415</lpage>
        </element-citation>
      </ref>
      <ref id="bib0445">
        <label>92</label>
        <element-citation publication-type="journal" id="sbref0445">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lyu</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Panigrahy</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ferrara</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Hammock</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>&#x3C9;-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer</article-title>
          <source>Prostaglandins Other Lipid Mediat.</source>
          <volume>113&#x2013;115</volume>
          <year>2014</year>
          <fpage>13</fpage>
          <lpage>20</lpage>
        </element-citation>
      </ref>
      <ref id="bib0450">
        <label>93</label>
        <element-citation publication-type="journal" id="sbref0450">
          <person-group person-group-type="author">
            <name>
              <surname>Watanabe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Arai</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Absence of interconversion of tocopherols in rainbow trout</article-title>
          <source>Bull. Jpn. Soc. Sci. Fish.</source>
          <volume>47</volume>
          <year>1981</year>
          <fpage>1455</fpage>
          <lpage>1462</lpage>
        </element-citation>
      </ref>
      <ref id="bib0455">
        <label>94</label>
        <element-citation publication-type="journal" id="sbref0455">
          <person-group person-group-type="author">
            <name>
              <surname>Weber</surname>
              <given-names>R.J.M.</given-names>
            </name>
            <name>
              <surname>Viant</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>MI-Pack: increased confidence of metabolite identification in mass spectra by integrating accurate masses and metabolic pathways</article-title>
          <source>Chemometr. Intell. Lab. Syst.</source>
          <volume>104</volume>
          <issue>1</issue>
          <year>2010</year>
          <fpage>75</fpage>
          <lpage>82</lpage>
        </element-citation>
      </ref>
      <ref id="bib0460">
        <label>95</label>
        <element-citation publication-type="journal" id="sbref0460">
          <person-group person-group-type="author">
            <name>
              <surname>Weber</surname>
              <given-names>R.J.M.</given-names>
            </name>
            <name>
              <surname>Southam</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Viant</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of isotopic abundance measurements in high resolution FT-ICR and orbitrap mass spectra for improved confidence of metabolite identification</article-title>
          <source>Anal. Chem</source>
          <volume>83</volume>
          <year>2011</year>
          <fpage>3737</fpage>
          <lpage>3743</lpage>
          <pub-id pub-id-type="pmid">21466230</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0465">
        <label>96</label>
        <element-citation publication-type="journal" id="sbref0465">
          <person-group person-group-type="author">
            <name>
              <surname>Westerbacka</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kolak</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kiviluoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Arkkila</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sir&#xE9;n</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hamsten</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Yki-J&#xE4;rvinen</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects</article-title>
          <source>Diabetes</source>
          <volume>56</volume>
          <issue>11</issue>
          <year>2007</year>
          <fpage>2759</fpage>
          <lpage>2765</lpage>
          <pub-id pub-id-type="pmid">17704301</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0470">
        <label>97</label>
        <element-citation publication-type="journal" id="sbref0470">
          <person-group person-group-type="author">
            <name>
              <surname>Wold</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Cross-validatory estimation of the number of components in factor and principal components models</article-title>
          <source>Technometrics</source>
          <volume>20</volume>
          <issue>4</issue>
          <year>1978</year>
          <fpage>397</fpage>
          <lpage>405</lpage>
        </element-citation>
      </ref>
      <ref id="bib0475">
        <label>98</label>
        <element-citation publication-type="journal" id="sbref0475">
          <person-group person-group-type="author">
            <name>
              <surname>Wold</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ruhe</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wold</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Dunn</surname>
              <given-names>W.J.</given-names>
              <suffix>III</suffix>
            </name>
          </person-group>
          <article-title>The collinearity problem in linear regression The partial least squares (PLS) approach to generalized inverses</article-title>
          <source>SIAM J. Sci. Stat. Comput.</source>
          <volume>5</volume>
          <year>1984</year>
          <fpage>735</fpage>
          <lpage>743</lpage>
        </element-citation>
      </ref>
      <ref id="bib0480">
        <label>99</label>
        <element-citation publication-type="journal" id="sbref0480">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Takahara</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Oyadomari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress</article-title>
          <source>Mol. Biol. Cell</source>
          <volume>21</volume>
          <issue>17</issue>
          <year>2010</year>
          <fpage>2975</fpage>
          <lpage>2986</lpage>
          <pub-id pub-id-type="pmid">20631254</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0485">
        <label>100</label>
        <element-citation publication-type="journal" id="sbref0485">
          <person-group person-group-type="author">
            <name>
              <surname>Yan</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Reciprocal inhibiting interactive mechanism between the estrogen receptor and aryl hydrocarbon receptor signaling pathways in goldfish (<italic>Carassius auratus</italic>) exposed to 17b-estradiol and benzo[a]pyrene</article-title>
          <source>Comp. Biochem. Physiol. C Toxicol. Pharmacol.</source>
          <volume>156</volume>
          <issue>1</issue>
          <year>2012</year>
          <fpage>17</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">22425873</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0490">
        <label>101</label>
        <element-citation publication-type="journal" id="sbref0490">
          <person-group person-group-type="author">
            <name>
              <surname>Hennig</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Hammock</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Slim</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Toborek</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Saraswathi</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>L.W.</given-names>
            </name>
          </person-group>
          <article-title>PCB-induced oxidative stress in endothelial cells: modulation by nutrients</article-title>
          <source>Int. J. Hyg. Environ. Health</source>
          <volume>205</volume>
          <issue>1-2</issue>
          <year>2002</year>
          <fpage>95</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="pmid">12018021</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0495">
        <label>102</label>
        <element-citation publication-type="journal" id="sbref0495">
          <person-group person-group-type="author">
            <name>
              <surname>Lavado</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Schlenk</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Microsomal biotransformation of chlorpyrifos, parathion and fenthion in rainbow trout (<italic>Oncorhynchus mykiss</italic>) and coho salmon (<italic>Oncorhynchus kisutch</italic>): mechanistic insights into interspecific differences in toxicity</article-title>
          <source>Aquat. Toxicol.</source>
          <volume>101</volume>
          <issue>1</issue>
          <year>2011</year>
          <fpage>57</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">20947181</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="sec0150" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>The following are Supplementary data to this article:<supplementary-material content-type="local-data" id="upi0010"><media xlink:href="mmc1.docx"/></supplementary-material></p>
    </sec>
    <ack id="ack0005">
      <title>Acknowledgments</title>
      <p>The authors would like to thank Betty Irgens, Eva Mykkeltvedt and Synn&#xF8;ve Wintertun (NIFES) for their contribution with the experimental work. The LTQ FT Ultra used in this research was obtained, through the Birmingham Science City Translational Medicine: Experimental Medicine Network of Excellence project, with support from Advantage West Midlands (AWM). This work was funded by the <funding-source id="gs0005">Norwegian Research Council (NRC)</funding-source>, Grant number 200506 and <funding-source id="gs0010">NIFES, Norway</funding-source>.</p>
    </ack>
    <fn-group>
      <fn id="sec0145" fn-type="supplementary-material">
        <label>Appendix A</label>
        <p>Supplementary data associated with this article can be found, in the online version, at <ext-link ext-link-type="doi" xlink:href="10.1016/j.toxrep.2016.01.008" id="intr0010">http://dx.doi.org/10.1016/j.toxrep.2016.01.008</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biochem Biophys Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Biochem Biophys Rep</journal-id>
      <journal-title-group>
        <journal-title>Biochemistry and Biophysics Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2405-5808</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28955944</article-id>
      <article-id pub-id-type="pmc">5613697</article-id>
      <article-id pub-id-type="publisher-id">S2405-5808(16)30131-5</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbrep.2016.08.001</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fundamental study on a gene transfection methodology for mammalian cells using water-in-oil droplet deformation in a DC electric field</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kurita</surname>
            <given-names>Hirofumi</given-names>
          </name>
          <email>kurita@ens.tut.ac.jp</email>
          <xref rid="aff0005" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">&#x204E;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takao</surname>
            <given-names>Yasuhiro</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kishikawa</surname>
            <given-names>Kenta</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takashima</surname>
            <given-names>Kazunori</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Numano</surname>
            <given-names>Rika</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
          <xref rid="aff0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mizuno</surname>
            <given-names>Akira</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
      </contrib-group>
      <aff id="aff0005"><label>a</label>Department of Environmental and Life Sciences, Graduate School of Engineering, Toyohashi University of Technology, 1-1 Hibarigaoka, Tempaku-cho, Toyohashi, Aichi 441-8580, Japan</aff>
      <aff id="aff0010"><label>b</label>Electronics-Inspired Interdisciplinary Research Institute, Toyohashi University of Technology, 1-1 Hibarigaoka, Tempaku-cho, Toyohashi, Aichi 441-8580, Japan</aff>
      <author-notes>
        <corresp id="cor1"><label>&#x204E;</label>Corresponding author. <email>kurita@ens.tut.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>12</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <volume>8</volume>
      <fpage>81</fpage>
      <lpage>88</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>5</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>8</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 The Authors</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="ab0010">
        <p>We have developed a gene transfection method called water-in-oil droplet electroporation (EP) that uses a dielectric oil and a liquid droplet containing live cells and exogenous DNA. When a cell suspension droplet is placed between a pair of electrodes, an intense DC electric field can induce droplet deformation, resulting in an instantaneous short circuit caused by the droplet elongating and contacting the two electrodes simultaneously. Small transient pores are generated in the cell membrane during the short, allowing the introduction of exogenous DNA into the cells. The droplet EP was characterized by varying the following experimental parameters: applied voltage, number of short circuits, type of medium (electric conductivity), concentration of exogenous DNA, and size of the droplet. In addition, the formation of transient pores in the cell membrane during droplet EP and the transfection efficiency were evaluated.</p>
      </abstract>
      <abstract abstract-type="author-highlights" id="ab0015">
        <title>Highlights</title>
        <p>
          <list list-type="simple">
            <list-item id="u0005">
              <label>&#x2022;</label>
              <p>Characterization of water-in-oil droplet electroporation.</p>
            </list-item>
            <list-item id="u0010">
              <label>&#x2022;</label>
              <p>The electric field strength is the most critical experimental parameter.</p>
            </list-item>
            <list-item id="u0015">
              <label>&#x2022;</label>
              <p>The volume of the droplet affects viability and gene expression.</p>
            </list-item>
            <list-item id="u05010">
              <label>&#x2022;</label>
              <p>Droplet deformation under a DC electric field is critical.</p>
            </list-item>
          </list>
        </p>
      </abstract>
      <kwd-group id="keys0005">
        <title>Keywords</title>
        <kwd>Electroporation</kwd>
        <kwd>Water-in-oil droplet</kwd>
        <kwd>DC electric field</kwd>
        <kwd>Droplet deformation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>Electroporation (EP) is the most widely used physical method for delivering cell-impermeable molecules into cells due to its versatility and simplicity. EP generates transient pores in the cell membrane when the transmembrane potential exceeds a critical threshold value, altering the permeability of the membrane by application of an external electric field <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>. Many theoretical <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref> and experimental <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>, <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref> approaches have been investigated in an attempt to explain the mechanisms underlying EP, especially those involved in gene transfer. Advanced EP devices have been developed by combining microfabrication techniques and microfluidics <xref rid="bib12" ref-type="bibr">[12]</xref>, <xref rid="bib13" ref-type="bibr">[13]</xref>, <xref rid="bib14" ref-type="bibr">[14]</xref>, <xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib17" ref-type="bibr">[17]</xref>, <xref rid="bib18" ref-type="bibr">[18]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>. EP offers several important advantages compared to viral, chemical, and liposome-based transfection methods, including low cost, reduced safety concerns, simple operation, and no restriction on the cell type or properties of the exogenous material. However, most commercial EP-based transfection methods require the use of specialized, expensive, pulse generators to produce short electrical pulses at high voltage.</p>
      <p>We previously reported a cell electroporation and gene electrotransfer in small volumes using small amounts of cells by water-in-oil droplet actuation in a direct current (DC) electric field (<xref rid="f0005" ref-type="fig">Fig. 1</xref>). When an aqueous droplet is suspended in a dielectric liquid such as oil, it can be moved between a pair of electrodes upon application of a DC electric field (droplet bouncing) <xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib21" ref-type="bibr">[21]</xref>. Our previous study showed that <italic>Escherichia coli</italic> cells were transformed by the bouncing motion of a droplet containing the bacterial cells and plasmid DNA <xref rid="bib22" ref-type="bibr">[22]</xref>. In addition, we found that a more intense electric field can induce droplet elongation, leading to instantaneous short circuiting caused by the droplet contacting the two electrodes simultaneously. The electric pulses delivered to the cells suspended in the droplet are those linked to these &#x201C;shorts&#x201D;. Small pores could be made in the cell membrane during the shorts, allowing the gene electrotransfer. Our further investigation demonstrated efficient transfection of mammalian cells by the droplet actuation in a DC electric field <xref rid="bib23" ref-type="bibr">[23]</xref>; this methodology is termed &#x201C;droplet EP&#x201D; in this paper. However, various parameters affecting the efficiency of droplet EP, such as applied voltage, concentration and exogenous DNA concentration, have not been elucidated for a given electrode geometry. Investigating the effects of these parameters on cell viability and gene expression could contribute to not only efficient transfection, but also to exploring the mechanism underlying this novel gene transfer method.<fig id="f0005"><label>Fig.&#xA0;1</label><caption><p>Schematic illustration of water-in-oil droplet EP.</p></caption><alt-text id="at0005">Fig.&#xA0;1</alt-text><graphic xlink:href="gr1"/></fig></p>
      <p>The aim of this study is to characterize the factors affecting the efficiency of droplet EP by systematically varying the applied voltage, number of short circuits, type of EP medium (electric conductivity), concentration of exogenous DNA, and size of the droplet. A luciferase-expressing plasmid DNA was used as the exogenous DNA and high-throughput assays were conducted in 96-well plates. The results of this investigation provided conditions for efficient droplet EP. Furthermore, we also investigated the formation of transient pores on the cell membrane using a cell-impermeable nucleic acid staining dye (YO-PRO-1 uptake assay). Finally, transfection efficiency was evaluated by expression of fluorescent protein (Venus, improved yellow fluorescent protein) and by flow cytometry under the optimized conditions identified from the luciferase-expressing experiments.</p>
    </sec>
    <sec id="s0010">
      <label>2</label>
      <title>Materials and methods</title>
      <sec id="s0015">
        <label>2.1</label>
        <title>Cell culture</title>
        <p>Human embryonic kidney (HEK) 293 cells (JCRB Cell Bank) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 4&#xA0;mM <sc>l</sc>-glutamine (Wako Pure Chemicals), 10% fetal bovine serum (FBS, One Shot&#x2122; fetal bovine serum, Thermo Fisher Scientific), and penicillin/streptomycin (PS) (Wako Pure Chemicals) at 37&#xA0;&#xB0;C, 5% CO<sub>2</sub>. Cells at 50&#x2013;70% confluence in T25 flasks were treated with 0.25% trypsin-EDTA (Wako Pure Chemicals), harvested by centrifugation, and suspended in DMEM/10% FBS/PS. The cells were then washed with droplet EP medium before final re-suspension in the same medium and the cell concentration was adjusted. Four types of droplet EP medium were used: (1) DMEM with or without 10% FBS, (2) Dulbecco's phosphate-buffered saline without magnesium chloride and calcium chloride (<sc>d</sc>-PBS (-), Wako Pure Chemicals), (3) a low ionic strength 0.28&#xA0;M mannitol, and (4) a mixture of <sc>d</sc>-PBS (-) and 0.28&#xA0;M mannitol (at a 1:1 ratio).</p>
      </sec>
      <sec id="s0020">
        <label>2.2</label>
        <title>Plasmid DNA preparation</title>
        <p>Gene expression after droplet EP was confirmed using two types of plasmid DNA. For the luminometric assay of luciferase expression, pGL4.51 [luc2/CMV/Neo] vector (Promega), a 6358&#xA0;bp plasmid DNA encoding firefly luciferase, was amplified in <italic>Escherichia coli</italic> DH5<italic>&#x3B1;</italic> and purified using a QIAGEN Plasmid Maxi kit (Qiagen) according to the manufacturer's protocol. For the fluorescent protein expression and flow cytometry assays, the Venus yellow fluorescent protein vector provided by Prof. A. Miyawaki (Brain Science Institute, RIKEN) was used <xref rid="bib23" ref-type="bibr">[23]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>. The amplification and purification procedures used in these assays were the same as for the luciferase-expressing vector. Following purification, endotoxin was removed using an endotoxin removal kit (MiraCLEAN&#xAE;, Mirus). The purified plasmid DNAs were dissolved in sterile water and the concentration of each DNA solution was determined using a UV&#x2013;vis spectrometer (GeneQuant1300, GE Healthcare).</p>
      </sec>
      <sec id="s0025">
        <label>2.3</label>
        <title>Water-in-oil droplet electroporation</title>
        <p><xref rid="f0010" ref-type="fig">Fig. 2</xref> shows the experimental setup for droplet EP used in this study. A 24-well cell culture plate (TPP) was used as an oil reservoir. One well of the plate was first filled with 1.5&#xA0;mL of fluorocarbon oil (Fluorinert&#x2122; FC-96, 3M), then 1&#xA0;mL of silicone oil (KF96-1, 100&#xA0;cSt kinematic viscosity, 2.74 dielectric constant, 965&#xA0;kg/m<sup>3</sup> density; Shin-Etsu Chemical Co.) without surfactant was added. A pair of pin electrodes (one ground, one high-voltage (HV)), kindly manufactured by Nepa Gene Co., Ltd., was set in the well. The gap between the electrodes was 6&#xA0;mm. The appropriately prepared cell suspension (2.0&#x2013;4.0&#xA0;&#x3BC;l) was dispensed in the silicone oil and a high voltage was then supplied using a DC HV power supply (HAR-30R10; Matsusada Precision Inc.). During DC HV application, the intense electric field can induce droplet deformation, leading to instantaneous short circuiting caused by the droplet contacting the two electrodes simultaneously. Short circuiting produces a distinctive sound and the number of shorts was counted. Typically, only one short was allowed to occur in one experiment and the DC HV power supply was turned off manually following the designated number of shorts. Following droplet EP, the droplet was recovered and transferred to an appropriate medium for further experiments.<fig id="f0010"><label>Fig.&#xA0;2</label><caption><p>Experimental setup for droplet EP investigated in this study.</p></caption><alt-text id="at0010">Fig.&#xA0;2</alt-text><graphic xlink:href="gr2"/></fig></p>
      </sec>
      <sec id="s0030">
        <label>2.4</label>
        <title>Cell viability and luciferase expression measurement</title>
        <p>Cell viability and gene expression measurements were conducted in a single well of a 96-well plate using a ONE-Glo&#x2122;+Tox luciferase reporter and cell viability assay kit (Promega). The cell viability assay and luciferase expression assay are based on a fluorometric measurement and a luminometric measurement, respectively. The effects of applied voltage, number of short circuits, EP medium, concentration of DNA, and the volume of the droplet on cell viability and luciferase expression were investigated. An appropriate amount of the luciferase-expressing plasmid DNA was added to the cell suspension prepared as described above, then the suspension was dispensed into the oil and droplet EP was performed. The droplet was then transferred to 100&#xA0;&#x3BC;l of DMEM/10% FBS/PS in a 96-well opaque microplate (Nunc LumiNunc 96-well plate, Thermo Fisher Scientific). Following 24&#xA0;h incubation at 37&#xA0;&#xB0;C, 5% CO<sub>2</sub>, cell viability and luciferase expression were measured using a multimode microplate reader (Varioskan Flash, Thermo Fisher Scientific) according to the manufacturer's protocol.</p>
      </sec>
      <sec id="s0035">
        <label>2.5</label>
        <title>YO-PRO-1 uptake assay with fluorometric detection and microscopic observation</title>
        <p>Transient membrane pore formation during droplet EP was confirmed using the YO-PRO-1 uptake assay, conducted as previously described with some modifications <xref rid="bib23" ref-type="bibr">[23]</xref>, <xref rid="bib25" ref-type="bibr">[25]</xref>. YO-PRO-1 was purchased from Life Technologies. A 3.0&#xA0;&#x3BC;l droplet containing 1.0&#xD7;10<sup>4</sup> HEK293 cells suspended in DMEM with 10% FBS and 1&#xA0;&#x3BC;M YO-PRO-1 was added to the silicone oil and droplet EP was performed. The droplet was transferred to 100&#xA0;&#x3BC;l of DMEM with 1&#xA0;&#x3BC;M YO-PRO-1 in a 96-well opaque microplate (Immuno Standard Modules Black, Thermo Fisher Scientific). After 1&#xA0;h incubation at 37&#xA0;&#xB0;C, 5% CO<sub>2</sub>, the fluorescence of the cells was measured by the multimode microplate reader using 485/528&#xA0;nm (excitation/emission) wavelengths, in accordance with the fluorescence properties of YO-PRO-1. Cell proliferation and YO-PRO-1 uptake after droplet EP were confirmed by transferring the droplet to DMEM/10% FBS/PS and <inline-formula><mml:math id="M1" altimg="si0001.gif" overflow="scroll"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.25em"/><mml:mrow><mml:mi mathvariant="normal">&#x3BC;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:mrow></mml:math></inline-formula> YO-PRO-1 in an 8-well cover glass chamber (Nunc&#x2122; Lab-Tek&#x2122; II cover glass chamber, Thermo Fisher Scientific) and incubating for 24&#xA0;h at 37&#xA0;&#xB0;C, 5% CO<sub>2</sub>. The cells were subsequently microscopically observed using an inverted fluorescence microscope (TE-2000U; Nikon) equipped with a 10&#xD7; objective lens (Plan Fluor; Nikon) and a digital camera (D5000; Nikon).</p>
      </sec>
      <sec id="s0040">
        <label>2.6</label>
        <title>Expression of fluorescent protein and flow cytometry</title>
        <p>A 2.0&#xA0;&#x3BC;l aliquot of DMEM without serum containing&#xA0;1.0&#xD7;10<sup>4</sup> HEK293 cells and 0.75&#xA0;&#x3BC;g of Venus-expressing plasmid DNA was added to the silicone oil. The number of shorts was set to one. At least ten droplets were subjected to droplet EP to obtain each experimental data point, and each droplet was transferred to a separate well of a 24-well cell culture plate containing 400&#xA0;&#x3BC;l of DMEM/10% FBS/PS, then incubated for 48&#xA0;h at 37&#xA0;&#xB0;C, 5% CO<sub>2</sub>. Microscopic observation was subsequently conducted to confirm Venus expression, as described above. The cell culture was then trypsinized, harvested by centrifugation, and suspended in buffer containing <sc>d</sc>-PBS (-) and 7-amino-actinomycin D (7-AAD, Beckman Coulter, Inc.) to stain the dead cells. Venus expression and cell viability were measured by flow cytometry with a CytoFLEX flow cytometer (Beckman Coulter, Inc.). At least 10,000 cells were analyzed for each experimental point. Transfection efficiency was calculated by dividing the number of Venus-expressing cells (Venus positive) by the number of live cells (7-AAD negative). Viability was calculated by dividing the number of 7-AAD positive cells by the number of all counted cells.</p>
      </sec>
    </sec>
    <sec id="s0045">
      <label>3</label>
      <title>Results</title>
      <sec id="s0050">
        <label>3.1</label>
        <title>Cell viability and luciferase expression</title>
        <p><xref rid="f0015" ref-type="fig">Fig. 3</xref> shows cell viability and luciferase activity 24&#xA0;h after droplet EP. The results obtained using two negative controls are also shown, where &#x201C;Ctrl&#x201D; means that an aliquot of the cell suspension was directly added to the 96-well plate, and &#x201C;Ctrl (oil)&#x201D; means that another aliquot of the same suspension was dispersed in silicone oil, kept for 3&#xA0;min without applying DC HV, then transferred into the 96-well plate. The conditions used were summarized in <xref rid="t0005" ref-type="table">Table 1</xref>. In conventional electroporation, if the applied voltage is too high, the pores formed in the cell membranes will be too large resulting in cell death. If the voltage is too low, the pore sizes will be inadequate for DNA to cross the cell membranes, resulting in unsuccessful gene expression. Thus, electroporation produces a trade-off between viability and transfection efficiency. The results shown in <xref rid="f0015" ref-type="fig">Fig. 3</xref> indicate that cell viability gradually decreased with increasing applied voltage. On the other hand, luciferase activities markedly increased compared with negative control (without DC HV application). However, significant differences in luciferase activities were not observed in the range of an applied voltage of 2.5&#x2013;3.5&#xA0;kV. This could be attributed to well-based fluorometric (viability) and luminometric (luciferase expression) assays. The One-Glo&#x2122;+Tox luciferase reporter and cell viability kit enables simultaneous measurement of the relative number of viable cells and luciferase activity in a cell culture population. Although this approach is very useful to determine how experimental parameters influence transfection, data obtained from a microplate reader are the sum of the amount of luminescence in the well containing both live and dead cells. The viability at 3.5&#xA0;kV clearly decreased compared to 3.0&#xA0;kV of applied voltage, but a significant difference in luciferase activities was not observed. Therefore, higher transfection efficiency at 3.5&#xA0;kV could be obtained compared with 3.0&#xA0;kV. The results shown in <xref rid="f0015" ref-type="fig">Fig. 3</xref> demonstrate that the applied voltage significantly affects the outcome of droplet EP and therefore applied voltage was used as an experimental variable in the following experiments.<fig id="f0015"><label>Fig.&#xA0;3</label><caption><p>Cell viability (open circle with line) and luciferase activity (bar) 24&#xA0;h after droplet EP. Data are expressed as the mean&#xB1;standard deviation (SD) (<italic>n</italic>=3&#x2013;4). The conditions were: droplet EP medium: DMEM w/o serum, volume of the droplet: 3&#xA0;&#x3BC;l, amount of plasmid DNA: 250&#xA0;ng, cell number: 10,000, number of shorts: 1 short.</p></caption><alt-text id="at0015">Fig.&#xA0;3</alt-text><graphic xlink:href="gr3"/></fig><table-wrap id="t0005" position="float"><label>Table&#xA0;1</label><caption><p>Experimental parameters for cell viability and luciferase expression.</p></caption><alt-text id="at0035">Table&#xA0;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Figure #</th><th># of shorts</th><th>EP buffer</th><th>Amount of DNA [ng]</th><th>Cell # [&#xD7;10<sup>4</sup>]</th><th>Droplet vol. [&#x3BC;l]</th></tr><tr><th/><th/><th/><th>(DNA conc. [ng/&#x3BC;l])</th><th>(cell conc. [&#xD7;10<sup>4</sup>/&#x3BC;l])</th><th/></tr></thead><tbody><tr><td>3</td><td>1</td><td>DMEM w/o FBS</td><td>250 (83.3)</td><td>1.0 (0.33)</td><td>3.0</td></tr><tr><td>4</td><td/><td/><td/><td/><td/></tr><tr><td>(a), (f)</td><td>1, 2, 3</td><td>DMEM w/o FBS</td><td>250 (83.3)</td><td>1.0 (0.33)</td><td>3.0</td></tr><tr><td/><td/><td><sc>d</sc>-PBS(-)</td><td/><td/><td/></tr><tr><td>(b), (g)</td><td>1</td><td>0.28&#xA0;M mannitol</td><td>250 (83.3)</td><td>1.0 (0.33)</td><td>3.0</td></tr><tr><td/><td/><td><sc>d</sc>-PBS+mannitol (1:1)</td><td/><td/><td/></tr><tr><td/><td/><td/><td>62.5 (20.8)</td><td/><td/></tr><tr><td>(c), (h)</td><td>1</td><td>DMEM w/o FBS</td><td>125 (41.7)</td><td>1.0 (0.33)</td><td>3.0</td></tr><tr><td/><td/><td/><td>250 (83.3)</td><td/><td/></tr><tr><td/><td/><td/><td>250 (125)</td><td>1.0 (0.5)</td><td>2.0</td></tr><tr><td>(d), (i)</td><td>1</td><td>DMEM w/o FBS</td><td>250 (83.3)</td><td>1.0 (0.33)</td><td>3.0</td></tr><tr><td/><td/><td/><td>250 (62.5)</td><td>1.0 (0.25)</td><td>4.0</td></tr><tr><td>(e), (j)</td><td>1</td><td>DMEM w/o FBS</td><td>500, 1000 (250)</td><td>0.5, 1.0 (0.25)</td><td>2.0, 4.0</td></tr></tbody></table></table-wrap></p>
        <p><xref rid="f0020" ref-type="fig">Fig. 4</xref> shows the effect of applied voltage, number of shorts, droplet EP medium, concentration of plasmid DNA, and volume of the droplet on cell viability and luciferase expression 24&#xA0;h after droplet EP. Detailed experimental parameters are summarized in <xref rid="t0005" ref-type="table">Table 1</xref>. Experimental data in a pair of viability and luciferase activity were obtained by using a cell suspension prepared with a single cell culture. However, each pair of the data was obtained on different days. Therefore, the cell health under different cell conditions, such as the number of passages, confluency before droplet EP, was not completely the same in different experimental parameters. It could be attributed that some of the same experimental conditions showed different results in <xref rid="f0020" ref-type="fig">Fig. 4</xref>. In addition, our previous results based on trypan blue assay demonstrated that the use of silicone oil had little effect on the viability of HEK293 cells in water-in-oil droplets <xref rid="bib23" ref-type="bibr">[23]</xref>. However, the viability of &#x201C;Ctrl (oil)&#x201D; in <xref rid="f0020" ref-type="fig">Fig. 4</xref> varied from 120% to 60%. One possible reason for this could be the sequence of the experiment. In this experiment, the cell suspension without any treatment was initially transferred in a 96-well plate, then droplet EP was performed in order. Finally, the same suspension was dispersed in silicone oil, kept for 3&#xA0;min without applying DC HV, then transferred into the 96-well plate. Therefore, cells in &#x201C;Ctrl (oil)&#x201D; were kept in suspension for a long time, which could have contributed to the cell health in this experiment. The other possible reason is transferring the droplet from the oil to a 96-well plate. This is one of the drawbacks of this transfection method. It is difficult to completely recover the treated cells. Thus this process could affect the reproducibility of the measurement of viability and luciferase activity.<fig id="f0020"><label>Fig.&#xA0;4</label><caption><p>Cell viability (a)&#x2013;(e) and luciferase activity (f)&#x2013;(j) 24&#xA0;h after droplet EP using various experimental conditions. Data are expressed as the mean&#xB1;standard deviation (SD) (<italic>n</italic>=3&#x2013;4). The experimental variables for each result were: (a) and (f): number of shorts, (b) and (g): droplet EP medium, (c) and (h): concentration of DNA, (d) and (i): size of droplet, keeping the number of cells and amount of DNA in each droplet constant, and (e) and (j) size of droplet, keeping the concentrations of cells and DNA in each droplet constant.</p></caption><alt-text id="at0020">Fig.&#xA0;4</alt-text><graphic xlink:href="gr4"/></fig></p>
        <p><xref rid="f0020" ref-type="fig">Fig. 4</xref>(a) and (f) show the effect of the number of shorts. The distinctive sound caused by shorts meant each short could be counted. The applied voltage was varied from 2.5 to 4.0&#xA0;kV. <xref rid="f0020" ref-type="fig">Fig. 4</xref>(a) indicates that cell viability was affected by increasing both the applied voltage and the number of shorts, with both stronger electric fields and an increased number of shorts inducing more cellular damage. <xref rid="f0020" ref-type="fig">Fig. 4</xref>(f) shows a increase in luciferase activity with droplet EP, consistent with the results shown in <xref rid="f0015" ref-type="fig">Fig. 3</xref>, whereas the number of shorts did not apparently affect gene expression. As stated previously, decreased luciferase activity is likely attributable to lower cell viability.</p>
        <p><xref rid="f0020" ref-type="fig">Fig. 4</xref>(b) and (g) show the effect of the EP medium on viability and luciferase activity using applied voltages in the range 2.0&#x2013;3.2&#xA0;kV. The three media tested were: (1) <sc>d</sc>-PBS (-), (2) a low ionic strength 0.28&#xA0;M mannitol, and (3) a mixture of <sc>d</sc>-PBS (-) and 0.28&#xA0;M mannitol (at a ratio of 1:1). The electrical conductivities of the media measured using a conductivity meter (Thermo Scientific) were 15.8&#xA0;mS/cm, 8.9&#xA0;&#x3BC;S/cm, and 8.7&#xA0;mS/cm, respectively. In the other experiments, DMEM without serum was used as the EP medium; the conductivity of this medium is almost the same as that of <sc>d</sc>-PBS (-), and cell viability and luciferase expression after droplet EP in DMEM without serum showed a similar trend to that observed using <sc>d</sc>-PBS (-) (data not shown).</p>
        <p>The threshold voltage required for droplet deformation was dependent on the electrical conductivity of the droplet EP medium. No droplet deformation was observed at an applied voltage of 2.0&#xA0;kV using <sc>d</sc>-PBS (-) and the mixture of <sc>d</sc>-PBS (-) and 0.28&#xA0;M mannitol. Therefore, droplet bouncing, described in the introduction, was conducted for 3&#xA0;min at 2.0&#xA0;kV in both media. Furthermore, no droplet deformation was observed at applied voltages of 2.0 and 2.3&#xA0;kV using the 0.28&#xA0;M mannitol and so droplet bouncing was conducted for 3&#xA0;min at 2.0 and 2.3&#xA0;kV in this media. <xref rid="f0020" ref-type="fig">Fig. 4</xref>(b) shows that cell viability in low electrical conductivity media decreased drastically with increasing applied voltage compared to when the cells were in high electrical conductivity media, consistent with the threshold voltage required for droplet deformation. Although cell viability in mannitol and PBS+mannitol showed similar trend, luciferase activity was not observed in the case of mannitol as shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>(g). This suggests that electric current in the electric pulsation could be required for sufficient gene electrotransfer.</p>
        <p><xref rid="f0020" ref-type="fig">Fig. 4</xref>(c) and (h) show the effect of the concentration of exogenous DNA on cell viability and luciferase activity in DMEM w/o serum and keeping all the other parameters the same as described above. <xref rid="f0020" ref-type="fig">Fig. 4</xref>(c) shows that the effect of the concentration of DNA on cell viability was smaller than the effect of the number of shorts, whereas luciferase activity was strongly affected by the concentration of exogenous DNA for each applied voltage (<xref rid="f0020" ref-type="fig">Fig. 4</xref>(h)), with an increasing concentration of DNA resulting in enhanced gene expression, as generally reported. Viability plotted in <xref rid="f0020" ref-type="fig">Fig. 4</xref>(c) expect at 2.0&#xA0;kV, 83.3&#xA0;ng/&#x3BC;l was relatively high compared with the other graphs seen in <xref rid="f0020" ref-type="fig">Fig. 4</xref>. In addition, the viability at 2.0&#xA0;kV, 83.3&#xA0;ng/&#x3BC;l was particularly low compared with the other applied voltage. Therefore this low viability could be attributed to some experimental error including transferring the droplet from the oil to a 96 well plate, as mentioned above. <xref rid="f0020" ref-type="fig">Fig. 4</xref>(d) and (i) show the effect of size of the droplet as it was varied between 2.0, 3.0, and 4.0&#xA0;&#x3BC;l. Therefore, a smaller droplet contained both cells and DNA at higher concentration. <xref rid="f0020" ref-type="fig">Fig. 4</xref>(d) shows that the viability 24&#xA0;h after droplet EP was not affected by the volume of the droplets but was affected by the number of shorts, consistent with the effect of the concentration of DNA (<xref rid="f0020" ref-type="fig">Fig. 4</xref>(c)). In contrast, <xref rid="f0020" ref-type="fig">Fig. 4</xref>(i) shows a marked decrease in luciferase expression with an increase in the volume of the droplets, suggesting that a smaller droplet with a higher concentration of cells and DNA results in more efficient transfection. However, the volume of the droplet should be correlated with the deformation of the droplet. In particular, smaller droplet should be more flattened at the moment of the short, a higher electric field could be created. Therefore, cells inside the droplet would be exposed to different electrical field intensities depending on the volume of the droplet. To examine the effect of the volume of the droplet on viability and luciferase expression while keeping the cell and DNA concentrations the same, a 2.5&#xD7;10<sup>3</sup>&#xA0;cells/&#x3BC;l cell suspension containing 250&#xA0;ng/&#x3BC;l plasmid DNA was prepared in DMEM without FBS. In one experiment, 4.0&#xA0;&#x3BC;l droplets were subjected to droplet EP, then the droplet was transferred to one well of a 96-well plate. In a second experiment, two 2.0&#xA0;&#x3BC;l droplets were separately subjected to droplet EP, then both droplets were transferred to the same well of a 96-well plate. This experimental procedure allowed evaluation of the effect of the size of the droplet on droplet EP when maintaining the same cell and DNA concentration and the results are shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>(e) and (j). <xref rid="f0020" ref-type="fig">Fig. 4</xref>(e) indicates that the cell viability decreased as the applied voltage increased and that viability decreased as the size of the droplet decreased. This suggests that both stronger electric fields and much smaller droplet size cause more cellular damage. However, luciferase activity was notably increased as the volume of the droplet decreased for each applied voltage (<xref rid="f0020" ref-type="fig">Fig. 4</xref>(j)) and again this can be attributed to the electric field strength being stronger in smaller sized droplets.</p>
      </sec>
      <sec id="s0055">
        <label>3.2</label>
        <title>YO-PRO-1 uptake assay</title>
        <p>The results of the YO-PRO-1 uptake assays are shown in <xref rid="f0025" ref-type="fig">Fig. 5</xref>. A cell-impermeable nucleic acid staining dye YO-PRO-1 was used to confirm the formation of transient pores on the cell membrane. <xref rid="f0025" ref-type="fig">Fig. 5</xref>(a) shows the result of fluorometric measurements 1&#xA0;h after droplet EP and shows a significant increase in fluorescence intensity compared to in the absence of DC HV application. Furthermore, a higher applied voltage resulted in a larger increase in fluorescence intensity. However, not only transient pore formation but also dead cells possibly lead to an increase in fluorescence intensity. To investigate whether the treated cells were viable or not, cell proliferation following droplet EP was confirmed. <xref rid="f0025" ref-type="fig">Fig. 5</xref>(b) shows the results of microscopic observation after droplet EP and 24&#xA0;h incubation. Although the number of cells that appeared in &#x201C;Ctrl&#x201D; is less than one in &#x201C;3.0&#xA0;kV&#x201D;, comparison of the two phase contrast images shows that the morphology of the treated cells was similar to that of the control. Thus, it can be concluded that there is no notable difference in cell proliferation. In contrast, the fluorescent images are clearly different: cells treated with an applied voltage of 3.0&#xA0;kV were stained with YO-PRO-1, indicating that YO-PRO-1 molecules entered the cells and bound to intracellular nucleic acids, and that therefore transient pores were formed during droplet EP.<fig id="f0025"><label>Fig.&#xA0;5</label><caption><p>YO-PRO-1 uptake assay. (a) Fluorescence intensity 1&#xA0;h after droplet EP. Data are expressed as the mean&#xB1;standard deviation (SD) (<italic>n</italic>=4). Statistical analysis was performed using Student's <italic>t</italic>-test. Statistical significance was recognized at *<italic>p</italic>&lt;0.05. (b) Microscopic images after 24&#xA0;h incubation following droplet EP ((upper) phase contrast (PC) (lower) fluorescence (FL)).</p></caption><alt-text id="at0025">Fig.&#xA0;5</alt-text><graphic xlink:href="gr5"/></fig></p>
      </sec>
      <sec id="s0060">
        <label>3.3</label>
        <title>Fluorescent protein expression and flow cytometry</title>
        <p><xref rid="f0030" ref-type="fig">Fig. 6</xref> shows the results of microscopic observation after droplet EP and 48&#xA0;h incubation. The amount of DNA was increased (750&#xA0;ng/2.0&#xA0;&#x3BC;l-droplet) to provide sufficient fluorescence intensity. <xref rid="f0030" ref-type="fig">Fig. 6</xref>(a) shows phase contrast and fluorescent images without HV treatment and after 48&#xA0;h incubation. Consistent with the results in <xref rid="f0025" ref-type="fig">Fig. 5</xref>(b), cell proliferation was observed whereas Venus expression was not. <xref rid="f0030" ref-type="fig">Fig. 6</xref>(b) and (c) show phase contrast and fluorescent images after droplet EP with an applied voltage of 2.0&#xA0;kV or 3.0&#xA0;kV, respectively, and subsequent 48&#xA0;h incubation. Comparison of <xref rid="f0030" ref-type="fig">Fig. 6</xref>(b) and(c) with <xref rid="f0030" ref-type="fig">Fig. 6</xref>(a) shows no notable difference in cell proliferation. In contrast, healthy cells with significant signal intensity are observed in <xref rid="f0030" ref-type="fig">Fig. 6</xref>(b) and (c). In addition, comparison of the fluorescent images in <xref rid="f0030" ref-type="fig">Fig. 6</xref>(b) and (c) shows a larger number of Venus expressing cells with higher fluorescence intensity in <xref rid="f0030" ref-type="fig">Fig. 6</xref>(c). <xref rid="t0010" ref-type="table">Table 2</xref> summarizes the viability and the transfection efficiency after droplet EP and 48&#xA0;h incubation. The results show that cell viability gradually decreased with increasing applied voltage, and the expression of fluorescent protein was enhanced with increasing applied voltage. This result agreed with the luciferase-expression experiment.<fig id="f0030"><label>Fig.&#xA0;6</label><caption><p>Microscopic images of fluorescent protein expressing cells after 48&#xA0;h incubation following droplet EP ((upper) phase contrast (PC) (lower) fluorescence (FL)). (a) Without droplet EP, (b) 2.0&#xA0;kV applied voltage, and (c) 3.0&#xA0;kV applied voltage. Scale bars: 100&#xA0;&#xB5;m.</p></caption><alt-text id="at0030">Fig.&#xA0;6</alt-text><graphic xlink:href="gr6"/></fig><table-wrap id="t0010" position="float"><label>Table&#xA0;2</label><caption><p>Viability and transfection efficiency after 48&#xA0;h incubation following droplet EP.</p></caption><alt-text id="at0040">Table&#xA0;2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Experimental condition</th><th>Viability (%)</th><th>Transfection efficiency (%)</th></tr></thead><tbody><tr><td>Ctrl</td><td>98</td><td>0.1</td></tr><tr><td>2.0&#xA0;kV</td><td>96</td><td>1.0</td></tr><tr><td>3.0&#xA0;kV</td><td>69</td><td>13.0</td></tr></tbody></table></table-wrap></p>
      </sec>
    </sec>
    <sec id="s0065">
      <label>4</label>
      <title>Discussion</title>
      <p>In this paper, various experimental parameters of the droplet EP method were examined to characterize our method. As shown in <xref rid="f0015" ref-type="fig">Fig.&#xA0;3</xref>, <xref rid="f0020" ref-type="fig">Fig.&#xA0;4</xref>, an increase in the applied voltage resulted in decreased cell viability and enhanced gene expression. The data shown in <xref rid="f0025" ref-type="fig">Fig. 5</xref> indicate that the formation of transient pores during droplet EP and uptake of cell impermeable molecules were enhanced by increasing the applied voltage. The Venus expression experiment showed that cell viability as measured by flow cytometry was consistent with the data shown in <xref rid="f0015" ref-type="fig">Fig.&#xA0;3</xref>, <xref rid="f0020" ref-type="fig">Fig.&#xA0;4</xref>, and the Venus and luciferase expression data showed similar trends. Taken together, the results suggest that the electric field strength is the most critical experimental parameter affecting cell viability, gene expression, and transient pore formation, the latter of which is essential for transfection. This finding suggests that the mechanism underlying droplet EP is similar to that of conventional EP. In addition, <xref rid="f0020" ref-type="fig">Fig. 4</xref>(a) indicates that cell viability decreased as the number of shorts increased. The short corresponds to the pulsed electric field in conventional EP and further supports our conclusion that droplet EP is similar to conventional EP. The application of both theoretical and experimental techniques, such as uptake of cell impermeable material and reporter gene expression, showed that higher electric field strength induces a larger number of transient membrane pores in conventional EP <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib25" ref-type="bibr">[25]</xref>, <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>. Since YO-PRO-1 uptake and gene expression observed in this study showed similar trends with conventional EP, it appears that the size and number of transient pores generated by application of a pulsed electric field are the dominant parameters affecting the efficiency of transfection. Our results indicate that approximately 3.0&#xA0;kV, which is equivalent to an electric field strength of 5.0&#xA0;kV/cm, is optimal for the experimental configuration used here. However, a more intense electric field &gt;5.0&#xA0;kV/cm would be generated near the wire electrodes due to the &#x201C;edge&#x201D; effect, as mentioned in the previous report <xref rid="bib23" ref-type="bibr">[23]</xref>. In addition, the optimum electric field strength will be dependent on the cell line, and therefore further studies are required using different cell lines.</p>
      <p><xref rid="f0020" ref-type="fig">Fig. 4</xref>(b) indicates that the electrical conductivity of the droplet EP medium affects cell viability, with viability being drastically decreased in media with lower electrical conductivity as the applied voltage increased. This drastic change in cell viability arises from the threshold voltage for droplet deformation. In addition, luciferase activity was not observed in the case of mannitol as shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>(g). This suggests that electric current in the electric pulsation could be required. However, further electrical conductivity experiments are required to provide more experimental data points. <xref rid="f0020" ref-type="fig">Fig. 4</xref>(h) and (i) indicate that an increase in the concentration of DNA and a decrease in the volume of the droplet notably enhance luciferase expression, suggesting that both the concentration of DNA and the cells strongly influence gene expression due to an increase in the frequency of collisions between cells and DNA molecules during droplet EP. One of the advantage of droplet EP is that a smaller volume of cell suspension is required compared with conventional EP, perhaps allowing EP using much higher concentrations of cells and DNA than is possible with conventional EP. <xref rid="f0020" ref-type="fig">Fig. 4</xref>(e) and (j) clearly show that the volume of the droplet affects viability and gene expression after droplet EP and may be correlated with deformation of the droplet. As shown in <xref rid="f0005" ref-type="fig">Fig. 1</xref>, instantaneous short circuiting caused by the droplet causes an extension of the long axis of the droplet until the droplet spans the distance between the electrodes. The lower viability and higher luciferase activity with a smaller droplet indicate that the cells inside the droplet were exposed to higher electric field. The possible reason is that the thickness of the expanded droplet could affect the electric field forming at the tips of the expanded droplet. Although the current value has not been measured yet, a smaller droplet might lead to an increase of current density and it could also affect the transfection, as suggested in previous report <xref rid="bib28" ref-type="bibr">[28]</xref>. The characteristics of the electrical pulse delivered by droplet deformation and the correlation with the transfection will be investigated in future work.</p>
      <p>Although the transfection efficiency of EP depends on various experimental conditions such as the cell line, confluency of the cells, and pulse parameters, typical EP using commercially available equipment provides transfection efficiency of 10&#x2013;20% <xref rid="bib27" ref-type="bibr">[27]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>. Therefore, the transfection efficiency of our method is comparable, as summarized in <xref rid="t0010" ref-type="table">Table 2</xref>, as was cell viability, but in contrast with conventional methods, an expensive pulse generator and special reagents are not required. In addition, droplet EP works well with 5000&#x2013;10,000 cells, a number well suited for typical multi-well plate experiments. This enables high-throughput assays and may find applications in life science, for example, in the functional analysis of specific genes, chemicals, and possibly signaling pathways. However, the reproducibility and operability of the droplet EP method requires improvement for these future applications and this can be addressed by improving the experimental setup.</p>
    </sec>
    <sec id="s0070">
      <label>5</label>
      <title>Conclusion</title>
      <p>This paper describes the characterization of droplet EP by varying various experimental parameters and demonstrates that the electric field strength is the most critical experimental parameter affecting cell viability, gene expression, and transient pore formation, which is essential for transfection. Our findings suggest that droplet EP is similar to conventional EP. The number of shorts and electrical conductivity of the medium also affect cell viability. A higher concentration of cells and DNA in the droplet aids efficient transfection. The volume of the droplet affects viability and gene expression after droplet EP and may be correlated with deformation of the droplet. Droplet deformation under the DC electric field is critical in our electroporation method.</p>
    </sec>
  </body>
  <back>
    <ref-list id="bibliog0005">
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal" id="sbref1">
          <person-group person-group-type="author">
            <name>
              <surname>Neumann</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Schaefer-Ridder</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hofschneider</surname>
              <given-names>P.H.</given-names>
            </name>
          </person-group>
          <article-title>Gene transfer into mouse lyoma cells by electroporation in high electric fields</article-title>
          <source>EMBO J.</source>
          <volume>1</volume>
          <issue>7</issue>
          <year>1982</year>
          <fpage>841</fpage>
          <lpage>845</lpage>
          <pub-id pub-id-type="pmid">6329708</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal" id="sbref2">
          <person-group person-group-type="author">
            <name>
              <surname>Yarmush</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Golberg</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ser&#x161;a</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kotnik</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Miklav&#x10D;i&#x10D;</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Electroporation-based technologies for medicine: principles, applications, and challenges</article-title>
          <source>Annu. Rev. Biomed. Eng.</source>
          <volume>16</volume>
          <year>2014</year>
          <fpage>295</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">24905876</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal" id="sbref3">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Smye</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Membrane electroporation theories: a review</article-title>
          <source>Med. Biol. Eng. Comput.</source>
          <volume>44</volume>
          <issue>1&#x2013;2</issue>
          <year>2006</year>
          <fpage>5</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">16929916</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal" id="sbref4">
          <person-group person-group-type="author">
            <name>
              <surname>Krassowska</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Filev</surname>
              <given-names>P.D.</given-names>
            </name>
          </person-group>
          <article-title>Modeling electroporation in a single cell</article-title>
          <source>Biophys. J.</source>
          <volume>92</volume>
          <issue>2</issue>
          <year>2007</year>
          <fpage>404</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="pmid">17056739</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal" id="sbref5">
          <person-group person-group-type="author">
            <name>
              <surname>Pavlin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Miklav&#x10D;i&#x10D;</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>The effective conductivity and the induced transmembrane potential in dense cell system exposed to DC and AC electric fields</article-title>
          <source>IEEE Trans. Plasma Sci.</source>
          <volume>37</volume>
          <issue>1</issue>
          <year>2009</year>
          <fpage>99</fpage>
          <lpage>106</lpage>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal" id="sbref6">
          <person-group person-group-type="author">
            <name>
              <surname>Pucihar</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kotnik</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Miklav&#x10D;i&#x10D;</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Teissi&#xE9;</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Kinetics of transmembrane transport of small molecules into electropermeabilized cells</article-title>
          <source>Biophys. J.</source>
          <volume>95</volume>
          <issue>6</issue>
          <year>2008</year>
          <fpage>2837</fpage>
          <lpage>2848</lpage>
          <pub-id pub-id-type="pmid">18539632</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal" id="sbref7">
          <person-group person-group-type="author">
            <name>
              <surname>Pavlin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kandu&#x161;er</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>New insights into the mechanisms of gene electrotransfer &#x2013; experimental and theoretical analysis</article-title>
          <source>Sci. Rep.</source>
          <volume>5</volume>
          <year>2015</year>
          <fpage>9132</fpage>
          <pub-id pub-id-type="pmid">25778848</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal" id="sbref8">
          <person-group person-group-type="author">
            <name>
              <surname>Golzio</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Teissi&#xE9;</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rols</surname>
              <given-names>M.-P.</given-names>
            </name>
          </person-group>
          <article-title>Direct visualization at the single-cell level of electrically mediated gene delivery</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>99</volume>
          <issue>3</issue>
          <year>2002</year>
          <fpage>1292</fpage>
          <lpage>1297</lpage>
          <pub-id pub-id-type="pmid">11818537</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal" id="sbref9">
          <person-group person-group-type="author">
            <name>
              <surname>Paganin-Gioanni</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bellard</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Escoffre</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Rols</surname>
              <given-names>M.-P.</given-names>
            </name>
            <name>
              <surname>Teissi&#xE9;</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Golzio</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>108</volume>
          <issue>26</issue>
          <year>2011</year>
          <fpage>10443</fpage>
          <lpage>10447</lpage>
          <pub-id pub-id-type="pmid">21670256</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal" id="sbref10">
          <person-group person-group-type="author">
            <name>
              <surname>Haberl</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kandu&#x161;er</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Flisar</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hod&#x17E;i&#x107;</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bregar</surname>
              <given-names>V.B.</given-names>
            </name>
            <name>
              <surname>Miklav&#x10D;i&#x10D;</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Escoffre</surname>
              <given-names>J.-M.</given-names>
            </name>
            <name>
              <surname>Rols</surname>
              <given-names>M.-P.</given-names>
            </name>
            <name>
              <surname>Pavlin</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Effect of different parameters used for in vitro gene electrotransfer on gene expression efficiency, cell viability and visualization of plasmid DNA at the membrane level</article-title>
          <source>J. Gene Med.</source>
          <volume>15</volume>
          <issue>5</issue>
          <year>2013</year>
          <fpage>169</fpage>
          <lpage>181</lpage>
          <pub-id pub-id-type="pmid">23564663</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal" id="sbref11">
          <person-group person-group-type="author">
            <name>
              <surname>Rosazza</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Buntz</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rie&#xDF;</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>W&#xF6;ll</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zumbusch</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rols</surname>
              <given-names>M.-P.</given-names>
            </name>
          </person-group>
          <article-title>Intracellular tracking of single-plasmid DNA particles after delivery by electroporation</article-title>
          <source>Mol. Ther.</source>
          <volume>21</volume>
          <issue>12</issue>
          <year>2013</year>
          <fpage>2217</fpage>
          <lpage>2226</lpage>
          <pub-id pub-id-type="pmid">23941812</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal" id="sbref12">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>K.F.</given-names>
            </name>
          </person-group>
          <article-title>A microfluidic electroporation device for cell lysis</article-title>
          <source>Lab Chip</source>
          <volume>5</volume>
          <year>2005</year>
          <fpage>23</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">15616736</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal" id="sbref13">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>H.-Y.</given-names>
            </name>
            <name>
              <surname>Bhunia</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>A microfluidic flow-through device for high throughput electrical lysis of bacterial cells based on continuous DC voltage</article-title>
          <source>Biosens. Bioelectron.</source>
          <volume>22</volume>
          <issue>5</issue>
          <year>2006</year>
          <fpage>582</fpage>
          <lpage>588</lpage>
          <pub-id pub-id-type="pmid">16530400</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal" id="sbref14">
          <person-group person-group-type="author">
            <name>
              <surname>Guignet</surname>
              <given-names>E.G.</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Suspended-drop electroporation for high-throughput delivery of biomolecules into cells</article-title>
          <source>Nat. Methods</source>
          <volume>5</volume>
          <issue>5</issue>
          <year>2008</year>
          <fpage>393</fpage>
          <lpage>395</lpage>
          <pub-id pub-id-type="pmid">18408727</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal" id="sbref15">
          <person-group person-group-type="author">
            <name>
              <surname>Geng</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zhan</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H.-Y.</given-names>
            </name>
            <name>
              <surname>Witting</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Cornetta</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Flow-through electroporation based on constant voltage for large-volume transfection of cells</article-title>
          <source>J. Control. Release</source>
          <volume>144</volume>
          <issue>1</issue>
          <year>2010</year>
          <fpage>91</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">20117155</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal" id="sbref16">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>An efficient and high-throughput electroporation microchip applicable for siRNA delivery</article-title>
          <source>Lab Chip</source>
          <volume>11</volume>
          <issue>1</issue>
          <year>2011</year>
          <fpage>163</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="pmid">20957267</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal" id="sbref17">
          <person-group person-group-type="author">
            <name>
              <surname>Adamo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Arione</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sharei</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>K.F.</given-names>
            </name>
          </person-group>
          <article-title>Flow-through comb electroporation device for delivery of macromolecules</article-title>
          <source>Anal. Chem.</source>
          <volume>85</volume>
          <issue>3</issue>
          <year>2013</year>
          <fpage>1637</fpage>
          <lpage>1641</lpage>
          <pub-id pub-id-type="pmid">23259401</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal" id="sbref18">
          <person-group person-group-type="author">
            <name>
              <surname>Trainito</surname>
              <given-names>C.I.</given-names>
            </name>
            <name>
              <surname>Fran&#xE7;ais</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Le Pioufle</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Monitoring the permeabilization of a single cell in a microfluidic device, through the estimation of its dielectric properties based on combined dielectrophoresis and electrorotation in situ experiments</article-title>
          <source>Electrophoresis</source>
          <volume>36</volume>
          <issue>9&#x2013;10</issue>
          <year>2015</year>
          <fpage>1115</fpage>
          <lpage>1122</lpage>
          <pub-id pub-id-type="pmid">25641658</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal" id="sbref19">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>A flow-through cell electroporation device for rapidly and efficiently transfecting massive amounts of cells in vitro and ex vivo</article-title>
          <source>Sci. Rep.</source>
          <volume>6</volume>
          <year>2016</year>
          <fpage>18469</fpage>
          <pub-id pub-id-type="pmid">26728941</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal" id="sbref20">
          <person-group person-group-type="author">
            <name>
              <surname>Hase</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>S.N.</given-names>
            </name>
            <name>
              <surname>Yoshikawa</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Rhythmic motion of a droplet under a dc electric field</article-title>
          <source>Phys. Rev. E &#x2013; Stat. Nonlinear Soft Matter Phys.</source>
          <volume>74</volume>
          <issue>4</issue>
          <year>2006</year>
          <fpage>046301</fpage>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal" id="sbref21">
          <person-group person-group-type="author">
            <name>
              <surname>Im</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Noh</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>N.W.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>I.S.</given-names>
            </name>
          </person-group>
          <article-title>Influences of electric field on living cells in a charged water-in-oil droplet under electrophoretic actuation</article-title>
          <source>Biomicrofluidics</source>
          <volume>5</volume>
          <issue>4</issue>
          <year>2011</year>
          <fpage>044112</fpage>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal" id="sbref22">
          <person-group person-group-type="author">
            <name>
              <surname>Asada</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kurita</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Antoniu</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Yasuda</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Takashima</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>A novel gene transformation technique using water-in-oil droplet in an electrostatic field</article-title>
          <source>IEEE Trans. Ind. Appl.</source>
          <volume>49</volume>
          <issue>1</issue>
          <year>2013</year>
          <fpage>311</fpage>
          <lpage>315</lpage>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal" id="sbref23">
          <person-group person-group-type="author">
            <name>
              <surname>Kurita</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Asada</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Matsuo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kishikawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Numano</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Novel parallelized electroporation by electrostatic manipulation of a water-in-oil droplet as a microreactor</article-title>
          <source>PLoS One</source>
          <volume>10</volume>
          <issue>12</issue>
          <year>2015</year>
          <fpage>e0144254</fpage>
          <pub-id pub-id-type="pmid">26649904</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal" id="sbref24">
          <person-group person-group-type="author">
            <name>
              <surname>Nagai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sawano</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Miyawaki</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Circularly permuted green fluorescent proteins engineered to sense Ca<sup>2+</sup></article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>98</volume>
          <issue>6</issue>
          <year>2001</year>
          <fpage>3197</fpage>
          <lpage>3202</lpage>
          <pub-id pub-id-type="pmid">11248055</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <mixed-citation publication-type="other" id="othref0005">Dermol, J., Pakhomova, O.N., Xiao, S., Pakhomov, A.G., Miklav&#x10D;i&#x10D;, D., 2016. In: Proceedings of the 1st World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food &amp; Environmental Technologies. Portoro&#x17E;, Slovenia, 6&#x2013;10 September 2015. Springer Singapore. Ch. Cell Sensitization is Induced by a Wide Range of Permeabilizing Electric Fields, pp. 163&#x2013;166.</mixed-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal" id="sbref25">
          <person-group person-group-type="author">
            <name>
              <surname>Pakhomov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gianulis</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Vernier</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Semenov</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pakhomova</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Multiple nanosecond electric pulses increase the number but not the size of long-lived nanopores in the cell membrane</article-title>
          <source>Biochim. Biophys. Acta &#x2013; Biomembr.</source>
          <volume>1848</volume>
          <issue>4</issue>
          <year>2015</year>
          <fpage>958</fpage>
          <lpage>966</lpage>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal" id="sbref26">
          <person-group person-group-type="author">
            <name>
              <surname>Marjanovi&#x10D;</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Haberl</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Miklav&#x10D;i&#x10D;</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kandu&#x161;er</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pavlin</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Analysis and comparison of electrical pulse parameters for gene electrotransfer of two different cell lines</article-title>
          <source>J. Membr. Biol.</source>
          <volume>236</volume>
          <issue>1</issue>
          <year>2010</year>
          <fpage>97</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="pmid">20645081</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal" id="sbref27">
          <person-group person-group-type="author">
            <name>
              <surname>Shintaku</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hakamada</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Measurement of local electric field in microdevices for low-voltage electroporation of adherent cells</article-title>
          <source>Microsyst. Technol.</source>
          <volume>20</volume>
          <issue>2</issue>
          <year>2014</year>
          <fpage>303</fpage>
          <lpage>313</lpage>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal" id="sbref28">
          <person-group person-group-type="author">
            <name>
              <surname>Marjanovi&#x10D;</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kandu&#x161;er</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Miklav&#x10D;i&#x10D;</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Keber</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pavlin</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Comparison of flow cytometry, fluorescence microscopy and spectrofluorometry for analysis of gene electrotransfer efficiency</article-title>
          <source>J. Membr. Biol.</source>
          <volume>247</volume>
          <issue>12</issue>
          <year>2014</year>
          <fpage>1259</fpage>
          <lpage>1267</lpage>
          <pub-id pub-id-type="pmid">25146882</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="s0080">
      <label>Appendix A</label>
      <title>Transparency document</title>
      <p>
        <supplementary-material content-type="local-data" id="ec0005">
          <caption>
            <title>Transparency documentApplication 1</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ack0005">
      <title>Acknowledgment</title>
      <p>This work was supported by a <funding-source id="gs1">Grant-in-Aid for Young Scientists</funding-source> (B) (24760648 to H.K.) and a Grant-in-Aid for Scientific Research (C) (24590350 to R.N. and 26390096 to H.K.) from the <funding-source id="gs4">Japan Society for the Promotion of Science</funding-source> (JSPS), and a Grant-in-Aid for Scientific Research in Innovative Areas &#x201C;Plasma Medical Innovation&#x201D; (24108005 to A.M.) from the <funding-source id="gs5">Ministry of Education, Culture, Sports, Science and Technology</funding-source> (MEXT), Japan. R.N. was also supported in part by <funding-source id="gs6">Takeda Science Foundation</funding-source> and <funding-source id="gs7">The Tatematsu Foundation</funding-source>. We would like to thank Prof. A. Miyawaki of BSI, RIKEN for providing the plasmids encoding fluorescent protein. The electrodes were provided by Nepa Gene Co., Ltd.</p>
    </ack>
    <fn-group>
      <fn id="s0075" fn-type="supplementary-material">
        <label>Appendix A</label>
        <p>Transparency document associated with this article can be found in the online version at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrep.2016.08.001" id="ir0005">doi:10.1016/j.bbrep.2016.08.001</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biochem Biophys Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Biochem Biophys Rep</journal-id>
      <journal-title-group>
        <journal-title>Biochemistry and Biophysics Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2405-5808</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28955930</article-id>
      <article-id pub-id-type="pmc">5613635</article-id>
      <article-id pub-id-type="publisher-id">S2405-5808(16)30116-9</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbrep.2016.07.008</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pyruvate decarboxylase activity of the acetohydroxyacid synthase of <italic>Thermotoga maritima</italic></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Eram</surname>
            <given-names>Mohammad S.</given-names>
          </name>
          <xref rid="fn1" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Kesen</given-names>
          </name>
          <email>kma@uwaterloo.ca</email>
          <xref rid="cor1" ref-type="corresp">&#x204E;</xref>
        </contrib>
      </contrib-group>
      <aff id="aff0005">Department of Biology, University of Waterloo, Waterloo, Ontario, Canada</aff>
      <author-notes>
        <corresp id="cor1"><label>&#x204E;</label>Corresponding author. <email>kma@uwaterloo.ca</email></corresp>
        <fn id="fn1">
          <label>1</label>
          <p id="ntp0010">Present address: Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>16</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="collection">
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <volume>7</volume>
      <fpage>394</fpage>
      <lpage>399</lpage>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>20</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>7</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 The Authors</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="ab0010">
        <p>Acetohydroxyacid synthase (AHAS) catalyzes the production of acetolactate from pyruvate. The enzyme from the hyperthermophilic bacterium <italic>Thermotoga maritima</italic> has been purified and characterized (<italic>k</italic><sub>cat</sub> ~100&#xA0;s<sup>&#x2212;1</sup>). It was found that the same enzyme also had the ability to catalyze the production of acetaldehyde and CO<sub>2</sub> from pyruvate, an activity of pyruvate decarboxylase (PDC) at a rate approximately 10% of its AHAS activity. Compared to the catalytic subunit, reconstitution of the individually expressed and purified catalytic and regulatory subunits of the AHAS stimulated both activities of PDC and AHAS. Both activities had similar pH and temperature profiles with an optimal pH of 7.0 and temperature of 85&#xA0;&#xB0;C. The enzyme kinetic parameters were determined, however, it showed a non-Michaelis-Menten kinetics for pyruvate only. This is the first report on the PDC activity of an AHAS and the second bifunctional enzyme that might be involved in the production of ethanol from pyruvate in hyperthermophilic microorganisms.</p>
      </abstract>
      <abstract abstract-type="graphical" id="ab0015">
        <title>Graphical abstract</title>
        <p>
          <fig id="f0025" position="anchor">
            <alt-text id="at0030">fx1</alt-text>
            <graphic xlink:href="fx1"/>
          </fig>
        </p>
      </abstract>
      <abstract abstract-type="author-highlights" id="ab0020">
        <title>Highlights</title>
        <p>
          <list list-type="simple">
            <list-item id="u0005">
              <label>&#x2022;</label>
              <p>The acetohydroxyacid synthase of <italic>T. maritima</italic> has pyruvate decarboxylase activity</p>
            </list-item>
            <list-item id="u0010">
              <label>&#x2022;</label>
              <p>The AHAS and PDC activities share the same temperature and pH optima</p>
            </list-item>
            <list-item id="u0015">
              <label>&#x2022;</label>
              <p>Reconstitution of the catalytic and regulatory subunits increases both PDC and AHAS activities</p>
            </list-item>
          </list>
        </p>
      </abstract>
      <kwd-group id="keys0005">
        <title>Abbreviations</title>
        <kwd>AHAS, acetohydroxyacid synthase</kwd>
        <kwd>BCAA, branched chain amino acid</kwd>
        <kwd>CCE, crude cell extract</kwd>
        <kwd>CFE, cell-free extract</kwd>
        <kwd>HTCCE, heat-treated crude cell extract</kwd>
        <kwd>IMAC, immobilized metal affinity chromatography</kwd>
        <kwd>PDC, pyruvate decarboxylase</kwd>
        <kwd>TmAHAS, <italic>Thermotoga maritima</italic> acetohydroxyacid synthase</kwd>
        <kwd>TPP, thiamine pyrophosphate</kwd>
      </kwd-group>
      <kwd-group id="keys0010">
        <title>Keywords</title>
        <kwd>
          <italic>Thermotoga maritima</italic>
        </kwd>
        <kwd>Pyruvate decarboxylase</kwd>
        <kwd>Acetohydroxyacid synthase</kwd>
        <kwd>Hyperthermophiles</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>Ethanol is an end-product of fermentation in many extreme thermophiles and some hyperthermophiles <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>. Although some of the enzymes (<italic>e.g.</italic>, alcohol dehydrogenases) involved in the ethanol fermentation pathways have been isolated and characterized from hyper/thermophilic archaea and bacteria, there is limited information available about other enzymes involved in these metabolic pathways. One of the essential questions about the ethanol production by hyper/thermophiles, is the source of the aldehydes which are the substrates for the alcohol dehydrogenases catalyzing the production of alcohols.</p>
      <p>Acetaldehyde is the key intermediate in the ethanol production pathway and it can be produced by either non-oxidative decarboxylation of pyruvate catalyzed by TPP-dependent enzyme pyruvate decarboxylase (PDC, EC 4.1.1.1) or the reduction of acetyl-CoA catalyzed by a CoA-dependent acetaldehyde dehydrogenase (AcDH, EC 1.2.1.10). However, search of the genome sequences of the thermophilic and hyperthermophilic bacteria and archaea against the commonly-known (yeast and bacterial) PDC and AcDH amino acid sequences, failed to detect any orthologues <xref rid="bib5" ref-type="bibr">[5]</xref>. Consequently, the potential role of alternative enzyme(s) for the catalysis of the acetaldehyde production from pyruvate is proposed. One such enzyme was discovered to be the bifunctional pyruvate decarboxylase/pyruvate ferredoxin oxidoreductase (PDC/POR) and was described the first time in the hyperthermophilic archaeon <italic>Pyrococcus furiosus</italic>
<xref rid="bib6" ref-type="bibr">[6]</xref>. The bifunctional enzyme is shown to be able to catalyze both non-oxidative and oxidative decarboxylation of pyruvate to produce acetaldehyde and acetyl-CoA, respectively <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref> and the bifunctionality seems to be a universal trait of hyperthermophilic (archaeal and bacterial) PORs.</p>
      <p>When the genome sequences of various archaea and bacteria were explored for the orthologues of the commonly-known PDCs, the closest hit (when present) is almost exclusively the enzyme acetohydroxyacid synthase (<xref rid="s0040" ref-type="sec">Supplementary Table 1</xref>). Like PDC, acetohydroxyacid synthase (AHAS) is a thiamine pyrophosphate (TPP) &#x2013; and Mg<sup>2+</sup>-dependent enzyme. Given the high homology levels of the AHAS to the commonly-known PDCs and considering the high frequency of multi-functionality in the superfamily of TPP-dependent enzymes, the question arises: can the enzyme AHAS also catalyze the non-oxidative decarboxylation of pyruvate to acetaldehyde?</p>
      <p>It has been shown that <italic>Thermotoga maritima</italic> does not require the addition of any branched chain amino acids (BCAA) to the growth medium for optimal growth, suggesting the organism is equipped for biosynthesis of these compounds <xref rid="bib9" ref-type="bibr">[9]</xref>. The properties of an anabolic AHAS from the hyperthermophilic bacterium <italic>T. maritima</italic> has recently been reported <xref rid="bib10" ref-type="bibr">[10]</xref>. The purified catalytic subunit of the enzyme is FAD- and TPP-dependent and efficiently catalyzes the production of acetolactate from pyruvate with a <italic>k</italic><sub>cat</sub> of about 100&#xA0;s<sup>&#x2212;1</sup>. Here we report the determination of the ability of this very same enzyme for catalyzing the production of the acetaldehyde via a non-oxidative decarboxylation of pyruvate.</p>
    </sec>
    <sec id="s0010">
      <label>2</label>
      <title>Materials and methods</title>
      <sec id="s0015">
        <label>2.1</label>
        <title>Recombinant protein expression and purification</title>
        <p>The recombinant plasmids for the expression of genes encoding the catalytic and regulatory subunits were constructed and propagated in <italic>Escherichia coli</italic> strain DH5&#x3B1;. The recombinant proteins overexpressed under the control of T7 polymerase of the plasmid pET30a (+) (Novagen, WI, USA) in <italic>E. coli</italic> BL21 (DE3) Rosetta 2 [F<sup>&#x2212;</sup>
<italic>ompT hsdS</italic>B (rB<sup>&#x2212;</sup> mB<sup>&#x2212;</sup>) <italic>gal dcm</italic> pRARE27 (<italic>CamR</italic>)] (Novagen, WI, USA) as described elsewhere <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>. The recombinant catalytic subunit was purified by heat-induced precipitation of the host proteins (1&#xA0;h at 80&#xA0;&#xB0;C) followed by DEAE and HAP column chromatography as described previously <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>. The AHAS activity was followed during the purification and the purity of the final active fractions were tested by SDS-PAGE. The inactive small subunit was also overexpressed in the same host and purified by denaturing IMAC and on column refolding of the denatured protein using a previously described procedure <xref rid="bib10" ref-type="bibr">[10]</xref>. The purity of the desired protein in the fractions was checked on SDS-PAGE. When necessary, anaerobic procedures were followed as described elsewhere <xref rid="bib7" ref-type="bibr">[7]</xref>.</p>
      </sec>
      <sec id="s0020">
        <label>2.2</label>
        <title>Enzyme assays</title>
        <p>A discontinuous colorimetric assay was used to measure the AHAS activity via the production of acetolactate from pyruvate as described elsewhere <xref rid="bib10" ref-type="bibr">[10]</xref>.</p>
        <p>PDC activity was assayed by measuring the rate of the production of acetaldehyde from pyruvate <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>. The final concentration of acetaldehyde and isobutyraldehyde were determined using a calibration curve prepared by linear regression plotting of known concentrations of each product processed under the same assay conditions. Unless specified, both PDC and AHAS activities were measured using the purified large (catalytic) subunit of TmAHAS.</p>
        <p>All enzyme assays were carried out in duplicates, in 8&#xA0;ml vials under anaerobic conditions at 80&#xA0;&#xB0;C, unless otherwise specified. When specified, sodium pyruvate was replaced with 50&#xA0;mM of 2-ketoisovalerate.</p>
      </sec>
      <sec id="s0025">
        <label>2.3</label>
        <title>Biochemical and biophysical characterization</title>
        <p>The pH dependency of both activities of PDC and AHAS were determined in a range between 4.0 and 11.0. The pH values expressed throughout this manuscript were adjusted and measured at room temperature. In each case, assays were carried out at 80&#xA0;&#xB0;C, under anaerobic conditions using 100&#xA0;mM buffers degassed as described previously. The following list of buffers was used for the various pH values: sodium acetate buffer (pKa=4.76, &#x394;pKa/&#xB0;C=0.0002) was used for the pH range between 4 and 5.6, sodium phosphate buffer (pKa 7.20, &#x394;pKa/&#xB0;C=&#x2212;0.0028) for pH values 6.0, 7.0, and 7.5, HEPES buffer (pKa 7.39, &#x394;PKa/&#xB0;C=&#x2212;0.014) for pH values 7.5, 8.0, 8.5 and 9.0 and glycine buffer (pKa 9.55, &#x394;pKa/&#xB0;C=&#x2212;0.0025) the pH values 9.0, 9.5, 10.0, and 10.5. Finally, CAPS buffer (pKa 10.40, &#x394;pKa/&#xB0;C=&#x2212;0.009) was used 10.0, 10.5, and 11.0.</p>
        <p>The steady state kinetics was determined under optimal assay conditions and at 80&#xA0;&#xB0;C. The kinetic parameters were determined for pyruvate (5&#x2013;125&#xA0;mM), TPP (0.05&#x2013;4&#xA0;mM), and FAD (0.05&#x2013;40&#xA0;&#xB5;M) by applying various concentrations of each component and keeping the concentration of other assay components constant. All of the assays were repeated in triplicate. The activity then was assayed for various concentrations, and the kinetic parameters were calculated from the best fit of the results to the Michaelis-Menten equation by non-linear regression using SigmaPlot&#xAE; software (SYSTAT Software Inc., CA, USA). The oxygen sensitivity of each activity was tested by exposing an enzyme aliquot to ambient atmosphere at 4&#xA0;&#xB0;C by gentle stirring and comparing the PDC and AHAS activities at different time courses with the control preparation kept under anaerobic conditions. Both enzyme samples were protected from light through the experiments.</p>
        <p>The temperature dependence of enzymes was determined by measuring the enzyme activity at different temperatures ranging from 30&#xA0;&#xB0;C to 95&#xA0;&#xB0;C under anaerobic conditions and in 100&#xA0;mM EPPS buffer, pH 8.4 containing 10&#xA0;mM MgCl<sub>2</sub>. Thermal stability of the enzyme was determined by incubation of an anaerobic enzyme preparation and determining the residual activity at different time points compared to unheated control.</p>
      </sec>
    </sec>
    <sec id="s0030">
      <label>3</label>
      <title>Results and discussion</title>
      <p>AHAS is a member of the decarboxylase family that catalyzes the reactions whose initial step is decarboxylation of 2-keto acids. The decarboxylase family is one of the five members of TPP-dependent enzymes superfamily <xref rid="bib12" ref-type="bibr">[12]</xref>. AHAS shares a common ancestry with pyruvate decarboxylase <xref rid="bib13" ref-type="bibr">[13]</xref>, <xref rid="bib14" ref-type="bibr">[14]</xref>, <xref rid="bib15" ref-type="bibr">[15]</xref> as is indeed apparent from its sequence homology levels to the PDCs from various organisms (<xref rid="s0040" ref-type="sec">Supplementary Table 1</xref>) and pyruvate oxidase (POX) <xref rid="bib16" ref-type="bibr">[16]</xref>. Considering the catalytic mechanism of the enzyme, it is also believed that the enzyme is very close to pyruvate decarboxylase.</p>
      <p>The recombinant AHAS from <italic>T. maritima</italic> is shown to catalyze the production of the acetolactate from pyruvate in a TPP- and FAD-dependent manner <xref rid="bib10" ref-type="bibr">[10]</xref>. The cell free extracts (CFEs) prepared from the clones expressing the large (catalytic) subunits showed PDC activity and no detectable PDC activity was observed in the CFEs prepared from the clones expressing the small (regulatory) subunit. The purified TmAHAS exhibited a specific activity of 17.7&#xA0;U&#xA0;mg<sup>&#x2212;1</sup> for PDC at 80&#xA0;&#xB0;C.</p>
      <p>The ability of a catabolic AHAS (ALS) in catalyzing non-oxidative decarboxylation of 2-ketoisobutyrate (3-methyl-2-oxobutyrate) is reported <xref rid="bib17" ref-type="bibr">[17]</xref>. To investigate the ability of the recombinant anabolic TmAHAS for non-oxidative decarboxylation of other 2-keto acids, the decarboxylase activity assays were conducted with 2-ketoisovalerate instead of pyruvate. A standard curve was prepared with the product of decarboxylation reaction, isobutyraldehyde. Although with lower affinity, the recombinant TmAHAS was able to non-oxidatively decarboxylate the 2-ketoisovalerate to isobutyraldehyde with a rate about 10% of that when pyruvate was used.</p>
      <p>The optimal pH and temperature for both PDC and AHAS activities were 7.0 (<xref rid="f0005" ref-type="fig">Fig. 1</xref>) and 85&#xA0;&#xB0;C (<xref rid="f0010" ref-type="fig">Fig. 2</xref>), respectively. Both PDC and AHAS activities were quite stable and only about 40% of each activity were lost after five days incubation at 4&#xA0;&#xB0;C (without stirring). The kinetic parameters were determined for each substrate (pyruvate, TPP, and FAD) at pH 7.0 and 80&#xA0;&#xB0;C for both PDC and AHAS activities (<xref rid="t0005" ref-type="table">Table 1</xref>). Interestingly the effect of the pyruvate concentration on the velocity of the PDC reaction catalyzed by TmAHAS did not follow a usual Michaelis-Menten kinetics, but displayed a sigmoid cooperative effect (<xref rid="f0015" ref-type="fig">Fig. 3</xref>). Several repeats of the same experiment resulted in the similar curve shapes. The non-Michaelis-Menten kinetics for AHAS substrate pyruvate is a common phenomenon and the positive cooperativity is reported from the AHAS activities of <italic>Lactococcus lactis</italic>
<xref rid="bib18" ref-type="bibr">[18]</xref>, <italic>Serratia marcescens</italic>
<xref rid="bib19" ref-type="bibr">[19]</xref>, <italic>Haemophilus influenza</italic>
<xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib21" ref-type="bibr">[21]</xref>, <italic>Mycobacterium tuberculosis</italic>
<xref rid="bib22" ref-type="bibr">[22]</xref>, <xref rid="bib23" ref-type="bibr">[23]</xref>, and the mesophilic archaeon <italic>Methanococcus aeolicus</italic>
<xref rid="bib24" ref-type="bibr">[24]</xref>. However, AHAS activity of the TmAHAS followed the Michaelis-Menten kinetics, indicating a possible change of enzyme conformation induced by the substrate pyruvate affects its PDC activity only. It is assumed that the active site for catalyzing both PDC and AHAS activities should be the same. But how such conformational change could only affect the PDC not AHAS activity remains unknown. A structural study of the enzyme by using X-ray crystallography maybe helpful to provide answers to the question in the future. The difference in catalysis by PDC and AHAS may also be shown by slightly higher <italic>K</italic><sub>m</sub> values measured for AHAS activity, because the apparent <italic>K</italic><sub>m</sub> values for FAD of both activities were 0.12&#xA0;&#xB5;M and 0.15&#xA0;&#xB5;M for PDC and AHAS, respectively, and the apparent <italic>K</italic><sub>m</sub> value for TPP were 35&#xA0;&#xB5;M and 57&#xA0;&#xB5;M for PDC and AHAS, respectively. No apparent <italic>K</italic><sub>m</sub> value for pyruvate due to the non-Michaelis-Menten kinetics of the PDC activity (<xref rid="t0005" ref-type="table">Table 1</xref>).<fig id="f0005"><label>Fig. 1</label><caption><p>pH dependency of PDC and AHAS activities of recombinant TmAHAS. The relative activities of 100% equals to highest measured specific activity for both enzymes at 80&#xA0;&#xB0;C and in sodium phosphate buffer, pH 7.0 (17.7&#xA0;U&#xA0;mg<sup>&#x2212;1</sup> for PDC and 114&#xA0;U&#xA0;mg<sup>&#x2212;1</sup> for AHAS activity). The open symbols represent the PDC activity and the filled symbols represent the AHAS activity. The plus symbols represent the sodium acetate buffer (pH values 4.0, 5.0, and 5.5); the triangles and inverted triangles represent the sodium phosphate buffer (pH 6.2, 7.0, 7.5, and 8.0); the square symbols represent the EPPS buffer (pH 8.0, 8.4, 9.0, and 9.5); the diamonds represent glycine buffer (pH 9.5 and 10); and circles represent the CAPS buffer (pH 10.5 and 11.0). Each point is an average of experimental values in duplicates.</p></caption><alt-text id="at0005">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig><fig id="f0010"><label>Fig. 2</label><caption><p>Determination of optimal temperatures of PDC and AHAS activities of recombinant TmAHAS. The reaction mixtures were equilibrated at each temperature for 4&#xA0;min before adding the enzyme. The relative activities of 100% equals to highest measured specific activity for both enzymes at 85&#xA0;&#xB0;C (18.6&#xA0;U&#xA0;mg<sup>&#x2212;1</sup> for PDC and 235&#xA0;U&#xA0;mg<sup>&#x2212;1</sup> for AHAS activity). The open symbols indicate the PDC and the filled symbols indicate the AHAS activity. Each point is an average of experimental values in duplicates.</p></caption><alt-text id="at0010">Fig. 2</alt-text><graphic xlink:href="gr2"/></fig><fig id="f0015"><label>Fig. 3</label><caption><p>Dependence of PDC (B) and AHAS (A) activities on pyruvate concentration. Each point is an average of experimental values in duplicates (three independent repeats). The curves are the theoretical fit of data to the hyperbolic and sigmoid plot equations for PDC and AHAS activities, respectively.</p></caption><alt-text id="at0015">Fig. 3</alt-text><graphic xlink:href="gr3"/></fig><table-wrap id="t0005" position="float"><label>Table 1</label><caption><p>Apparent kinetic parameters for PDC and AHAS activities of recombinant TmAHAS.</p></caption><alt-text id="at0025">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Substrate</th><th colspan="3">AHAS activity<xref rid="tblt0005-fn1" ref-type="table-fn">a</xref><hr/></th><th colspan="3">PDC activity<hr/></th></tr><tr><th>Apparent <italic>K</italic><sub>m</sub> (&#xB5;M)</th><th>Apparent <italic>V</italic><sub>max</sub> (U&#xA0;mg<sup>&#x2212;1</sup>)</th><th><italic>k</italic><sub>cat</sub> (S<sup>&#x2212;1</sup>)</th><th>Apparent <italic>K</italic><sub>m</sub> (&#xB5;M)</th><th>Apparent <italic>V</italic><sub>max</sub> (U&#xA0;mg<sup>&#x2212;1</sup>)</th><th><italic>k</italic><sub>cat</sub> (S<sup>&#x2212;1</sup>)</th></tr></thead><tbody><tr><td>Pyruvate</td><td>16,400&#xB1;1900</td><td>246&#xB1;7</td><td>99</td><td>ND</td><td>ND</td><td>ND</td></tr><tr><td>TPP</td><td>57&#xB1;6.0</td><td>242&#xB1;4</td><td>97</td><td>35&#xB1;0.6</td><td>25.9&#xB1;0.6</td><td>8</td></tr><tr><td>FAD</td><td>0.15&#xB1;0.07</td><td>134&#xB1;11</td><td>54</td><td>0.12&#xB1;0.05</td><td>18.1&#xB1;1.7</td><td>7</td></tr></tbody></table><table-wrap-foot><fn><p>ND, not determined as the saturation curve was not following the Michaelis-Menten kinetics.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblt0005-fn1"><label>a</label><p id="ntp0005">Kinetic parameters are from <xref rid="bib10" ref-type="bibr">[10]</xref>.</p></fn></table-wrap-foot></table-wrap></p>
      <p>Activation of the enzyme by a rapid and cooperative reconstitution of the catalytic and regulatory subunit is shown for various mesophilic <xref rid="bib22" ref-type="bibr">[22]</xref>, <xref rid="bib25" ref-type="bibr">[25]</xref>, <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref> and hyperthermophilic AHAS <xref rid="bib10" ref-type="bibr">[10]</xref>. The reconstitution of the enzyme TmAHAS resulted in considerable and reproducible increase of both PDC and AHAS activities. Both activities followed the same increment trend for most part, however, it appeared that when 1:5 ratio of catalytic and regulatory subunits were mixed, and the stimulatory effect of the regulatory subunit became significant as there were a 3-fold increase in PDC activity and only a slight increase in AHAS activity; But, no further increase of both activities were observed by mixing increasing ratios of catalytic to regulatory subunit up to 1:50 (<xref rid="f0020" ref-type="fig">Fig. 4</xref>). The small (regulatory) subunit MS in crude extract, cell-free extract and as a purified protein showed no activity of PDC and AHAS. Therefore, the increase in activities shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref> can be only resulted from the interaction of MS with the large (catalytic) subunit MI. However, only MI was used for measuring the activities shown in <xref rid="f0015" ref-type="fig">Fig. 3</xref>, indicating a conformational change induced by the increase of the substrate concentration (pyruvate), which affected the PDC activity only (not AHAC). Further studies including X-ray crystallography are required for understanding the mechanism involved.<fig id="f0020"><label>Fig. 4</label><caption><p>Effect of enzyme reconstitution on PDC and AHAS activities. Ml, the purified catalytic subunit of TmAHAS; Ms, the purified regulatory subunit of TmAHAS. The specific activity of 100% was considered for PDC and AHAS activities of catalytic subunit alone and was corresponding to 9.5&#xA0;U&#xA0;mg<sup>&#x2212;1</sup> for PDC and 145&#xA0;U&#xA0;mg<sup>&#x2212;1</sup> for AHAS activity.</p></caption><alt-text id="at0020">Fig. 4</alt-text><graphic xlink:href="gr4"/></fig></p>
      <p>As a well-known side reaction, AHASs are also capable of catalyzing the carboligation reactions and producing &#x3B1;-hydroxy ketones. During the reaction, decarboxylation of pyruvate generates a hydroxyethyl-TPP (HETDP), also known as &#x201C;active acetaldehyde&#x201D;, intermediate <xref rid="bib28" ref-type="bibr">[28]</xref> and the stereospecific condensation of this intermediate with aldehydes produces &#x3B1;-hydroxy ketones <xref rid="bib29" ref-type="bibr">[29]</xref>. The reaction has been extensively studied in pyruvate decarboxylases <xref rid="bib30" ref-type="bibr">[30]</xref>, and there have been some studies demonstrating higher efficiency of AHASs than the pyruvate decarboxylases, presumably because the condensation reaction is an intrinsic property of the AHASs <xref rid="bib31" ref-type="bibr">[31]</xref>, <xref rid="bib32" ref-type="bibr">[32]</xref>. Similar to PDC <xref rid="bib29" ref-type="bibr">[29]</xref>, <xref rid="bib33" ref-type="bibr">[33]</xref> AHAS I from <italic>E. coli</italic> is shown to be able to use a wide range of aldehydes as the second substrate, including benzaldehydes, heterocyclic, hetero-aromatic and non-aromatic aldehydes <xref rid="bib34" ref-type="bibr">[34]</xref>. As another side reaction, it is reported that some AHASs can catalyze oxidative decarboxylation of pyruvate or 2-oxobutyrate, yielding peracetic acid or peroxypropionic acid, respectively. During this reaction, the enzyme bond hydroxyethyl-TPP (E-HETPP) reacts with the molecular oxygen, leading to the formation of hydroperoxide-HETPP, which is then decomposed to peracetic acid and TPP. The rate of this oxygen-consuming reaction is approximately 1% of the AHAS activity in case of AHAS II from <italic>E. coli</italic>
<xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>. Within the members of the TPP-dependent enzymes, AHAS and pyruvate decarboxylases are the only enzymes that can catalyze this oxygenase side reaction <xref rid="bib37" ref-type="bibr">[37]</xref>. The PDC activity that is being reported here can be considered to be another &#x201C;side reaction&#x201D; of AHASs, though other possible side reactions of the enzyme were not tested.</p>
      <p>The principal catalytic mechanism of AHAS, follows the activation step of the enzyme is similar to those of the other pyruvate utilizing TPP-dependent enzymes especially the classic example of this group, PDC <xref rid="bib38" ref-type="bibr">[38]</xref>. Protonation of the N1 atom of pyrimidine ring by the highly conserved glutamine residue results in induction of a 1,4-iminotautomer. Due to the common &#x201C;V-conformation&#x201D; the 4-imino group is located in the proximity of the C<sub>2</sub> catalytic center of the AHAS, which results in de-protonation of the C<sub>2</sub> atom. The proton abstraction step gives rise to a highly reactive ylide <xref rid="bib39" ref-type="bibr">[39]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>. The nucleophilic attack of the ylide to the first molecule of pyruvate, results in production of 2-(2-lactyl)-TPP (also known as L-TPP or L-TDP). Later, decarboxylation of L-TPP gives the resonating carbanion/enamine forms of 2-(1-hydroxyethyl)-TPP (HETPP, also known as hydroxyethylidene-TPP), which acts as a central and highly reactive intermediate <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib41" ref-type="bibr">[41]</xref>, <xref rid="bib42" ref-type="bibr">[42]</xref>, <xref rid="bib43" ref-type="bibr">[43]</xref>.</p>
      <p>During the normal course of the catalysis, HETPP intermediate reacts in an enantio-specific manner with the second molecule of 2-keto acid (usually pyruvate or 2-ketobutyrate), resulting in the release of the product. The ability of heterologously expressed TmAHAS to generate acetaldehyde is most likely the result of protonation of the HETDP/enamine intermediate in C<sub>2</sub> position. This step, results in the releases of acetaldehyde from active site of the enzyme. Unfortunately, with the available data on recombinant TmAHAS, it is not possible to deduce further mechanistic details of PDC activity of the enzyme. Complete and accurate understanding of the mechanisms involved in acetaldehyde formation demands more in-depth study of the reaction intermediates and more importantly crystal structure of enzyme. Other than a preliminary X-ray crystal structure for catalytic subunit of <italic>E. coli</italic> AHAS II <xref rid="bib44" ref-type="bibr">[44]</xref>, so far, no crystal structure has been provided for any catalytic (large) subunit of AHAS <xref rid="bib45" ref-type="bibr">[45]</xref>.</p>
      <p>Catabolic AHAS (ALS) has been isolated and characterized mainly from enteric bacteria, including <italic>Enterobacter</italic>, certain <italic>Klebsiella</italic> and <italic>Serratia</italic> species, some lactic acid bacteria, and <italic>Bacillus subtilis</italic>. A typical ALS is an FAD-independent enzyme, composed of only one subunit of ~60&#xA0;kDa (no regulatory subunit) and the gene is generally located in the butanediol operon (when present). Despite catalyzing same reactions, anabolic and catabolic AHASs are very divergent, showing less than 30% amino acid sequence identity with each other <xref rid="bib37" ref-type="bibr">[37]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>, <xref rid="bib46" ref-type="bibr">[46]</xref>. Different factors can trigger activation of butanediol operon in bacteria, including low pH, presence of excess acetate and/or pyruvate, as well as growth during the stationary phase <xref rid="bib46" ref-type="bibr">[46]</xref>, <xref rid="bib47" ref-type="bibr">[47]</xref>, <xref rid="bib48" ref-type="bibr">[48]</xref>, <xref rid="bib49" ref-type="bibr">[49]</xref>, <xref rid="bib50" ref-type="bibr">[50]</xref>, <xref rid="bib51" ref-type="bibr">[51]</xref>. As an important development, it is shown that besides its synthase activity, the catabolic ALS of <italic>B. subtilis</italic> can also catalyze the non-oxidative decarboxylation of the 2-ketoisovalerate both <italic>in vitro</italic> and <italic>in vivo</italic>
<xref rid="bib17" ref-type="bibr">[17]</xref>. Considering the major mechanistic similarities between the anabolic and catabolic AHAS, the involvement of the anabolic AHAS in the similar non-oxidative decarboxylation reaction is not very surprising. However, understanding the mechanisms of differential non-Michaelis-Menten kinetics of TmAHAS may provide further insight into enzyme multifunctionality.</p>
      <p>Besides the bifunctional PDC/POR enzymes characterized in different hyperthermophilic archaea <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref> and bacteria <xref rid="bib8" ref-type="bibr">[8]</xref>, PDC/AHAS of <italic>T. maritima</italic> is the second type of acetaldehyde producing enzymes characterized in hyperthermophiles. Similar to the archaeal PDC/POR bifunctionality (and unlike the bacterial PDC/POR activity), the PDC to AHAS activity ratio was high. <italic>Thermotogales</italic> have been shown to be able to use both carbohydrates (simple and complex) and peptides as a source of carbon and energy, and many of them are capable of <italic>de novo</italic> synthesis of amino acids required for growth <xref rid="bib10" ref-type="bibr">[10]</xref>. Presumably, the &#x201C;extra&#x201D; amino acids imported and/or synthesized inside the cells would be channeled to the energy conservation process, during which they are decarboxylated after a transamination step. The reduced ferredoxin produced during the POR reaction can be used <italic>via</italic> different hydrogenase enzymes for energy conservation and acetyl-CoA is used for both biosynthesis and energy conservation.</p>
      <p>It seems that keto acids produced by catabolism of different amino acids and/or carbohydrates can be decarboxylated both oxidatively and non-oxidatively <italic>via</italic> either bifunctional PDC/POR or, when present, the bifunctional PDC/AHAS. The aldehydes resulted from the non-oxidative decarboxylation of keto acids can be further reduced to produce corresponding alcohols. This reduction is accompanied by the regeneration of oxidized NADP<sup>+</sup>.</p>
    </sec>
  </body>
  <back>
    <ref-list id="bibliog0005">
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal" id="sbref1">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Loessner</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Heider</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Effects of elemental sulfur on the metabolism of the deep-sea hyperthermophilic archaeon <italic>Thermococcus</italic> strain ES-1: characterization of a sulfur-regulated, non-heme iron alcohol dehydrogenase</article-title>
          <source>J. Bacteriol.</source>
          <volume>177</volume>
          <year>1995</year>
          <fpage>4748</fpage>
          <lpage>4756</lpage>
          <pub-id pub-id-type="pmid">7642502</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal" id="sbref2">
          <person-group person-group-type="author">
            <name>
              <surname>Balk</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Weijma</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Stams</surname>
              <given-names>A.J.M.</given-names>
            </name>
          </person-group>
          <article-title><italic>Thermotoga lettingae</italic> sp. nov., a novel thermophilic, methanol-degrading bacterium isolated from a thermophilic anaerobic reactor</article-title>
          <source>Int. J. Syst. Evol. Microbiol.</source>
          <volume>52</volume>
          <year>2002</year>
          <fpage>1361</fpage>
          <lpage>1368</lpage>
          <pub-id pub-id-type="pmid">12148651</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal" id="sbref3">
          <person-group person-group-type="author">
            <name>
              <surname>de Vrije</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Budde</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mars</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Claassen</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Efficient hydrogen production from the lignocellulosic energy crop Miscanthus by the extreme thermophilic bacteria <italic>Caldicellulosiruptor saccharolyticus</italic> and <italic>Thermotoga neapolitana</italic></article-title>
          <source>Biotechnol. Biofuels</source>
          <volume>2</volume>
          <year>2009</year>
          <fpage>12</fpage>
          <pub-id pub-id-type="pmid">19534765</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal" id="sbref4">
          <person-group person-group-type="author">
            <name>
              <surname>Ying</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of a zinc-containing alcohol dehydrogenase with stereoselectivity from the hyperthermophilic archaeon <italic>Thermococcus guaymasensis</italic></article-title>
          <source>J. Bacteriol.</source>
          <volume>193</volume>
          <year>2011</year>
          <fpage>3009</fpage>
          <lpage>3019</lpage>
          <pub-id pub-id-type="pmid">21515780</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal" id="sbref5">
          <person-group person-group-type="author">
            <name>
              <surname>Eram</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Decarboxylation of pyruvate to acetaldehyde for ethanol production by hyperthermophiles</article-title>
          <source>Biomolecules</source>
          <volume>3</volume>
          <year>2013</year>
          <fpage>578</fpage>
          <lpage>596</lpage>
          <pub-id pub-id-type="pmid">24970182</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal" id="sbref6">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hutchins</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>S.-J.S.</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>M.W.W.</given-names>
            </name>
          </person-group>
          <article-title>Pyruvate ferredoxin oxidoreductase from the hyperthermophilic archaeon, <italic>Pyrococcus furiosus</italic>, functions as a CoA-dependent pyruvate decarboxylase</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>94</volume>
          <year>1997</year>
          <fpage>9608</fpage>
          <lpage>9613</lpage>
          <pub-id pub-id-type="pmid">9275170</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal" id="sbref7">
          <person-group person-group-type="author">
            <name>
              <surname>Eram</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Oduaran</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>The bifunctional pyruvate decarboxylase/pyruvate ferredoxin oxidoreductase from <italic>Thermococcus guaymasensis</italic></article-title>
          <source>Archaea</source>
          <year>2014</year>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal" id="sbref8">
          <person-group person-group-type="author">
            <name>
              <surname>Eram</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Oduaran</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Molecular and biochemical characterization of bifunctional pyruvate decarboxylases and pyruvate ferredoxin oxidoreductases from <italic>Thermotoga maritima</italic> and <italic>Thermotoga hypogea</italic></article-title>
          <source>J. Biochem.</source>
          <year>2015</year>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal" id="sbref9">
          <person-group person-group-type="author">
            <name>
              <surname>Rinker</surname>
              <given-names>K.D.</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>Effect of carbon and nitrogen sources on growth dynamics and exopolysaccharide production for the hyperthermophilic archaeon<italic>Thermococcus litoralis</italic> and bacterium <italic>Thermotoga maritima</italic></article-title>
          <source>Biotechnol. Bioeng.</source>
          <volume>69</volume>
          <year>2000</year>
          <fpage>537</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="pmid">10898863</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal" id="ssbib20">
          <person-group person-group-type="author">
            <name>
              <surname>Eram</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Sarafuddin</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of acetohydroxyacid synthase from the hyperthermophilic bacterium <italic>Thermotoga maritima</italic></article-title>
          <source>Biochem. Biophys. Rep.</source>
          <volume>4</volume>
          <year>2015</year>
          <fpage>89</fpage>
          <lpage>97</lpage>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal" id="ssbib11">
          <person-group person-group-type="author">
            <name>
              <surname>Eram</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Sarafuddin</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Optimization of expression and properties of the recombinant acetohydroxyacid synthase of <italic>Thermotoga maritima</italic></article-title>
          <source>Data in Brief</source>
          <volume>5</volume>
          <year>2015</year>
          <fpage>489</fpage>
          <lpage>497</lpage>
          <pub-id pub-id-type="pmid">26629492</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal" id="sbref12">
          <person-group person-group-type="author">
            <name>
              <surname>Duggleby</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Domain relationships in thiamine diphosphate-dependent enzymes</article-title>
          <source>Acc. Chem. Res.</source>
          <volume>39</volume>
          <year>2006</year>
          <fpage>550</fpage>
          <lpage>557</lpage>
          <pub-id pub-id-type="pmid">16906751</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal" id="sbref13">
          <person-group person-group-type="author">
            <name>
              <surname>Neale</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Scopes</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Wettenhall</surname>
              <given-names>R.E.H.</given-names>
            </name>
            <name>
              <surname>Hoogenraad</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Nucleotide sequence of the pyruvate decarboxylase gene from <italic>Zymomonas mobilis</italic></article-title>
          <source>Nucleic Acids Res.</source>
          <volume>15</volume>
          <year>1987</year>
          <fpage>1753</fpage>
          <lpage>1761</lpage>
          <pub-id pub-id-type="pmid">3029726</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal" id="sbref14">
          <person-group person-group-type="author">
            <name>
              <surname>Green</surname>
              <given-names>J.B.A.</given-names>
            </name>
          </person-group>
          <article-title>Pyruvate decarboxylase is like acetolactate synthase (ILV2) and not like the pyruvate dehydrogenase E1 subunit</article-title>
          <source>FEBS Lett.</source>
          <volume>246</volume>
          <year>1989</year>
          <fpage>1</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">2651151</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal" id="sbref15">
          <person-group person-group-type="author">
            <name>
              <surname>Kellermann</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Seeboth</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Hollenberg</surname>
              <given-names>C.P.</given-names>
            </name>
          </person-group>
          <article-title>Analysis of the primary structure and promoter function of a pyruvate decarboxylase gene (PDCI) from <italic>Saccharomyces cerevisiae</italic></article-title>
          <source>Nucleic Acids Res.</source>
          <volume>14</volume>
          <year>1986</year>
          <fpage>8963</fpage>
          <lpage>8977</lpage>
          <pub-id pub-id-type="pmid">3537965</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal" id="sbref16">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>Y.Y.</given-names>
            </name>
            <name>
              <surname>Cronan</surname>
              <given-names>J.E.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <article-title>Common ancestry of <italic>Escherichia coli</italic> pyruvate oxidase and the acetohydroxy acid synthases of the branched-chain amino acid biosynthetic pathway</article-title>
          <source>J. Bacteriol.</source>
          <volume>170</volume>
          <year>1988</year>
          <fpage>3937</fpage>
          <lpage>3945</lpage>
          <pub-id pub-id-type="pmid">3045082</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal" id="sbref17">
          <person-group person-group-type="author">
            <name>
              <surname>Atsumi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Acetolactate synthase from <italic>Bacillus subtilis</italic> serves as a 2-Ketoisovalerate decarboxylase for isobutanol biosynthesis in <italic>Escherichia coli</italic></article-title>
          <source>Appl. Environ. Microbiol.</source>
          <volume>75</volume>
          <year>2009</year>
          <fpage>6306</fpage>
          <lpage>6311</lpage>
          <pub-id pub-id-type="pmid">19684168</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal" id="sbref18">
          <person-group person-group-type="author">
            <name>
              <surname>Snoep</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Teixeira de Mattos</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Starrenburg</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Hugenholtz</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Isolation, characterization, and physiological role of the pyruvate dehydrogenase complex and alpha-acetolactate synthase of <italic>Lactococcus lactis</italic> subsp. <italic>lactis</italic> bv. diacetylactis</article-title>
          <source>J. Bacteriol.</source>
          <volume>174</volume>
          <year>1992</year>
          <fpage>4838</fpage>
          <lpage>4841</lpage>
          <pub-id pub-id-type="pmid">1624471</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal" id="sbref19">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>Purification and characterization of the valine sensitive acetolactate synthase from <italic>Serratia marcescens</italic> ATCC 25419</article-title>
          <source>Biochim. Biophys. Acta (BBA)</source>
          <volume>1157</volume>
          <year>1993</year>
          <fpage>178</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">8507653</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal" id="sbref20">
          <person-group person-group-type="author">
            <name>
              <surname>Gedi</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>J.-Y.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>W.-M.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M.-Y.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.-C.</given-names>
            </name>
            <name>
              <surname>Koo</surname>
              <given-names>B.-S.</given-names>
            </name>
            <name>
              <surname>Govindwar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>M.-Y.</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of inhibitors of <italic>Haemophilus influenzae</italic> acetohydroxyacid synthase</article-title>
          <source>Enzym. Microb. Technol.</source>
          <volume>49</volume>
          <year>2011</year>
          <fpage>1</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal" id="sbref21">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>K.-J.</given-names>
            </name>
            <name>
              <surname>Noh</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>D.-E.</given-names>
            </name>
            <name>
              <surname>Ha</surname>
              <given-names>B.H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>M.-Y.</given-names>
            </name>
          </person-group>
          <article-title>Identification of the catalytic subunit of acetohydroxyacid synthase in <italic>Haemophilus influenzae</italic> and its potent inhibitors</article-title>
          <source>Arch. Biochem. Biophys.</source>
          <volume>466</volume>
          <year>2007</year>
          <fpage>24</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">17718999</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal" id="sbref22">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>K.-J.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Y.G.</given-names>
            </name>
            <name>
              <surname>Hahn</surname>
              <given-names>H.G.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>J.-D.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>M.-Y.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of acetohydroxyacid synthase from <italic>Mycobacterium tuberculosis</italic> and the identification of its new inhibitor from the screening of a chemical library</article-title>
          <source>FEBS Lett.</source>
          <volume>579</volume>
          <year>2005</year>
          <fpage>4903</fpage>
          <lpage>4910</lpage>
          <pub-id pub-id-type="pmid">16111681</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal" id="sbref23">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Chandra</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Biochemical and transcription analysis of acetohydroxyacid synthase isoforms in <italic>Mycobacterium tuberculosis</italic> identifies these enzymes as potential targets for drug development</article-title>
          <source>Microbiology</source>
          <volume>157</volume>
          <year>2011</year>
          <fpage>29</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">20884690</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal" id="sbref24">
          <person-group person-group-type="author">
            <name>
              <surname>Xing</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Whitman</surname>
              <given-names>W.B.</given-names>
            </name>
          </person-group>
          <article-title>Purification and characterization of the oxygen-sensitive acetohydroxy acid synthase from the archaebacterium <italic>Methanococcus aeolicus</italic></article-title>
          <source>J. Bacteriol.</source>
          <volume>176</volume>
          <year>1994</year>
          <fpage>1207</fpage>
          <lpage>1213</lpage>
          <pub-id pub-id-type="pmid">8113159</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal" id="sbref25">
          <person-group person-group-type="author">
            <name>
              <surname>Porat</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Vinogradov</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Vyazmensky</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>C.-D.</given-names>
            </name>
            <name>
              <surname>Chipman</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Abdelal</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Barak</surname>
              <given-names>Ze</given-names>
            </name>
          </person-group>
          <article-title>Cloning and characterization of acetohydroxyacid synthase from <italic>Bacillus stearothermophilus</italic></article-title>
          <source>J. Bacteriol.</source>
          <volume>186</volume>
          <year>2004</year>
          <fpage>570</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="pmid">14702326</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal" id="sbref26">
          <person-group person-group-type="author">
            <name>
              <surname>Vinogradov</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Vyazmensky</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Engel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Belenky</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kaplun</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kryukov</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Barak</surname>
              <given-names>Z.E.</given-names>
            </name>
            <name>
              <surname>Chipman</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Acetohydroxyacid synthase isozyme I from <italic>Escherichia coli</italic> has unique catalytic and regulatory properties</article-title>
          <source>Biochim. Biophys. Acta (BBA)</source>
          <volume>1760</volume>
          <year>2006</year>
          <fpage>356</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="pmid">16326011</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal" id="sbref27">
          <person-group person-group-type="author">
            <name>
              <surname>Pang</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Duggleby</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Expression, purification, characterization, and reconstitution of the large and small subunits of yeast acetohydroxyacid synthase</article-title>
          <source>Biochemistry</source>
          <volume>38</volume>
          <year>1999</year>
          <fpage>5222</fpage>
          <lpage>5231</lpage>
          <pub-id pub-id-type="pmid">10213630</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal" id="sbref28">
          <person-group person-group-type="author">
            <name>
              <surname>H&#xFC;bner</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Tittmann</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Killenberg-Jabs</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sch&#xE4;ffner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Spinka</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Neef</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kern</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kern</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Wikner</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ghisla</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Activation of thiamin diphosphate in enzymes</article-title>
          <source>Biochim. Biophys. Acta (BBA) &#x2013; Protein Struct. Mol. Enzymol.</source>
          <volume>1385</volume>
          <year>1998</year>
          <fpage>221</fpage>
          <lpage>228</lpage>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal" id="sbref29">
          <person-group person-group-type="author">
            <name>
              <surname>Iding</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Siegert</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mesch</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Pohl</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Application of alpha-keto acid decarboxylases in biotransformations</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1385</volume>
          <year>1998</year>
          <fpage>307</fpage>
          <lpage>322</lpage>
          <pub-id pub-id-type="pmid">9655924</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal" id="sbref30">
          <person-group person-group-type="author">
            <name>
              <surname>Ward</surname>
              <given-names>O.P.</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Enzymatic asymmetric synthesis by decarboxylases</article-title>
          <source>Curr. Opin. Biotechnol.</source>
          <volume>11</volume>
          <year>2000</year>
          <fpage>520</fpage>
          <lpage>526</lpage>
          <pub-id pub-id-type="pmid">11102784</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <element-citation publication-type="journal" id="sbref31">
          <person-group person-group-type="author">
            <name>
              <surname>Engel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vyazmensky</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Berkovich</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Barak</surname>
              <given-names>Ze</given-names>
            </name>
            <name>
              <surname>Merchuk</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chipman</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Column flow reactor using acetohydroxyacid synthase I from <italic>Escherichia coli</italic> as catalyst in continuous synthesis of <italic>R</italic>-phenylacetylcarbinol</article-title>
          <source>Biotechnol. Bioeng.</source>
          <volume>89</volume>
          <year>2005</year>
          <fpage>733</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="pmid">15685598</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <element-citation publication-type="journal" id="sbref32">
          <person-group person-group-type="author">
            <name>
              <surname>Engel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vyazmensky</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Geresh</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Barak</surname>
              <given-names>Z.E.</given-names>
            </name>
            <name>
              <surname>Chipman</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Acetohydroxyacid synthase: a new enzyme for chiral synthesis of <italic>R</italic>-phenylacetylcarbinol</article-title>
          <source>Biotechnol. Bioeng.</source>
          <volume>83</volume>
          <year>2003</year>
          <fpage>833</fpage>
          <lpage>840</lpage>
          <pub-id pub-id-type="pmid">12889023</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <label>33</label>
        <element-citation publication-type="journal" id="sbref33">
          <person-group person-group-type="author">
            <name>
              <surname>Crout</surname>
              <given-names>D.H.G.</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Heath</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Miles</surname>
              <given-names>C.O.</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Swoboda</surname>
              <given-names>B.E.P.</given-names>
            </name>
            <name>
              <surname>Gravestock</surname>
              <given-names>M.B.</given-names>
            </name>
          </person-group>
          <article-title>Applications of hydrolytic and decarboxylating enzymes in biotransformations</article-title>
          <source>Biocatal. Biotransform.</source>
          <volume>9</volume>
          <year>1994</year>
          <fpage>1</fpage>
          <lpage>30</lpage>
        </element-citation>
      </ref>
      <ref id="bib34">
        <label>34</label>
        <element-citation publication-type="journal" id="sbref34">
          <person-group person-group-type="author">
            <name>
              <surname>Engel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vyazmensky</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Berkovich</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Barak</surname>
              <given-names>Ze</given-names>
            </name>
            <name>
              <surname>Chipman</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Substrate range of acetohydroxy acid synthase I from <italic>Escherichia coli</italic> in the stereoselective synthesis of &#x3B1;-hydroxy ketones</article-title>
          <source>Biotechnol. Bioeng.</source>
          <volume>88</volume>
          <year>2004</year>
          <fpage>825</fpage>
          <lpage>831</lpage>
          <pub-id pub-id-type="pmid">15558598</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <label>35</label>
        <element-citation publication-type="journal" id="sbref35">
          <person-group person-group-type="author">
            <name>
              <surname>Abell</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Schloss</surname>
              <given-names>J.V.</given-names>
            </name>
          </person-group>
          <article-title>Oxygenase side reactions of acetolactate synthase and other carbanion-forming enzymes</article-title>
          <source>Biochemistry</source>
          <volume>30</volume>
          <year>2002</year>
          <fpage>7883</fpage>
          <lpage>7887</lpage>
        </element-citation>
      </ref>
      <ref id="bib36">
        <label>36</label>
        <element-citation publication-type="journal" id="sbref36">
          <person-group person-group-type="author">
            <name>
              <surname>Tse</surname>
              <given-names>J.M.T.</given-names>
            </name>
            <name>
              <surname>Schloss</surname>
              <given-names>J.V.</given-names>
            </name>
          </person-group>
          <article-title>The oxygenase reaction of acetolactate synthase</article-title>
          <source>Biochemistry</source>
          <volume>32</volume>
          <year>1993</year>
          <fpage>10398</fpage>
          <lpage>10403</lpage>
          <pub-id pub-id-type="pmid">8399183</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <label>37</label>
        <element-citation publication-type="journal" id="sbref37">
          <person-group person-group-type="author">
            <name>
              <surname>Chipman</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Barak</surname>
              <given-names>Ze</given-names>
            </name>
            <name>
              <surname>Schloss</surname>
              <given-names>J.V.</given-names>
            </name>
          </person-group>
          <article-title>Biosynthesis of 2-aceto-2-hydroxy Acids: Acetolactate synthases and Acetohydroxyacid synthases</article-title>
          <source>Biochim. Biophys. Acta (BBA) &#x2013; Protein Struct. Mol. Enzymol.</source>
          <volume>1385</volume>
          <year>1998</year>
          <fpage>401</fpage>
          <lpage>419</lpage>
        </element-citation>
      </ref>
      <ref id="bib38">
        <label>38</label>
        <element-citation publication-type="journal" id="sbref38">
          <person-group person-group-type="author">
            <name>
              <surname>Bar-Ilan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Balan</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Tittmann</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Golbik</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Vyazmensky</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hubner</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Barak</surname>
              <given-names>Ze</given-names>
            </name>
            <name>
              <surname>Chipman</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Binding and activation of thiamin diphosphate in acetohydroxyacid synthase</article-title>
          <source>Biochemistry</source>
          <volume>40</volume>
          <year>2001</year>
          <fpage>11946</fpage>
          <lpage>11954</lpage>
          <pub-id pub-id-type="pmid">11570896</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <label>39</label>
        <element-citation publication-type="journal" id="sbref39">
          <person-group person-group-type="author">
            <name>
              <surname>Lie</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Celik</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Jorgensen</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Schiott</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Cofactor activation and substrate binding in pyruvate decarboxylase</article-title>
          <source>Biochemistry</source>
          <volume>44</volume>
          <year>2005</year>
          <fpage>14792</fpage>
          <lpage>14806</lpage>
          <pub-id pub-id-type="pmid">16274227</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <label>40</label>
        <element-citation publication-type="journal" id="sbref40">
          <person-group person-group-type="author">
            <name>
              <surname>McCourt</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Duggleby</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Acetohydroxyacid synthase and its role in the biosynthetic pathway for branched-chain amino acids</article-title>
          <source>Amino Acids</source>
          <volume>31</volume>
          <year>2006</year>
          <fpage>173</fpage>
          <lpage>210</lpage>
          <pub-id pub-id-type="pmid">16699828</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <label>41</label>
        <element-citation publication-type="journal" id="sbref41">
          <person-group person-group-type="author">
            <name>
              <surname>Kluger</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Tittmann</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Thiamin diphosphate catalysis: enzymic and nonenzymic covalent intermediates</article-title>
          <source>Chem. Rev.</source>
          <volume>108</volume>
          <year>2008</year>
          <fpage>1797</fpage>
          <lpage>1833</lpage>
          <pub-id pub-id-type="pmid">18491870</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <label>42</label>
        <element-citation publication-type="journal" id="sbref42">
          <person-group person-group-type="author">
            <name>
              <surname>Candy</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Duggleby</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Structure and properties of pyruvate decarboxylase and site-directed mutagenesis of the <italic>Zymomonas mobilis</italic> enzyme</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1385</volume>
          <year>1998</year>
          <fpage>323</fpage>
          <lpage>338</lpage>
          <pub-id pub-id-type="pmid">9655927</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <label>43</label>
        <element-citation publication-type="journal" id="sbref43">
          <person-group person-group-type="author">
            <name>
              <surname>Tittmann</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Golbik</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Uhlemann</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Khailova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Chipman</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Duggleby</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Hubner</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>NMR analysis of covalent intermediates in thiamin diphosphate enzymes</article-title>
          <source>Biochemistry</source>
          <volume>42</volume>
          <year>2003</year>
          <fpage>7885</fpage>
          <lpage>7891</lpage>
          <pub-id pub-id-type="pmid">12834340</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <label>44</label>
        <element-citation publication-type="journal" id="sbref44">
          <person-group person-group-type="author">
            <name>
              <surname>Niu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>X.-D.</given-names>
            </name>
          </person-group>
          <article-title>Preliminary X-ray crystallographic studies of the catalytic subunit of <italic>Escherichia coli</italic> AHAS II with its cofactors</article-title>
          <source>Acta Crystallogr. Sect. F.</source>
          <volume>67</volume>
          <year>2011</year>
          <fpage>659</fpage>
          <lpage>661</lpage>
        </element-citation>
      </ref>
      <ref id="bib45">
        <label>45</label>
        <element-citation publication-type="journal" id="sbref45">
          <person-group person-group-type="author">
            <name>
              <surname>Gedi</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>M.-Y.</given-names>
            </name>
          </person-group>
          <article-title>Bacterial acetohydroxyacid synthase and its inhibitors &#x2013; a summary of their structure, biological activity and current status</article-title>
          <source>FEBS J.</source>
          <volume>279</volume>
          <year>2012</year>
          <fpage>946</fpage>
          <lpage>963</lpage>
          <pub-id pub-id-type="pmid">22284339</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <label>46</label>
        <element-citation publication-type="journal" id="sbref46">
          <person-group person-group-type="author">
            <name>
              <surname>Duggleby</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>Acetohydroxyacid synthase</article-title>
          <source>J. Biochem. Mol. Biol.</source>
          <volume>33</volume>
          <year>2000</year>
          <fpage>1</fpage>
          <lpage>36</lpage>
        </element-citation>
      </ref>
      <ref id="bib47">
        <label>47</label>
        <element-citation publication-type="journal" id="sbref47">
          <person-group person-group-type="author">
            <name>
              <surname>St&#xF6;rmer</surname>
              <given-names>F.C.</given-names>
            </name>
          </person-group>
          <article-title>The pH 6 acetolactate-forming enzyme from <italic>Aerobacter aerogenes.</italic> I. Kinetic studies</article-title>
          <source>J. Biol. Chem.</source>
          <volume>243</volume>
          <year>1968</year>
          <fpage>3735</fpage>
          <lpage>3739</lpage>
          <pub-id pub-id-type="pmid">5661161</pub-id>
        </element-citation>
      </ref>
      <ref id="bib48">
        <label>48</label>
        <element-citation publication-type="journal" id="sbref48">
          <person-group person-group-type="author">
            <name>
              <surname>St&#xF6;rmer</surname>
              <given-names>F.C.</given-names>
            </name>
          </person-group>
          <article-title>The pH 6 acetolactate-forming enzyme from <italic>Aerobacter aerogenes</italic>.II. Evidence that it is not a flavoprotein</article-title>
          <source>J. Biol. Chem.</source>
          <volume>243</volume>
          <year>1968</year>
          <fpage>3740</fpage>
          <lpage>3741</lpage>
          <pub-id pub-id-type="pmid">5658549</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <label>49</label>
        <element-citation publication-type="journal" id="sbref49">
          <person-group person-group-type="author">
            <name>
              <surname>St&#xF6;rmer</surname>
              <given-names>F.C.</given-names>
            </name>
          </person-group>
          <article-title>Evidence for induction of the 2,3-butanediol-forming enzymes in <italic>Aerobacter aerogenes</italic></article-title>
          <source>FEBS Lett.</source>
          <volume>2</volume>
          <year>1968</year>
          <fpage>36</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="pmid">11946262</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <label>50</label>
        <element-citation publication-type="journal" id="sbref50">
          <person-group person-group-type="author">
            <name>
              <surname>Tsau</surname>
              <given-names>J.-L.</given-names>
            </name>
            <name>
              <surname>Guffanti</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Montville</surname>
              <given-names>T.J.</given-names>
            </name>
          </person-group>
          <article-title>Conversion of pyruvate to acetoin helps to maintain pH homeostasis in <italic>Lactobacillus plantarum</italic></article-title>
          <source>Appl. Environ. Microbiol.</source>
          <volume>58</volume>
          <year>1992</year>
          <fpage>891</fpage>
          <lpage>894</lpage>
          <pub-id pub-id-type="pmid">16348677</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <label>51</label>
        <element-citation publication-type="journal" id="sbref51">
          <person-group person-group-type="author">
            <name>
              <surname>Renna</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Najimudin</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Winik</surname>
              <given-names>L.R.</given-names>
            </name>
            <name>
              <surname>Zahler</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of the <italic>Bacillus subtilis alsS</italic>, <italic>alsD</italic>, and <italic>alsR</italic> genes involved in post-exponential-phase production of acetoin</article-title>
          <source>J. Bacteriol.</source>
          <volume>175</volume>
          <year>1993</year>
          <fpage>3863</fpage>
          <lpage>3875</lpage>
          <pub-id pub-id-type="pmid">7685336</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="s0040">
      <label>Appendix A</label>
      <title>Transparency document</title>
      <p><supplementary-material content-type="local-data" id="ec0005"><caption><p>Supplementary material</p></caption><media xlink:href="mmc1.pdf"/></supplementary-material>.</p>
      <p><supplementary-material content-type="local-data" id="ec0010"><caption><p>Supplementary material</p></caption><media xlink:href="mmc2.pdf"/></supplementary-material>.</p>
      <p><supplementary-material content-type="local-data" id="ec0015"><caption><p>Supplementary material</p></caption><media xlink:href="mmc3.xlsx"/></supplementary-material>.</p>
    </sec>
    <ack id="ack0005">
      <title>Acknowledgments</title>
      <p>The authors are grateful to Mr. Alton Wong, Benozir Sarafuddin, and Frank Gong for their helps with growth of the organisms and some purification aspects. This work was supported by research grant from the <funding-source id="gs1">Natural Sciences and Engineering Research Council of Canada</funding-source> (NSERC), (grant number 227233) to KM.</p>
    </ack>
    <fn-group>
      <fn id="s0035" fn-type="supplementary-material">
        <label>Appendix A</label>
        <p>Transparency document associated with this article can be found in the online version at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbrep.2016.07.008" id="ir6566">10.1016/j.bbrep.2016.07.008</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">mSystems</journal-id>
      <journal-id journal-id-type="iso-abbrev">mSystems</journal-id>
      <journal-id journal-id-type="hwp">msys</journal-id>
      <journal-id journal-id-type="pmc">msys</journal-id>
      <journal-id journal-id-type="publisher-id">mSystems</journal-id>
      <journal-title-group>
        <journal-title>mSystems</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2379-5077</issn>
      <publisher>
        <publisher-name>American Society for Microbiology</publisher-name>
        <publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28951891</article-id>
      <article-id pub-id-type="pmc">5613172</article-id>
      <article-id pub-id-type="publisher-id">mSystems00116-17</article-id>
      <article-id pub-id-type="doi">10.1128/mSystems.00116-17</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
          <subj-group>
            <subject>Host-Microbe Biology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Thiamine Acquisition Strategies Impact Metabolism and Competition in the Gut Microbe <italic>Bacteroides thetaiotaomicron</italic></article-title>
        <alt-title alt-title-type="running-head">Thiamine Acquisition Strategies of <italic>B.&#xA0;thetaiotaomicron</italic></alt-title>
        <alt-title alt-title-type="short-authors">Costliow and Degnan</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Costliow</surname>
            <given-names>Zachary A.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Degnan</surname>
            <given-names>Patrick H.</given-names>
          </name>
        </contrib>
        <aff>
          <addr-line>Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA</addr-line>
        </aff>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Gilbert</surname>
            <given-names>Jack A.</given-names>
          </name>
          <role>Editor</role>
          <aff>University of Chicago</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address correspondence to Patrick H. Degnan, <email>pdegnan@illinois.edu</email>.</corresp>
        <fn fn-type="other">
          <p><bold>Citation</bold> Costliow ZA, Degnan PH. 2017. Thiamine acquisition strategies impact metabolism and competition in the gut microbe <italic>Bacteroides thetaiotaomicron</italic>. mSystems 2:e00116-17. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mSystems.00116-17">https://doi.org/10.1128/mSystems.00116-17</ext-link>.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>9</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <season>Sep-Oct</season>
        <year>2017</year>
      </pub-date>
      <volume>2</volume>
      <issue>5</issue>
      <elocation-id>e00116-17</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>8</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>8</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Costliow and Degnan</copyright-holder>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="sys005172138001.pdf"/>
      <abstract abstract-type="precis">
        <p>Variation in the ability of gut microbes to transport, synthesize, and compete for vitamin B<sub>1</sub> (thiamine) is expected to impact the structure and stability of the microbiota, and ultimately this variation may have both direct and indirect effects on human health. Our study identifies the diverse strategies employed by gut <italic>Bacteroidetes</italic> to acquire thiamine. We demonstrate how the presence or absence of thiamine biosynthesis or transport dramatically affects the abundance of <italic>B.&#xA0;thetaiotaomicron</italic> in a competitive environment. This study adds further evidence that altering the presence or concentrations of water-soluble vitamins such as thiamine may be an effective method for manipulating gut community composition. In turn, targeted thiamine delivery could be used therapeutically to alter dysbiotic communities linked to disease.</p>
      </abstract>
      <abstract>
        <title>ABSTRACT</title>
        <p>Thiamine (vitamin B<sub>1</sub>) is an essential cofactor for all organisms. Humans primarily acquire thiamine through their diet, and thiamine deficiencies have adverse neurological effects. However, the role gut microbes play in modulating thiamine availability is poorly understood, and little is known about how thiamine impacts the stability of microbial gut communities. To investigate thiamine&#x2019;s role in the gut, we utilized the model gut microbe <italic>Bacteroides thetaiotaomicron</italic>. Transcriptome sequencing (RNA-seq) revealed a global downregulation of thiamine and amino acid biosynthesis, glycolysis, and purine metabolism when thiamine was present. Using genetic mutants with thiamine biosynthesis and transport locus mutations, we determined both systems were critical for growth in thiamine-deficient medium. The defect in the double transport mutant suggests an uncharacterized feedback mechanism between thiamine transport and biosynthesis in <italic>B.&#xA0;thetaiotaomicron</italic>. Mutant phenotypes were recapitulated during pairwise competitions, reinforcing the importance of encoding versatile thiamine acquisition mechanisms when thiamine concentrations are variable. In addition, liquid chromatography-mass spectrometry (LC-MS) analyses corroborate that exogenous thiamine levels affect the internal thiamine pool of <italic>B.&#xA0;thetaiotaomicron</italic>. Furthermore, we computationally examined the ability of other gut microbes to acquire thiamine and identified lineage-specific differences in thiamine acquisition strategies. Among the <italic>Bacteroidetes</italic>, the capacities for both thiamine transport and biosynthesis are common. Together, these data show that thiamine acquisition mechanisms used by <italic>B.&#xA0;thetaiotaomicron</italic> not only are critical for its physiology and fitness but also provide the opportunity to model how other gut microbes may respond to the shifting availability of thiamine in the gut.</p>
        <p><bold>IMPORTANCE</bold> Variation in the ability of gut microbes to transport, synthesize, and compete for vitamin B<sub>1</sub> (thiamine) is expected to impact the structure and stability of the microbiota, and ultimately this variation may have both direct and indirect effects on human health. Our study identifies the diverse strategies employed by gut <italic>Bacteroidetes</italic> to acquire thiamine. We demonstrate how the presence or absence of thiamine biosynthesis or transport dramatically affects the abundance of <italic>B.&#xA0;thetaiotaomicron</italic> in a competitive environment. This study adds further evidence that altering the presence or concentrations of water-soluble vitamins such as thiamine may be an effective method for manipulating gut community composition. In turn, targeted thiamine delivery could be used therapeutically to alter dysbiotic communities linked to disease.</p>
        <p><bold>Author Video</bold>: An <ext-link ext-link-type="uri" xlink:href="https://www.youtube.com/watch?v=h3r1Pk2dkWA">author video summary</ext-link> of this article is available.</p>
      </abstract>
      <kwd-group>
        <title>KEYWORDS</title>
        <kwd>competition</kwd>
        <kwd>microbiome</kwd>
        <kwd>
          <italic>pnuT</italic>
        </kwd>
        <kwd>thiamine pyrophosphate (TPP)</kwd>
        <kwd>vitamin B<sub>1</sub></kwd>
      </kwd-group>
      <funding-group>
        <award-group id="award1">
          <funding-source>Roy J. Carver Charitable Trust (Carver Charitable Trust)
<named-content content-type="funder-id">https://doi.org/10.13039/100001024</named-content></funding-source>
          <award-id>15-4501</award-id>
          <principal-award-recipient>Patrick Degnan</principal-award-recipient>
        </award-group>
      </funding-group>
      <counts>
        <count count="10" count-type="supplementary-material"/>
        <fig-count count="6"/>
        <table-count count="1"/>
        <equation-count count="0"/>
        <ref-count count="45"/>
        <page-count count="17"/>
        <word-count count="9644"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>September/October 2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0">
      <title>INTRODUCTION</title>
      <p>Thiamine, a small metabolite vitamin is an essential cofactor in all three domains of life. Thiamine is necessary for glycolysis, the tricarboxylic acid (TCA) cycle, branched-chain amino acid metabolism, and nucleotide metabolism (<xref rid="B1" ref-type="bibr">1</xref>). Deficiencies of thiamine in humans can lead to neurodegenerative disorders, such as Wernicke&#x2019;s encephalopathy and beriberi, as well as heart failure, ataxia, and paralysis (<xref rid="B2" ref-type="bibr">2</xref>). In humans, thiamine is believed to be primarily derived from dietary sources, such as protein-rich foods as well as fortified grains (<xref rid="B2" ref-type="bibr">2</xref>), and is absorbed throughout the small and large intestines (<xref rid="B3" ref-type="bibr">3</xref>). However, there is evidence that thiamine availability is modulated by or acquired from the dense and diverse microbial communities present in the gastrointestinal tract (<xref rid="B3" ref-type="bibr">3</xref><xref ref-type="bibr" rid="B4">&#x2013;</xref><xref rid="B5" ref-type="bibr">5</xref>).</p>
      <p>Competition for and production of small metabolites such as vitamins, amino acids, and short-chain fatty acids influence the composition (e.g., abundance and types) of microbes that inhabit the gastrointestinal tract (<xref rid="B6" ref-type="bibr">6</xref><xref ref-type="bibr" rid="B7">&#x2013;</xref><xref rid="B8" ref-type="bibr">8</xref>). As such, small metabolites are therapeutic candidates for treatment of diseases associated with radical changes in gut microbial community composition, such as Alzheimer&#x2019;s, diabetes, and obesity (<xref rid="B9" ref-type="bibr">9</xref><xref ref-type="bibr" rid="B10">&#x2013;</xref><xref rid="B11" ref-type="bibr">11</xref>). Indirect evidence suggests thiamine may influence gut community structure. Metagenomic analysis of human cohorts of different ages determined that not only did overall microbial communities change with age, but the abundance of microbial thiamine biosynthesis genes increased with the age of the host (<xref rid="B12" ref-type="bibr">12</xref>). Conversely, in a separate study the activity of human intestinal thiamine transporters was observed to decrease with age (<xref rid="B13" ref-type="bibr">13</xref>). These observations may indicate a lower requirement for thiamine by the host with age or possibly an increase in thiamine availability due to microbial production in older individuals. While these correlative data exist, little is known mechanistically about how the competition for and production of thiamine impact individual gut microbes like <italic>Bacteroides thetaiotaomicron</italic>, microbial gastrointestinal communities, or human health.</p>
      <p>Microbial thiamine biosynthesis is a bifurcated pathway involving the synthesis of two precursors that are condensed to form thiamine (<xref rid="B14" ref-type="bibr">14</xref>). Microbes that lack complete <italic>de novo</italic> biosynthesis of thiamine often encode partial biosynthetic pathways of the precursors thiazole and hydroxymethyl pyrimidine phosphate or simply phosphorylate free thiamine into the biologically active form, thiamine pyrophosphate (TPP) (<xref rid="B15" ref-type="bibr">15</xref>). Organisms that lack or have incomplete biosynthetic pathways require transporters for thiamine or its precursors. Humans exclusively transport free thiamine in the proximal small intestine as well as in the large intestine (<xref rid="B13" ref-type="bibr">13</xref>), while some microbes like <italic>Salmonella enterica</italic> use an ABC transporter to acquire thiamine and its phosphorylated forms (<xref rid="B16" ref-type="bibr">16</xref>). However, despite our understanding of thiamine biosynthesis and metabolism in humans and a limited number of model organisms, little is known about thiamine acquisition strategies among most beneficial gut microbes.</p>
      <p>Initial comparative genomic analyses of several gut microbes suggested that the <italic>Bacteroidetes</italic>, a phylum that can comprise as much as 50% of the gastrointestinal community (<xref rid="B17" ref-type="bibr">17</xref>), possess a canonical thiamine biosynthesis pathway (<xref rid="B18" ref-type="bibr">18</xref>). In addition, a novel transport system was predicted due to the presence of <italic>cis</italic>-acting RNA regulatory elements, TPP riboswitches, preceding putative transport genes (<xref rid="B18" ref-type="bibr">18</xref>). However, limited investigation of thiamine acquisition in the <italic>Bacteroidetes</italic> has been attempted (<xref rid="B19" ref-type="bibr">19</xref>). Here, we have carried out a bioinformatic analysis of 641 gut-associated microbes and performed a transcriptomic, genetic, and competitive characterization of the prominent gut microbe <italic>B.&#xA0;thetaiotaomicron</italic> in response to thiamine. In turn, we have characterized (i) the effect of thiamine on the transcriptome, (ii) the predicted thiamine biosynthesis and transport genes, (iii) the competitive defects of biosynthesis and transport mutants, and (iv) the effects that exogenous thiamine has on the internal thiamine pool of <italic>B.&#xA0;thetaiotaomicron</italic>.</p>
    </sec>
    <sec sec-type="results" id="s1">
      <title>RESULTS</title>
      <sec id="s1.1">
        <title>Global gene expression response of <italic>B.&#xA0;thetaiotaomicron</italic> to thiamine availability.</title>
        <p><italic>B.&#xA0;thetaiotaomicron</italic>, a prominent gut microbe, is typical of the <italic>Bacteroidetes</italic> in its thiamine acquisition strategy, containing TPP riboswitch-regulated biosynthesis (<italic>thiSEGCHF-tenI</italic> [<italic>BT0653</italic> to <italic>BT0647</italic>]), putative outer membrane transporter (<italic>OMthi</italic> [<italic>BT2390</italic>]), and putative inner membrane transporter, and thiamine pyrophosphorylase (<italic>pnuT-tnr3</italic> [<italic>BT2396</italic> to <italic>BT2397</italic>]) operons (<xref rid="B18" ref-type="bibr">18</xref>). TPP riboswitches can act at the transcriptional or translational level (<xref rid="B20" ref-type="bibr">20</xref>), and it is uncertain how they function in the <italic>Bacteroidetes</italic>. To investigate the response of <italic>B.&#xA0;thetaiotaomicron</italic> to the availability of thiamine, strand-specific transcriptome sequencing (RNA-seq) was performed on cultures grown in minimal medium supplemented with either 0 or 15&#xA0;&#xB5;M thiamine in duplicate. A total of 34,890,999 reads were recovered, ranging from approximately 8 million to 9.5 million reads per sample that were quality filtered, trimmed, and analyzed with Rockhopper (see <xref ref-type="supplementary-material" rid="tabS1">Table&#xA0;S1</xref>&#xA0;in the supplemental material) (<xref rid="B21" ref-type="bibr">21</xref>). Of the 4,778 coding sequences in the <italic>B.&#xA0;thetaiotaomicron</italic> genome, 151 showed a &#x2265;2-fold expression change (false-discovery rate [FDR], <italic>q</italic> &#x2264; 0.05). Of the three putative TPP riboswitch-regulated operons, the biosynthetic operon as a whole was significantly downregulated when thiamine was present (<xref ref-type="fig" rid="fig1">Fig.&#xA0;1A</xref>). No significant differential expression was observed at either of the predicted transport operons (<xref ref-type="fig" rid="fig1">Fig.&#xA0;1A</xref>). This is in striking contrast to the multiple vitamin B<sub>12</sub> riboswitch-regulated B<sub>12</sub> transporters in <italic>B.&#xA0;thetaiotaomicron</italic>, which exhibit a strong transcriptional induction when grown under vitamin B<sub>12</sub>-limiting conditions (<xref rid="B6" ref-type="bibr">6</xref>). However, this does not rule out their involvement in thiamine transport, particularly as the putative inner membrane transporter, PnuT, has been heterologously expressed in <italic>Escherichia coli</italic> and demonstrated to transport thiamine (<xref rid="B19" ref-type="bibr">19</xref>).</p>
        <supplementary-material content-type="local-data" id="tabS1">
          <object-id pub-id-type="doi">10.1128/mSystems.00116-17.6</object-id>
          <label>TABLE&#xA0;S1&#xA0;</label>
          <p>Samples used for the RNA sequencing experiment. Download <inline-supplementary-material id="tabs1" mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="sys005172138sd2.xls" content-type="local-data">TABLE&#xA0;S1, XLS file, 0.02 MB</inline-supplementary-material>.</p>
          <permissions>
            <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder>Costliow and Degnan</copyright-holder>
            <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
              <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
            </license>
          </permissions>
        </supplementary-material>
        <fig id="fig1" orientation="portrait" position="float">
          <label>FIG&#xA0;1&#xA0;</label>
          <caption>
            <p>Transcriptomic response of <italic>B.&#xA0;thetaiotaomicron</italic> to exogenous thiamine. (A) A schematic of TPP riboswitch-regulated operons is shown with expression fold changes indicated and colored according to the heat map. Asterisks indicate individual genes that are significantly downregulated (<italic>q</italic> &#x2264; 0.05) in the presence of thiamine. (B) Genome-wide expression response of <italic>B.&#xA0;thetaiotaomicron</italic> to thiamine. Gray circles indicate genes that are not significantly up- or downregulated, red circles are genes significantly downregulated in the presence of thiamine, and green circles are genes significantly upregulated (<italic>q</italic> &#x2264; 0.05). (C) KEGG gene clusters that contain genes which are significantly downregulated. The numbers to the right of each KEGG pathway denote the number of genes downregulated in each category. Underlined categories indicate KEGG pathways that are significantly downregulated through GSEA analysis (<italic>P</italic> &#x2264; 0.05).</p>
          </caption>
          <graphic xlink:href="sys0051721380001"/>
        </fig>
        <p>In addition to the genes in the biosynthetic operon, 148 other genes were differentially expressed due to exogenous thiamine in the environment. In fact, 132 of the 151 differentially regulated genes were downregulated when 15&#xA0;&#xB5;M thiamine was present in the medium (<xref ref-type="fig" rid="fig1">Fig.&#xA0;1B</xref>). Using gene set enrichment analysis (GSEA), we determined if specific pathways are differentially expressed due to thiamine availability (<xref rid="B22" ref-type="bibr">22</xref>). Significantly downregulated KEGG pathways in the presence of exogenous thiamine were observed in thiamine metabolism, amino acid biosynthesis, purine metabolism, the TCA cycle, coenzyme A biosynthesis, and pyruvate metabolism (FDR-corrected <italic>P</italic> &#x2264; 0.001) (<xref ref-type="fig" rid="fig1">Fig.&#xA0;1C</xref>). This suggests that in the presence of excess exogenous thiamine, <italic>B.&#xA0;thetaiotaomicron</italic> downregulates transcription of the thiamine biosynthetic pathway in order to maintain homeostatic levels of internal thiamine. In addition to this, <italic>B.&#xA0;thetaiotaomicron</italic> also decreases transcription of thiamine-dependent pathways such as branched-chain amino acid biosynthesis, glycolysis, and the citric acid cycle when excess thiamine is present. This decreased expression in the presence of excess thiamine is counterintuitive to what was expected. Normally, it is expected that expression of cofactor-dependent enzymes is positively correlated with the concentration of the cofactor (e.g., iron) (<xref rid="B23" ref-type="bibr">23</xref>). In the case of thiamine in <italic>B.&#xA0;thetaiotaomicron</italic>, we observe the opposite. The expression of thiamine-dependent enzymes was inversely correlated.</p>
      </sec>
      <sec id="s1.2">
        <title>Genetic analysis of thiamine acquisition genes in <italic>B.&#xA0;thetaiotaomicron.</italic></title>
        <p>To assess the conditions under which thiamine biosynthesis and uptake are important for the growth of <italic>B.&#xA0;thetaiotaomicron</italic> and validate the role of the predicted transporters in thiamine uptake, a series of in-frame genetic deletions were generated. We focused on the three TPP riboswitch-regulated operons, removing the entirety of the downstream biosynthetic or putative transport coding sequences. The resulting mutant strains and their complements (<xref ref-type="table" rid="tab1">Table&#xA0;1</xref>) were evaluated for their ability to grow under a range of exogenous thiamine concentrations.</p>
        <table-wrap id="tab1" orientation="portrait" position="float">
          <label>TABLE&#xA0;1&#xA0;</label>
          <caption>
            <p>Deletion loci and complements generated in this study</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col width="3497" span="1"/>
              <col width="5437" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th rowspan="1" colspan="1">Strain type</th>
                <th rowspan="1" colspan="1">Description</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">WT</td>
                <td rowspan="1" colspan="1">Wild-type deletion background, &#x394;<italic>BT2275</italic> FUdR<sup>r</sup>, intact thiamine biosynthetic and transport operons<xref ref-type="table-fn" rid="ngtab1.1"><sup>a</sup></xref></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Deletion mutants</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;BioThi</td>
                <td rowspan="1" colspan="1">Deletion of thiamine biosynthetic operon <italic>thiSEGCHF-tenI</italic> (<italic>BT0647&#x2013;BT0653</italic> [797661&#x2013;803616])</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;<italic>OMthi</italic></td>
                <td rowspan="1" colspan="1">Deletion of putative outer membrane, TonB-dependent thiamine transporter <italic>BT2390</italic> (2977834&#x2013;2980058)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;<italic>pnuT</italic></td>
                <td rowspan="1" colspan="1">Deletion of putative inner membrane thiamine transporter <italic>BT2396</italic> (2992218&#x2013;2992778)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;&#x394;BioThi-<italic>OMthi</italic></td>
                <td rowspan="1" colspan="1">Deletion of <italic>BT0647&#x2013;BT0653</italic> and <italic>BT2390</italic></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;&#x394;BioThi-<italic>pnuT</italic></td>
                <td rowspan="1" colspan="1">Deletion of <italic>BT0647&#x2013;BT0653</italic> and <italic>BT2396</italic></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;&#x394;Transport</td>
                <td rowspan="1" colspan="1">Deletion of <italic>BT2390</italic> and <italic>BT2396</italic></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;&#x394;&#x394;</td>
                <td rowspan="1" colspan="1">Deletion of <italic>BT0647&#x2013;BT0653</italic>, <italic>BT2390</italic>, and <italic>BT2396</italic></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Complementation constructs</td>
                <td rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;BioThi+pBioThi</td>
                <td rowspan="1" colspan="1"><italic>BT0647&#x2013;BT0653</italic> complemented in <italic>trans</italic></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;&#x394;BioThi-<italic>OMthi</italic>+pBioThi</td>
                <td rowspan="1" colspan="1"><italic>BT0647&#x2013;BT0653</italic> complemented in <italic>trans</italic></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;&#x394;BioThi-<italic>pnuT</italic>+pBioThi</td>
                <td rowspan="1" colspan="1"><italic>BT0647&#x2013;BT0653</italic> complemented in <italic>trans</italic></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;&#x394;Transport+p<italic>OMthi</italic></td>
                <td rowspan="1" colspan="1"><italic>BT2390</italic> complemented in <italic>trans</italic></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;&#x394;Transport+p<italic>pnuT</italic></td>
                <td rowspan="1" colspan="1"><italic>BT2396</italic> complemented in <italic>trans</italic></td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">&#x2003;&#x2003;&#x2003;&#x2003;&#x394;&#x394;Transport+p<italic>pnuT</italic>+<italic>OMthi</italic></td>
                <td rowspan="1" colspan="1"><italic>BT2396</italic> and <italic>BT2390</italic> complemented <italic>in trans</italic></td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn fn-type="other" id="ngtab1.1">
              <label>a</label>
              <p>For details, see reference <xref rid="B33" ref-type="bibr">33</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Wild-type <italic>B.&#xA0;thetaiotaomicron</italic> readily grows in media without added thiamine (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2A</xref>) (<xref rid="B24" ref-type="bibr">24</xref>), which corresponds with elevated expression of the TPP riboswitch-regulated <italic>thiSEGCHF-tenI</italic> operon identified by RNA-seq. Therefore, deletion of the major thiamine biosynthetic operon (&#x394;BioThi [<italic>BT0653</italic> to <italic>BT0647</italic>]) is expected to completely inhibit growth in minimal medium without thiamine. Indeed, growth inhibition occurs in the &#x394;BioThi mutant, severely attenuating terminal cell densities (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2A</xref> and <xref ref-type="fig" rid="fig2">B</xref>). Partial growth of the &#x394;BioThi mutant is recovered when the medium is supplemented with &#x2265;1&#xA0;nM thiamine (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2B</xref>). The calculated 50% effective concentration (EC<sub>50</sub>: the effective concentration of thiamine at which the terminal optical density at 600 nm [OD<sub>600</sub>] of the mutant attains 50% of the wild-type level) (see <xref ref-type="supplementary-material" rid="tabS2">Table&#xA0;S2</xref>&#xA0;in the supplemental material) for the &#x394;BioThi mutant is 2.8&#xA0;nM (95% confidence interval [CI], 1.4 to 5.5&#xA0;nM), showing that biosynthesis is critical in thiamine-deficient environments. This growth defect can be complemented when the <italic>thiSEGCHF-tenI</italic> operon and its native promoter are returned to the &#x394;BioThi mutant in <italic>trans</italic> (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2B</xref>), alleviating the requirement for exogenous thiamine and returning the EC<sub>50</sub> to 0&#xA0;nM thiamine (<xref ref-type="supplementary-material" rid="tabS2">Table&#xA0;S2</xref>). Together these data suggest that <italic>B.&#xA0;thetaiotaomicron</italic> does in fact encode thiamine transporters that likely function in the low-nanomolar range. This is comparable to other characterized thiamine transporters such as ThiPQ-TbpA in <italic>Salmonella enterica</italic> serovar Typhimurium (<xref rid="B16" ref-type="bibr">16</xref>).</p>
        <supplementary-material content-type="local-data" id="tabS2">
          <object-id pub-id-type="doi">10.1128/mSystems.00116-17.7</object-id>
          <label>TABLE&#xA0;S2&#xA0;</label>
          <p>Effective concentrations for 50% WT growth represented as nanomolar concentration of thiamine required. Download <inline-supplementary-material id="tabs2" mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="sys005172138sd3.xls" content-type="local-data">TABLE&#xA0;S2, XLS file, 0.1 MB</inline-supplementary-material>.</p>
          <permissions>
            <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder>Costliow and Degnan</copyright-holder>
            <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
              <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
            </license>
          </permissions>
        </supplementary-material>
        <fig id="fig2" orientation="portrait" position="float">
          <label>FIG&#xA0;2&#xA0;</label>
          <caption>
            <p>Growth phenotypes of <italic>B.&#xA0;thetaiotaomicron</italic> thiamine acquisition mutants. Thiamine acquisition operons have differential effects on the ability of <italic>B.&#xA0;thetaiotaomicron</italic> to grow under thiamine-limiting conditions. (A) Representative growth curve of the wild-type (WT) and &#x394;BioThi strains showing growth defects of the &#x394;BioThi mutant in a thiamine-deficient environment (0&#xA0;nM) and a thiamine-replete environment (10,000&#xA0;nM). An arrow indicates the maximal growth point at ~17.5&#xA0;h used to calculate the percentage of growth of the WT in minimal medium supplemented with 10,000&#xA0;nM thiamine to compare growth phenotypes across concentrations of thiamine in panels B to D. (B) Single mutants with mutation of the outer membrane transporter (&#x394;<italic>OMthi</italic>) and inner membrane transporter (&#x394;<italic>pnuT</italic>) loci showed no defect, while &#x394;BioThi strains were variably attenuated in thiamine concentrations of &lt;100&#xA0;nM, and complementation of &#x394;BioThi with the entire loci with the native promoter expressed in <italic>trans</italic> can fully complement the mutant. (C) Mutants lacking biosynthesis (&#x394;BioThi) and a single transport gene (<italic>pnuT</italic> or <italic>OMthi</italic>) have severe growth phenotypes at &lt;100&#xA0;nM thiamine but can be complemented with the biosynthesis locus under its native promoter to wild-type or near-wild-type levels. (D) The double transport mutant (&#x394;&#x394;Transport) and triple locus mutant (&#x394;&#x394;&#x394;) were both highly attenuated in thiamine concentrations of &lt;1,000&#xA0;nM. Complementation of single transporters in the &#x394;&#x394;Transport background can partially rescue the severe growth phenotype. SEM, standard error of the mean.</p>
          </caption>
          <graphic xlink:href="sys0051721380002"/>
        </fig>
        <p>To determine if the predicted TPP riboswitch-regulated inner (<italic>pnuT</italic> [<italic>BT2396</italic>]) and outer (<italic>OMthi</italic> [<italic>BT2390</italic>]) membrane transporters are responsible for transporting thiamine, individual transporter deletions were constructed in the wild-type background (&#x394;<italic>pnuT</italic> and &#x394;<italic>OMthi</italic>). Regardless of the thiamine concentration in the medium, growth of the single transporter mutants never significantly varied from wild type (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2B</xref>). This result was expected as the thiamine biosynthesis pathway is fully intact. Therefore, to further investigate the role of these transporters, double mutants consisting of either the biosynthetic operon and a single transporter or both transporters were generated.</p>
        <p>Deletion of the biosynthetic operon in conjunction with either the inner membrane (&#x394;&#x394;BioThi-<italic>pnuT</italic>) or outer membrane (&#x394;&#x394;BioThi-<italic>OMthi</italic>) transporters resulted in mutants that required ~10 times more thiamine (1,000&#xA0;nM) than the &#x394;BioThi mutant to achieve growth equal to that of the wild type (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2C</xref>). The EC<sub>50</sub> for the double mutants increased to 15.8&#xA0;nM (95% CI, 8.1 to 31&#xA0;nM) thiamine for the biosynthesis and outer membrane transporter mutant and to 10.9&#xA0;nM (95% CI, 9.2 to 13&#xA0;nM) for the biosynthesis and inner membrane transporter double mutant compared to an EC<sub>50</sub> of 2.8&#xA0;nM (95% CI, 1.4 to 5.5&#xA0;nM) in the biosynthesis mutant (<xref ref-type="supplementary-material" rid="tabS2">Table&#xA0;S2</xref>). Thus, partial disruption of thiamine transport in the absence of a complete biosynthetic pathway further attenuates but does not completely abolish thiamine-dependent growth. Growth of either of these two mutant backgrounds can be fully complemented by restoring the major thiamine biosynthesis operon in <italic>trans</italic> (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2C</xref>).</p>
        <p>Compared to the individual biosynthesis and transporter mutants, deletion of both transporters while the biosynthesis locus is fully intact (&#x394;&#x394;Transport) has a highly deleterious effect on growth (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2D</xref>). This mutant requires at least 10&#xA0;&#xB5;M thiamine to achieve wild-type growth and has an EC<sub>50</sub> of 30.3&#xA0;nM (95% CI, 22.8 to 40.3&#xA0;nM) (<xref ref-type="supplementary-material" rid="tabS2">Table&#xA0;S2</xref>). To ensure this phenotype was not due to an inability to transport cysteine, the only thiamine precursor present in the minimal medium, the double transport mutant was grown with an alternate sulfur source. The growth phenotype of the mutant in the modified medium was unchanged, suggesting that neither transporter is likely involved in cysteine transport (see <xref ref-type="supplementary-material" rid="textS1">Text&#xA0;S1</xref>&#xA0;and <xref ref-type="supplementary-material" rid="figS1">Fig.&#xA0;S1</xref> in the supplemental material).</p>
        <supplementary-material content-type="local-data" id="textS1">
          <object-id pub-id-type="doi">10.1128/mSystems.00116-17.1</object-id>
          <label>TEXT&#xA0;S1&#xA0;</label>
          <p>Supplemental results and methods. Download <inline-supplementary-material id="texts1" mimetype="application" mime-subtype="pdf" xlink:href="sys005172138s1.pdf" content-type="local-data">TEXT&#xA0;S1, PDF file, 0.1 MB</inline-supplementary-material>.</p>
          <permissions>
            <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder>Costliow and Degnan</copyright-holder>
            <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
              <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
            </license>
          </permissions>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="figS1">
          <object-id pub-id-type="doi">10.1128/mSystems.00116-17.2</object-id>
          <label>FIG&#xA0;S1&#xA0;</label>
          <p>Putative <italic>B.&#xA0;thetaiotaomicron</italic> thiamine transporters are specific for thiamine. Download <inline-supplementary-material id="figs1" mimetype="application" mime-subtype="pdf" xlink:href="sys005172138sf7.pdf" content-type="local-data">FIG&#xA0;S1, PDF file, 0.2 MB</inline-supplementary-material>.</p>
          <permissions>
            <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder>Costliow and Degnan</copyright-holder>
            <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
              <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
            </license>
          </permissions>
        </supplementary-material>
        <p>Individual complementation constructs were generated for the inner and outer membrane components and introduced in <italic>trans</italic> into the double transport mutant (&#x394;&#x394;Transport+p<italic>pnuT</italic> and &#x394;&#x394;Transport+p<italic>OMthi</italic>). Although we did not observe full complementation by either of the two constructs, they did significantly improve the EC<sub>50</sub> from 30.3&#xA0;nM (95% CI, 22.8 to 40.3&#xA0;nM) in the double transport mutant to 1.9&#xA0;nM (95% CI, 0.8 to 4.4&#xA0;nM) and 0.1&#xA0;nM (95% CI, 0 to 1.9&#xA0;nM) (<xref ref-type="supplementary-material" rid="tabS2">Table&#xA0;S2</xref>) in the outer and inner membrane transport complements, respectively (<italic>t</italic>&#xA0;test, <italic>P</italic> &lt; 0.0001) (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2D</xref>). In addition to single transport complements, a double transport complement (&#x394;&#x394;Transport+p<italic>pnuT+OMthi</italic>) was made and tested with similar results to the single transport complements. The double complement allowed for better fitness at low levels of thiamine, achieving &gt;35% of wild-type growth at 0&#xA0;nM added thiamine and greater than 80% of wild-type growth at 10&#xA0;nM (see <xref ref-type="supplementary-material" rid="figS2">Fig.&#xA0;S2</xref> in the supplemental material). It also significantly improved the &#x394;&#x394;Transport mutant&#x2019;s EC<sub>50</sub> from 30.3&#xA0;nM to 0.1&#xA0;nM (95% CI, 0 to 0.2&#xA0;nM) (<xref ref-type="supplementary-material" rid="tabS2">Table&#xA0;S2</xref>). While not uncommon, it is possible that with introduction of the complementation vectors in <italic>trans</italic>, the complements were not expressed at the same level as the wild type or are missing key upstream elements preventing the strains from growing as well as wild-type <italic>B.&#xA0;thetaiotaomicron</italic> (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2D</xref>).</p>
        <supplementary-material content-type="local-data" id="figS2">
          <object-id pub-id-type="doi">10.1128/mSystems.00116-17.3</object-id>
          <label>FIG&#xA0;S2&#xA0;</label>
          <p>Growth of dually complemented &#x394;&#x394;Transport mutant. Download <inline-supplementary-material id="figs2" mimetype="application" mime-subtype="pdf" xlink:href="sys005172138sf8.pdf" content-type="local-data">FIG&#xA0;S2, PDF file, 0.1 MB</inline-supplementary-material>.</p>
          <permissions>
            <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder>Costliow and Degnan</copyright-holder>
            <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
              <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
            </license>
          </permissions>
        </supplementary-material>
        <p>A final triple mutant of all three TPP-regulated loci was generated (&#x394;&#x394;&#x394;). This strain demonstrated a similar level of growth inhibition to the double transport mutant (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2D</xref>). It required 10&#xA0;&#xB5;M thiamine in the medium to attain 100% wild-type growth (EC<sub>50</sub> of 51.9&#xA0;nM; 95% CI, 42.4 to 63.6&#xA0;nM) (<xref ref-type="supplementary-material" rid="tabS2">Table&#xA0;S2</xref>). It is important to note that growth defects only affected the terminal density of the mutants, and the doubling times remained fairly constant (~2&#xA0;h). Together these data confirm the crucial role these operons play in producing and acquiring thiamine.</p>
      </sec>
      <sec id="s1.3">
        <title>Factors affecting the phenotype of the double transport mutant.</title>
        <p>To determine if dysregulation of biosynthesis played a role in the severe growth phenotype of the double transport mutant, reverse transcription-quantitative PCR (RT-qPCR) was performed. Consistent with the RNA-seq data (<xref ref-type="fig" rid="fig1">Fig.&#xA0;1</xref>), expression of the major biosynthetic operon in wild-type <italic>B.&#xA0;thetaiotaomicron</italic> is upregulated under thiamine-deficient conditions (0 and 100&#xA0;nM) compared to under the replete condition (10,000&#xA0;nM) (<xref ref-type="fig" rid="fig3">Fig.&#xA0;3A</xref> and <xref ref-type="fig" rid="fig3">B</xref>). In a thiamine-deficient environment, gene <italic>thiC</italic> (<xref ref-type="fig" rid="fig3">Fig.&#xA0;3A</xref>) is expressed 9.2-fold higher in 0&#xA0;nM thiamine than in 10,000&#xA0;nM and 3.3-fold higher than in 100&#xA0;nM thiamine (<xref ref-type="fig" rid="fig3">Fig.&#xA0;3A</xref>). Similarly the expression of<italic> thiS</italic> is expressed 2.7-fold to 2-fold higher in 0&#xA0;nM thiamine than in 10,000 and 100&#xA0;nM, respectively (<xref ref-type="fig" rid="fig3">Fig.&#xA0;3B</xref>). As noted above the &#x394;&#x394;Transport mutant cannot be cultured in 0&#xA0;nM thiamine, but <italic>thiC</italic> and <italic>thiS</italic> expression was determined in 100 and 10,000&#xA0;nM thiamine. In marked contrast with the wild type, expression of <italic>thiC</italic> and <italic>thiS</italic> is repressed over 100-fold in media with 100 or 10,000&#xA0;nM thiamine. These data suggest that transport and biosynthesis are linked and likely contribute to the severe growth defect in the &#x394;&#x394;Transport mutant despite the presence of an intact biosynthetic operon.</p>
        <fig id="fig3" orientation="portrait" position="float">
          <label>FIG&#xA0;3&#xA0;</label>
          <caption>
            <p>Analysis of thiamine biosynthesis in the wild type and double transport mutant. Expression of biosynthesis was quantitated via RT-qPCR of <italic>thiC</italic> (A) and <italic>thiS</italic> (B) in both wild-type and double transport mutant backgrounds of <italic>B.&#xA0;thetaiotaomicron</italic> at 0, 100, and 10,000&#xA0;nM concentrations of thiamine for the wild type and 100 and 10,000&#xA0;nM concentrations of thiamine for the double transport mutant. Expression of <italic>tnr3</italic> was also measured in the wild type and double transport mutant at 0 and 10,000&#xA0;nM thiamine (C) in order to ensure that the double transport mutant did not have a polar effect on downstream genes. SD, standard deviation; N.G., no growth was achieved to carry out the experiment; N.T., not tested at a certain concentration.</p>
          </caption>
          <graphic xlink:href="sys0051721380003"/>
        </fig>
        <p>In addition, we also performed RT-PCR on <italic>tnr3</italic>, which occurs immediately downstream of <italic>pnuT</italic>, to ensure that the generation of the &#x394;&#x394;Transport mutant did not have a polar effect (<xref ref-type="fig" rid="fig3">Fig.&#xA0;3C</xref>). The expression of <italic>tnr3</italic> remains unchanged in wild-type and the &#x394;&#x394;Transport mutant cells regardless of the thiamine concentration tested. Given this result, we infer that the fitness defect is not due to a polar effect of deleting the transport genes.</p>
      </sec>
      <sec id="s1.4">
        <title>Consequences of thiamine acquisition on competition.</title>
        <p>We investigated the competitive capacities of the <italic>B.&#xA0;thetaiotaomicron</italic> thiamine acquisition mutants in pairwise competitions with wild-type <italic>B.&#xA0;thetaiotaomicron</italic>. To determine if coculture increased (competition) or decreased (cross-feeding) the individual phenotypes, mixed cultures were serially passaged for 5&#xA0;days in media with 0, 10, 100, 10,000&#xA0;nM exogenous thiamine, and strain abundances were monitored through time by qPCR (<xref ref-type="fig" rid="fig4">Fig.&#xA0;4</xref>; see <xref ref-type="supplementary-material" rid="figS3">Fig.&#xA0;S3</xref> in the supplemental material). The single transport mutants (&#x394;<italic>pnuT</italic> and &#x394;<italic>OMthi</italic>) successfully coexisted with wild-type <italic>B.&#xA0;thetaiotaomicron</italic> under every condition tested (<xref ref-type="fig" rid="fig4">Fig.&#xA0;4A</xref> and <xref ref-type="fig" rid="fig4">B</xref>). The mutants maintained 60 to 80% of the population throughout the 5&#xA0;days of serial passaging. Although the abundance of the mutants fluctuated during passaging, this was likely due to stochastic effects during the daily inoculations (<xref ref-type="supplementary-material" rid="figS3">Fig.&#xA0;S3</xref>). Together, these results extend the individual growth findings and show that cells lacking either the inner or outer membrane transporters are not at a disadvantage when grown in competition with the wild-type strain that encodes both fully intact transporters.</p>
        <supplementary-material content-type="local-data" id="figS3">
          <object-id pub-id-type="doi">10.1128/mSystems.00116-17.4</object-id>
          <label>FIG&#xA0;S3&#xA0;</label>
          <p>Barcoded competitions of individual acquisition mutants and wild-type cells. Download <inline-supplementary-material id="figs3" mimetype="application" mime-subtype="pdf" xlink:href="sys005172138sf9.pdf" content-type="local-data">FIG&#xA0;S3, PDF file, 0.4 MB</inline-supplementary-material>.</p>
          <permissions>
            <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder>Costliow and Degnan</copyright-holder>
            <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
              <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
            </license>
          </permissions>
        </supplementary-material>
        <fig id="fig4" orientation="portrait" position="float">
          <label>FIG&#xA0;4&#xA0;</label>
          <caption>
            <p>Single competitions between the wild type and thiamine acquisition mutants. Competitions between wild-type <italic>B.&#xA0;thetaiotaomicron</italic> and the (A) &#x394;<italic>OMthi</italic>, (B) <italic>&#x394;pnuT</italic>, (C), &#x394;BioThi, (D) &#x394;&#x394;BioThi-<italic>OMthi</italic>, (E) &#x394;&#x394;BioThi-<italic>pnuT</italic>, (E) &#x394;&#x394;Transport, and (F) &#x394;&#x394;&#x394; thiamine acquisition mutants were performed over 4 or 5&#xA0;days in defined thiamine concentrations. Strain abundances were quantified by qPCR and are represented as a percentage of the entire community at 4 concentrations of thiamine (0, 10, 100, and 10,000&#xA0;nM). Error bars represent the standard error of the mean from three biological replicates.</p>
          </caption>
          <graphic xlink:href="sys0051721380004"/>
        </fig>
        <p>In contrast, the &#x394;BioThi mutant was rapidly outcompeted in the absence of thiamine, falling to &lt;0.1% of the population by day 5, despite initially making up 90% of the population. As exogenous thiamine levels were increased, the fitness defect was alleviated. At 10&#xA0;nM thiamine, the wild type dominated the competition; by day 5, however, the &#x394;BioThi mutant only dropped to 44% of the population. As the concentrations of thiamine increased to 100 and 10,000&#xA0;nM, the &#x394;BioThi mutant showed no fitness defect, maintaining &#x2265;80% of the population throughout the competition (<xref ref-type="fig" rid="fig4">Fig.&#xA0;4C</xref>). Similarly, the &#x394;&#x394;BioThi-<italic>pnuT</italic> and &#x394;&#x394;BioThi-<italic>OMthi</italic> strains are dramatically outcompeted in 0 and 10&#xA0;nM added thiamine to the level that they are not even detectable. As thiamine is increased in concentration, the abundance of the double biosynthesis and transporter mutants stabilizes at ~55% of the population for the &#x394;&#x394;BioThi-<italic>OMthi</italic> mutant and ~66% of the population for the &#x394;&#x394;BioThi-<italic>pnuT</italic> mutant, respectively (<xref ref-type="fig" rid="fig4">Fig.&#xA0;4D</xref> and <xref ref-type="fig" rid="fig4">E</xref>). The &#x394;&#x394;Transport and &#x394;&#x394;&#x394; mutants were also interrogated for their competitive abilities. We observed severe phenotypes with both mutants in 0, 10, and 100&#xA0;nM thiamine (<xref ref-type="fig" rid="fig4">Fig.&#xA0;4F</xref> and <xref ref-type="fig" rid="fig4">G</xref>). The mutants were rapidly outcompeted by the wild type within the first 3&#xA0;days and driven below the level of detection by day 5 (<xref ref-type="supplementary-material" rid="figS3">Fig.&#xA0;S3</xref>). Only in 10,000&#xA0;nM did the &#x394;&#x394;Transport mutant and the &#x394;&#x394;&#x394; mutant coexist with the wild type&#x2014;maintaining 40% and 80%, respectively, at day 5. These results essentially mirror the individual growth data for the mutants and suggest that wild-type <italic>B.&#xA0;thetaiotaomicron</italic> does not cooperate with or facilitate the growth of these mutants, indicating that <italic>B.&#xA0;thetaiotaomicron</italic> does not appear to release thiamine to the environment under <italic>in vitro</italic> growth conditions.</p>
      </sec>
      <sec id="s1.5">
        <title>Quantification of cell-associated thiamine.</title>
        <p>Intracellular concentrations of thiamine, thiamine monophosphate (TMP), and TPP were measured after wild-type <italic>B.&#xA0;thetaiotaomicron</italic> cultures were grown in four different concentrations of thiamine (0, 10, 100, and 10,000&#xA0;nM). In all the <italic>B.&#xA0;thetaiotaomicron</italic> cultures tested, the cofactor form TPP is the predominant moiety, averaging between 100,000 and 250,000 molecules per cell (<xref ref-type="fig" rid="fig5">Fig.&#xA0;5A</xref>) and constituting 70 to 87% of the total thiamine (<xref ref-type="fig" rid="fig5">Fig.&#xA0;5B</xref>). Therefore, despite a 10,000&#xD7; increase in the amount of exogenous thiamine, the internal concentration changes no more than 2.5-fold. As such, thiamine moieties appear to be maintained within some homeostatic range. However, as exogenous thiamine levels increase, we did detect marginally significant increases in thiamine and TMP concentrations (<xref ref-type="fig" rid="fig5">Fig.&#xA0;5A</xref>). While TMP maintains 9 to 14% of the thiamine pool in spite of its increased concentrations, thiamine itself increases from ~2 to 16% of the total pool (<xref ref-type="fig" rid="fig5">Fig.&#xA0;5B</xref>). These data suggest thiamine may be entering the cell via nonspecific mechanisms&#x2014;the same mechanisms responsible for the ability of the &#x394;&#x394;Transport and &#x394;&#x394;&#x394; mutants to grow in 10,000&#xA0;nM thiamine. As a result, this excess thiamine may impede or exceed the capacity of the thiamine pyrophosphorylase, Tnr3.</p>
        <fig id="fig5" orientation="portrait" position="float">
          <label>FIG&#xA0;5&#xA0;</label>
          <caption>
            <p>Quantification of thiamine pools in <italic>B.&#xA0;thetaiotaomicron</italic>. (A) Intracellular quantification of thiamine and its phosphorylated moieties indicates that total quantities of thiamine, TMP, and TPP increase to various degrees as exogenous thiamine is increased. The values shown represent the average and standard error of the mean from six biological replicates. Letters for individual moieties indicate groups that are not significantly different from each other (<italic>P</italic> &#x2264; 0.05, Tukey&#x2019;s honestly significant difference [HSD] test). (B) The proportions of thiamine and TMP increase as the concentration of exogenous thiamine increases, while the proportion of TPP decreases.</p>
          </caption>
          <graphic xlink:href="sys0051721380005"/>
        </fig>
      </sec>
      <sec id="s1.6">
        <title><bold>Identification of thiamine acquisition genes in gut</bold>
<italic>Bacteroidetes</italic>.</title>
        <p>To expand upon the knowledge gained from our experiments in <italic>B.&#xA0;thetaiotaomicron</italic>, we interrogated 641 genomes from 5 phyla and 11 classes of gut bacteria for the presence of thiamine-dependent enzymes. Every one of the 641 genomes encoded at least one thiamine-dependent enzyme (<xref ref-type="fig" rid="fig6">Fig.&#xA0;6A</xref>). We then determined the route by which these bacteria acquire thiamine by examining their genome&#x2019;s ability to synthesize, transport, or recycle thiamine. Only 48% (307/641) of the genomes investigated have readily identifiable, complete thiamine biosynthesis pathways, implying that many gut microbes likely compete with one another and/or the host for this essential cofactor (<xref ref-type="fig" rid="fig6">Fig.&#xA0;6A</xref>).</p>
        <fig id="fig6" orientation="portrait" position="float">
          <label>FIG&#xA0;6&#xA0;</label>
          <caption>
            <p><italic>In silico</italic> predictions of thiamine acquisition pathways. (A) Schematic phylogeny of 11 classes of cultivable gut-associated bacteria and corresponding pie charts indicating the proportion of genomes that encode a thiamine-dependent enzyme and predicted thiamine acquisition strategies. Values in parentheses represent the number of genome sequences in each class. (B) The presence and absence of predicted thiamine biosynthesis and transport genes in diverse gut <italic>Bacteroidetes</italic> are indicated. The phylogeny represents a maximum likelihood reconstruction of gut <italic>Bacteroidetes</italic> species. Numbers in parentheses represent the number of individual strains analyzed, and nodes marked with black circles indicate bootstrap values of &#x2265;75. The asterisk indicates that one of the five <italic>B.&#xA0;uniformis</italic> genomes analyzed is missing <italic>pnuT</italic> and <italic>tnr3</italic>, but this may be an assembly artifact. (C) Schematic representation of thiamine biosynthesis in the <italic>Bacteroidetes</italic>. Arrow colors correspond to the key in panel B. Gene names in gray are missing, and names in green are genes that are not solely dedicated to the biosynthesis of thiamine.</p>
          </caption>
          <graphic xlink:href="sys0051721380006"/>
        </fig>
        <p>All of the gut <italic>Bacteroidetes</italic> genomes examined exhibit evidence of requiring thiamine (<italic>n =</italic> 114). This includes encoding one or more putatively thiamine-dependent enzymes (mean &#xB1; SD, 13 &#xB1; 2 genes) or a thiamine-binding riboswitch (mean &#xB1; SD, 2 &#xB1; 1 genes). As such, thiamine biosynthesis and transport genes occur in 94% (107/114) of gut-associated <italic>Bacteroidetes</italic> (<xref ref-type="fig" rid="fig6">Fig.&#xA0;6B</xref>). A minority of sequenced <italic>Bacteroidetes</italic> from the gut encode biosynthesis (<italic>n =</italic> 2) or transport (<italic>n =</italic> 5) alone.</p>
        <p>Thiamine biosynthesis occurs in one of two configurations in gut-associated <italic>Bacteroidetes</italic>. The majority of genomes, including <italic>B.&#xA0;thetaiotaomicron</italic>, have a pathway in which 4-amino-2-methyl-5-diphosphomethylpyrimidine (HMP-PP) is synthesized by ThiC and ThiD (blue in <xref ref-type="fig" rid="fig6">Fig.&#xA0;6B</xref> and <xref ref-type="fig" rid="fig6">C</xref>) and 2-(2-carboxy-4-methylthiazol-5-yl)ethyl phosphate (cTHz-P) is produced by ThiSFGH-TenI (orange in <xref ref-type="fig" rid="fig6">Fig.&#xA0;6B</xref> and <xref ref-type="fig" rid="fig6">C</xref>) (<xref rid="B14" ref-type="bibr">14</xref>). These precursors are condensed into thiamine monophosphate by ThiE or YjbQ (tan in <xref ref-type="fig" rid="fig6">Fig.&#xA0;6B</xref> and <xref ref-type="fig" rid="fig6">C</xref>), which is then phosphorylated into the biologically active form of thiamine pyrophosphate by ThiL (green in <xref ref-type="fig" rid="fig6">Fig.&#xA0;6B</xref> and <xref ref-type="fig" rid="fig6">C</xref>). A handful of gut-associated <italic>Bacteroidetes</italic> have replaced the canonical cTHz-P biosynthetic branch with a THI4-like thiazole synthase enzyme (13/109; EC 2.8.1.10) (fuchsia in <xref ref-type="fig" rid="fig6">Fig.&#xA0;6B</xref> and <xref ref-type="fig" rid="fig6">C</xref>). Regardless, all 109 genomes encoding a major biosynthetic operon also encode a TPP riboswitch immediately upstream (<xref rid="B18" ref-type="bibr">18</xref>).</p>
        <p>None of the gut-associated <italic>Bacteroidetes</italic> possesses a recognizable thiamine ABC transport system similar to the characterized ThiQP-TbpA of Gram-negative bacteria or YkoEDC of Gram-positive bacteria (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B18" ref-type="bibr">18</xref>). Moreover, <italic>Bacteroidetes</italic> lack the ThiT thiamine transporter and the CytX and ThiW precursor transport proteins (<xref rid="B18" ref-type="bibr">18</xref>). Thus, like <italic>B.&#xA0;thetaiotaomicron</italic>, the previously uncharacterized inner and outer membrane transporters (PnuT and OMthi) are widely conserved in gut <italic>Bacteroidetes</italic>, with more than three-quarters (91/114) of the genomes analyzed carrying both <italic>OMthi</italic> and <italic>pnuT</italic> (<xref ref-type="fig" rid="fig6">Fig.&#xA0;6B</xref>). However, heterogeneity in the presence and genomic organization of these genes exists. While <italic>B.&#xA0;thetaiotaomicron</italic> carries a split operon, most genomes contain <italic>OMthi</italic>, <italic>pnuT</italic>, and <italic>tnr3</italic> as a single operon, and others have apparently lost some or all of these genes (e.g., <italic>Bacteroides coprocola</italic>). In most instances, the TPP riboswitch is retained and sometimes duplicated when the operon is split.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s2">
      <title>DISCUSSION</title>
      <p>Thiamine is an essential cofactor for all living organisms: as such, its availability impacts human health as well as that of our microbiota. Here, we have identified substantial genetic diversity within and among gut bacterial phyla for acquiring thiamine, suggesting diverse strategies are employed leading to opportunities for cooperation and/or competition (<xref ref-type="fig" rid="fig6">Fig.&#xA0;6A</xref>). Among the <italic>Bacteroidetes</italic>, a ubiquitous and abundant gut phylum responsible for carbohydrate fermentation, fatty acid production, and immune function (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>), we identified three distinct strategies for thiamine acquisition: biosynthesis and transport, biosynthesis alone, and transport alone. We analyzed the expression profiles, dissected the genetics, and examined the competitive advantages of these strategies in <italic>B.&#xA0;thetaiotaomicron</italic>, demonstrating the importance of both thiamine biosynthesis and transport.</p>
      <p>Our results demonstrate that the biosynthesis of thiamine is essential for growth and competition of <italic>B.&#xA0;thetaiotaomicron</italic> in environments with limited thiamine availability. Like many <italic>Bacteroidetes</italic>, <italic>B.&#xA0;thetaiotaomicron</italic> carries a major biosynthetic gene operon (BioThi [<italic>BT0653</italic> to <italic>BT0647</italic>]), which includes essential enzymes for both HMP-PP and cTHz-P production and condensation (<xref ref-type="fig" rid="fig1">Fig.&#xA0;1A</xref> and <xref ref-type="fig" rid="fig6">6B</xref>). Our genome-wide expression profiling identified evidence of thiamine-dependent regulation of this locus that we attribute to the TPP-binding riboswitch preceding this operon. This expression response is consistent with reanalysis of microarray data from <italic>B.&#xA0;thetaiotaomicron</italic> grown both <italic>in vitro</italic> and <italic>in vivo</italic> under thiamine-variable conditions (see <xref ref-type="supplementary-material" rid="figS4">Fig.&#xA0;S4</xref> in the supplemental material) (<xref rid="B27" ref-type="bibr">27</xref>). Subsequent deletion of the entire biosynthetic operon in <italic>B.&#xA0;thetaiotaomicron</italic> renders it auxotrophic for thiamine, severely impairing growth in media with less than 10&#xA0;nM thiamine. Both the genetic organization of the locus and a similar growth defect of a <italic>thiC</italic> deletion mutant are seen in <italic>S.&#xA0;enterica</italic> (<xref rid="B28" ref-type="bibr">28</xref>). Moreover, the defect in <italic>B.&#xA0;thetaiotaomicron</italic>, which can be complemented by restoring the entire biosynthetic operon in <italic>trans</italic>, is recapitulated during coculture with wild-type cells. Competitions result in the &#x394;BioThi mutant being outcompeted by the wild-type cells during a multiday coculture experiment under low- or no-thiamine concentrations. We note that thiamine availability in the gut is expected to fluctuate due to various factors, including host genetics, diet, and intestinal adsorption. Measurements of thiamine in the intestinal lumen range between 20 and 2,000&#xA0;nM (<xref rid="B13" ref-type="bibr">13</xref>). As such, a gut microbe&#x2019;s ability to synthesize its own thiamine is likely most important during transient drops in thiamine availability to enable the microbe&#x2019;s own growth. We predict that gut microbes that we have identified that are wholly dependent on thiamine transport, such as members of the genus <italic>Alistipes</italic> and many members of the bacilli (<xref ref-type="fig" rid="fig6">Fig.&#xA0;6</xref>), to be adversely affected during such drops in thiamine availability.</p>
      <supplementary-material content-type="local-data" id="figS4">
        <object-id pub-id-type="doi">10.1128/mSystems.00116-17.5</object-id>
        <label>FIG&#xA0;S4&#xA0;</label>
        <p>Microarray measurements of thiamine biosynthesis and transport gene expression. Download <inline-supplementary-material id="figs4" mimetype="application" mime-subtype="pdf" xlink:href="sys005172138sf10.pdf" content-type="local-data">FIG&#xA0;S4, PDF file, 0.1 MB</inline-supplementary-material>.</p>
        <permissions>
          <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
          <copyright-year>2017</copyright-year>
          <copyright-holder>Costliow and Degnan</copyright-holder>
          <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
            <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
          </license>
        </permissions>
      </supplementary-material>
      <p>Our global transcriptomic analysis revealed differential responses of thiamine acquisition operons to exogenous thiamine. Under conditions of excess thiamine, we have shown that <italic>B.&#xA0;thetaiotaomicron</italic> downregulates the BioThi operon. However, we found that transcripts for the putative inner (<italic>pnuT</italic>) and outer (<italic>OMthi</italic>) membrane transporter genes adjacent to TPP-binding riboswitches show minimal expression differences (<xref ref-type="fig" rid="fig1">Fig.&#xA0;1A</xref>). These proteins were previously predicted to function in thiamine transport (<xref rid="B18" ref-type="bibr">18</xref>), and PnuT was recently shown to transport thiamine in a heterologous host (<xref rid="B19" ref-type="bibr">19</xref>). Curiously, individual deletions of these transporters have no effect on the growth of mutants individually or in coculture with wild-type cells. However, deletion of both transport genes in tandem yielded a severe growth defect (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2</xref>). After ruling out an additional role of these transporters for importing a critical precursor (<xref ref-type="supplementary-material" rid="figS1">Fig.&#xA0;S1</xref>), we speculate that they may play a role in thiamine recycling or that there is an uncharacterized connection between biosynthesis and transport of thiamine. When we measured expression of the BioThi operon in the double transport mutant using RT-qPCR we found expression of <italic>thiC</italic> and <italic>thiS</italic> was downregulated (<xref ref-type="fig" rid="fig3">Fig.&#xA0;3A</xref> and <xref ref-type="fig" rid="fig3">B</xref>). This raises the possibility that an unknown protein regulatory mechanism may be dysregulated and repressing biosynthesis in the &#x394;&#x394;Transport mutant. Regardless, further investigations are warranted to disentangle thiamine biosynthesis and transport and their interconnected pathways.</p>
      <p>The dual transport and biosynthesis pathways appear to facilitate the ability of wild-type <italic>B.&#xA0;thetaiotaomicron</italic> to maintain a fairly stable intracellular concentration of the cofactor TPP (&lt;3-fold), despite radical changes in extracellular thiamine concentrations. However, these increases in intracellular concentrations of the thiamine moieties are sufficient to lead to the downregulation of the BioThi operon in addition to a suite of thiamine-dependent pathways, including amino acid metabolism and nucleotide biosynthesis. It is possible that the increased proportion of thiamine to TPP may provide a signal sensed by unknown regulatory mechanisms, outside the regulatory riboswitches that control biosynthesis and transport genes. These additional regulatory factors are likely important for modulating responses to the stress of variable levels of exogenous thiamine.</p>
      <p>We observed that competitions between <italic>B.&#xA0;thetaiotaomicron</italic> and thiamine acquisition mutants yielded similar results to growth of the mutants in isolation (<xref ref-type="fig" rid="fig2">Fig.&#xA0;2</xref> and <xref ref-type="fig" rid="fig4">4</xref>), suggesting that <italic>B.&#xA0;thetaiotaomicron</italic> does not release thiamine into the environment. Confirming this hypothesis, no thiamine was detected in the supernatant of spent cultures of <italic>B.&#xA0;thetaiotaomicron</italic> grown in thiamine-free medium (data not shown). This is not in line with previously published data in which thiamine was still detectable in the feces of a select group of humans who were completely thiamine starved (<xref rid="B4" ref-type="bibr">4</xref>). It was inferred that the thiamine detectable in these patients was derived from their microbial communities (<xref rid="B4" ref-type="bibr">4</xref>). This leads us to speculate that other gut microbes, including divergent <italic>Bacteroidetes</italic> or <italic>Proteobacteria</italic>, release thiamine as they are the most prevalent thiamine synthesizers. Alternatively, host-driven cell lysis (<xref rid="B29" ref-type="bibr">29</xref>), microbe-microbe antagonism and/or intoxication (<xref rid="B30" ref-type="bibr">30</xref>), or some gut-specific signal results in the liberation of this essential cofactor.</p>
      <p>As an essential small molecule, thiamine appears to have an important role in the persistence of microbes in the gut. The universal requirement for this cofactor and the diverse strategies for acquisition result in scenarios that would force competition or cooperation among gut microbes. Among <italic>B.&#xA0;thetaiotaomicron</italic> mutants encoding a single acquisition strategy, we have observed competitive defects, similar to what has been seen for B<sub>12</sub> transport (<xref rid="B6" ref-type="bibr">6</xref>). However, more complex communities may be crucial to enabling cooperation; thus, modeling the dynamics of thiamine in natural or reconstructed gut communities will be a way forward to understand these dynamics. It thus remains possible that cofactors such as thiamine may be utilized to manipulate gut communities. Ultimately such manipulation may play a role in the combating of diseases such as diabetes, obesity, and cancer.</p>
    </sec>
    <sec sec-type="materials|methods" id="s3">
      <title>MATERIALS AND METHODS</title>
      <sec id="s3.1">
        <title>Bacterial culturing and genetic manipulation.</title>
        <p>Routine culturing of <italic>B.&#xA0;thetaiotaomicron</italic> VPI-5482 occurred anaerobically at 37&#xB0;C in liquid tryptone-yeast extract-glucose (TYG) medium (<xref rid="B24" ref-type="bibr">24</xref>) or Difco brain heart infusion (BHI) agar with the addition of 10% defibrinated horse blood (Quad Five, Ryegate, MT). Cultures were grown anaerobically within a vinyl anaerobic chamber with an input gas mixture consisting of 70% nitrogen, 20% carbon dioxide, and 10% hydrogen (Coy Laboratory Products, Grass Lake, MI). <italic>Escherichia coli</italic> S17-1 &#x3BB; <italic>pir</italic> strains used for cloning and conjugation of suicide vectors were grown in LB medium at 37&#xB0;C aerobically. Antibiotics were added to the medium when appropriate in the following concentrations: ampicillin, 100&#xA0;&#x3BC;g/ml; gentamicin, 200&#xA0;&#x3BC;g/ml; erythromycin, 25&#xA0;&#x3BC;g/ml; tetracycline, 2&#xA0;&#x3BC;g/ml; and 5-fluoro-2&#x2032;-deoxyuridine (FUdR), 200&#xA0;&#xB5;g/ml.</p>
        <p>Markerless deletions were generated via allelic exchange and confirmed by PCR (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B31" ref-type="bibr">31</xref>). Briefly, HiFi <italic>Taq</italic> MasterMix (Kapa Biosystems, Wilmington, MA) was used to amplify the right and left flanks of thiamine-associated loci by PCR, which were then combined by splicing by overlap extension (SOE) PCR. Purified SOE products were restriction digested and cloned into pExchange_tdk vector by standard methods (<xref rid="B32" ref-type="bibr">32</xref>). Sequence-confirmed vectors were then conjugated from donor <italic>E.&#xA0;coli</italic> S17-1 &#x3BB; <italic>pir</italic> strains into recipient <italic>B.&#xA0;thetaiotaomicron</italic> strains. Transconjugants were colony purified and screened for successful mutants by PCR (<xref ref-type="table" rid="tab1">Table&#xA0;1</xref>). Complementation and bar-coded vectors were all constructed in pNBU2 vectors and were introduced into the genome in a single copy (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Construction and conjugation of pNBU2 vectors was done by the same methods as pExchange_tdk vectors. A complete list of primers and vectors used for this study is provided in <xref ref-type="supplementary-material" rid="tabS3">Table&#xA0;S3</xref>&#xA0;in the supplemental material.</p>
        <supplementary-material content-type="local-data" id="tabS3">
          <object-id pub-id-type="doi">10.1128/mSystems.00116-17.8</object-id>
          <label>TABLE&#xA0;S3&#xA0;</label>
          <p>Primers, vectors, and strains used in this study. Download <inline-supplementary-material id="tabs3" mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="sys005172138sd4.xls" content-type="local-data">TABLE&#xA0;S3, XLS file, 0.03 MB</inline-supplementary-material>.</p>
          <permissions>
            <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder>Costliow and Degnan</copyright-holder>
            <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
              <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
            </license>
          </permissions>
        </supplementary-material>
      </sec>
      <sec id="s3.2">
        <title>Thiamine transcriptomic response.</title>
        <p>A modified minimal medium was used for all thiamine growth assays (after Varel and Bryant [<xref rid="B34" ref-type="bibr">34</xref>] and Scholle et al. [<xref rid="B35" ref-type="bibr">35</xref>]). The modified minimal medium consisted of glucose (27.8&#xA0;mM), ammonium chloride (6.0 mM), <sc>l</sc>-cysteine freebase (4.1&#xA0;mM), sodium carbonate (3.8&#xA0;mM), iron sulfate (0.3&#xA0;mM), vitamin B<sub>12</sub> (5.8&#xA0;&#x3BC;M), a histidine-hematin solution (0.1% 1.9&#xA0;mM hematin in 0.2&#xA0;M histidine), 1 M potassium phosphate buffer at a pH of 7.2 (2%), and a premixed mineral solution (5%). The mineral solution consisted of 3 M sodium chloride, 3.6&#xA0;mM calcium chloride dehydrate, 1.6&#xA0;mM magnesium sulfate, 1&#xA0;mM manganese chloride tetrahydrate, and 84.1&#xA0;&#x3BC;M cobalt chloride hexahydrate. Replicate cultures of wild-type <italic>B.&#xA0;thetaiotaomicron</italic> were grown overnight in 5&#xA0;ml minimal medium supplemented with 10,000&#xA0;nM thiamine HCl (THI; &gt;99% pure) (Sigma-Aldrich, St. Louis, MO). Aliquots of each culture were pelleted by centrifugation (1&#xA0;min at 13,300 &#xD7; <italic>g</italic>), culture supernatants were decanted, and the cells were washed 4 times in minimal medium with 0&#xA0;nM thiamine. Cells were inoculated into 10&#xA0;ml of minimal medium with either 0 or 15&#xA0;&#x3BC;M thiamine HCl at a final dilution of 1:2,000 in biological duplicate. Cell growth was monitored, and cells were harvested between an OD<sub>600</sub> of 0.4 and 0.6 on a UV spectrometer. Total RNA was extracted using the Qiagen RNeasy kit and stored at &#x2212;80&#xB0;C. Total RNA was DNase treated with DNase I (Thermo Fisher, Waltham, MA) and the NEB DNase treatment protocol. DNase-treated RNAs were recleaned using the Qiagen RNeasy kit (Hilden, Germany), quantitated using a Qubit 2.0 (Life Technologies, Inc., Carlsbad, CA), and stored at &#x2212;80&#xB0;C.</p>
        <p>RNA was submitted for integrity analysis, rRNA depletion, and library construction at the W. M. Keck Center for Comparative and Functional Genomics at the University of Illinois at Urbana-Champaign.</p>
        <p>For targeted gene expression analysis, total RNA was purified as described above and used to generate cDNA libraries using a first-strand cDNA synthesis kit (Thermo Fisher, Waltham, MA). RT-qPCR was performed on a Bio-Rad CFX Connect instrument (Bio-Rad, Hercules, CA) and SYBR Fast MasterMix 2&#xD7; Universal (Kapa Biosystems, Wilmington, MA) following the manufacturer&#x2019;s instructions for triplicate biological samples in technical triplicates. Four genes were amplified: the 16S rRNA, <italic>thiC</italic>, <italic>thiS</italic>, and <italic>tnr3</italic> genes. 16S rRNA primers were used as the control gene (<xref rid="B6" ref-type="bibr">6</xref>), and novel primers for <italic>thiC</italic>, <italic>thiS</italic>, and <italic>tnr3</italic> were designed using Primer3 (<xref rid="B36" ref-type="bibr">36</xref>). Standard curves were used to evaluate the efficiency of the amplification: all 4 genes had <italic>R</italic><sup>2</sup> values of &#x2265;0.985 and slopes of between &#x2212;3.33 and &#x2212;3.40. Relative expression changes were calculated by the quantification cycle (&#x394;&#x394;<italic>C</italic><sub><italic>q</italic></sub>) method (<xref rid="B37" ref-type="bibr">37</xref>).</p>
      </sec>
      <sec id="s3.3">
        <title>RNA sequencing analysis.</title>
        <p>RNA-seq reads from each sample were quality filtered using a custom R script and fastx_clipper (<ext-link ext-link-type="uri" xlink:href="http://hannonlab.cshl.edu/fastx_toolkit/index.html">http://hannonlab.cshl.edu/fastx_toolkit/index.html</ext-link>). Filtered RNA-seq data were analyzed using the Rockhopper program (<xref rid="B21" ref-type="bibr">21</xref>) to identify differentially expressed genes between thiamine-replete and thiamine-deficient samples. Reads were aligned to the <italic>B.&#xA0;thetaiotaomicron</italic> VPI-5482 genome, and significantly differentially expressed genes were identified (&#x2265;2-fold change and <italic>q</italic> &#x2264; 0.05).</p>
      </sec>
      <sec id="s3.4">
        <title>Assaying thiamine-dependent growth phenotypes.</title>
        <p><italic>B.&#xA0;thetaiotaomicron</italic> wild-type, mutant, and complemented strains were grown and washed in minimal medium with 0&#xA0;&#xB5;M thiamine as described above for RNA-seq. Cells were normalized, diluted to an OD<sub>600</sub> of 0.0004, and dispensed into 96-well plates with thiamine HCl, thiamine monophosphate HCl (TMP; &gt;95% pure) (Sigma-Aldrich, St. Louis, MO), and thiamine pyrophosphate chloride (TPP; &gt;98%) (Thermo Fisher Scientific, Waltham, MA) at concentrations ranging from 0 to 10,000&#xA0;nM (modified from Degnan et al. [<xref rid="B6" ref-type="bibr">6</xref>]). Cell growth was measured over the course of 25&#xA0;h using a BioTek Synergy HTX Multi-Mode microplate reader in conjunction with a BioStack3 microplate stacker (BioTek, Winooski, VT). All phenotypic assays were averaged from three to nine biological replicates with three technical replicates each. All phenotypes were calculated as a percentage of WT growth achieved in minimal medium plus 10,000&#xA0;nM THI at 17.5&#xA0;h. Pairwise Student&#x2019;s <italic>t</italic>&#xA0;tests were carried out using GraphPad Prism v6, and <italic>P</italic>&#xA0;values of &#x2264;0.05 were considered significant.</p>
      </sec>
      <sec id="s3.5">
        <title><italic>In vitro</italic> competition assays.</title>
        <p>Cells were grown for 16&#xA0;h in minimal medium supplemented with 10,000&#xA0;nM thiamine HCl. Cells were pelleted and washed 4 times with minimal medium. Cell OD<sub>600</sub> values were normalized to 0.01. Cells were inoculated 1:100 into an Axygen deep-well plate (Corning, Inc., Corning, NY) in biological triplicate for each mutant at 4 different concentrations (0, 10, 100, and 10,000&#xA0;nM) of thiamine HCl in minimal medium. Cultures were incubated anaerobically at 37&#xB0;C for 24&#xA0;h and passaged 1:1,000 into the same medium type they were previously grown in (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Time points were taken for 4 to 5&#xA0;days, and samples were saved in medium plus 20% glycerol at &#x2212;80&#xB0;C. Samples were prepped for genomic DNA (gDNA) using the HotShot method (<xref rid="B38" ref-type="bibr">38</xref>), and the relative abundance of each bar-coded strain was determined using qPCR in reference to a standard curve on a Bio-Rad CFX Connect instrument (Bio-Rad, Hercules, CA) and SYBR Fast MasterMix 2&#xD7; Universal (Kapa Biosystems, Wilmington, MA) (<xref rid="B6" ref-type="bibr">6</xref>). Data were analyzed by the efficiency-corrected &#x394;<italic>C</italic><sub><italic>q</italic></sub> method (<xref rid="B37" ref-type="bibr">37</xref>).</p>
      </sec>
      <sec id="s3.6">
        <title>Quantification of thiamine in <italic>B.&#xA0;thetaiotaomicron</italic> and medium.</title>
        <p><italic>B.&#xA0;thetaiotaomicron</italic> was grown in either 0, 10, 100, or 10,000&#xA0;nM thiamine HCl to the mid-log phase (OD<sub>600</sub> of ~0.5). Cells were pelleted at 10,000 &#xD7; <italic>g</italic> for 2&#xA0;min. Cells were washed three times with phosphate-buffered saline (PBS). Cells and medium aliquots were submitted to the Roy J. Carver Biotechnology Centre&#x2019;s Metabolomics Center at the University of Illinois at Urbana-Champaign for quantification of thiamine, thiamine monophosphate, and thiamine diphosphate. Samples were analyzed with the 5500 QTRAP liquid chromatography-tandem mass spectrometry (LC-MS/MS) system (Sciex, Framingham, MA). Software Analyst 1.6.2 was used for data acquisition and analysis. The 1200 series high-performance liquid chromatography (HPLC) system (Agilent Technologies, Santa Clara, CA) includes a degasser, an autosampler, and a binary pump. The LC separation was performed on a Phenomenex Polar column (4.6 by 100&#xA0;mm, 4&#xA0;&#x3BC;m) with mobile phase A (0.1% formic acid in water) and mobile phase B (0.1% formic acid in acetonitrile). The flow rate was 0.4&#xA0;ml/min. The linear gradient was 0 to 3&#xA0;min at 95% A, 6 to 9&#xA0;min at 0% A, and 10 to 15&#xA0;min at 95% A. The autosampler was set at 10&#xB0;C. The injection volume was 100&#xA0;&#x3BC;l. Mass spectra were acquired under positive electrospray ionization (ESI) with an ion spray voltage of +5,000&#xA0;V. The source temperature was 450&#xB0;C. The curtain gas, ion source gas 1, and ion source gas 2 were 33, 50, and 65, respectively. Multiple reaction monitoring (MRM) was used for quantitation: thiamine, <italic>m</italic>/<italic>z</italic> 265.0 and 122.0; thiamine monophosphate, <italic>m</italic>/<italic>z</italic> 345.1 and 122.0, and thiamine diphosphate, <italic>m</italic>/<italic>z</italic> 425.1 and 122.0.</p>
      </sec>
      <sec id="s3.7">
        <title>Computational prediction of thiamine-associated genes.</title>
        <p>Thiamine biosynthesis and transport genes and thiamine-dependent genes were identified searching for gene-specific TIGRFAM (<xref rid="B39" ref-type="bibr">39</xref>) when available or PFAM (<xref rid="B40" ref-type="bibr">40</xref>) hidden Markov models with HMMR (--tc_cut) (see <xref ref-type="supplementary-material" rid="tabS4">Table&#xA0;S4</xref>&#xA0;in the supplemental material) in 641 gut bacteria, including 114 <italic>Bacteroidetes</italic> genomes available in RefSeq from the Human Microbiome Project (see <xref ref-type="supplementary-material" rid="tabS5">Table&#xA0;S5</xref>&#xA0;in the supplemental material) (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>). Predicted annotations were confirmed with BLAST and PFAM hidden Markov models (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B43" ref-type="bibr">43</xref>). Homologs of <italic>B.&#xA0;thetaiotaomicron</italic> VPI-5482 loci were confirmed and compared among the other 113 <italic>Bacteroidetes</italic> genomes using a reciprocal best BLAST approach. In addition, Infernal 2.0 was used to detect putative TPP riboswitches adjacent to thiamine-associated genes (RF00059) (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). The presence or absence of biosynthetic and transporter genes was used to categorize the route of thiamine acquisition. Microbes capable of complete &#x201C;biosynthesis&#x201D; have the ability to synthesize both HMP-PP (<italic>thiC</italic> or <italic>thi5</italic> and <italic>thiD</italic>) and cTHz-P (<italic>thiGH</italic> or <italic>thi4</italic> in addition to <italic>tenI</italic>) and possess thiamine condensation genes (<italic>thiE</italic> and/or <italic>yjbQ</italic>) and a thiamine kinase. Microbes categorized as capable of &#x201C;recycling&#x201D; lack the ability to completely synthesize either thiazole and/or HMP-PP <italic>de novo</italic> but retain the thiamine kinase enzymes. Microbes were categorized as capable of &#x201C;transport&#x201D; if any gene predicted to transport thiamine was identified. Finally, microbes were categorized as &#x201C;incomplete/uncertain&#x201D; if we were unable to identify any thiamine transporters and/or sufficient genes to carry out thiamine biosynthesis or recycling. Additionally, using an approach identical to that described by Degnan et al. (<xref rid="B6" ref-type="bibr">6</xref>), a set of 13 core genes conserved among all three domains of life were identified in the 641 gut microbial genomes and aligned, and a phylogeny was reconstructed by the maximum likelihood method.</p>
        <supplementary-material content-type="local-data" id="tabS4">
          <object-id pub-id-type="doi">10.1128/mSystems.00116-17.9</object-id>
          <label>TABLE&#xA0;S4&#xA0;</label>
          <p>Search queries used to identify thiamine-dependent and thiamine acquisition genes. Download <inline-supplementary-material id="tabs4" mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="sys005172138sd5.xls" content-type="local-data">TABLE&#xA0;S4, XLS file, 0.1 MB</inline-supplementary-material>.</p>
          <permissions>
            <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder>Costliow and Degnan</copyright-holder>
            <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
              <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
            </license>
          </permissions>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="tabS5">
          <object-id pub-id-type="doi">10.1128/mSystems.00116-17.10</object-id>
          <label>TABLE&#xA0;S5&#xA0;</label>
          <p>Genomes investigated for thiamine acquisition and thiamine-dependent genes. Download <inline-supplementary-material id="tabs5" mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="sys005172138sd6.xls" content-type="local-data">TABLE&#xA0;S5, XLS file, 0.1 MB</inline-supplementary-material>.</p>
          <permissions>
            <copyright-statement>Copyright &#xA9; 2017 Costliow and Degnan.</copyright-statement>
            <copyright-year>2017</copyright-year>
            <copyright-holder>Costliow and Degnan</copyright-holder>
            <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
              <license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
            </license>
          </permissions>
        </supplementary-material>
      </sec>
      <sec id="s3.8">
        <title>Accession number(s).</title>
        <p>RNA-seq data generated for this project have been submitted to the NCBI SRA database under accession no. <ext-link ext-link-type="uri" xlink:href="https://trace.ncbi.nlm.nih.gov/Traces/sra/?study=SRP116143">SRP116143</ext-link>.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGMENTS</title>
      <p>We thank members of the P. H. Degnan and A. K. Hansen labs for comments on the manuscript. We also thank Zhong (Lucas) Li from the Roy J. Carver Biotechnology Centre&#x2019;s Metabolomics Center and Alvaro Hernandez from the W. M. Keck Center for Comparative and Functional Genomics at the University of Illinois at Urbana-Champaign for technical services.</p>
      <p>This work was supported by an investigator award from the Roy J. Carver Charitable Trust to P.H.D. (15-4501) and University of Illinois at Urbana-Champaign start-up funds to P.H.D. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donnino</surname><given-names>M</given-names></name></person-group>
<year>2004</year>
<article-title>Gastrointestinal beriberi: a previously unrecognized syndrome</article-title>. <source>Ann Intern Med</source>
<volume>141</volume>:<fpage>898</fpage>&#x2013;<lpage>899</lpage>. doi:<pub-id pub-id-type="doi">10.7326/0003-4819-141-11-200412070-00035</pub-id>.<pub-id pub-id-type="pmid">15583247</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kerns</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Arundel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chawla</surname><given-names>LS</given-names></name></person-group>
<year>2015</year>
<article-title>Thiamin deficiency in people with obesity</article-title>. <source>Adv Nutr</source>
<volume>6</volume>:<fpage>147</fpage>&#x2013;<lpage>153</lpage>. doi:<pub-id pub-id-type="doi">10.3945/an.114.007526</pub-id>.<pub-id pub-id-type="pmid">25770253</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iwase</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Higaki</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Mikata</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Miyazaki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kamiike</surname><given-names>W</given-names></name></person-group>
<year>2002</year>
<article-title>Reduced thiamine (vitamin B<sub>1</sub>) levels following gastrectomy for gastric cancer</article-title>. <source>Gastric Cancer</source>
<volume>5</volume>:<fpage>77</fpage>&#x2013;<lpage>82</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s101200200013</pub-id>.<pub-id pub-id-type="pmid">12111582</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Najjar</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Holt</surname><given-names>LE</given-names></name></person-group>
<year>1943</year>
<article-title>The biosynthesis of thiamine in man</article-title>. <source>JAMA</source>
<volume>123</volume>:<fpage>683</fpage>&#x2013;<lpage>684</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.1943.02840460017005</pub-id>.</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lonsdale</surname><given-names>D</given-names></name></person-group>
<year>2012</year>
<article-title>Thiamin(e): the spark of life</article-title>. <source>Subcell Biochem</source>
<volume>56</volume>:<fpage>199</fpage>&#x2013;<lpage>227</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-94-007-2199-9_11</pub-id>.<pub-id pub-id-type="pmid">22116701</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Degnan</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Barry</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Mok</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Taga</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Goodman</surname><given-names>AL</given-names></name></person-group>
<year>2014</year>
<article-title>Human gut microbes use multiple transporters to distinguish vitamin B<sub>12</sub> analogs and compete in the gut</article-title>. <source>Cell Host Microbe</source>
<volume>15</volume>:<fpage>47</fpage>&#x2013;<lpage>57</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2013.12.007</pub-id>.<pub-id pub-id-type="pmid">24439897</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donia</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Fischbach</surname><given-names>MA</given-names></name></person-group>
<year>2015</year>
<article-title>Human microbiota. Small molecules from the human microbiota</article-title>. <source>Science</source> 349:1254766. doi:<pub-id pub-id-type="doi">10.1126/science.1254766</pub-id>.</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>R&#xED;os-Covi&#xE1;n</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ruas-Madiedo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Margolles</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gueimonde</surname><given-names>M</given-names></name>, <name name-style="western"><surname>de los Reyes-Gavil&#xE1;n</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Salazar</surname><given-names>N</given-names></name></person-group>
<year>2016</year>
<article-title>Intestinal short chain fatty acids and their link with diet and human health</article-title>. <source>Front Microbiol</source>
<volume>7</volume>:<fpage>185</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2016.00185</pub-id>.<pub-id pub-id-type="pmid">26925050</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hill</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Lukiw</surname><given-names>WJ</given-names></name></person-group>
<year>2015</year>
<article-title>Microbial-generated amyloids and Alzheimer&#x2019;s disease (AD)</article-title>. <source>Front Aging Neurosci</source>
<volume>7</volume>:<fpage>9</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnagi.2015.00009</pub-id>.<pub-id pub-id-type="pmid">25713531</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ley</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Volchkov</surname><given-names>PY</given-names></name>, <name name-style="western"><surname>Stranges</surname><given-names>PB</given-names></name>, <name name-style="western"><surname>Avanesyan</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Stonebraker</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>FS</given-names></name>, <name name-style="western"><surname>Szot</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Bluestone</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Chervonsky</surname><given-names>AV</given-names></name></person-group>
<year>2008</year>
<article-title>Innate immunity and intestinal microbiota in the development of type 1 diabetes</article-title>. <source>Nature</source>
<volume>455</volume>:<fpage>1109</fpage>&#x2013;<lpage>1113</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature07336</pub-id>.<pub-id pub-id-type="pmid">18806780</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Coyle</surname><given-names>WJ</given-names></name></person-group>
<year>2009</year>
<article-title>The microbiome and obesity: is obesity linked to our gut flora?</article-title>
<source>Curr Gastroenterol Rep</source>
<volume>11</volume>:<fpage>307</fpage>&#x2013;<lpage>313</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11894-009-0045-z</pub-id>.<pub-id pub-id-type="pmid">19615307</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yatsunenko</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rey</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Manary</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Trehan</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Dominguez-Bello</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Contreras</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Magris</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hidalgo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Baldassano</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Anokhin</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Heath</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Warner</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Reeder</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kuczynski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Caporaso</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Lozupone</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Lauber</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Clemente</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Knights</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Knight</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>JI</given-names></name></person-group>
<year>2012</year>
<article-title>Human gut microbiome viewed across age and geography</article-title>. <source>Nature</source>
<volume>486</volume>:<fpage>222</fpage>&#x2013;<lpage>227</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature11053</pub-id>.<pub-id pub-id-type="pmid">22699611</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Said</surname><given-names>HM</given-names></name></person-group>
<year>2011</year>
<article-title>Intestinal absorption of water-soluble vitamins in health and disease</article-title>. <source>Biochem J</source>
<volume>437</volume>:<fpage>357</fpage>&#x2013;<lpage>372</lpage>. doi:<pub-id pub-id-type="doi">10.1042/BJ20110326</pub-id>.<pub-id pub-id-type="pmid">21749321</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koenigsknecht</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Downs</surname><given-names>DM</given-names></name></person-group>
<year>2010</year>
<article-title>Thiamine biosynthesis can be used to dissect metabolic integration</article-title>. <source>Trends Microbiol</source>
<volume>18</volume>:<fpage>240</fpage>&#x2013;<lpage>247</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tim.2010.03.003</pub-id>.<pub-id pub-id-type="pmid">20382023</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manzetti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van der Spoel</surname><given-names>D</given-names></name></person-group>
<year>2014</year>
<article-title>Thiamin function, metabolism, uptake, and transport</article-title>. <source>Biochemistry</source>
<volume>53</volume>:<fpage>821</fpage>&#x2013;<lpage>835</lpage>. doi:<pub-id pub-id-type="doi">10.1021/bi401618y</pub-id>.<pub-id pub-id-type="pmid">24460461</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Webb</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Claas</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Downs</surname><given-names>D</given-names></name></person-group>
<year>1998</year>
<article-title><italic>thiBPQ</italic> encodes an ABC transporter required for transport of thiamine and thiamine pyrophosphate in <italic>Salmonella typhimurium</italic></article-title>. <source>J Biol Chem</source>
<volume>273</volume>:<fpage>8946</fpage>&#x2013;<lpage>8950</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.273.15.8946</pub-id>.<pub-id pub-id-type="pmid">9535878</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Claesson</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Cusack</surname><given-names>S</given-names></name>, <name name-style="western"><surname>O&#x2019;Sullivan</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Greene-Diniz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>de Weerd</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Flannery</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Marchesi</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Falush</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Dinan</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Stanton</surname><given-names>C</given-names></name>, <name name-style="western"><surname>van Sinderen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>O&#x2019;Connor</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Harnedy</surname><given-names>N</given-names></name>, <name name-style="western"><surname>O&#x2019;Connor</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>C</given-names></name>, <name name-style="western"><surname>O&#x2019;Mahony</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Shanahan</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Twomey</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>O&#x2019;Toole</surname><given-names>PW</given-names></name></person-group>
<year>2011</year>
<article-title>Composition, variability, and temporal stability of the intestinal microbiota of the elderly</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>108</volume>(<issue>Suppl 1</issue>):<fpage>4586</fpage>&#x2013;<lpage>4591</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1000097107</pub-id>.<pub-id pub-id-type="pmid">20571116</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodionov</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Vitreschak</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Mironov</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Gelfand</surname><given-names>MS</given-names></name></person-group>
<year>2002</year>
<article-title>Comparative genomics of thiamin biosynthesis in procaryotes. New genes and regulatory mechanisms</article-title>. <source>J Biol Chem</source>
<volume>277</volume>:<fpage>48949</fpage>&#x2013;<lpage>48959</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M208965200</pub-id>.<pub-id pub-id-type="pmid">12376536</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genee</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Bali</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>Siedler</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bonde</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Gronenberg</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Kristensen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Sommer</surname><given-names>MO</given-names></name></person-group>
<year>2016</year>
<article-title>Functional mining of transporters using synthetic selections</article-title>. <source>Nat Chem Biol</source>
<volume>12</volume>:<fpage>1015</fpage>&#x2013;<lpage>1022</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nchembio.2189</pub-id>.<pub-id pub-id-type="pmid">27694800</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nudler</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Mironov</surname><given-names>AS</given-names></name></person-group>
<year>2004</year>
<article-title>The riboswitch control of bacterial metabolism</article-title>. <source>Trends Biochem Sci</source>
<volume>29</volume>:<fpage>11</fpage>&#x2013;<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tibs.2003.11.004</pub-id>.<pub-id pub-id-type="pmid">14729327</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tjaden</surname><given-names>B</given-names></name></person-group>
<year>2015</year>
<article-title><italic>De novo</italic> assembly of bacterial transcriptomes from RNA-seq data</article-title>. <source>Genome Biol</source>
<volume>16</volume>:<fpage>1</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13059-014-0572-2</pub-id>.<pub-id pub-id-type="pmid">25583448</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Subramanian</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tamayo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mootha</surname><given-names>VK</given-names></name>, <name name-style="western"><surname>Mukherjee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ebert</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Gillette</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Paulovich</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Pomeroy</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Golub</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Lander</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Mesirov</surname><given-names>JP</given-names></name></person-group>
<year>2005</year>
<article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>102</volume>:<fpage>15545</fpage>&#x2013;<lpage>15550</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>.<pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>AWB</given-names></name>, <name name-style="western"><surname>Todd</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Curson</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Lei</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nikolaidou-Katsaridou</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gelfand</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Rodionov</surname><given-names>DA</given-names></name></person-group>
<year>2007</year>
<article-title>Living without Fur: the subtlety and complexity of iron-responsive gene regulation in the symbiotic bacterium <italic>Rhizobium</italic> and other alpha-proteobacteria</article-title>. <source>Biometals</source>
<volume>20</volume>:<fpage>501</fpage>&#x2013;<lpage>511</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10534-007-9085-8</pub-id>.<pub-id pub-id-type="pmid">17310401</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Holdeman</surname><given-names>LV</given-names></name>, <name name-style="western"><surname>Cato</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>WEC</given-names></name></person-group>
<year>1977</year>
<source>Anaerobe Laboratory manual</source>, <edition>4th</edition> ed. <publisher-name>Virginia Polytechnic Institute and State University Anaerobe Laboratory</publisher-name>, <publisher-loc>Blacksburg, VA</publisher-loc>.</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wexler</surname><given-names>HM</given-names></name></person-group>
<year>2007</year>
<article-title><italic>Bacteroides</italic>: the good, the bad, and the nitty-gritty</article-title>. <source>Clin Microbiol Rev</source>
<volume>20</volume>:<fpage>593</fpage>&#x2013;<lpage>621</lpage>. doi:<pub-id pub-id-type="doi">10.1128/CMR.00008-07</pub-id>.<pub-id pub-id-type="pmid">17934076</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kosiewicz</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Zirnheld</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Alard</surname><given-names>P</given-names></name></person-group>
<year>2011</year>
<article-title>Gut microbiota, immunity, and disease: a complex relationship</article-title>. <source>Front Microbiol</source>
<volume>2</volume>:<fpage>180</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2011.00180</pub-id>.<pub-id pub-id-type="pmid">21922015</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonnenburg</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Leip</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Westover</surname><given-names>BP</given-names></name>, <name name-style="western"><surname>Weatherford</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Buhler</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>JI</given-names></name></person-group>
<year>2005</year>
<article-title>Glycan foraging <italic>in vivo</italic> by an intestine-adapted bacterial symbiont</article-title>. <source>Science</source>
<volume>307</volume>:<fpage>1955</fpage>&#x2013;<lpage>1959</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1109051</pub-id>.<pub-id pub-id-type="pmid">15790854</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmer</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Dougherty</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Downs</surname><given-names>DM</given-names></name></person-group>
<year>2012</year>
<article-title>Analysis of ThiC variants in the context of the metabolic network of <italic>Salmonella enterica</italic></article-title>. <source>J Bacteriol</source>
<volume>194</volume>:<fpage>6088</fpage>&#x2013;<lpage>6095</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.01361-12</pub-id>.<pub-id pub-id-type="pmid">22961850</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fouts</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>St&#xE4;rkel</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hartmann</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Llorente</surname><given-names>C</given-names></name>, <name name-style="western"><surname>DePew</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Moncera</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Brenner</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Hooper</surname><given-names>LV</given-names></name>, <name name-style="western"><surname>Schnabl</surname><given-names>B</given-names></name></person-group>
<year>2016</year>
<article-title>Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation</article-title>. <source>Cell Host Microbe</source>
<volume>19</volume>:<fpage>227</fpage>&#x2013;<lpage>239</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2016.01.003</pub-id>.<pub-id pub-id-type="pmid">26867181</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wexler</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Whitney</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Bobay</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Xavier</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Schofield</surname><given-names>WB</given-names></name>, <name name-style="western"><surname>Barry</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Tran</surname><given-names>BQ</given-names></name>, <name name-style="western"><surname>Goo</surname><given-names>YA</given-names></name>, <name name-style="western"><surname>Goodlett</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Ochman</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mougous</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Goodman</surname><given-names>AL</given-names></name></person-group>
<year>2016</year>
<article-title>Human symbionts inject and neutralize antibacterial toxins to persist in the gut</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>113</volume>:<fpage>3639</fpage>&#x2013;<lpage>3644</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1525637113</pub-id>.<pub-id pub-id-type="pmid">26957597</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koropatkin</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Martens</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>TJ</given-names></name></person-group>
<year>2008</year>
<article-title>Starch catabolism by a prominent human gut symbiont is directed by the recognition of amylose helices</article-title>. <source>Structure</source>
<volume>16</volume>:<fpage>1105</fpage>&#x2013;<lpage>1115</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.str.2008.03.017</pub-id>.<pub-id pub-id-type="pmid">18611383</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Sambrook</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fritsch</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Maniatis</surname><given-names>T</given-names></name></person-group>
<year>2001</year>
<source>Molecular cloning: a laboratory manual</source>, <edition>3rd</edition> ed. <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>, <publisher-loc>Cold Spring Harbor, NY</publisher-loc>.</mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martens</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Chiang</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Gordon</surname><given-names>JI</given-names></name></person-group>
<year>2008</year>
<article-title>Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont</article-title>. <source>Cell Host Microbe</source>
<volume>4</volume>:<fpage>447</fpage>&#x2013;<lpage>457</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2008.09.007</pub-id>.<pub-id pub-id-type="pmid">18996345</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varel</surname><given-names>VH</given-names></name>, <name name-style="western"><surname>Bryant</surname><given-names>MP</given-names></name></person-group>
<year>1974</year>
<article-title>Nutritional features of <italic>Bacteroides fragilis</italic> subsp. fragilis</article-title>. <source>Appl Microbiol</source>
<volume>28</volume>:<fpage>251</fpage>&#x2013;<lpage>257</lpage>.<pub-id pub-id-type="pmid">4853401</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scholle</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Steffen</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Goodman</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Woods</surname><given-names>DR</given-names></name></person-group>
<year>1990</year>
<article-title>Expression and regulation of a <italic>Bacteroides fragilis</italic> sucrose utilization system cloned in <italic>Escherichia coli</italic></article-title>. <source>Appl Environ Microbiol</source>
<volume>56</volume>:<fpage>1944</fpage>&#x2013;<lpage>1948</lpage>.<pub-id pub-id-type="pmid">2166474</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Untergasser</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cutcutache</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Koressaar</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Faircloth</surname><given-names>BC</given-names></name>, <name name-style="western"><surname>Remm</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rozen</surname><given-names>SG</given-names></name></person-group>
<year>2012</year>
<article-title>Primer3&#x2014;new capabilities and interfaces</article-title>. <source>Nucleic Acids Res</source>
<volume>40</volume>:<fpage>e115</fpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gks596</pub-id>.<pub-id pub-id-type="pmid">22730293</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bookout</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Cummins</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Mangelsdorf</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Pesola</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Kramer</surname><given-names>MF</given-names></name></person-group>
<year>2006</year>
<article-title>High-throughput real-time quantitative reverse transcription PCR</article-title>. <source>Curr Protoc Mol Biol</source> Chapter 15:Unit 15.8. doi:<pub-id pub-id-type="doi">10.1002/0471142727.mb1508s73</pub-id>.</mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Truett</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Heeger</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mynatt</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Truett</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Warman</surname><given-names>ML</given-names></name></person-group>
<year>2000</year>
<article-title>Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT)</article-title>. <source>BioTechniques</source>
<volume>29</volume>:<fpage>52</fpage>, <fpage>54</fpage>.<pub-id pub-id-type="pmid">10907076</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selengut</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Haft</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Davidsen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ganapathy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gwinn-Giglio</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>White</surname><given-names>O</given-names></name></person-group>
<year>2007</year>
<article-title>TIGRFAMs and genome properties: tools for the assignment of molecular function and biological process in prokaryotic genomes</article-title>. <source>Nucleic Acids Res</source>
<volume>35</volume>:<fpage>D260</fpage>&#x2013;<lpage>D264</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkl1043</pub-id>.<pub-id pub-id-type="pmid">17151080</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finn</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Bateman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Clements</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Coggill</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Eberhardt</surname><given-names>RY</given-names></name>, <name name-style="western"><surname>Eddy</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Heger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hetherington</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Holm</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Mistry</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sonnhammer</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Tate</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Punta</surname><given-names>M</given-names></name></person-group>
<year>2014</year>
<article-title>Pfam: the protein families database</article-title>. <source>Nucleic Acids Res</source>
<volume>42</volume>:<fpage>D222</fpage>&#x2013;<lpage>D230</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkt1223</pub-id>.<pub-id pub-id-type="pmid">24288371</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#x2019;Leary</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Brister</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Ciufo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Haddad</surname><given-names>D</given-names></name>, <name name-style="western"><surname>McVeigh</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Rajput</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Robbertse</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Smith-White</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ako-Adjei</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Astashyn</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Badretdin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Blinkova</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Brover</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Chetvernin</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ermolaeva</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Farrell</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Goldfarb</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Haft</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hatcher</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hlavina</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Joardar</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Kodali</surname><given-names>VK</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Maglott</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Masterson</surname><given-names>P</given-names></name>, <name name-style="western"><surname>McGarvey</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>O&#x2019;Neill</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Pujar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rangwala</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Rausch</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Riddick</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Schoch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Shkeda</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Storz</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Thibaud-Nissen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Tolstoy</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Tully</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Vatsan</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Wallin</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Landrum</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Kimchi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tatusova</surname><given-names>T</given-names></name>, <name name-style="western"><surname>DiCuccio</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kitts</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Pruitt</surname><given-names>KD</given-names></name></person-group>
<year>2016</year>
<article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation</article-title>. <source>Nucleic Acids Res</source>
<volume>44</volume>:<fpage>D733</fpage>&#x2013;<lpage>D745</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv1189</pub-id>.<pub-id pub-id-type="pmid">26553804</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>NIH HMP Working Group</collab>, <name name-style="western"><surname>Peterson</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Garges</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Giovanni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McInnes</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Schloss</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Bonazzi</surname><given-names>V</given-names></name>, <name name-style="western"><surname>McEwen</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Wetterstrand</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Deal</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Di Francesco</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Howcroft</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Karp</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Lunsford</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Wellington</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Belachew</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Giblin</surname><given-names>C</given-names></name>, <name name-style="western"><surname>David</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Salomon</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mullins</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Akolkar</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Begg</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Grandison</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Humble</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Khalsa</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Little</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Peavy</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Pontzer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Portnoy</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sayre</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Starke-Reed</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zakhari</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Read</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Guyer</surname><given-names>M</given-names></name></person-group>
<year>2009</year>
<article-title>The NIH Human Microbiome Project</article-title>. <source>Genome Res</source>
<volume>19</volume>:<fpage>2317</fpage>&#x2013;<lpage>2323</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gr.096651.109</pub-id>.<pub-id pub-id-type="pmid">19819907</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altschul</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Gish</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Lipman</surname><given-names>DJ</given-names></name></person-group>
<year>1990</year>
<article-title>Basic local alignment search tool</article-title>. <source>J Mol Biol</source>
<volume>215</volume>:<fpage>403</fpage>&#x2013;<lpage>410</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id>.<pub-id pub-id-type="pmid">2231712</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griffiths-Jones</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bateman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Khanna</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Eddy</surname><given-names>SR</given-names></name></person-group>
<year>2003</year>
<article-title>Rfam: an RNA family database</article-title>. <source>Nucleic Acids Res</source>
<volume>31</volume>:<fpage>439</fpage>&#x2013;<lpage>441</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkg006</pub-id>.<pub-id pub-id-type="pmid">12520045</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nawrocki</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Eddy</surname><given-names>SR</given-names></name></person-group>
<year>2013</year>
<article-title>Infernal 1.1: 100-fold faster RNA homology searches</article-title>. <source>Bioinformatics</source>
<volume>29</volume>:<fpage>2933</fpage>&#x2013;<lpage>2935</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btt509</pub-id>.<pub-id pub-id-type="pmid">24008419</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Toxicol Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Toxicol Rep</journal-id>
      <journal-title-group>
        <journal-title>Toxicology Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2214-7500</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">5615374</article-id>
      <article-id pub-id-type="publisher-id">S2214-7500(15)30074-3</article-id>
      <article-id pub-id-type="doi">10.1016/j.toxrep.2015.10.010</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Curcuminoids from <italic>Curcuma longa</italic>L. reduced intestinal mucositis induced by 5-fluorouracil in mice: Bioadhesive, proliferative, anti-inflammatory and antioxidant effects</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>dos Santos Filho</surname>
            <given-names>Edvande Xavier</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#xC1;vila</surname>
            <given-names>Paulo Henrique Marcelino</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bastos</surname>
            <given-names>Carla Caroline Cunha</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Batista</surname>
            <given-names>Aline Carvalho</given-names>
          </name>
          <xref rid="aff0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Naves</surname>
            <given-names>Let&#xED;cia Nasser</given-names>
          </name>
          <xref rid="aff0015" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marreto</surname>
            <given-names>Ricardo Neves</given-names>
          </name>
          <xref rid="aff0015" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lima</surname>
            <given-names>Eliana Martins</given-names>
          </name>
          <xref rid="aff0015" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mendon&#xE7;a</surname>
            <given-names>Elismauro Frascisco</given-names>
          </name>
          <xref rid="aff0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Valadares</surname>
            <given-names>Marize Campos</given-names>
          </name>
          <email>marizecv@ufg.br</email>
          <xref rid="aff0005" ref-type="aff">a</xref>
          <xref rid="cor0005" ref-type="corresp">&#x204E;</xref>
        </contrib>
      </contrib-group>
      <aff id="aff0005"><label>a</label>Laboratory of Pharmacology and Cellular Toxicology, Pharmacy Faculty, Federal University of Goi&#xE1;s, Goi&#xE2;nia, Brazil</aff>
      <aff id="aff0010"><label>b</label>Department of Stomatology, Dental Faculty, Federal University of Goi&#xE1;s, Goi&#xE2;nia, Brazil</aff>
      <aff id="aff0015"><label>c</label>Laboratory of Pharmaceutical Technology, Pharmacy Faculty, Federal University of Goi&#xE1;s, Goi&#xE2;nia, Brazil</aff>
      <author-notes>
        <corresp id="cor0005"><label>&#x204E;</label>Corresponding author at: Faculdade de Farm&#xE1;cia &#x2013; Universidade Federal de Goi&#xE1;s, Rua 240 esquina com 5&#xAA; Avenida, s/n, Setor Universit&#xE1;rio, Goi&#xE2;nia, Goi&#xE1;s, Brazil. CEP: 74605&#x2212;170.Fax: +55 62 3209 6039x202. <email>marizecv@ufg.br</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>23</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <volume>3</volume>
      <fpage>55</fpage>
      <lpage>62</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>15</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 The Authors</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="abs0005">
        <sec>
          <title>Introduction</title>
          <p>Intestinal mucositis is a frequent limiting factor in anticancer therapy and there is currently no broadly effective treatment targeted to cure this side effect.</p>
        </sec>
        <sec>
          <title>Objective</title>
          <p>This study aimed to evaluate the effects of a mucoadhesive formulation containing curcuminoids (MFC) from <italic>Curcuma longa</italic> L. on the pathogenesis of 5-fluorouracil (5-FU)-induced intestinal mucositis.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Three intraperitoneal 5-FU injections (200&#xA0;mg/kg) were used to induce intestinal mucositis in adult Swiss male mice. Treatment was provided orally (MFC 3.75, 7.5 and 15&#xA0;mg/kg), thirty minutes before 5-FU injections, daily until euthanasia. Duodenal samples were collected to perform morphometric and histopathological analysis, to investigate the expression of Ki-67, p53, Bax and Bcl-2 by immunohistochemistry, to evaluate neutrophil activity myeloperoxidase (MPO)-mediated and oxidative stress by malondialdehyde (MDA) determination. Mice body weight was assessed as well.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>As expected, 5-FU induced a significant weight loss (&#x223C;17%, <italic>P&#xA0;</italic>&lt;&#xA0;0.001), shortening in villi height (&#x223C;55.4%) and crypts depth (&#x223C;47%), and increased (&#x223C;64%) the histological severity score when compared to other groups (<italic>P&#xA0;</italic>&lt;&#xA0;0.05). These pathological changes were markedly alleviated by the three MFC treatment doses (<italic>P&#xA0;</italic>&lt;&#xA0;0.05), in special with the dose MFC 15&#xA0;mg/kg. This dose also stimulated cell proliferation by &#x223C;90% in the epithelial cells lining from villi and crypts (<italic>P&#xA0;</italic>&lt;&#xA0;0.05), reduced MPO levels and MDA formation by 60% and 44%, respectively (<italic>P&#xA0;</italic>&lt;&#xA0;0.05).</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Our data suggest the therapeutic potential of the formulation for treating intestinal mucositis in mice. Supplementary studies are underway searching for the elucidation of mechanisms involved in the protective effects of MFC in order to make this formulation a clinical tool for mucositis treatment.</p>
        </sec>
      </abstract>
      <kwd-group id="kwd0005">
        <title>Keywords</title>
        <kwd>Mucoadhesive formulation</kwd>
        <kwd>Curcuminoids</kwd>
        <kwd><italic>Curcuma longa</italic> L</kwd>
        <kwd>Intestinal mucositis</kwd>
        <kwd>5-Fluorouracil</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec0005">
      <label>1</label>
      <title><bold>I</bold>ntroductio<bold>n</bold></title>
      <p>The clinical term mucositis describes a syndrome characterized by ulceration in the entire gastrointestinal tract mucosa and associated symptoms <xref rid="bib0005" ref-type="bibr">[1]</xref>. The frequency of mucositis cases varies and is influenced by factors such as patient&#x2019;s diagnosis, age, health status, and the type, dose and drug administration frequency <xref rid="bib0010" ref-type="bibr">[2]</xref>.</p>
      <p>It is very difficult to thoroughly survey the occurrence of oral and, in particular, intestinal mucositis induced by chemotherapy and/or radiotherapy in humans. This is due to the fact that it is not a locally mediated process but rather, a systemic one, with concomitant oral lesions, emesis, anorexia, adynamia, abdominal pain and, in particular, diarrhea <xref rid="bib0015" ref-type="bibr">[3]</xref>. 5-Fluorouracil, methotrexate and other antimetabolite agents are the most established causes of chemotherapy-induced mucositis. These agents attack tumor cells and constantly dividing normal cell types, which result in destruction of the basal cells and damage to connective tissue in the gastrointestinal tract <xref rid="bib0005" ref-type="bibr">[1]</xref>, <xref rid="bib0010" ref-type="bibr">[2]</xref>, <xref rid="bib0020" ref-type="bibr">[4]</xref>.</p>
      <p>Even though scientists have been studying mucositis for over thirty years <xref rid="bib0025" ref-type="bibr">[5]</xref>, there is still no truly effective treatment targeted to cure this side effect <xref rid="bib0010" ref-type="bibr">[2]</xref>, <xref rid="bib0030" ref-type="bibr">[6]</xref>. Current palliative treatments for intestinal mucositis include anti-inflammatories, systemic antibiotics, antidiarrheal medication and nonspecific painkillers <xref rid="bib0020" ref-type="bibr">[4]</xref>, <xref rid="bib0030" ref-type="bibr">[6]</xref>, <xref rid="bib0035" ref-type="bibr">[7]</xref>. While no approach has yet standard gold proven efficacy, numerous agents are in used. Compounds such as growth factors (palifermin), free radical scavengers (amifostine), probiotics (<italic>Lactobacillus</italic> spp.), zinc sulphate, antioxidants (n-acetyl cysteine, <sc>l</sc>-glutamine), benzydamine hydrochloride and coating agents (CAM2028, Gelclair, MuGard) have been tested with proved efficacy <xref rid="bib0020" ref-type="bibr">[4]</xref>, <xref rid="bib0025" ref-type="bibr">[5]</xref>, <xref rid="bib0030" ref-type="bibr">[6]</xref>, <xref rid="bib0035" ref-type="bibr">[7]</xref>, <xref rid="bib0040" ref-type="bibr">[8]</xref>, <xref rid="bib0045" ref-type="bibr">[9]</xref>.</p>
      <p>Herbal products, particularly those with anti-inflammatory and antioxidant activities such as acteoside <xref rid="bib0050" ref-type="bibr">[10]</xref>, iberogast <xref rid="bib0055" ref-type="bibr">[11]</xref>,<italic>Chimonanthus nitens</italic> var. <italic>salicifolius</italic>
<xref rid="bib0060" ref-type="bibr">[12]</xref>, <italic>Bidens pilosa</italic> L. <xref rid="bib0065" ref-type="bibr">[13]</xref> and <italic>Rhodiola algida</italic>
<xref rid="bib0070" ref-type="bibr">[14]</xref> are promising for the treatment of the mucositis. <italic>Curcuma longa</italic> L. (also known as turmeric), belongs to the ginger family (Zingiberaceae) and is traditionally used in cooking for flavoring purposes <xref rid="bib0075" ref-type="bibr">[15]</xref>. The anti-inflammatory, antioxidant and antitumor properties of <italic>C. longa</italic> L. constituents spurred the investigation of the molecular mechanisms associated with these biological activities <xref rid="bib0075" ref-type="bibr">[15]</xref>, <xref rid="bib0080" ref-type="bibr">[16]</xref>. This is a chemically diverse herb and up until 2011, approximately 235 chemical compounds, mainly phenolic and terpenoid, have been identified <xref rid="bib0085" ref-type="bibr">[17]</xref>.</p>
      <p>It has been shown that formulations containing mucoadhesive polymers, such as poloxamer 407, have the potential to treat mucositis <xref rid="bib0020" ref-type="bibr">[4]</xref>, <xref rid="bib0030" ref-type="bibr">[6]</xref>, <xref rid="bib0065" ref-type="bibr">[13]</xref>. Mucoadhesive systems interact with mucin that covers mucosa, thereby promoting prolonged and localized contact between the pharmaceutical dosage form and absorptive tissue <xref rid="bib0090" ref-type="bibr">[18]</xref>.</p>
      <p>Given the above, a mucoadhesive liquid formulation based on poloxamer 407 and curcuminoids from <italic>C. longa</italic> L. was developed to improve curcuminoids solubility and to promote intimate contact between the herbal active ingredients and gastrointestinal mucosa. This formulation is hypothesized to be effective in treating mice bearing 5-FU-induced intestinal mucositis.</p>
    </sec>
    <sec id="sec0010">
      <label>2</label>
      <title>Material and methods</title>
      <sec id="sec0015">
        <label>2.1</label>
        <title>Mucoadhesive formulation containing curcuminoids (MFC)</title>
        <p>MFC was prepared by mixing polyethylene glycol 400 and propilenglycol (1:1, v/v) in a heated reactor (65&#x2013;70&#xA0;&#xB0;C). Then, 9.0% (w/v) poloxamer 407 (Basf, Ludwigshafen, Germany) was added to the mixture under mechanical stirring until complete dispersion. After that, curcuminoids from <italic>C. longa</italic> L. extract (&gt;95% curcuminoid content, Gamma Com&#xE9;rcio Importa&#xE7;&#xE3;o &amp; Exporta&#xE7;&#xE3;o LTDA, S&#xE3;o Paulo, Brazil) was added to the organic phase and pH was adjusted by using 0.1&#xA0;M citric acid (pH 6.5). The final concentration of curcuminoids was 25&#xA0;mg/mL. An aqueous fraction was prepared by dispersing 6% (w/v) of poloxamer 407 in purified water, under constant stirring. After dispersion, Soluplus<sup>&#xAE;</sup> (Basf, Ludwigshafen, Germany), sodium metabisulphite and sodium bisulphite were added under stirring. The aqueous fraction was then heated up to 65&#xA0;&#xB0;C and poured into organic fraction. The mixture was stirred for 30&#xA0;min. MFC was then bottled in ambar flask and stored at room temperature until use. A blank mucoadhesive formulation (control) was prepared as described above, but without adding curcuminoids extract.</p>
      </sec>
      <sec id="sec0020">
        <label>2.2</label>
        <title>Mice</title>
        <p>Swiss (8&#x2013;10-week-old) male albino mice provided by our Institute&#x2019;s Central Bioterium were kept under controlled temperature (25&#xA0;&#xB1;&#xA0;2&#xA0;&#xB0;C) and light conditions (12h-light&#x2013;dark cycle), with free access to water and standard chow pellets (Presence nutri&#xE7;&#xE3;o animal, S&#xE3;o Paulo, Brazil). Mice were acclimatized for a week before beginning the experiments. All animal treatment and surgical procedures were carried out in accordance with the norms of the Brazilian College of Animal Experimentation (COBEA) and approved by the local Research Ethics Committee (Federal University of Goi&#xE1;s 036/2012).</p>
      </sec>
      <sec id="sec0025">
        <label>2.3</label>
        <title>Experimental design</title>
        <p>Considering that the 5-FU regime was able to induce mucositis homogeneously in the mice, as well as ethical aspects in the use of animals, three independent essays were performed with mice randomly allocated into five experimental groups (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>) of 5 animals each. Groups were as follow: negative control (blank mucoadhesive formulation 0.6&#xA0;mL/animal, via gavage, from day 1&#x2013;6); positive control (5-FU 200&#xA0;mg/kg, i.p., days 4&#x2013;6); and treated (MFC 3.75&#xA0;mg/kg; 7.5&#xA0;mg/kg and 15&#xA0;mg/kg, via gavage, from day 1&#x2013;6). 5-FU (Sigma&#x2013;Aldrich, St. Louis, USA) was diluted in sterile water and injected intraperitoneally (i.p.), daily, for 3 consecutive (days 4, 5 and 6) days into mice to induce mucositis. During the induction of mucositis, MFC treatment was given thirty minutes before 5-FU injections, daily throughout the trial to the respective groups via gavage. On the 7th day of the experiment, animals were anesthetized by 10&#xA0;mg/kg of xylazine and 100&#xA0;mg/kg of ketamine hydrochloride administered i.p. and euthanized by cervical dislocation <xref rid="bib0095" ref-type="bibr">[19]</xref>. Duodenal samples, 10&#xA0;cm after pyloric sphincter were removed to perform the assays.<fig id="fig0005"><label>Fig. 1</label><caption><p>Schematic representation of MFC treatment and intestinal mucositis induction by 5-FU.</p></caption><graphic xlink:href="gr1"/></fig></p>
      </sec>
      <sec id="sec0030">
        <label>2.4</label>
        <title>Body weight assessment</title>
        <p>Mice were daily weighed throughout the entire experimental period (7 days). The values were expressed as weight variation (%) in relation to the weight at the beginning of the experimental period <xref rid="bib0065" ref-type="bibr">[13]</xref>.</p>
      </sec>
      <sec id="sec0035">
        <label>2.5</label>
        <title>Morphometric and histopathological analysis</title>
        <p>Duodenal samples were fixed in 10% phosphate buffered formalin, embedded in paraffin, sectioned at 5&#xA0;&#x3BC;m thickness (Leica RM 2155, Heidelberg, Germany) and stained by hematoxylin and eosin (H&amp;E). For intestinal morphometric examination, villus height (estimated from top of the villus to crypt-villus junction) and crypt depth (defined as adjacent intussusception) were determined using the AxioVision 40 software (Carl Zeiss, Jena, Germany) and a light microscope (Axio Scope A1Carl Zeiss, Jena, Germany) at 20X and 40X objectives. In this triple-blinded trial, ten villi and crypts from each animal duodenal slide were measured and averaged for each group.</p>
        <p>Histopathological analysis evaluated the severity of intestinal tissue damage caused by 5-FU using ten different histological parameters, which consisted in villi and crypts size reduction, villi and crypts disruptions and abscess formation, muscularis thickening, epithelium and muscular layer integrity, inflammatory cells infiltration, vacuolization and mucosal edema. For each score, a value of 0&#x2013;3 was given and combined for an overall score <xref rid="bib0050" ref-type="bibr">[10]</xref>, <xref rid="bib0065" ref-type="bibr">[13]</xref>.</p>
      </sec>
      <sec id="sec0040">
        <label>2.6</label>
        <title>Immunohistochemistry for Ki-67, p53, Bax and Bcl-2</title>
        <p>Duodenal samples were embedded in paraffin, sectioned at 3&#xA0;&#x3BC;m thickness (Leica RM 2155, Heidelberg, Germany) and mounted on silane-coated slides. The slides were then deparaffinized, rehydrated in graded ethanol and washed with tris-buffered saline (TBS) (pH 7.4). This was followed by incubation in a citric acid buffer solution (pH 6.0) at 96&#xA0;&#xB0;C for 20&#xA0;min. Afterwards, slides were gradually cooled to room temperature and incubated in a 3% H<sub>2</sub>O<sub>2</sub> solution for 30&#xA0;min to block endogenous peroxidase activity. They were then incubated in bovine serum albumin (BSA 1%) for 20&#xA0;min. The next step was overnight incubation with one of the following primary antibodies (Santa Cruz Biotechnology, Santa Cruz, USA) at 4&#xA0;&#xB0;C: Ki-67 mouse monoclonal IgG1 (1:100); p53 mouse monoclonal IgG1 (1:50); Bax rabbit polyclonal IgG (1:50) and Bcl-2 mouse monoclonal IgG1 (1:50). After that, the streptavidin biotin peroxidase technique was performed. Slides were washed with TBS, incubated with secondary antibodies (ImmunoCruz&#x2122; mouse ABC staining systems sc-2017 or sc-2018, Santa Cruz Biotechnology, Santa Cruz, USA) for 30&#xA0;min, washed again to eliminate excess free antibodies, incubated with reagent enzyme (avidin&#xA0;+&#xA0;biotin HRP) and washed once more. Another incubation was performed with streptavidin-peroxidase complex for 30&#xA0;min followed by a TBS wash. Finally, slides were incubated in DAB developing solution (3.3'-diaminobenzidine) and counterstained with hematoxylin. The assays were performed in triplicate. Negative controls were obtained by replacing primary antibodies per 1% PBS&#x2013;BSA.</p>
        <p>Each slide was analyzed and photographed using a light microscopy (Axio Scope A1Carl Zeiss, Jena, Germany) at 40X objective. Also for each slide, a hundred duodenal epithelial cells were counted in ten consecutive fields to determine the percentage of positively stained cells expressing Ki-67, p53, Bax and Bcl-2.</p>
      </sec>
      <sec id="sec0045">
        <label>2.7</label>
        <title>Duodenal tissue homogenate preparation</title>
        <p>Tissue homogenate procedure was carried out as previously described by &#xC1;vila et al. <xref rid="bib0065" ref-type="bibr">[13]</xref>. Briefly, 250&#xA0;mg of duodenal tissue from participants of each group were collected and homogenized with hexadecyltrimethylammonium bromide buffer 0.5% by a dispersing machine (T25-digital Ultra-Turrax<sup>&#xAE;</sup>-IKA, Germany) at 10.000&#xA0;rpm, 25&#xA0;&#xB0;C for 5&#xA0;min. Homogenates were centrifuged at 2000&#xA0;rpm, 4&#xA0;&#xB0;C for 15&#xA0;min, and supernatants obtained were used for MPO and MDA analysis.</p>
      </sec>
      <sec id="sec0050">
        <label>2.8</label>
        <title>Myeloperoxidase (MPO) activity</title>
        <p>MPO activity assay was performed by adding 10&#xA0;&#x3BC;L of samples previously prepared to 96-well plastic plates (TPP, Trasadingen, Switzerland), containing 100&#xA0;&#x3BC;L of phosphate buffered saline, 100&#xA0;&#x3BC;L of H<sub>2</sub>O<sub>2</sub> 0.1% and 50&#xA0;&#x3BC;L of <italic>orto</italic>-dianisidine 1.3%. The absorbance reading was performed at 450&#xA0;nm wavelength. Results were expressed as active MPO unit per milligram of tissue <xref rid="bib0100" ref-type="bibr">[20]</xref>.</p>
      </sec>
      <sec id="sec0055">
        <label>2.9</label>
        <title>Malondialdehyde (MDA) determination</title>
        <p>Tissue MDA determination was carried out according to a modified method developed by Ohkawa et al. <xref rid="bib0105" ref-type="bibr">[21]</xref>. Briefly, 250&#xA0;&#x3BC;L of each previously prepared supernatant sample was homogenized with 25&#xA0;&#x3BC;L of butylated hydroxytoluene 4%. Immediately afterwards, 1&#xA0;mL of trichloroacetic acid solution 12%, 1&#xA0;mL of thiobarbituric acid solution 0.73% and 750&#xA0;&#x3BC;L of tris&#x2013;HCl buffer were added, and the tubes were incubated at 95&#xA0;&#xB0;C water bath for 50&#xA0;min. This mixture was later homogenized with 1.5&#xA0;mL of n-butanol, centrifuged at 5000&#xA0;rpm, 25&#xA0;&#xB0;C for 10&#xA0;min, and supernatants were collected to determine the absorbance at 532&#xA0;nm wavelength.</p>
      </sec>
      <sec id="sec0060">
        <label>2.10</label>
        <title>Statistical analysis</title>
        <p>Data are reported as means&#xA0;&#xB1;&#xA0;standard error of the mean. The inter-group variation was evaluated by One- or Two-way Analysis of Variance (ANOVA) followed by Bonferroni post-tests using the Windows version of GraphPad Prism 5.01 software (San Diego, CA, USA). <italic>P&#x2013;</italic>&lt;&#xA0;0.05 was considered statistically significant.</p>
      </sec>
    </sec>
    <sec id="sec0065">
      <label>3</label>
      <title>Results</title>
      <sec id="sec0070">
        <label>3.1</label>
        <title>Effect of MFC on animal body weight variation</title>
        <p>Intestinal mucositis usually leads to decrease in food intake and absorption capacity, and body weight analysis is an objective criterion for determining its severity <xref rid="bib0060" ref-type="bibr">[12]</xref>, <xref rid="bib0065" ref-type="bibr">[13]</xref>. As shown in <xref rid="fig0010" ref-type="fig">Fig. 2</xref>, all groups gained body weight until the 4th day, with the exception of the control group that gained weight throughout the entire experimental period, reaching a peak of 14.5&#xA0;&#xB1;&#xA0;0.33%. From day 4, animals only exposed to 5-FU doses (200&#xA0;mg/kg) showed significantly body weight loss (<italic>P&#xA0;</italic>&lt;&#xA0;0.001), reaching &#x223C;17% reduction on day 7. In these animals, MFC treatment attenuated 5-FU-induced body weight loss at all tested doses. Animals exposed to 5-FU and treated with 3.75; 7.5 or 15&#xA0;mg/kg of MFC showed body weight of 10.2&#xA0;&#xB1;&#xA0;0.34%, 9.2&#xA0;&#xB1;&#xA0;0.28%, and 8.1&#xA0;&#xB1;&#xA0;0.3%, respectively.<fig id="fig0010"><label>Fig. 2</label><caption><p>Body weight variation in mice subjected to intestinal mucositis and treated with MFC in relation to initial mass. Experiments performed in triplicate with 5 animals per group. Mice were daily weighed throughout the experimental period (7 days). Data &#x200B;&#x200B;expressed as mean&#xA0;&#xB1;&#xA0;SEM. <sup>***</sup><italic>P&#xA0;</italic>&lt;&#xA0;0.001 comparing 5-FU vs Control; <sup>#</sup><italic>P</italic> &lt;&#xA0;0.05 comparing 5-FU vs MFC 3.75&#xA0;mg/kg&#xA0;+&#xA0;5-FU; <sup>##</sup><italic>P&#xA0;</italic>&lt;&#xA0;0.001 comparing 5-FU vs MFC 7.5&#xA0;mg/kg&#xA0;+&#xA0;5-FU; and <sup>###</sup><italic>P&#xA0;</italic>&lt;&#xA0;0.001 comparing 5-FU vs MFC 15&#xA0;mg/kg&#xA0;+&#xA0;5-FU. For statistical analysis, one-way ANOVA and Bonferroni post-tests were applied.</p></caption><graphic xlink:href="gr2"/></fig></p>
      </sec>
      <sec id="sec0075">
        <label>3.2</label>
        <title>Protective effect of MFC on 5-FU-induced intestinal mucositis</title>
        <p>It is know that the reduction of intestinal length is a direct indicator of intestinal damage induced by chemotherapy drugs such as 5-FU and methotrexate <xref rid="bib0020" ref-type="bibr">[4]</xref>, <xref rid="bib0025" ref-type="bibr">[5]</xref>, <xref rid="bib0030" ref-type="bibr">[6]</xref>, <xref rid="bib0050" ref-type="bibr">[10]</xref>, <xref rid="bib0055" ref-type="bibr">[11]</xref>, <xref rid="bib0060" ref-type="bibr">[12]</xref>, <xref rid="bib0065" ref-type="bibr">[13]</xref>. Therefore, lengths of duodenal villi and crypts with different doses of MFC treatment were determined. As shown in <xref rid="fig0015" ref-type="fig">Fig. 3</xref>A and B, 100% of animals exposed to 5-FU showed a significant shortening in villi height (&#x223C;55.4%) and crypts depth (&#x223C;47%) when compared to control (<italic>P&#xA0;</italic>&lt;&#xA0;0.05). This reduction was markedly alleviated by the three MFC treatment doses (<italic>P&#xA0;</italic>&lt;&#xA0;0.05), with special emphasis on the MFC 15&#xA0;mg/kg. These results suggested that the 5-FU-induced duodenal mucositis could be prevented and/ or reduced by MFC.<fig id="fig0015"><label>Fig. 3</label><caption><p>Morphometric analysis of mice duodenum subjected to intestinal mucositis and treated with MFC. On day 7, duodenum segments were removed to measure villus height (panel A) and crypt depth (panel B). Data expressed as mean&#xA0;&#xB1;&#xA0;SEM. <sup>*</sup><italic>P&#xA0;</italic>&lt;&#xA0;0.05 comparing 5-FU vs Control and <sup>#</sup><italic>P&#xA0;</italic>&lt;&#xA0;0.05 comparing 5-FU vs MFC 3.75&#xA0;mg/kg&#xA0;+&#xA0;5-FU, MFC 7.5&#xA0;mg/kg&#xA0;+&#xA0;5-FU, MFC 15&#xA0;mg/kg&#xA0;+&#xA0;5-FU. For statistical analysis, two-way ANOVA and Bonferroni post-tests were applied.</p></caption><graphic xlink:href="gr3"/></fig></p>
        <p>Furthermore, 5-FU group had a significantly increased (&#x223C;64%) histological severity score when compared to all other groups, characterized by villi and crypts disruption and shortening, intense inflammatory infiltration, vacuolization and mucosal edema (<xref rid="fig0020" ref-type="fig">Fig. 4</xref>; <xref rid="tbl0005" ref-type="table">Table 1</xref>). Histological severity scores were significantly (<italic>P&#xA0;</italic>&lt;&#xA0;0.05) decreased in MFC treated groups, especially MFC 15&#xA0;mg/kg, except for those related to inflammatory infiltration.<fig id="fig0020"><label>Fig. 4</label><caption><p>Histological sections of mice duodenum subjected to intestinal mucositis and treated with MFC. Control (panels A and B) showing normal villi and crypts. 5-FU (panels C and D) showing villi shortening (arrows), crypts deepening, intense inflammatory infiltration, vacuolization and mucosal edema (arrowheads). MFC 3.75&#xA0;mg/kg&#xA0;+&#xA0;5-FU (panels E and F), MFC 7.5&#xA0;mg/kg&#xA0;+&#xA0;5-FU (panels G and H), MFC 15&#xA0;mg/kg&#xA0;+&#xA0;5-FU (panels I and J) showing villi and crypts preserved &#x2013; both in size and integrity &#x2013;, however, inflammatory infiltrate was observed. H&amp;E staining (panels A, C, E, G, I; 20X and B, D, F, H, J; 40X).</p></caption><graphic xlink:href="gr4"/></fig><table-wrap id="tbl0005" position="float"><label>Table 1</label><caption><p>Histopathological severity scores of mice duodenum subjected to intestinal mucositis and treated with MFC.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Groups</th><th align="left">Scores values</th></tr></thead><tbody><tr><td align="left">Control</td><td align="left">3 (1, 5)</td></tr><tr><td align="left">5-FU<xref rid="tblfn0005" ref-type="table-fn">*</xref></td><td align="left">15 (9, 18)</td></tr><tr><td align="left">MFC 3.75&#xA0;mg/kg&#xA0;+&#xA0;5-FU<xref rid="tblfn0010" ref-type="table-fn">**</xref></td><td align="left">7 (3, 10)</td></tr><tr><td align="left">MFC 7.5&#xA0;mg/kg&#xA0;+&#xA0;5-FU<xref rid="tblfn0010" ref-type="table-fn">**</xref></td><td align="left">7 (3, 12)</td></tr><tr><td align="left">MCF 15&#xA0;mg/kg&#xA0;+&#xA0;5-FU<xref rid="tblfn0010" ref-type="table-fn">**</xref></td><td align="left">5 (2, 9)</td></tr></tbody></table><table-wrap-foot><fn><p>Data expressed as median and range in parenthesis.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn0005"><label>*</label><p id="npar0005"><italic>P</italic>&#xA0;&lt;&#xA0;0.001 comparing 5-FU vs control.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn0010"><label>**</label><p id="npar0010"><italic>P</italic>&#xA0;&lt;&#xA0;0.05 comparing 5-FU vs MFC 3.75&#xA0;mg/kg&#xA0;+&#xA0;5-FU, MFC 7.5&#xA0;mg/kg&#xA0;+&#xA0;5-FU, and MFC 15&#xA0;mg/kg &#xA0;+&#xA0;5-FU. For statistical analysis, one-way ANOVA and Bonferroni post-tests were applied.</p></fn></table-wrap-foot></table-wrap></p>
        <p>In view of these analyses, MFC 15&#xA0;mg/kg demonstrated the most effective results in treating intestinal mucositis and was then chosen for subsequent investigations.</p>
      </sec>
      <sec id="sec0080">
        <label>3.3</label>
        <title>Effect of MFC on immunohistochemical detection of Ki-67, p53, Bax and Bcl-2</title>
        <p>Chemotherapy-induced mucositis is able to lead intestinal basal stem cell to apoptosis, due its toxicity to the cellular turnover in bowel tissue. Proteins of the Bcl-2 family play a central role in the execution-phase of cell apoptosis together with p53 <xref rid="bib0015" ref-type="bibr">[3]</xref>, <xref rid="bib0165" ref-type="bibr">[33]</xref>. The pattern of positive immunoexpression shown in <xref rid="fig0025" ref-type="fig">Fig. 5</xref> demonstrates an increased expression of pro-apoptotic members p53, Bax and the anti-apoptotic member Bcl-2 in 5-FU photomicrographs (<italic>P&#xA0;</italic>&lt;&#xA0;0.05). Such high expression was not observed among treated animals (MFC 15&#xA0;mg/kg), indicating less apoptosis (<xref rid="fig0030" ref-type="fig">Fig. 6</xref>).<fig id="fig0025"><label>Fig. 5</label><caption><p>Expression of Ki-67 (cell proliferation), p53 (pro-apoptotic), Bax (pro-apoptotic) and Bcl-2 (anti-apoptotic) in mice bearing intestinal mucositis and treated with MFC. See black arrows. Immunohistochemical staining, original magnification, 40X. Data expressed as mean&#xA0;&#xB1;&#xA0;SEM. <sup>*</sup><italic>P&#xA0;</italic>&lt;&#xA0;0.05 comparing 5-FU vs Control, <sup>#</sup><italic>P&#xA0;</italic>&lt;&#xA0;0.05 comparing 5-FU vs MFC 15&#xA0;mg/kg. For statistical analysis, two-way ANOVA and Bonferroni post-tests were applied.</p></caption><graphic xlink:href="gr5"/></fig><fig id="fig0030"><label>Fig. 6</label><caption><p>Effect of MFC treatment on MPO activity and MDA determination in duodenal portions of mice bearing intestinal mucositis. Experiments performed in triplicate with 5 animals per group. Data expressed as mean&#xA0;&#xB1;&#xA0;SEM. <sup>*</sup><italic>P&#xA0;</italic>&lt;&#xA0;0.05 comparing 5-FU vs Control, <sup>#</sup><italic>P&#xA0;</italic>&lt;&#xA0;0.05 comparing 5-FU vs MFC 15&#xA0;mg/kg. For statistical analysis, one-way ANOVA and Bonferroni post-tests were applied.</p></caption><graphic xlink:href="gr6"/></fig></p>
        <p>Cell proliferation is usually described in the healing stage of chemotherapy-induced mucositis <xref rid="bib0005" ref-type="bibr">[1]</xref>, <xref rid="bib0010" ref-type="bibr">[2]</xref>, <xref rid="bib0020" ref-type="bibr">[4]</xref>, <xref rid="bib0030" ref-type="bibr">[6]</xref>. As expected, the Ki-67 level in 5-FU mice decreased by &#x223C;90% compared to control (<italic>P&#xA0;</italic>&lt;&#xA0;0.05), and treatment with MFC at 15&#xA0;mg/kg induced greater expression of Ki-67 protein (<italic>P&#xA0;</italic>&lt;&#xA0;0.05), shown by strong nuclear staining on the epithelium of villi and crypts, which indicates cellular proliferation (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>).</p>
      </sec>
      <sec id="sec0085">
        <label>3.4</label>
        <title>Effect of MFC in MPO activity and MDA formation</title>
        <p>MPO is the most abundant enzyme present in azurophilic granules in neutrophils <xref rid="bib0100" ref-type="bibr">[20]</xref>. It is widely used as a neutrophil marker in inflamed tissue such as mucositis <xref rid="bib0050" ref-type="bibr">[10]</xref>, <xref rid="bib0065" ref-type="bibr">[13]</xref>, <xref rid="bib0110" ref-type="bibr">[22]</xref>. MPO activity in duodenal tissue of 5-FU-induced mucositis group was by 70% higher than in the control, and 60% higher relative to the treated group (<xref rid="fig0025" ref-type="fig">Fig. 5</xref>A, both <italic>P&#xA0;&lt;&#xA0;</italic>0.05). Additionally, there was no significant difference between treated (MFC 15&#xA0;mg/kg) and control group (<italic>P&#xA0;&lt;&#xA0;</italic>0.05).</p>
        <p>MDA is one of the final products widely adopted for a sensitive assay of lipid peroxidation and oxidative stress induced by ROS in intestinal tissue <xref rid="bib0065" ref-type="bibr">[13]</xref>, <xref rid="bib0115" ref-type="bibr">[23]</xref>, <xref rid="bib0120" ref-type="bibr">[24]</xref>. <xref rid="fig0025" ref-type="fig">Fig. 5</xref>B demonstrates there was an increase by &#x223C;51% in MDA formation when mice which received 5-FU were compared to control group (<italic>P&#xA0;&lt;&#xA0;</italic>0.05). Treatment with MFC 15&#xA0;mg/kg significantly reduced tissue oxidative stress and free radical production in about 44% (<italic>P&#xA0;&lt;&#xA0;</italic>0.05). Likewise, in MDA formation assay, there was no significant difference between treated and control group (<italic>P&#xA0;&lt;&#xA0;</italic>0.05).</p>
      </sec>
    </sec>
    <sec id="sec0090">
      <label>4</label>
      <title>Discussion</title>
      <p>As no broadly curative drug treatment for mucositis is commercially available, palliative procedures have been employed to alleviate its signs and symptoms <xref rid="bib0125" ref-type="bibr">[25]</xref>, <xref rid="bib0130" ref-type="bibr">[26]</xref>, <xref rid="bib0135" ref-type="bibr">[27]</xref>, <xref rid="bib0140" ref-type="bibr">[28]</xref>. For its intestinal manifestation, therapeutic and/or preventive approaches are applied for infection and pain control, induction of cell proliferation and reepithelialization <xref rid="bib0020" ref-type="bibr">[4]</xref>, <xref rid="bib0030" ref-type="bibr">[6]</xref>, <xref rid="bib0035" ref-type="bibr">[7]</xref>, <xref rid="bib0040" ref-type="bibr">[8]</xref>, <xref rid="bib0045" ref-type="bibr">[9]</xref>. Considering the range of cancers and the occurrence of intestinal mucositis by antineoplastic agents, it is necessary to search for therapeutic alternatives to alleviate this serious side effect. In this study, MFC exerted protective action against 5-FU-induced morphological and histological intestinal changes, especially at the dose of 15&#xA0;mg/kg. Such effectiveness is demonstrated by other anti-mucositis approaches <xref rid="bib0050" ref-type="bibr">[10]</xref>, <xref rid="bib0055" ref-type="bibr">[11]</xref>, <xref rid="bib0060" ref-type="bibr">[12]</xref>, <xref rid="bib0065" ref-type="bibr">[13]</xref>, <xref rid="bib0145" ref-type="bibr">[29]</xref>, <xref rid="bib0150" ref-type="bibr">[30]</xref>.</p>
      <p>Body weight analysis showed that MFC was capable of attenuating weight loss induced by 5-FU. Intestinal mucositis generated by chemotherapy potentially causes a decrease in food intake, which linked to a loss in intestinal absorptive capacity lead to diarrheal episodes and body mass loss <xref rid="bib0005" ref-type="bibr">[1]</xref>, <xref rid="bib0015" ref-type="bibr">[3]</xref>. Diarrhea is reported as high as 50&#x2013;80% in patients undergoing chemotherapy, and tends to become a limiting factor when severe <xref rid="bib0155" ref-type="bibr">[31]</xref>. Our data suggested improvements in food intake and nutrition in mice bearing mucositis treated with MFC. This result is consistent with other proposed experimental treatments for mucositis <xref rid="bib0050" ref-type="bibr">[10]</xref>, <xref rid="bib0055" ref-type="bibr">[11]</xref>, <xref rid="bib0060" ref-type="bibr">[12]</xref>, <xref rid="bib0065" ref-type="bibr">[13]</xref>, <xref rid="bib0070" ref-type="bibr">[14]</xref>, <xref rid="bib0160" ref-type="bibr">[32]</xref>.</p>
      <p>The occurrence of intestinal mucositis induced by chemotherapy is directly associated with decreased cell proliferation and increased apoptosis activity in mucosal epithelial cells and, consequently, the modulation of regulatory proteins, such as the Bcl-2 family <xref rid="bib0165" ref-type="bibr">[33]</xref>. In this context, the tumor suppressor gene p53 interacts with members of the Bcl-2 family in the mitochondrial membrane promoting the release of cytochrome c, thereby increasing the transcription of the Fas death receptor gene and inhibiting the secretion of growth factors during chemotherapy sections <xref rid="bib0015" ref-type="bibr">[3]</xref>, <xref rid="bib0165" ref-type="bibr">[33]</xref>.</p>
      <p>To elucidate the influence of MFC in cell proliferation/apoptosis activity in mucosal epithelial cells of mice bearing mice, an immunohistochemical identification of proteins Ki-67, p53, Bax and Bcl-2 was performed. Treatment with MFC 15&#xA0;mg/kg induced a slightly greater increase in the expression of Bcl-2 (anti-apoptotic) than in Bax (pro-apoptotic) in the epithelium of villi and crypts. Likewise, treatment discretely reduced p53 expression in the animal mucosa. On the other hand, Ki-67 protein increased approximately 90% of expression in villi and crypts epithelium duodenal, when compared to 5-FU group, which indicates that the formulation acted on the rate of intestinal cell proliferation. Recently, Reinke et al. <xref rid="bib0050" ref-type="bibr">[10]</xref>, Wright et al. <xref rid="bib0055" ref-type="bibr">[11]</xref>, &#xC1;vila et al. <xref rid="bib0065" ref-type="bibr">[13]</xref>, and Al-Refai <xref rid="bib0170" ref-type="bibr">[34]</xref>, also found that antineoplastic agents administration result in increased apoptosis and decreased cellularity in the small-intestinal mucosa. Like our findings, the imbalance of the rate cell proliferation observed by these authors was modulated by the treatment.</p>
      <p>With a view to measuring neutrophil infiltration in duodenal tissue, intestinal MPO activity was investigated. MPO levels were increased in duodenal tissue of 5-FU group, when compared to control. Otherwise, MPO amount in duodenal segments of mice treated with MFC was almost equivalent of normal levels, indicating less neutrophil infiltration and consequently less inflammation. Our data is consistent with the findings of Reinke et al. <xref rid="bib0050" ref-type="bibr">[10]</xref> and Ferreira et al. <xref rid="bib0160" ref-type="bibr">[32]</xref>.</p>
      <p>MDA quantification has been used as a marker for the production of reactive oxygen species (ROS). ROS are involved in numerous mechanisms of injury, and one of the most significant is lipid peroxidation present in cell membranes. In this analysis, we measured lipid peroxidation associated to oxidative stress through the production of MDA in duodenal tissue samples. MDA values found in mice bearing mucositis and treated with MFC were about 50% lower than the values of 5-FU group, and equivalent to those of the control group. Our data correlates to Marques et al. <xref rid="bib0175" ref-type="bibr">[35]</xref> and Cunha et al. <xref rid="bib0180" ref-type="bibr">[36]</xref>. Thus, considering MDA levels found, it is suggested that 5-FU acted as a pro-oxidant on intestinal epithelium by keeping mucosa under constant oxidative damage. Furthermore, we propose that MFC was capable of protecting this epithelium, through the antioxidant properties of curcuminoids and mucoadhesive physical protection effect of poloxamer 407.</p>
      <p>Mucoadhesive formulations allow intimate contact between the pharmaceutical form and the absorbing membrane by creating a film on the mucus layer lining of mucosa, thereby reducing its spread and protecting the drug from possible degradation in the intestinal lumen <xref rid="bib0185" ref-type="bibr">[37]</xref>. Therefore, the benefit rendered by mucoadhesive formulations would be a once daily regime, which would improve treatment compliance and reduce adverse effects <xref rid="bib0190" ref-type="bibr">[38]</xref>. Chen et al. <xref rid="bib0195" ref-type="bibr">[39]</xref> evaluated the potential of Poloxamer 407 as a thermogelling mucoadhesive polymer to improve curcuminoids bioavailability in primary culture cells. Their results revealed controlled curcuminoid release over a 24&#xA0;h period. In our study, it can suggest that the components of mucoadhesive formulation acted as vehicle for curcuminoids and probably increased the contact time between extract components and intestinal mucosa.</p>
      <p>In different parts of the world, the dry extract obtained from <italic>C. longa</italic> L. has been used for centuries associated with numerous biological activities <xref rid="bib0075" ref-type="bibr">[15]</xref>. However, as unformulated curcuminoids have relatively low bioavailability and poor aqueous solubility <xref rid="bib0080" ref-type="bibr">[16]</xref>, <xref rid="bib0200" ref-type="bibr">[40]</xref>. Yang et al. <xref rid="bib0205" ref-type="bibr">[41]</xref> observed that intestinal absorption of curcuminoids in murine models is only around 60%. Thus, our data further emphasizes the importance of the mucoadhesive formulation in reaching the expected clinical outcome against mucositis.</p>
      <p>A study conducted by Henrotin et al. <xref rid="bib0210" ref-type="bibr">[42]</xref> demonstrated that there are many molecular evidences to justify the potential of <italic>C. longa</italic> L. components (monoterpenes, diterpenes, sesquiterpenes) for the treatment of various inflammatory diseases. However, in animal bearing mucositis and treated with MFC we still observed inflammatory infiltrate, which could be attributed to the presence of other inflammatory cells than neutrophils, such as lymphocyte infiltration.</p>
      <p>Our data demonstrate that MFC exerted protective action against duodenal mucosa damage caused by 5-FU. It also stimulated cell proliferation, reduced weight loss, MPO levels and MDA formation. Supplementary studies are underway searching for the elucidation of mechanisms involved in the protective effects of MFC in order to make this formulation a clinical tool for the prevention and/or treatment of mucositis.</p>
    </sec>
    <sec id="sec0095">
      <title>Conflicts of interest</title>
      <p>The authors indicate no potential conflicts of interest.</p>
    </sec>
    <sec id="sec0100">
      <title>Transparency document</title>
    </sec>
  </body>
  <back>
    <ref-list id="bibl0005">
      <title>References</title>
      <ref id="bib0005">
        <label>1</label>
        <element-citation publication-type="journal" id="sbref0005">
          <person-group person-group-type="author">
            <name>
              <surname>Sonis</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Elting</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Keefe</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hauer-Jensen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bekele</surname>
              <given-names>B.N.</given-names>
            </name>
            <name>
              <surname>Raber-Durlacher</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Donnelly</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Rubenstein</surname>
              <given-names>E.B.</given-names>
            </name>
            <name>
              <surname>Mucositis Study Section of the Multinational Association for Supportive Care in Cancer</surname>
            </name>
            <name>
              <surname>International Society for Oral Oncology</surname>
            </name>
          </person-group>
          <article-title>Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients</article-title>
          <source>Cancer</source>
          <volume>100</volume>
          <year>2004</year>
          <fpage>1995</fpage>
          <lpage>2025</lpage>
          <pub-id pub-id-type="pmid">15108222</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0010">
        <label>2</label>
        <element-citation publication-type="journal" id="sbref0010">
          <person-group person-group-type="author">
            <name>
              <surname>Sonis</surname>
              <given-names>S.T.</given-names>
            </name>
          </person-group>
          <article-title>Regimen-related gastrointestinal toxicities in cancer patients</article-title>
          <source>Curr. Opin. Support Palliat Care</source>
          <volume>4</volume>
          <year>2010</year>
          <fpage>26</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">20040879</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0015">
        <label>3</label>
        <element-citation publication-type="journal" id="sbref0015">
          <person-group person-group-type="author">
            <name>
              <surname>Van Vliet</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Harmsen</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>de Bont</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Tissing</surname>
              <given-names>W.J.</given-names>
            </name>
          </person-group>
          <article-title>The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis</article-title>
          <source>PLoS Pathog.</source>
          <volume>6</volume>
          <year>2010</year>
          <fpage>e1000879</fpage>
          <pub-id pub-id-type="pmid">20523891</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0020">
        <label>4</label>
        <element-citation publication-type="journal" id="sbref0020">
          <person-group person-group-type="author">
            <name>
              <surname>Villa</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sonis</surname>
              <given-names>S.T.</given-names>
            </name>
          </person-group>
          <article-title>Mucositis: pathobiology and management</article-title>
          <source>Curr. Opin. Oncol.</source>
          <volume>27</volume>
          <year>2015</year>
          <fpage>159</fpage>
          <lpage>164</lpage>
          <pub-id pub-id-type="pmid">25774860</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0025">
        <label>5</label>
        <element-citation publication-type="journal" id="sbref0025">
          <person-group person-group-type="author">
            <name>
              <surname>Benz</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Degregorio</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Saks</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sambol</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Holleran</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ignoffo</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Cadman</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response</article-title>
          <source>Cancer Res.</source>
          <volume>45</volume>
          <year>1985</year>
          <fpage>3354</fpage>
          <lpage>3358</lpage>
          <pub-id pub-id-type="pmid">4005858</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0030">
        <label>6</label>
        <element-citation publication-type="journal" id="sbref0030">
          <person-group person-group-type="author">
            <name>
              <surname>Van Sebille</surname>
              <given-names>Y.Z.</given-names>
            </name>
            <name>
              <surname>Stansborough</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wardill</surname>
              <given-names>H.R.</given-names>
            </name>
            <name>
              <surname>Bateman</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Keefe</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Management of mucositis during chemotherapy: from pathophysiology to pragmatic therapeutics</article-title>
          <source>Curr. Oncol. Rep.</source>
          <volume>17</volume>
          <year>2015</year>
        </element-citation>
      </ref>
      <ref id="bib0035">
        <label>7</label>
        <element-citation publication-type="journal" id="sbref0035">
          <person-group person-group-type="author">
            <name>
              <surname>Posner</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Haddad</surname>
              <given-names>R.I.</given-names>
            </name>
          </person-group>
          <article-title>Novel agents for the treatment of mucositis</article-title>
          <source>J. Support Oncol.</source>
          <volume>5</volume>
          <year>2007</year>
          <fpage>33</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">18046996</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0040">
        <label>8</label>
        <element-citation publication-type="journal" id="sbref0040">
          <person-group person-group-type="author">
            <name>
              <surname>Rubenstein</surname>
              <given-names>E.B.</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Keefe</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>McGuire</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Elting</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Fox</surname>
              <given-names>P.C.</given-names>
            </name>
            <name>
              <surname>Cooksley</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sonis</surname>
              <given-names>S.T.</given-names>
            </name>
          </person-group>
          <article-title>Mucositis study section of the multinational association for supportive care in cancer; International Society for Oral Oncology,clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis</article-title>
          <source>Cancer</source>
          <volume>100</volume>
          <year>2004</year>
          <fpage>2026</fpage>
          <lpage>2046</lpage>
          <pub-id pub-id-type="pmid">15108223</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0045">
        <label>9</label>
        <element-citation publication-type="journal" id="sbref0045">
          <person-group person-group-type="author">
            <name>
              <surname>Keefe</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Sonis</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Bowen</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Emerging drugs for chemotherapy-induced mucositis</article-title>
          <source>Expert Opin. Emerg. Drugs</source>
          <volume>13</volume>
          <year>2008</year>
          <fpage>511</fpage>
          <lpage>522</lpage>
          <pub-id pub-id-type="pmid">18764726</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0050">
        <label>10</label>
        <element-citation publication-type="journal" id="sbref0050">
          <person-group person-group-type="author">
            <name>
              <surname>Reinke</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Kritas</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Polychronopoulos</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Skaltsounis</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Aligiannis</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>C.D.</given-names>
            </name>
          </person-group>
          <article-title>Herbal substance, acteoside, alleviates intestinal mucositis in mice</article-title>
          <source>Gastroenterol Res. Pract.</source>
          <volume>2015</volume>
          <year>2015</year>
        </element-citation>
      </ref>
      <ref id="bib0055">
        <label>11</label>
        <element-citation publication-type="journal" id="sbref0055">
          <person-group person-group-type="author">
            <name>
              <surname>Wright</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Yazbeck</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lymn</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Whitford</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Cheah</surname>
              <given-names>K.Y.</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Feinle-Bisset</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pilichiewicz</surname>
              <given-names>A.N.</given-names>
            </name>
            <name>
              <surname>Mashtoub</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Howarth</surname>
              <given-names>G.S.</given-names>
            </name>
          </person-group>
          <article-title>The herbal extract, iberogast, improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis</article-title>
          <source>Cancer Biol. Ther.</source>
          <volume>8</volume>
          <year>2009</year>
          <fpage>923</fpage>
          <lpage>929</lpage>
          <pub-id pub-id-type="pmid">19276679</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0060">
        <label>12</label>
        <element-citation publication-type="journal" id="sbref0060">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Schr&#xF6;der</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title><italic>Chimonanthus nitens</italic> var. <italic>salicifolius</italic> aqueous extract protects against 5-fluorouracil induced gastrointestinal mucositis in a mouse model</article-title>
          <source>Evid. Based Compl. Alt. Med.</source>
          <volume>2013</volume>
          <year>2013</year>
        </element-citation>
      </ref>
      <ref id="bib0065">
        <label>13</label>
        <element-citation publication-type="journal" id="sbref0065">
          <person-group person-group-type="author">
            <name>
              <surname>&#xC1;vila</surname>
              <given-names>P.H.M.</given-names>
            </name>
            <name>
              <surname>&#xC1;vila</surname>
              <given-names>R.I.</given-names>
            </name>
            <name>
              <surname>Filho</surname>
              <given-names>E.X.S.</given-names>
            </name>
            <name>
              <surname>Bastos</surname>
              <given-names>C.C.C.</given-names>
            </name>
            <name>
              <surname>Batista</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Mendon&#xE7;a</surname>
              <given-names>E.F.</given-names>
            </name>
            <name>
              <surname>Serpa</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Marreto</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Cruz</surname>
              <given-names>A.F.</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Valadares</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>Mucoadhesive formulation of <italic>Bidens pilosa</italic> L. (Asteraceae) reduces intestinal injury from 5-fluorouracil-induced mucositis in mice</article-title>
          <source>Toxicol. Rep.</source>
          <volume>2</volume>
          <year>2015</year>
          <fpage>563</fpage>
          <lpage>573</lpage>
        </element-citation>
      </ref>
      <ref id="bib0070">
        <label>14</label>
        <element-citation publication-type="journal" id="sbref0070">
          <person-group person-group-type="author">
            <name>
              <surname>Loo</surname>
              <given-names>W.T.</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>L.W.</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>M.N.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title><italic>Rhodiola algida</italic> improves chemotherapy-induced oral mucositis in breast cancer patients</article-title>
          <source>Expert Opin. Investig. Drugs</source>
          <volume>19</volume>
          <issue>Suppl. 1</issue>
          <year>2010</year>
          <fpage>91</fpage>
          <lpage>100</lpage>
        </element-citation>
      </ref>
      <ref id="bib0075">
        <label>15</label>
        <element-citation publication-type="journal" id="sbref0075">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Aggarwal</surname>
              <given-names>B.B.</given-names>
            </name>
          </person-group>
          <article-title>Multitargeting by turmeric, the golden spice: from kitchen to clinic</article-title>
          <source>Mol. Nutr. Food Res.</source>
          <volume>57</volume>
          <year>2013</year>
          <fpage>1510</fpage>
          <lpage>1528</lpage>
          <pub-id pub-id-type="pmid">22887802</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0080">
        <label>16</label>
        <element-citation publication-type="journal" id="sbref0080">
          <person-group person-group-type="author">
            <name>
              <surname>Naksuriya</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Okonogi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schiffelers</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Hennink</surname>
              <given-names>W.E.</given-names>
            </name>
          </person-group>
          <article-title>Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment</article-title>
          <source>Biomaterial</source>
          <volume>35</volume>
          <year>2014</year>
          <fpage>3365</fpage>
          <lpage>3383</lpage>
        </element-citation>
      </ref>
      <ref id="bib0085">
        <label>17</label>
        <element-citation publication-type="journal" id="sbref0085">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>G.R.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Aggarwal</surname>
              <given-names>B.B.</given-names>
            </name>
          </person-group>
          <article-title>Chemical composition and product quality control of turmeric (<italic>Curcuma longa</italic> L.)</article-title>
          <source>Pharm. Crops.</source>
          <volume>2</volume>
          <year>2011</year>
          <fpage>28</fpage>
          <lpage>54</lpage>
        </element-citation>
      </ref>
      <ref id="bib0090">
        <label>18</label>
        <element-citation publication-type="journal" id="sbref0090">
          <person-group person-group-type="author">
            <name>
              <surname>Varum</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>McConnell</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Veiga</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Basit</surname>
              <given-names>A.W.</given-names>
            </name>
          </person-group>
          <article-title>Mucoadhesion and the gastrointestinal tract</article-title>
          <source>Crit. Rev. Ther. Drug Carrier. Syst.</source>
          <volume>25</volume>
          <year>2008</year>
          <fpage>207</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="pmid">18540839</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0095">
        <label>19</label>
        <element-citation publication-type="book" id="sbref0095">
          <person-group person-group-type="author">
            <name>
              <surname>Hubrecht</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kirkwood</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <chapter-title>The UFAW Handbook on the Care and Management of Laboratory and Other Research Animals</chapter-title>
          <edition>8th ed.</edition>
          <year>2010</year>
          <publisher-name>Wiley-Blackwell</publisher-name>
          <publisher-loc>United Kingdom</publisher-loc>
        </element-citation>
      </ref>
      <ref id="bib0100">
        <label>20</label>
        <element-citation publication-type="journal" id="sbref0100">
          <person-group person-group-type="author">
            <name>
              <surname>Bradley</surname>
              <given-names>P.P.</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Rothstein</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Cellular and extracellular myeloperoxidase in pyogenic inflammation</article-title>
          <source>Blood</source>
          <volume>60</volume>
          <year>1982</year>
          <fpage>618</fpage>
          <lpage>622</lpage>
          <pub-id pub-id-type="pmid">6286012</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0105">
        <label>21</label>
        <element-citation publication-type="journal" id="sbref0105">
          <person-group person-group-type="author">
            <name>
              <surname>Ohkawa</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ohishi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Yagi</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction</article-title>
          <source>Anal Biochem.</source>
          <volume>95</volume>
          <year>1979</year>
          <fpage>351</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="pmid">36810</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0110">
        <label>22</label>
        <element-citation publication-type="journal" id="sbref0110">
          <person-group person-group-type="author">
            <name>
              <surname>Lima-J&#xFA;nior</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Figueiredo</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Freitas</surname>
              <given-names>H.C.</given-names>
            </name>
            <name>
              <surname>Melo</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>D.V.</given-names>
            </name>
            <name>
              <surname>Leite</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Medeiros</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Marques-Neto</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Vale</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Brito</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Ori&#xE1;</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>F.Q.</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation</article-title>
          <source>Cancer. Chemother. Pharmacol.</source>
          <volume>4</volume>
          <year>2012</year>
          <fpage>931</fpage>
          <lpage>942</lpage>
        </element-citation>
      </ref>
      <ref id="bib0115">
        <label>23</label>
        <element-citation publication-type="journal" id="sbref0115">
          <person-group person-group-type="author">
            <name>
              <surname>Okur</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>K&#xFC;&#xE7;&#xFC;kaydin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>K&#xF6;se</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Konta&#x15F;</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Do&#x11F;am</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kazez</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Hypoxia-induced necrotizing enterocolitis in the immature rat: the role of lipid peroxidation and management by vitamin E</article-title>
          <source>J. Pediatr. Surg.</source>
          <volume>10</volume>
          <year>1995</year>
          <fpage>1416</fpage>
          <lpage>1419</lpage>
        </element-citation>
      </ref>
      <ref id="bib0120">
        <label>24</label>
        <element-citation publication-type="journal" id="sbref0120">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE1;</surname>
              <given-names>O.M.S.</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>N.N.F.</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>M.T.S.</given-names>
            </name>
            <name>
              <surname>Lalla</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Oliva</surname>
              <given-names>M.L.V.</given-names>
            </name>
            <name>
              <surname>Caran</surname>
              <given-names>E.M.M.</given-names>
            </name>
          </person-group>
          <article-title>Glycine supplementation reduces the severity of chemotherapy-induced oral mucositis in hamsters</article-title>
          <source>Nat. Sci.</source>
          <volume>5</volume>
          <year>2013</year>
          <fpage>972</fpage>
          <lpage>978</lpage>
        </element-citation>
      </ref>
      <ref id="bib0125">
        <label>25</label>
        <element-citation publication-type="journal" id="sbref0125">
          <person-group person-group-type="author">
            <name>
              <surname>McGuire</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Fulton</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Correa</surname>
              <given-names>M.E.P.</given-names>
            </name>
            <name>
              <surname>Eilers</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Elad</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Oberle-Edwards</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Bowen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lalla</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)</surname>
            </name>
          </person-group>
          <article-title>Systematic review of basic oral care for the management of oral mucositis in cancer patients</article-title>
          <source>Support. Care Cancer</source>
          <volume>21</volume>
          <year>2013</year>
          <fpage>3165</fpage>
          <lpage>3177</lpage>
          <pub-id pub-id-type="pmid">24018908</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0130">
        <label>26</label>
        <element-citation publication-type="journal" id="sbref0130">
          <person-group person-group-type="author">
            <name>
              <surname>Nicolatou-Galitis</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Sarri</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bowen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Di Palma</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kouloulias</surname>
              <given-names>V.E.</given-names>
            </name>
            <name>
              <surname>Niscola</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Riesenbeck</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Stokman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tissing</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Yeoh</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Elad</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lalla</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)</surname>
            </name>
          </person-group>
          <article-title>Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients</article-title>
          <source>Support. Care Cancer</source>
          <volume>21</volume>
          <year>2013</year>
          <fpage>3179</fpage>
          <lpage>3189</lpage>
          <pub-id pub-id-type="pmid">23702538</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0135">
        <label>27</label>
        <element-citation publication-type="journal" id="sbref0135">
          <person-group person-group-type="author">
            <name>
              <surname>Saunders</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Elad</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Allemano</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bossi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>van de Wetering</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>N.G.</given-names>
            </name>
            <name>
              <surname>Potting</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>K.K.</given-names>
            </name>
            <name>
              <surname>Freidank</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Bowen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dennis</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Lalla</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)</surname>
            </name>
          </person-group>
          <article-title>Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients</article-title>
          <source>Support. Care Cancer</source>
          <volume>21</volume>
          <year>2013</year>
          <fpage>3191</fpage>
          <lpage>3207</lpage>
          <pub-id pub-id-type="pmid">23832272</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0140">
        <label>28</label>
        <element-citation publication-type="journal" id="sbref0140">
          <person-group person-group-type="author">
            <name>
              <surname>Oton-Leite</surname>
              <given-names>A.F.</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>G.B.</given-names>
            </name>
            <name>
              <surname>Morais</surname>
              <given-names>M.O.</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>T.A.</given-names>
            </name>
            <name>
              <surname>Leles</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Valadares</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Pinezi</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Batista</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Mendon&#xE7;a</surname>
              <given-names>E.F.</given-names>
            </name>
          </person-group>
          <article-title>Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients</article-title>
          <source>Lasers Surg. Med.</source>
          <volume>47</volume>
          <year>2015</year>
          <fpage>296</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">25824475</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0145">
        <label>29</label>
        <element-citation publication-type="journal" id="sbref0145">
          <person-group person-group-type="author">
            <name>
              <surname>Cool</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Dyer</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Xian</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Geier</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Howarth</surname>
              <given-names>G.S.</given-names>
            </name>
          </person-group>
          <article-title>Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats</article-title>
          <source>Growth Horm. IGF Res.</source>
          <volume>15</volume>
          <year>2005</year>
          <fpage>72</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="pmid">15701575</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0150">
        <label>30</label>
        <element-citation publication-type="journal" id="sbref0150">
          <person-group person-group-type="author">
            <name>
              <surname>Son</surname>
              <given-names>T.G.</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Heo</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Protective effect of genistein on radiation-induced intestinal injury in tumor bearing mice</article-title>
          <source>BMC Complement Altern. Med.</source>
          <volume>13</volume>
          <year>2013</year>
        </element-citation>
      </ref>
      <ref id="bib0155">
        <label>31</label>
        <element-citation publication-type="journal" id="sbref0155">
          <person-group person-group-type="author">
            <name>
              <surname>Stein</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Voigt</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Jordan</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management</article-title>
          <source>Ther. Adv. Med. Oncol.</source>
          <volume>2</volume>
          <year>2010</year>
          <fpage>51</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">21789126</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0160">
        <label>32</label>
        <element-citation publication-type="journal" id="sbref0160">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Leonel</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Melo</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>R.R.</given-names>
            </name>
            <name>
              <surname>Cara</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>V.N.</given-names>
            </name>
            <name>
              <surname>Correia</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Alvarez-Leite</surname>
              <given-names>J.I.</given-names>
            </name>
          </person-group>
          <article-title>Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration</article-title>
          <source>Lipids</source>
          <volume>47</volume>
          <year>2012</year>
          <fpage>669</fpage>
          <lpage>678</lpage>
          <pub-id pub-id-type="pmid">22648862</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0165">
        <label>33</label>
        <element-citation publication-type="journal" id="sbref0165">
          <person-group person-group-type="author">
            <name>
              <surname>Pritchard</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Potten</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Hickman</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia</article-title>
          <source>Cancer Res.</source>
          <volume>58</volume>
          <year>1998</year>
          <fpage>5453</fpage>
          <lpage>5465</lpage>
          <pub-id pub-id-type="pmid">9850079</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0170">
        <label>34</label>
        <element-citation publication-type="journal" id="sbref0170">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Refai</surname>
              <given-names>A.S.</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical study of the effect of chamomile extract on 5-fluorouracil induced intestinal mucositis in Albino rats</article-title>
          <source>J. Clin. Cell Immunol.</source>
          <volume>5</volume>
          <year>2014</year>
        </element-citation>
      </ref>
      <ref id="bib0175">
        <label>35</label>
        <element-citation publication-type="journal" id="sbref0175">
          <person-group person-group-type="author">
            <name>
              <surname>Marques</surname>
              <given-names>L.H.S.</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>C.M.G.</given-names>
            </name>
            <name>
              <surname>Lameiro</surname>
              <given-names>T.M.M.</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>C.A.R.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of lipid peroxidation levels on mucosa colonic cells after application of hydrogen peroxide in enemas. Experimental study in rats</article-title>
          <source>Rev. Bras. Colo-Proctol.</source>
          <volume>30</volume>
          <year>2010</year>
          <fpage>272</fpage>
          <lpage>280</lpage>
        </element-citation>
      </ref>
      <ref id="bib0180">
        <label>36</label>
        <element-citation publication-type="journal" id="sbref0180">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>C.M.G.</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Lameiro</surname>
              <given-names>T.M.M.</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>L.H.S.</given-names>
            </name>
            <name>
              <surname>Margarido</surname>
              <given-names>N.F.</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Reduction in oxidative stress levels in the colonic mucosa without fecal stream after the application of enemas containing aqueous Ilex paraguariensis extract</article-title>
          <source>Acta Cir. Bras.</source>
          <volume>26</volume>
          <year>2011</year>
          <fpage>289</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">21808842</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0185">
        <label>37</label>
        <element-citation publication-type="journal" id="sbref0185">
          <person-group person-group-type="author">
            <name>
              <surname>Grabovac</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Guggi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bernkop-Schn&#xFC;rch</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>Comparison of the mucoadhesive properties of various polymers</article-title>
          <source>Adv. Drug Deliv. Rev.</source>
          <volume>57</volume>
          <year>2005</year>
          <fpage>1713</fpage>
          <lpage>1723</lpage>
          <pub-id pub-id-type="pmid">16183163</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0190">
        <label>38</label>
        <element-citation publication-type="journal" id="sbref0190">
          <person-group person-group-type="author">
            <name>
              <surname>Chinna Reddy</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Chaitanya</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Madhusudan Rao</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>A Review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods</article-title>
          <source>Daru</source>
          <volume>19</volume>
          <year>2011</year>
          <fpage>385</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="pmid">23008684</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0195">
        <label>39</label>
        <element-citation publication-type="journal" id="sbref0195">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>P.H.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>Y.C.</given-names>
            </name>
          </person-group>
          <article-title><italic>In vitro</italic> biocompatibility of thermally gelling liquid mucoadhesive loaded curcuminoids in colorectal cancer chemoprevention</article-title>
          <source>Int. J. Colorectal Dis.</source>
          <volume>27</volume>
          <year>2012</year>
          <fpage>869</fpage>
          <lpage>878</lpage>
          <pub-id pub-id-type="pmid">22222465</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0200">
        <label>40</label>
        <element-citation publication-type="journal" id="sbref0200">
          <person-group person-group-type="author">
            <name>
              <surname>Prasad</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tyagi</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Aggarwal</surname>
              <given-names>B.B.</given-names>
            </name>
          </person-group>
          <article-title>Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice</article-title>
          <source>Cancer Res. Treat.</source>
          <volume>46</volume>
          <year>2014</year>
          <fpage>2</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">24520218</pub-id>
        </element-citation>
      </ref>
      <ref id="bib0205">
        <label>41</label>
        <element-citation publication-type="journal" id="sbref0205">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>K.Y.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>T.Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>T.H.</given-names>
            </name>
          </person-group>
          <article-title>Oral bioavailability of curcumin in rat and the herbal analysis from <italic>Curcuma longa</italic> by LC&#x2013;MS/MS</article-title>
          <source>J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.</source>
          <volume>853</volume>
          <year>2007</year>
          <fpage>183</fpage>
          <lpage>189</lpage>
        </element-citation>
      </ref>
      <ref id="bib0210">
        <label>42</label>
        <element-citation publication-type="journal" id="sbref0210">
          <person-group person-group-type="author">
            <name>
              <surname>Henrotin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Priem</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Mobasheri</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis curcumin for osteoarthritis management</article-title>
          <source>Springerplus</source>
          <volume>2</volume>
          <year>2013</year>
        </element-citation>
      </ref>
    </ref-list>
    <ack id="ack0005">
      <title>Acknowledgements</title>
      <p>The authors acknowledge the support of Funda&#xE7;&#xE3;o de Apoio a Pesquisa da Universidade Federal de Goi&#xE1;s (FUNAPE), Fundo de Amparo a Pesquisa do Estado de Goi&#xE1;s (FAPEG), Conselho Nacional de Desenvolvimento Cient&#xED;fico e Tecnol&#xF3;gico (CNPq), Financiadora de Estudos e Projetos (FINEP) and Coordena&#xE7;&#xE3;o de Aperfei&#xE7;oamento de Pessoal de N&#xED;vel Superior (CAPES).</p>
    </ack>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Microb Ecol Health Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Microb. Ecol. Health Dis</journal-id>
      <journal-id journal-id-type="archive">ZMEH</journal-id>
      <journal-id journal-id-type="publisher-id">zmeh20</journal-id>
      <journal-title-group>
        <journal-title>Microbial Ecology in Health and Disease</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0891-060X</issn>
      <issn pub-type="epub">1651-2235</issn>
      <publisher>
        <publisher-name>Taylor &amp; Francis</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28959177</article-id>
      <article-id pub-id-type="pmc">5614383</article-id>
      <article-id pub-id-type="publisher-id">1345574</article-id>
      <article-id pub-id-type="doi">10.1080/16512235.2017.1345574</article-id>
      <article-categories>
        <subj-group subj-group-type="article-type">
          <subject>Original Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ancient permafrost staphylococci carry antibiotic resistance genes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kashuba</surname>
            <given-names>Elena</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001"/>
          <xref ref-type="aff" rid="AFF0002"/>
          <xref ref-type="author-notes" rid="FT0001"/>
          <xref ref-type="corresp" rid="AN0001"/>
          <xref ref-type="bio" rid="B0001"/>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7001-4035</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dmitriev</surname>
            <given-names>Alexey A.</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0003"/>
          <xref ref-type="bio" rid="B0001"/>
          <xref ref-type="author-notes" rid="FT0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kamal</surname>
            <given-names>Shady Mansour</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001"/>
          <xref ref-type="bio" rid="B0001"/>
          <xref ref-type="aff" rid="AFF0004"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Melefors</surname>
            <given-names>Ojar</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001"/>
          <xref ref-type="bio" rid="B0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Griva</surname>
            <given-names>Gennady</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0005"/>
          <xref ref-type="bio" rid="B0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>R&#xF6;mling</surname>
            <given-names>Ute</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001"/>
          <xref ref-type="bio" rid="B0001"/>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3812-6621</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ernberg</surname>
            <given-names>Ingemar</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0001"/>
          <xref ref-type="bio" rid="B0001"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kashuba</surname>
            <given-names>Vladimir</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0006"/>
          <xref ref-type="bio" rid="B0001"/>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9416-8282</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brouchkov</surname>
            <given-names>Anatoli</given-names>
          </name>
          <xref ref-type="aff" rid="AFF0007"/>
          <xref ref-type="bio" rid="B0001"/>
        </contrib>
        <aff id="AFF0001"><label><sup>a</sup></label>
<institution><named-content content-type="department">Department of Microbiology, Tumor and Cell Biology (MTC)</named-content>, <named-content content-type="institution-name">Karolinska Institutet</named-content></institution>, <named-content content-type="city">Stockholm</named-content>, <country>Sweden</country></aff>
        <aff id="AFF0002"><label><sup>b</sup></label>
<institution><named-content content-type="department">Laboratory of Cancer Genetics, R.E. Kavetsky Institute of Experimental Pathology</named-content>, <named-content content-type="institution-name">Oncology and Radiobiology, NASU</named-content></institution>, <named-content content-type="city">Kyiv</named-content>, <country>Ukraine</country></aff>
        <aff id="AFF0003"><label><sup>c</sup></label>
<institution><named-content content-type="department">Engelhardt Institute of Molecular Biology</named-content>, <named-content content-type="institution-name">Russian Academy of Sciences</named-content></institution>, <named-content content-type="city">Moscow</named-content>, <country>Russia</country></aff>
        <aff id="AFF0004"><label><sup>d</sup></label>
<institution><named-content content-type="department">Department of Microbiology and Immunology, Faculty of Pharmaceutical Sciences &amp; Pharmaceutical Industries</named-content>, <named-content content-type="institution-name">Future University in Egypt</named-content></institution>, <named-content content-type="city">New Cairo</named-content>, <country>Egypt</country></aff>
        <aff id="AFF0005"><label><sup>e</sup></label>
<institution><named-content content-type="department">Siberian Branch of RAS</named-content>, <named-content content-type="institution-name">Institute of the Earth Cryosphere</named-content></institution>, <named-content content-type="city">Tyumen</named-content>, <country>Russia</country></aff>
        <aff id="AFF0006"><label><sup>f</sup></label>
<institution><named-content content-type="department">Department of Molecular Oncogenetics</named-content>, <named-content content-type="institution-name">Institute of Molecular Biology and Genetics, NASU</named-content></institution>, <named-content content-type="city">Kyiv</named-content>, <country>Ukraine</country></aff>
        <aff id="AFF0007"><label><sup>g</sup></label>
<institution><named-content content-type="department">Faculty of Geology</named-content>, <named-content content-type="institution-name">Lomonosov Moscow State University</named-content></institution>, <named-content content-type="city">Moscow</named-content>, <country>Russia</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="AN0001">CONTACT Elena Kashuba <email xlink:href="Elena.Kashuba@ki.se">Elena.Kashuba@ki.se</email><institution><named-content content-type="department">Department of Microbiology, Tumor and Cell Biology (MTC)</named-content>, <named-content content-type="institution-name">Karolinska Institutet</named-content></institution>, <named-content content-type="city">Stockholm</named-content>, <country>Sweden</country></corresp>
        <fn id="FT0001">
          <label>*</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>1</month>
        <year>2017</year>
        <!--string-date: 2017-->
      </pub-date>
      <volume>28</volume>
      <issue>1</issue>
      <elocation-id>1345574</elocation-id>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>1</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>6</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2017 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group.</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="16512235.2017.1345574.pdf"/>
      <abstract>
        <title>ABSTRACT</title>
        <p><bold>Background</bold>: Permafrost preserves a variety of viable ancient microorganisms. Some of them can be cultivated after being kept at subzero temperatures for thousands or even millions of years.</p>
        <p><bold>Objective</bold>: To cultivate bacterial strains from permafrost.</p>
        <p><bold>Design</bold>: We isolated and cultivated two bacterial strains from permafrost that was obtained at Mammoth Mountain in Siberia and attributed to the Middle Miocene. Bacterial genomic DNA was sequenced with 40&#x2013;60&#xD7; coverage and high-quality contigs were assembled. The first strain was assigned to <italic>Staphylococcus warneri</italic> species (designated MMP1) and the second one to <italic>Staphylococcus hominis</italic> species (designated MMP2), based on the classification of 16S ribosomal RNA genes and genomic sequences.</p>
        <p><bold>Results</bold>: Genomic sequence analysis revealed the close relation of the isolated ancient bacteria to the modern bacteria of this species. Moreover, several genes associated with resistance to different groups of antibiotics were found in the <italic>S. hominis</italic> MMP2 genome.</p>
        <p><bold>Conclusions</bold>: These findings supports a hypothesis that antibiotic resistance has an ancient origin. The enrichment of cultivated bacterial communities with ancient permafrost strains is essential for the analysis of bacterial evolution and antibiotic resistance.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>KEYWORDS</title>
        <kwd>Permafrost</kwd>
        <kwd>genome sequence</kwd>
        <kwd>evolution</kwd>
        <kwd>antibiotic resistance</kwd>
        <kwd>microbial physiology</kwd>
        <kwd>biofilm</kwd>
        <kwd>
          <italic>Staphylococcus</italic>
        </kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <named-content content-type="funder-name">the Swedish Institute, the Concern Foundation (Los Angeles) and the Cancer Research Institute (New York)</named-content>
          </funding-source>
          <award-id>00743-2010</award-id>
        </award-group>
        <funding-statement>This work was supported by the Swedish Institute, the Concern Foundation (Los Angeles), and the Cancer Research Institute (New York).</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="4"/>
        <ref-count count="47"/>
        <page-count count="9"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p>Psychrotrophs and psychrophiles are microorganisms that can survive or even thrive in cold places [<xref rid="CIT0001">1</xref>,<xref rid="CIT0002">2</xref>]. Investigations of glacier ice at the Vostok station in the Antarctic [<xref rid="CIT0003">3</xref>] and surface snow from the South Pole [<xref rid="CIT0004">4</xref>] revealed that bacteria, fungi, diatoms, and other microorganisms were probably trapped in the snow and remained in the ice for thousands of years. Microbial activity was also found in ice sediments of perennial and permanent lake ice [<xref rid="CIT0005">5</xref>,<xref rid="CIT0006">6</xref>] and in the Antarctic Sea [<xref rid="CIT0007">7</xref>,<xref rid="CIT0008">8</xref>]. Anaerobic microorganisms were isolated from glacier samples in the Arctic [<xref rid="CIT0009">9</xref>,<xref rid="CIT0010">10</xref>] and Greenland [<xref rid="CIT0011">11</xref>].</p>
      <p>Permafrost (permafrost soil) is soil that stays at 5&#x2013;10&#xBA;C below zero for 2&#xA0;years or longer. Most of the permafrost is located in lands close to the North and South Poles. However, some permafrost exists at much lower latitudes. A thin active layer of the soil above the permafrost usually thaws during the summer. The thickness of this active layer varies depending on season and location, but is typically 0.6&#x2013;4.0&#xA0;m. In the northern Lena and Yana River basins in Siberia (Russia), the permafrost depth may be more than 1400&#xA0;m. The structure of permafrost is very stable, with nothing changing for thousands and even millions of years. The permafrost environment is considered extreme because of subzero temperatures and background radiation over geological timescales. The age of permafrost can be proven by its history of freezing, geological conditions, and radioisotope dating [<xref rid="CIT0012">12</xref>,<xref rid="CIT0013">13</xref>].</p>
      <p>Permafrost sediments contain microorganisms [<xref rid="CIT0014">14</xref>&#x2013;<xref rid="CIT0017">17</xref>]. Viable bacterial strains have been isolated from 25,000-year-old ice wedges from Alaska [<xref rid="CIT0012">12</xref>,<xref rid="CIT0018">18</xref>,<xref rid="CIT0019">19</xref>]. These bacteria, which were isolated from the rest of the world for a long period (thousands and millions of years), are invaluable for studies on modern diseases and the evolutionary history of microorganisms.</p>
      <p>Ancient viable microorganisms were claimed to have been be cultured from Dominican amber, considered to be 20&#x2013;40 million years old [<xref rid="CIT0020">20</xref>]. In our previous collaborative work, viable bacteria were obtained from permafrost of the Mammoth Mountain, Siberia, aged 40,000 to 4 million years depending on the sampling depth [<xref rid="CIT0013">13</xref>,<xref rid="CIT0016">16</xref>,<xref rid="CIT0021">21</xref>]. Moreover, the genomic DNA of one strain of bacteria, identified as <italic>Bacillus cereus</italic>, was isolated and sequenced [<xref rid="CIT0022">22</xref>].</p>
      <p>In the present work, we aimed to enrich the number of viable bacteria from permafrost, study their morphology, and analyze the genomic sequences.</p>
    </sec>
    <sec id="S0002">
      <title>Material and methods</title>
      <sec id="S0002-S2001">
        <title>Permafrost samples and microorganism cultivation</title>
        <p>In this article, we describe bacterial strains isolated from permafrost in the River Lena region in Central Yakutia, Russia. According to the composition of seeds, pollen, and leaves, this permafrost is of Middle Miocene, and thus the permafrost may be up to 3.5 million years old [<xref rid="CIT0021">21</xref>]. Permafrost samples were taken from an exposure, due to river erosion, on the Mammoth Mountain on the Aldan River, as described in detail previously [<xref rid="CIT0021">21</xref>].</p>
        <p>In brief, permafrost samples were taken in July 2009 at a depth of about 50&#xA0;m below the surface and below the active layer of 1&#xA0;m. Samples of the frozen soil were cut with a handsaw or a circular saw and preserved at a temperature of about &#x2212;15&#xB0;C. Permafrost was kept frozen until delivery to the laboratory at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet (MTC). Collected material (approximately 10&#xA0;cm<sup>3</sup>) was kept at &#x2212;20&#xB0;C at MTC. Smaller blocks of permafrost were cut out using a sterile handsaw at &#x2212;20&#xB0;C (in the freeze room at MTC). These blocks were fragmented under sterile conditions using a sterile hammer. Small portions of still-frozen soil were drilled out of the bigger block in a laminar flow cabinet, after sterilization of the cabinet by an ultraviolet-C germicidal lamp for 15&#xA0;min. These samples were bathed in 90% ethanol and put in Lauri&#x2013;Bertani (LB) medium (about 6&#xA0;g of soil in 5&#xA0;ml of LB medium). A suspension possibly containing microorganisms was plated on a large (14.5&#xA0;cm diameter) Petri dish with rich yeast extract peptone dextrose (YPD) medium without glucose. Two LB plates with no suspension were used as a negative control. Plates were incubated at 37&#xB0;C. Two different colonies were isolated on 18 January 2010. Both strains were cultured individually, on agar plates and in liquid LB medium supplemented with glucose (2% w/v). No colonies were observed on the control plates.</p>
      </sec>
      <sec id="S0002-S2002">
        <title>Transmission electron microscopy</title>
        <p>Cells were grown in tryptic soy broth (TSB) at 37&#xB0;C overnight. Fixation was achieved in a mixture of 2% glutaraldehyde and 1% formaldehyde in 0.1&#xA0;M phosphate-buffered saline (PBS), pH 7.4, at room temperature and stored at +4&#xBA;C. After fixation, cells were rinsed in 0.1&#xA0;M PBS and centrifuged. The pellets were then post-fixed in 2% osmium tetroxide (TAAB, Aldermaston, UK) solution in 0.1&#xA0;M PBS at 4&#xB0;C for 2&#xA0;h, dehydrated in ethanol followed by acetone, and embedded in LX-112 (Ladd, Williston, VT, USA). The ultrathin sections (approximately 50&#x2013;60&#xA0;nm) were cut by a Leica Ultracut UCT (Leica, Vienna, Austria). Sections were contrasted with uranyl acetate followed by lead citrate and examined in a Hitachi HT 7700 (Hitachi, Tokyo, Japan) at 80&#xA0;kV. Digital images were taken with a Veleta camera (Olympus Soft Imaging Solutions, M&#xFC;nster, Germany).</p>
      </sec>
      <sec id="S0002-S2003">
        <title>Biofilm formation</title>
        <p>The ability of bacteria to form biofilms was assessed on Congo red (CR) agar, as described previously [<xref rid="CIT0023">23</xref>]. In brief, bacterial strains were grown in TSB medium overnight. For all strains, the cell density was adjusted to optical density (OD)&#xA0;=&#xA0;1 and 10&#xA0;&#x3BC;l of cell suspension was plated on a CR agar plate (3% TSB, 0.75% glucose, 0.008% CR dye, and 1% agar). Cells were grown at 37&#xB0;C for 17&#xA0;h. The black color of the grown colony indicates biofilm formation, while a reddish or pinkish color indicates no or less biofilm. For the quantitative studies on biofilms, experiments were performed as described previously [<xref rid="CIT0024">24</xref>]. In brief, strains were grown overnight in TSB and diluted to an OD of 0.01 in TSB the next morning. For each strain, 200&#xA0;&#x3BC;l of the diluted culture was loaded into 16 wells of a flat-bottomed 96-well microtiter plate (TPP, Trasadingen, Switzerland). Following 24&#xA0;h of incubation at 37&#xB0;C, the cell density was measured at <italic>&#x3BB;</italic>&#xA0;=&#xA0;595&#xA0;nm. Wells were carefully emptied and washed with the physiological saline. Biofilm attached to the wells was stained with 250&#xA0;&#x3BC;l of 0.4% crystal violet (CV) for 10&#xA0;min. After removing CV and washing, the dye was dissolved in 250&#xA0;&#x3BC;l of 30% acetic acid, and absorbance at <italic>&#x3BB;</italic>&#xA0;=&#xA0;595&#xA0;nm was measured. Relative biofilm formation was calculated as the ratio of the absorbance of the CV-stained biofilm matrix to the cell density at &#x3BB;&#xA0;=&#xA0;595&#xA0;nm.</p>
      </sec>
      <sec id="S0002-S2004">
        <title>Genomic sequencing</title>
        <p>Bacterial genomic DNA was isolated from liquid cultures originating from a single colony using a PowerSoil&#xAE; DNA Isolation Kit (MO BIO Labs, Carlsbad, CA, USA) on 15 February 2010. The quality and concentration of the extracted DNA was verified using a NanoDrop&#x2122; spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) and by electrophoresis in the 0.8% agarose gel.</p>
        <p>Next, 500&#xA0;ng of DNA from each strain was used for Roche 454 library preparation according to the manufacturer&#x2019;s protocol (<ext-link ext-link-type="uri" xlink:href="http://www.454.com">www.454.com</ext-link>) and sequenced in one or two lanes of a four-region FLX Titanium picotiter plate on a Roche 454 FLX instrument (Roche, Basel, Switzerland).</p>
      </sec>
      <sec id="S0002-S2005">
        <title>Sequence assembly</title>
        <p>Genome <italic>de novo</italic> assembly was performed using a Roche GS De Novo Assembler (version 2.7) with default parameters. Alignments to reference genomes were performed with a Roche GS Reference Mapper (version 2.7) with default parameters.</p>
      </sec>
      <sec id="S0002-S2006">
        <title>Classification</title>
        <p>The 16S ribosomal RNA (rRNA) genes were classified using SINA Alignment Service version 1.2.11 [<xref rid="CIT0025">25</xref>] with default parameters. NCBI Microbial Nucleotide BLAST [<xref rid="CIT0026">26</xref>] with <italic>de novo</italic> assembled contigs, database of draft genomes, and the Megablast algorithm was also applied.</p>
      </sec>
      <sec id="S0002-S2007">
        <title>Genome annotation</title>
        <p>Genome annotation was performed using NCBI Prokaryotic Genome Automatic Annotation Pipeline (PGAAP) [<xref rid="CIT0027">27</xref>]. Plasmid sequences were identified with PlasmidFinder version 1.3 [<xref rid="CIT0028">28</xref>]. The identity threshold was set to 85%.</p>
      </sec>
      <sec id="S0002-S2008">
        <title>Phylogenetic analysis</title>
        <p>We used MEGA version 6.06 [<xref rid="CIT0029">29</xref>] and maximum likelihood method with default parameters for phylogenetic tree building on the basis of 16S rRNA sequences. Known 16S rRNA sequences were obtained from the SILVA database [<xref rid="CIT0030">30</xref>]. The MUSCLE algorithm was applied for sequence alignment. Bootstrap values were calculated based on 1000 replications.</p>
      </sec>
      <sec id="S0002-S2009">
        <title>Detection of antibiotic resistance and virulence genes</title>
        <p>The search for antibiotic resistance and virulence genes was performed with ResFinder version 2.1 [<xref rid="CIT0031">31</xref>] and VirulenceFinder version 1.5 [<xref rid="CIT0032">32</xref>] web services. The identity threshold was set to 85% and the minimum length to 40% for both tools.</p>
      </sec>
    </sec>
    <sec id="S0003">
      <title>Results</title>
      <sec id="S0003-S2001">
        <title>Phenotype characteristics</title>
        <p>The novel strains of microorganisms, which were called MMP1 (Mammoth Mountain Permafrost 1) and MMP2 (Mammoth Mountain Permafrost 2), showed an ability to proliferate under ordinary culturing conditions, both on agar plates and in liquid LB medium. On LB agar plates, both strains produced opaque colonies, which were slightly rough and had wavy edges. MMP1 and MMP2 displayed as whitish to yellowish smooth round colonies on tryptic soy agar (TSA) plates (<xref rid="F0001">Figure 1</xref>). Cultivation was carried out at 37&#xB0;C and with intensive aeration (shaking) to reach the logarithmic phase of growth. The cultures were maintained by reseeding on agar plates and were also stored with glycerol (40%) at &#x2212;80&#xB0;C.<fig id="F0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Morphology of colonies on tryptic soy agar plates. Mammoth Mountain Permafrost 1 (MMP1, <italic>Staphylococcus warneri</italic>) and MMP2 (<italic>Staphylococcus hominis</italic>) display as whitish to yellowish smooth round colonies.</p></caption><graphic content-type="color" xlink:href="ZMEH_A_1345574_F0001_C"/></fig></p>
        <p>MMP1 cells had a smooth surface and the majority of the cell population showed a fully formed septum (<xref rid="F0002">Figure 2(a</xref>)). MMP2 had an irregular cell surface and few cells formed the septum (<xref rid="F0002">Figure 2(b</xref>)), as shown by ultrastructural analysis of bacteria grown up to the stationary phase by TEM.<fig id="F0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Ultrastructural analysis by thin-section transmission electron microscopy from cells in the stationary phase. (A) Mammoth Mountain Permafrost 1 (MMP1, <italic>Staphylococcus warneri</italic>) cells have a smooth surface and the majority of the cell population shows a fully formed septum (having just divided). (B) MMP2 (<italic>Staphylococcus hominis</italic>) cells have an irregular cell surface and few cells have formed a septum.</p></caption><graphic content-type="black-white" xlink:href="ZMEH_A_1345574_F0002_B"/></fig></p>
      </sec>
      <sec id="S0003-S2002">
        <title>Biofilm formation</title>
        <p>To assess the ability of ancient bacteria to form biofilm, MMP1 and MMP2 were grown on CR plates. For MMP1, the formation of the reddish smooth colonies was observed (<xref rid="F0003">Figure 3(a</xref>)), indicating biofilm formation. MMP2 showed a greater ability to form biofilms, as can be concluded from the appearance of the black rough colonies (<xref rid="F0003">Figure 3</xref>). Bacterial strains which had previously been characterized for their biofilm formation capacity, i.e. <italic>Staphylococcus aureus SC08</italic> and <italic>S. epidermidis ATCC 12228</italic> [<xref rid="CIT0033">33</xref>], served as the positive and negative controls, respectively.<fig id="F0003" fig-type="figure" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Mammoth Mountain Permafrost 1 (MMP1, <italic>Staphylococcus warneri</italic>) and MMP2 (<italic>Staphylococcus hominis</italic>) can form biofilms. (A) Colony morphology of bacteria on Congo red agar plates. The reddish smooth colony morphology of MMP1 indicates less biofilm formation; the black rough colony of MMP2 indicates high biofilm formation. <italic>Staphylococcus aureus SC08</italic> and <italic>S. epidermidis ATCC 12228</italic> are positive and negative controls, respectively. (B) Quantitative assay on biofilm formation in 96-well plates. Relative biofilm formation shows that MMP1 forms less biofilm than MMP2 (<italic>p</italic>&#xA0;&lt;&#xA0;0.05). <italic>Staphylococcus aureus SC08</italic> and <italic>S. epidermidis ATCC 12228</italic> are positive and negative controls, respectively. OD, optical density.</p></caption><graphic content-type="color" xlink:href="ZMEH_A_1345574_F0003_C"/></fig></p>
        <p>These data were confirmed by a relative biofilm formation assay in 96-well plates (<xref rid="F0003">Figure 3(b</xref>)). MMP1 formed less biofilm than MMP2, and this difference was statistically significant (<italic>p</italic>&#xA0;&lt;&#xA0;0.05).</p>
      </sec>
      <sec id="S0003-S2003">
        <title>Sequencing data on the ancient strains</title>
        <p>For the ancient strain MMP1, 421.5&#xA0;k reads with average length of 361 bases were obtained. The reads were assembled in 56 contigs (35 large ones) with total length equal to 2.44&#xA0;M bases. The sequencing coverage was about 60&#xD7;. For the ancient strain MMP2, 272.8&#xA0;k reads with an average length of 323 bases were obtained. The reads were assembled in 84 contigs (65 large ones) with total length equal to 2.21&#xA0;M bases. Hence, the sequencing coverage was about 40&#xD7;. The N50 value was 171.3&#xA0;k bases for strain MMP1 and 92.5&#xA0;k bases for strain MMP2, indicating that the assemblies were of a high quality. The detailed information is presented in <xref rid="T0001">Table 1</xref>.<table-wrap id="T0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Summary of <italic>de novo</italic> assembly of the two ancient strains.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="center"/><col width="1*" align="center"/></colgroup><thead><tr><th align="left">Feature</th><th align="center">Strain MMP1</th><th align="center">Strain MMP2</th></tr></thead><tbody><tr><td align="left">Total reads</td><td align="center">421,504</td><td align="center">272,754</td></tr><tr><td align="left">Total bases</td><td align="center">152,337,898</td><td align="center">88,093,644</td></tr><tr><td align="left">Average read length</td><td align="center">361</td><td align="center">323</td></tr><tr><td align="left">Aligned reads</td><td align="center">416,749 (98.9%)</td><td align="center">270,165 (99.1%)</td></tr><tr><td align="left">Aligned bases</td><td align="center">150,511,972 (98.8%)</td><td align="center">87,169,378 (99.0%)</td></tr><tr><td align="left">Large contigs</td><td align="center">35</td><td align="center">65</td></tr><tr><td align="left">Bases in large contigs</td><td align="center">2,438,922</td><td align="center">2,205,320</td></tr><tr><td align="left">All contigs</td><td align="center">56</td><td align="center">84</td></tr><tr><td align="left">Bases in all contigs</td><td align="center">2,442,906</td><td align="center">2,209,742</td></tr><tr><td align="left">N50</td><td align="center">171,280</td><td align="center">92,490</td></tr><tr><td align="left">L50</td><td align="center">4</td><td align="center">8</td></tr><tr><td align="left">Sequencing coverage</td><td align="center">~&#xA0;60&#xD7;</td><td align="center">~&#xA0;40&#xD7;</td></tr></tbody></table><table-wrap-foot><fn><p>MMP1, Mammoth Mountain Permafrost 1; MMP2, Mammoth Mountain Permafrost 2.</p></fn></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="S0003-S2004">
        <title>Classification</title>
        <p>Contigs containing 16S rRNA genes of the ancient strains were found using NCBI BLAST: #27 (1619 bases) for MMP1 and #59 (1541 bases) for MMP2. Based on 16S rRNA gene sequences, both bacteria were classified by SINA as being of genus <italic>Staphylococcus</italic>. The nearest neighbors for strain MMP1 were strains of <italic>S. warneri</italic> and <italic>S. pasteuri</italic> species (<italic>S. warneri</italic> group), and the nearest neighbors for strain MMP2 were strains of <italic>S. haemolyticus</italic> and <italic>S. hominis</italic> species (<italic>S. haemolyticus</italic> group). The same results were obtained using the <italic>de novo</italic> assembled contigs and NCBI Microbial Nucleotide BLAST through <italic>Staphylococcus</italic> group (taxid: 90964). To determine the species of the examined strains more precisely, the raw reads of strain MMP1 were aligned to NCBI representative genomes <italic>S. warneri</italic> SG1 and <italic>S. pasteuri</italic> SP1. The same procedure was performed for strain MMP2 and NCBI representative genomes <italic>S. hominis</italic> subsp. <italic>hominis</italic> C80 and <italic>S. haemolyticus</italic> JCSC1435. All representative genomes are complete genomes, except for <italic>S. hominis</italic> subsp. <italic>hominis</italic> C80, which is a scaffold. The results of the mapping are summarized in <xref rid="T0002">Table 2</xref>.<table-wrap id="T0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Summary of reference mapping for the two ancient <italic>Staphylococcus</italic> (<italic>S</italic>.) strains.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/></colgroup><thead><tr><th align="left">&#xA0;</th><th colspan="2" align="center"><italic>S</italic>. strain MMP1<hr/></th><th colspan="2" align="center"><italic>S</italic>. strain MMP2<hr/></th></tr><tr><th align="left">Feature</th><th align="center"><italic>S. warneri</italic> SG1</th><th align="center"><italic>S. pasteuri</italic> SP1</th><th align="center"><italic>S. hominis</italic> subsp. <italic>hominis</italic> C80</th><th align="center"><italic>S. haemolyticus</italic> JCSC1435</th></tr></thead><tbody><tr><td align="left">Mapped reads</td><td align="center">397,917 (94.4%)</td><td align="center">377,756 (89.6%)</td><td align="center">235,160 (86.2%)</td><td align="center">108,373 (39.7%)</td></tr><tr><td align="left">Mapped bases</td><td align="center">142,222,185 (93.4%)</td><td align="center">134,746,471 (88.5%)</td><td align="center">75,170,689 (85.3%)</td><td align="center">16,664,461 (18.9%)</td></tr><tr><td align="left">Large contigs</td><td align="center">53</td><td align="center">156</td><td align="center">107</td><td align="center">152</td></tr><tr><td align="left">Bases in large contigs</td><td align="center">2,315,018</td><td align="center">2,252,460</td><td align="center">2,018,054</td><td align="center">171,102</td></tr><tr><td align="left">All contigs</td><td align="center">66</td><td align="center">212</td><td align="center">161</td><td align="center">1563</td></tr><tr><td align="left">Bases in all contigs</td><td align="center">2,318,257</td><td align="center">2,266,066</td><td align="center">2,030,477</td><td align="center">435,147</td></tr><tr><td align="left">N50</td><td align="center">113,255</td><td align="center">27,262</td><td align="center">38,136</td><td align="center">1,208</td></tr></tbody></table><table-wrap-foot><fn><p>MMP1, Mammoth Mountain Permafrost 1; MMP2, Mammoth Mountain Permafrost 2.</p></fn></table-wrap-foot></table-wrap></p>
        <p>As seen from <xref rid="T0002">Table 2</xref>, strain MMP1 showed a significantly higher similarity to the reference <italic>S. warneri</italic> SG1 compared to <italic>S. pasteuri</italic> SP1 (93.4% vs 88.5% of reads were mapped), and strain MMP2 showed a significantly higher similarity to reference <italic>S. hominis</italic>subsp. <italic>hominis</italic> C80 compared to <italic>S. haemolyticus</italic> JCSC1435 (85.3% vs 18.9%). Thus, ancient <italic>Staphylococcus</italic> strains MMP1 and MMP2 were assigned to <italic>S. warneri</italic> and <italic>S. hominis</italic> species, respectively [<xref rid="CIT0034">34</xref>]. A phylogenetic tree was built including several known <italic>S. warneri</italic>, <italic>S. pasteuri</italic>, <italic>S. hominis</italic>, and <italic>S. haemolyticus</italic> strains, and the two examined ancient strains, on the basis of 16S rRNA sequences (<xref rid="F0004">Figure 4</xref>). The ancient strains revealed close relations to the modern ones within species.<fig id="F0004" fig-type="figure" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Phylogenetic tree based on 16S ribosomal RNA gene sequences of ancient and modern <italic>Staphylococcus</italic> strains. The ancient strains are marked by arrows. The maximum likelihood method was used for the phylogenetic analysis. Bootstrap values are shown next to the branches. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. All positions containing gaps and missing data were eliminated. There were 1169 positions in total in the final data set.</p></caption><graphic content-type="black-white" xlink:href="ZMEH_A_1345574_F0004_B"/></fig></p>
      </sec>
      <sec id="S0003-S2005">
        <title>Annotation</title>
        <p>Two contigs (#23: 4058 bases; and #24: 4946 bases) from <italic>S. warneri</italic> MMP1 genome and three contigs (#51: 2458 bases; #53: 2908 bases; and #54: 2458 bases) from <italic>S. hominis</italic> MMP2 genome were recognized as plasmids by PlasmidFinder. An additional alignment test showed that all five plasmids were complete and circular.</p>
        <p>The genome annotation results obtained by NCBI PGAAP indicate a close relation of features of ancient <italic>Staphylococcus</italic> strains to those of modern reference strains (<xref rid="T0003">Table 3</xref>).<table-wrap id="T0003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Annotation of <italic>Staphylococcus</italic> (<italic>S</italic>.) strains.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="char" char="."/><col width="1*" align="char" char="."/><col width="1*" align="char" char="."/><col width="1*" align="char" char="."/><col width="1*" align="char" char="."/><col width="1*" align="char" char="."/></colgroup><thead><tr><th align="left">Feature</th><th align="center" char="."><italic>S. warn</italic>. MMP1</th><th align="center" char="."><italic>S. warn</italic>. SG1</th><th align="center" char="."><italic>S. past</italic>. SP1</th><th align="center" char="."><italic>S. hom</italic>. MMP2</th><th align="center" char="."><italic>S. hom</italic>. C80</th><th align="center" char="."><italic>S. haem</italic>. JCSC1435</th></tr></thead><tbody><tr><td align="left">Genome length (Mb)</td><td align="char" char=".">2.44</td><td align="char" char=".">2.49</td><td align="char" char=".">2.56</td><td align="char" char=".">2.21</td><td align="char" char=".">2.27</td><td align="char" char=".">2.69</td></tr><tr><td align="left">G+C content</td><td align="char" char=".">32.5</td><td align="char" char=".">32.7</td><td align="char" char=".">32.7</td><td align="char" char=".">31.3</td><td align="char" char=".">31.3</td><td align="char" char=".">32.8</td></tr><tr><td align="left">Gene count</td><td align="char" char=".">2375</td><td align="char" char=".">2381</td><td align="char" char=".">2470</td><td align="char" char=".">2193</td><td align="char" char=".">2255</td><td align="char" char=".">2580</td></tr><tr><td align="left">Protein count</td><td align="char" char=".">2252</td><td align="char" char=".">2285</td><td align="char" char=".">2377</td><td align="char" char=".">2070</td><td align="char" char=".">2128</td><td align="char" char=".">2457</td></tr><tr><td align="left">rRNA</td><td align="center" char=".">4</td><td align="center" char=".">16</td><td align="center" char=".">16</td><td align="center" char=".">6</td><td align="center" char=".">21</td><td align="center" char=".">16</td></tr><tr><td align="left">tRNA</td><td align="center" char=".">59</td><td align="center" char=".">58</td><td align="center" char=".">46</td><td align="center" char=".">57</td><td align="center" char=".">58</td><td align="center" char=".">60</td></tr><tr><td align="left">Pseudogene</td><td align="center" char=".">60</td><td align="center" char=".">22</td><td align="center" char=".">31</td><td align="center" char=".">60</td><td align="center" char=".">48</td><td align="center" char=".">47</td></tr></tbody></table><table-wrap-foot><fn><p><italic>S. warn., Staphylococcus warneri; S. past., S. pasteuri; S. hom., S. hominis; S. haem., S. haemolyticus</italic>; MMP1, Mammoth Mountain Permafrost 1; MMP2, Mammoth Mountain Permafrost 2; G+C, guanine and cytosine; rRNA, ribosomal RNA; tRNA, transfer RNA.</p></fn></table-wrap-foot></table-wrap></p>
        <p>Whole Genome Shotgun projects have been deposited at DDBJ/EMBL/GenBank: LNVI00000000 for MMP1 and LNTW00000000 for MMP2. The versions described in this article are LNVI01000000 (MMP1) and LNTW01000000 (MMP2).</p>
      </sec>
      <sec id="S0003-S2006">
        <title>Antibiotic resistance and virulence genes</title>
        <p>Staphylococci are known to be resistant to different groups of antibiotics [<xref rid="CIT0035">35</xref>]. The ancient strains were tested for genes, the presence of which is known to be associated with antibiotic resistance, using ResFinder. <italic>Staphylococcus warneri</italic> MMP1 showed no resistance genes and <italic>S. hominis</italic> MMP2 possessed multiple genes associated with resistance to aminoglycoside, beta-lactam, MLS (macrolide, lincosamide, and streptogramin B), and phenicol antibiotic groups (<xref rid="T0004">Table 4</xref>). All identified genes showed at least 99% identity and 100% length query (except for the <italic>blaZ</italic> gene and <italic>S. hominis</italic> MMP2, with 96% identity and 100% length query).<table-wrap id="T0004" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Patterns of resistance genes in <italic>Staphylococcus</italic> (<italic>S</italic>.) strains.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="left"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/><col width="1*" align="center"/></colgroup><thead><tr><th align="left">Antibiotic group</th><th align="center">Resistance genes</th><th align="center"><italic>S. warn</italic>. MMP1</th><th align="center"><italic>S. warn</italic>. SG1</th><th align="center"><italic>S. past</italic>. SP1</th><th align="center"><italic>S. hom</italic>. MMP2</th><th align="center"><italic>S. hom</italic>. C80</th><th align="center"><italic>S. haem</italic>. JCSC1435</th></tr></thead><tbody><tr><td rowspan="3" align="left">Aminoglycoside</td><td align="left"><italic>aac(6</italic>&#x2019;<italic>)/aph(2</italic>&#x201D;)</td><td align="left">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">+</td></tr><tr><td align="left"><italic>aph(3</italic>&#x2019;<italic>)-III</italic></td><td align="left">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td></tr><tr><td align="left"><italic>ant(6)-Ia</italic></td><td align="left">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td></tr><tr><td rowspan="2" align="left">Beta-lactam</td><td align="left"><italic>blaZ</italic></td><td align="left">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td><td align="center">+</td></tr><tr><td align="left"><italic>mecA</italic></td><td align="left">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">+</td></tr><tr><td align="left">Fosfomycin</td><td align="left"><italic>fosB</italic></td><td align="left">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">+</td></tr><tr><td align="left">Fusidic acid</td><td align="left"><italic>fusB</italic></td><td align="left">&#xA0;</td><td align="center">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td></tr><tr><td align="left">MLS</td><td align="left"><italic>msr(A)</italic></td><td align="left">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">+</td><td align="center">+</td><td align="center">+</td></tr><tr><td rowspan="2" align="left">Macrolide</td><td align="left"><italic>erm(C)</italic></td><td align="left">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">+</td></tr><tr><td align="left"><italic>mph(C)</italic></td><td align="left">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td><td align="center">+</td></tr><tr><td align="left">Phenicol</td><td align="left"><italic>cat(pC194)</italic></td><td align="left">&#xA0;</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td><td align="center">+</td><td align="center">&#xA0;</td><td align="center">&#xA0;</td></tr></tbody></table><table-wrap-foot><fn><p>Genomic DNA of Mammoth Mountain Permafrost 1 (MMP1) and Mammoth Mountain Permafrost 2 (MMP2) strains was isolated on 15 February 2010.</p></fn><fn><p><italic>S. warn., Staphylococcus warneri; S. past., S. pasteuri; S. hom., S. hominis; S. haem., S. haemolyticus</italic>; MMP1, Mammoth Mountain Permafrost 1; MLS, macrolide, lincosamide, and streptogramin B.</p></fn></table-wrap-foot></table-wrap></p>
        <p>Some <italic>Staphylococcus</italic> species are known to be pathogenic [<xref rid="CIT0036">36</xref>]. We examined the <italic>Staphylococcus</italic> strains using VirulenceFinder and no virulence genes were identified in either the representative or the ancient genomes.</p>
      </sec>
    </sec>
    <sec id="S0004">
      <title>Discussion</title>
      <p>It used to be thought that microorganisms present in the permafrost were mostly in a dormant or dead state. However, there is a growing body of evidence that various microorganisms isolated from permafrost and glacier ice are capable of growing, i.e. they show metabolic activity. Hence, permafrost may contain a vast number of viable microorganisms that may have a tremendous impact on a biosphere. Studies on permafrost microbial communities may lead to potentially important biotechnological applications, such as cold-tolerant enzymes [<xref rid="CIT0037">37</xref>].</p>
      <p>A significant number of viable microorganisms from permafrost has been isolated from several Arctic and Antarctic sites. These include aerobic heterotrophs, and nitrogen-fixing, sulfur-oxidizing, sulfur-reducing, and anaerobic bacteria. These microorganisms are psychrotrophic, mesophilic, and thermophilic. For example, aerobic heterotrophic plate counts were detected in 192 out of 220 samples (87%) from nine Siberian permafrost collections [<xref rid="CIT0038">38</xref>].</p>
      <p>The 16S rRNA from a number of permafrost microorganisms has been amplified and sequenced. Members of three major lineages were found: Gammaproteobacteria (mostly Xanthomonadaceae), Actinobacteria, and Firmicutes. The bacteria also included Actinomycetales (Arthrobacter and Microbacteriaceae), followed by Firmicutes (<italic>Exiguobacterium</italic> and <italic>Planomicrobium</italic>), Bacteroidetes (<italic>Flavobacterium</italic>), Gammaproteobacteria (<italic>Psychrobacter</italic>), and Alphaproteobacteria (<italic>Sphingomonas</italic>). Both culture and culture-independent approaches showed the presence of high and low guanine and cytosine (G+C)-content Gram-positive bacteria and <italic>Gammaproteobacteria</italic> [<xref rid="CIT0015">15</xref>,<xref rid="CIT0039">39</xref>].</p>
      <p>Some of the 16S rRNA gene sequences of environmental clones matched those of <italic>Arthrobacter</italic> isolates. Two-thirds of the isolates grew at &#x2212;2.5&#xB0;C, indicating that they are psychroactive, and all are closely related to phylogenetic groups with strains from other cold environments, most commonly from Antarctica. The culturable and non-culturable microorganisms found in the terrestrial permafrost provide a prototype for possible life on the cryogenic planets of the Solar System [<xref rid="CIT0017">17</xref>,<xref rid="CIT0040">40</xref>].</p>
      <p>The ability to recover viable bacteria from permafrost depends strongly on the age of the permafrost. The number and variety of microorganisms diminish with the increasing age of the permafrost. There is probably an upper time limit to the viability of microorganisms [<xref rid="CIT0021">21</xref>].</p>
      <p>In the present paper, we report on the isolation and culturing of two ancient <italic>Staphylococcus</italic> strains, named MMP1 and MMP2. Genomes of the ancient bacteria were sequenced (with coverage of 40&#x2013;60&#xD7;) and annotated. Analysis of the sequences allowed us to classify the examined bacteria as <italic>S. warneri</italic> MMP1 and <italic>S. hominis</italic> MMP2.</p>
      <p>Both 16S rRNA and whole genome analyses of the ancient <italic>Staphylococcus</italic> strains indicated their close genetic affinity with today&#x2019;s <italic>Staphylococcus</italic> isolates. <italic>Staphylococcus</italic> MMP1 and <italic>S</italic>. MMP2 16S rRNAs were assigned to branches with modern ones within the species and 86&#x2013;94% of reads obtained for the ancient strains were successfully mapped to appropriate representative genomes. A previous study showed that 2.3- and 1.8-billion-year-old deep-sea mud-inhabiting sulfur-cycling microbial communities were essentially identical and, furthermore, they were identical to the modern microbial biotas discovered off the coast of South America [<xref rid="CIT0041">41</xref>].</p>
      <p>Many genes and gene mutations are known to be associated with bacterial pathogenicity or antibiotic resistance [<xref rid="CIT0042">42</xref>,<xref rid="CIT0043">43</xref>]. We performed a search for such genes in the examined ancient strains to elucidate whether these genes were present in <italic>Staphylococcus</italic> genomes 3 million years ago.</p>
      <p><italic>Staphylococcus</italic> species are divergent in their pathogenicity [<xref rid="CIT0036">36</xref>], and within species, patterns of virulence genes can be drastically different [<xref rid="CIT0044">44</xref>]. It is known that <italic>S. warneri</italic> and <italic>S. hominis</italic> species are not pathogenic [<xref rid="CIT0036">36</xref>] and we showed that this was also likely to be true 3 million years ago, as no virulence genes were identified in either of these ancient <italic>Staphylococcus</italic> strains.</p>
      <p>As well as patterns of virulence genes, patterns of antibiotic resistance genes vary from strain to strain [<xref rid="CIT0045">45</xref>]. For <italic>S. warneri</italic> MMP1, no resistance genes were observed. However, for <italic>S. hominis</italic> MMP2, multiple genes associated with resistance to different groups of antibiotics were identified. It has been shown that 30,000-year-old bacteria also contained antibiotic resistance genes in their genomes [<xref rid="CIT0046">46</xref>], and evidence has been presented in support of this finding [<xref rid="CIT0047">47</xref>]. Our results strengthen the hypothesis that antibiotic resistance is an ancient feature.</p>
    </sec>
  </body>
  <back>
    <bio id="B0001">
      <p>EK, GG, VK, UR, and AB conceived and designed the work; EK, SMK, OM, GG, VK, and AB performed the experiments; EK, AD, OM, IE, SMK, UR, and VK analyzed the data; and EK and AD drafted the work. All authors revised the work critically for important intellectual content, approved the version to be published, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>
    </bio>
    <sec id="S0005">
      <title>Disclosure statement</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>[1]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansson</surname><given-names>JK</given-names></name>, <name><surname>Ta&#x15F;</surname><given-names>N.</given-names></name></person-group><article-title>The microbial ecology of permafrost</article-title>. <source>Nat Rev Microbiol</source>. <year>2014</year>;<volume>12</volume>:<fpage>414</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">24814065</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0002">
        <label>[2]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikrad</surname><given-names>MP</given-names></name>, <name><surname>Kerkhof</surname><given-names>LJ</given-names></name>, <name><surname>H&#xE4;ggblom</surname><given-names>MM</given-names></name></person-group>
<article-title>The subzero microbiome: microbial activity in frozen and thawing soils</article-title>. <source>FEMS Microbiol Ecol</source>. <year>2016</year>;<volume>92</volume>:<fpage>fiw081</fpage>.<pub-id pub-id-type="pmid">27106051</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0003">
        <label>[3]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abyzov</surname><given-names>SS</given-names></name>, <name><surname>Mitskevich</surname><given-names>IN</given-names></name>, <name><surname>Poglazova</surname><given-names>MN</given-names></name>, et al</person-group>
<article-title>Microflora in the basal strata at Antarctic ice core above the Vostok lake</article-title>. <source>Adv Space Res</source>. <year>2001</year>;<volume>28</volume>:<fpage>701</fpage>&#x2013;<lpage>706</lpage>.<pub-id pub-id-type="pmid">11803975</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0004">
        <label>[4]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>EJ</given-names></name>, <name><surname>Lin</surname><given-names>S</given-names></name>, <name><surname>Capone</surname><given-names>DG</given-names></name></person-group>
<article-title>Bacterial activity in South Pole snow</article-title>. <source>Appl Environ Microbiol</source>. <year>2000</year>;<volume>66</volume>:<fpage>4514</fpage>&#x2013;<lpage>4517</lpage>.<pub-id pub-id-type="pmid">11010907</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0005">
        <label>[5]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pernthaler</surname><given-names>J</given-names></name>, <name><surname>Glockner</surname><given-names>FO</given-names></name>, <name><surname>Unterholzner</surname><given-names>S</given-names></name>, et al</person-group>
<article-title>Seasonal community and population dynamics of pelagic bacteria and archaea in a high mountain lake</article-title>. <source>Appl Environ Microbiol</source>. <year>1998</year>;<volume>64</volume>:<fpage>4299</fpage>&#x2013;<lpage>4306</lpage>.<pub-id pub-id-type="pmid">9797280</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0006">
        <label>[6]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Psenner</surname><given-names>R</given-names></name>, <name><surname>Sattler</surname><given-names>B</given-names></name></person-group>
<article-title>Life at the freezing point</article-title>. <source>Science</source>. <year>1998</year>;<volume>280</volume>:<fpage>2073</fpage>&#x2013;<lpage>2074</lpage>.<pub-id pub-id-type="pmid">9669962</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0007">
        <label>[7]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>JP</given-names></name>, <name><surname>McCammon</surname><given-names>SA</given-names></name>, <name><surname>Brown</surname><given-names>MV</given-names></name>, et al</person-group>
<article-title>Diversity and association of psychrophilic bacteria in Antarctic sea ice</article-title>. <source>Appl Environ Microbiol</source>. <year>1997</year>;<volume>63</volume>:<fpage>3068</fpage>&#x2013;<lpage>3078</lpage>.<pub-id pub-id-type="pmid">9251193</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0008">
        <label>[8]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>JP</given-names></name>, <name><surname>Nichols</surname><given-names>DS</given-names></name></person-group>
<article-title>Novel members of the family Flavobacteriaceae from Antarctic maritime habitats including Subsaximicrobium wynnwilliamsii gen. nov., sp. nov., Subsaximicrobium saxinquilinus sp. nov., Subsaxibacter broadyi gen. nov., sp. nov., Lacinutrix copepodicola gen. nov., sp. nov., and novel species of the genera Bizionia, Gelidibacter and Gillisia</article-title>. <source>Int J Syst Evol Microbiol</source>. <year>2005</year>;<volume>55</volume>:<fpage>1471</fpage>&#x2013;<lpage>1486</lpage>.<pub-id pub-id-type="pmid">16014468</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0009">
        <label>[9]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skidmore</surname><given-names>M</given-names></name>, <name><surname>Anderson</surname><given-names>SP</given-names></name>, <name><surname>Sharp</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Comparison of microbial community compositions of two subglacial environments reveals a possible role for microbes in chemical weathering processes</article-title>. <source>Appl Environ Microbiol</source>. <year>2005</year>;<volume>71</volume>:<fpage>6986</fpage>&#x2013;<lpage>6997</lpage>.<pub-id pub-id-type="pmid">16269734</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0010">
        <label>[10]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>TL</given-names></name>, <name><surname>Peters</surname><given-names>JW</given-names></name>, <name><surname>Skidmore</surname><given-names>ML</given-names></name>, et al</person-group>
<article-title>Molecular evidence for an active endogenous microbiome beneath glacial ice</article-title>. <source>Isme J</source>. <year>2013</year>;<volume>7</volume>:<fpage>1402</fpage>&#x2013;<lpage>1412</lpage>.<pub-id pub-id-type="pmid">23486249</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0011">
        <label>[11]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>PP</given-names></name>, <name><surname>Miteva</surname><given-names>VI</given-names></name>, <name><surname>Brenchley</surname><given-names>JE</given-names></name></person-group>
<article-title>Phylogenetic analysis of anaerobic psychrophilic enrichment cultures obtained from a greenland glacier ice core</article-title>. <source>Appl Environ Microbiol</source>. <year>2003</year>;<volume>69</volume>:<fpage>2153</fpage>&#x2013;<lpage>2160</lpage>.<pub-id pub-id-type="pmid">12676695</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0012">
        <label>[12]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>T</given-names></name>, <name><surname>Tanaka</surname><given-names>M</given-names></name>, <name><surname>Moriizumi</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>Phylogenetic analysis of bacteria preserved in a permafrost ice wedge for 25,000 years</article-title>. <source>Appl Environ Microbiol</source>. <year>2007</year>;<volume>73</volume>:<fpage>2360</fpage>&#x2013;<lpage>2363</lpage>.<pub-id pub-id-type="pmid">17293514</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0013">
        <label>[13]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filippova</surname><given-names>SN</given-names></name>, <name><surname>Surgucheva</surname><given-names>NA</given-names></name>, <name><surname>Sorokin</surname><given-names>VV</given-names></name>, et al</person-group>
<article-title>Diversity of bacterial forms in ice wedge of the Mamontova Gora Glacial complex (central Yakutiya)</article-title>. <source>Mikrobiologiia</source>. <year>2014</year>;<volume>83</volume>:<fpage>225</fpage>&#x2013;<lpage>235</lpage>.</mixed-citation>
      </ref>
      <ref id="CIT0014">
        <label>[14]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedmann</surname><given-names>EI</given-names></name></person-group>
<article-title>Extreme environments and exobiology</article-title>. <source>Plant Biosyst</source>. <year>1993</year>;<volume>127</volume>:<fpage>369</fpage>&#x2013;<lpage>376</lpage>.<pub-id pub-id-type="pmid">11539430</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0015">
        <label>[15]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>T</given-names></name>, <name><surname>Reeves</surname><given-names>RH</given-names></name>, <name><surname>Gilichinsky</surname><given-names>DA</given-names></name>, et al</person-group>
<article-title>Characterization of viable bacteria from Siberian permafrost by 16S rDNA sequencing</article-title>. <source>Microb Ecol</source>. <year>1997</year>;<volume>33</volume>:<fpage>169</fpage>&#x2013;<lpage>179</lpage>.<pub-id pub-id-type="pmid">9115180</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0016">
        <label>[16]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivkina</surname><given-names>EM</given-names></name>, <name><surname>Friedmann</surname><given-names>EI</given-names></name>, <name><surname>McKay</surname><given-names>CP</given-names></name>, et al</person-group>
<article-title>Metabolic activity of permafrost bacteria below the freezing point</article-title>. <source>Appl Environ Microbiol</source>. <year>2000</year>;<volume>66</volume>:<fpage>3230</fpage>&#x2013;<lpage>3233</lpage>.<pub-id pub-id-type="pmid">10919774</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0017">
        <label>[17]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilichinsky</surname><given-names>DA</given-names></name>, <name><surname>Wilson</surname><given-names>GS</given-names></name>, <name><surname>Friedmann</surname><given-names>EI</given-names></name>, et al</person-group>
<article-title>Microbial populations in Antarctic permafrost: biodiversity, state, age, and implication for astrobiology</article-title>. <source>Astrobiology</source>. <year>2007</year>;<volume>7</volume>:<fpage>275</fpage>&#x2013;<lpage>311</lpage>.<pub-id pub-id-type="pmid">17480161</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0018">
        <label>[18]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>T</given-names></name>, <name><surname>Kato</surname><given-names>T</given-names></name>, <name><surname>Tanaka</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Glaciibacter superstes gen. nov., sp. nov., a novel member of the family Microbacteriaceae isolated from a permafrost ice wedge</article-title>. <source>Int J Syst Evol Microbiol</source>. <year>2009</year>;<volume>59</volume>:<fpage>482</fpage>&#x2013;<lpage>486</lpage>.<pub-id pub-id-type="pmid">19244426</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0019">
        <label>[19]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>T</given-names></name>, <name><surname>Kato</surname><given-names>T</given-names></name>, <name><surname>Tanaka</surname><given-names>M</given-names></name>, et al</person-group>
<article-title>Tomitella biformata gen. nov., sp. nov., a new member of the suborder Corynebacterineae isolated from a permafrost ice wedge</article-title>. <source>Int J Syst Evol Microbiol</source>. <year>2010</year>;<volume>60</volume>:<fpage>2803</fpage>&#x2013;<lpage>2807</lpage>.<pub-id pub-id-type="pmid">20081023</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0020">
        <label>[20]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenblatt</surname><given-names>CL</given-names></name>, <name><surname>Davis</surname><given-names>A</given-names></name>, <name><surname>Clement</surname><given-names>BG</given-names></name>, et al</person-group>
<article-title>Diversity of microorganisms isolated from amber</article-title>. <source>Microb Ecol</source>. <year>1999</year>;<volume>38</volume>:<fpage>58</fpage>&#x2013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">10384010</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0021">
        <label>[21]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>DC</given-names></name>, <name><surname>Brouchkov</surname><given-names>A</given-names></name>, <name><surname>Griva</surname><given-names>G</given-names></name>, et al</person-group>
<article-title>Isolation and characterization of bacteria from ancient Siberian permafrost sediment</article-title>. <source>Biol (Basel)</source>. <year>2013</year>;<volume>2</volume>:<fpage>85</fpage>&#x2013;<lpage>106</lpage>.</mixed-citation>
      </ref>
      <ref id="CIT0022">
        <label>[22]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>EV</given-names></name>, <name><surname>Brouchkov</surname><given-names>AV</given-names></name>, <name><surname>Kurilshikov</surname><given-names>AM</given-names></name>, et al</person-group>
<article-title>Draft genome sequence of bacillus cereus strain F, isolated from ancient permafrost</article-title>. <source>Genome Announc</source>. <year>2013</year>;<volume>1</volume>:<fpage>e00561</fpage>&#x2013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">23908292</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0023">
        <label>[23]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johannes</surname><given-names>KM</given-names></name>, <name><surname>Matthias</surname><given-names>A</given-names></name>, <name><surname>Horstkotte</surname><given-names>H</given-names></name>, et al</person-group>
<article-title>Evaluation of different detection methods of biofilm formation in Staphylococcus aureus</article-title>. <source>Med Microbiol Immunol</source>. <year>2002</year>;<volume>191</volume>:<fpage>101</fpage>&#x2013;<lpage>106</lpage>.<pub-id pub-id-type="pmid">12410349</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0024">
        <label>[24]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x2019;Toole</surname><given-names>GA</given-names></name></person-group>
<article-title>Microtiter dish biofilm formation assay</article-title>. <source>J Vis Exp</source>. <year>2011</year>;<volume>47</volume>:<page-range>pii: 2437</page-range>.</mixed-citation>
      </ref>
      <ref id="CIT0025">
        <label>[25]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruesse</surname><given-names>E</given-names></name>, <name><surname>Peplies</surname><given-names>J</given-names></name>, <name><surname>Gl&#xF6;ckner</surname><given-names>FO</given-names></name></person-group>
<article-title>SINA: accurate high-throughput multiple sequence alignment of ribosomal RNA genes</article-title>. <source>Bioinformatics</source>. <year>2012</year>;<volume>28</volume>:<fpage>1823</fpage>&#x2013;<lpage>1829</lpage>.<pub-id pub-id-type="pmid">22556368</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0026">
        <label>[26]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Schwartz</surname><given-names>S</given-names></name>, <name><surname>Wagner</surname><given-names>L</given-names></name>, et al</person-group>
<article-title>A greedy algorithm for aligning DNA sequences</article-title>. <source>J Comput Mol Cell Biol</source>. <year>2000</year>;<volume>7</volume>:<fpage>203</fpage>&#x2013;<lpage>214</lpage>.</mixed-citation>
      </ref>
      <ref id="CIT0027">
        <label>[27]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angiuoli</surname><given-names>SV</given-names></name>, <name><surname>Gussman</surname><given-names>A</given-names></name>, <name><surname>Klimke</surname><given-names>W</given-names></name>, et al</person-group>
<article-title>Toward an online repository of Standard Operating Procedures (SOPs) for (meta)genomic annotation</article-title>. <source>Omics: J Integr Biol</source>. <year>2008</year>;<volume>12</volume>:<fpage>137</fpage>&#x2013;<lpage>141</lpage>.</mixed-citation>
      </ref>
      <ref id="CIT0028">
        <label>[28]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carattoli</surname><given-names>A</given-names></name>, <name><surname>Zankari</surname><given-names>E</given-names></name>, <name><surname>Garcia-Fernandez</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing</article-title>. <source>Antimicrob Agents Chem</source>. <year>2014</year>;<volume>58</volume>:<fpage>3895</fpage>&#x2013;<lpage>3903</lpage>.</mixed-citation>
      </ref>
      <ref id="CIT0029">
        <label>[29]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>K</given-names></name>, <name><surname>Stecher</surname><given-names>G</given-names></name>, <name><surname>Peterson</surname><given-names>D</given-names></name>, et al</person-group>
<article-title>MEGA6: molecular evolutionary genetics analysis version 6.0</article-title>. <source>Mol Biol Evol</source>. <year>2013</year>;<volume>30</volume>:<fpage>2725</fpage>&#x2013;<lpage>2729</lpage>.<pub-id pub-id-type="pmid">24132122</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0030">
        <label>[30]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quast</surname><given-names>C</given-names></name>, <name><surname>Pruesse</surname><given-names>E</given-names></name>, <name><surname>Yilmaz</surname><given-names>P</given-names></name>, et al</person-group>
<article-title>The SILVA ribosomal RNA gene database project: improved data processing and web-based tools</article-title>. <source>Nucleic Acids Res</source>. <year>2013</year>;<volume>41</volume>:<fpage>D590</fpage>&#x2013;<lpage>596</lpage>.<pub-id pub-id-type="pmid">23193283</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0031">
        <label>[31]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zankari</surname><given-names>E</given-names></name>, <name><surname>Hasman</surname><given-names>H</given-names></name>, <name><surname>Kaas</surname><given-names>RS</given-names></name>, et al</person-group>
<article-title>Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing</article-title>. <source>J Antimicrobial Chem</source>. <year>2013</year>;<volume>68</volume>:<fpage>771</fpage>&#x2013;<lpage>777</lpage>.</mixed-citation>
      </ref>
      <ref id="CIT0032">
        <label>[32]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joensen</surname><given-names>KG</given-names></name>, <name><surname>Scheutz</surname><given-names>F</given-names></name>, <name><surname>Lund</surname><given-names>O</given-names></name>, et al</person-group>
<article-title>Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli</article-title>. <source>J Clin Microbiol</source>. <year>2014</year>;<volume>52</volume>:<fpage>1501</fpage>&#x2013;<lpage>1510</lpage>.<pub-id pub-id-type="pmid">24574290</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0033">
        <label>[33]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YQ</given-names></name>, <name><surname>Ren</surname><given-names>SX</given-names></name>, <name><surname>Li</surname><given-names>HL</given-names></name>, et al</person-group>
<article-title>Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228)</article-title>. <source>Mol Microbiol</source>. <year>2003</year>;<volume>49</volume>:<fpage>1577</fpage>&#x2013;<lpage>1593</lpage>.<pub-id pub-id-type="pmid">12950922</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0034">
        <label>[34]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatusova</surname><given-names>T</given-names></name>, <name><surname>Ciufo</surname><given-names>S</given-names></name>, <name><surname>Fedorov</surname><given-names>B</given-names></name>, et al</person-group>
<article-title>RefSeq microbial genomes database: new representation and annotation strategy</article-title>. <source>Nucleic Acids Res</source>. <year>2014</year>;<volume>42</volume>:<fpage>D553</fpage>&#x2013;<lpage>559</lpage>.<pub-id pub-id-type="pmid">24316578</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0035">
        <label>[35]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitali</surname><given-names>LA</given-names></name>, <name><surname>Petrelli</surname><given-names>D</given-names></name>, <name><surname>Lamikanra</surname><given-names>A</given-names></name>, et al</person-group>
<article-title>Diversity of antibiotic resistance genes and staphylococcal cassette chromosome mec elements in faecal isolates of coagulase-negative staphylococci from Nigeria</article-title>. <source>BMC Microbiol</source>. <year>2014</year>;<volume>14</volume>:<fpage>106</fpage>.<pub-id pub-id-type="pmid">24766644</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0036">
        <label>[36]</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gotz</surname><given-names>F</given-names></name>, <name><surname>Bannerman</surname><given-names>T</given-names></name>, <name><surname>Schleifer</surname><given-names>K</given-names></name></person-group>
<source>The genera Staphylococcus and Macrococcus</source>. In&#xA0;Dworkin&#xA0;M,&#xA0;editor. The Prokaryotes, vol. 6. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer US</publisher-name>; <year>2006</year>.</mixed-citation>
      </ref>
      <ref id="CIT0037">
        <label>[37]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavicchioli</surname><given-names>R</given-names></name>, <name><surname>Siddiqui</surname><given-names>KS</given-names></name>, <name><surname>Andrews</surname><given-names>D</given-names></name>, et al</person-group>
<article-title>Low-temperature extremophiles and their applications</article-title>. <source>Curr Opin Biotechnol</source>. <year>2002</year>;<volume>13</volume>:<fpage>253</fpage>&#x2013;<lpage>261</lpage>.<pub-id pub-id-type="pmid">12180102</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0038">
        <label>[38]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilichinsky</surname><given-names>D</given-names></name>, <name><surname>Khlebnikova</surname><given-names>G</given-names></name>, <name><surname>Zvyagintsev</surname><given-names>D</given-names></name>, et al</person-group>
<article-title>Microbiological characterization by studying sedimentary deposits of cryolithozone</article-title>. <source>Izvestiya AN SSSR, Ser Geol</source>. <year>1989</year>;<volume>63</volume>:<fpage>114</fpage>&#x2013;<lpage>126</lpage>.</mixed-citation>
      </ref>
      <ref id="CIT0039">
        <label>[39]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinsa-Leasure</surname><given-names>SM</given-names></name>, <name><surname>Bhavaraju</surname><given-names>L</given-names></name>, <name><surname>Rodrigues</surname><given-names>JL</given-names></name>, et al</person-group>
<article-title>Characterization of a bacterial community from a Northeast Siberian seacoast permafrost sample</article-title>. <source>FEMS Microbiol Ecol</source>. <year>2010</year>;<volume>74</volume>:<fpage>103</fpage>&#x2013;<lpage>113</lpage>.<pub-id pub-id-type="pmid">20695892</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0040">
        <label>[40]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnivetskaya</surname><given-names>TA</given-names></name>, <name><surname>Petrova</surname><given-names>MA</given-names></name>, <name><surname>Urbance</surname><given-names>J</given-names></name>, et al</person-group>
<article-title>Bacterial community in ancient Siberian permafrost as characterized by culture and culture-independent methods</article-title>. <source>Astrobiology</source>. <year>2006</year>;<volume>6</volume>:<fpage>400</fpage>&#x2013;<lpage>414</lpage>.<pub-id pub-id-type="pmid">16805696</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0041">
        <label>[41]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schopf</surname><given-names>JW</given-names></name>, <name><surname>Kudryavtsev</surname><given-names>AB</given-names></name>, <name><surname>Walter</surname><given-names>MR</given-names></name>, et al</person-group>
<article-title>Sulfur-cycling fossil bacteria from the 1.8-Ga Duck Creek Formation provide promising evidence of evolution&#x2019;s null hypothesis</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2015</year>;<volume>112</volume>:<fpage>2087</fpage>&#x2013;<lpage>2092</lpage>.<pub-id pub-id-type="pmid">25646436</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0042">
        <label>[42]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khardori</surname><given-names>N</given-names></name></person-group>
<article-title>Future of diagnostic microbiology</article-title>. <source>Indian J Med Microbiol</source>. <year>2014</year>;<volume>32</volume>:<fpage>371</fpage>&#x2013;<lpage>377</lpage>.<pub-id pub-id-type="pmid">25297019</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0043">
        <label>[43]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piddock</surname><given-names>LJ</given-names></name></person-group>
<article-title>Understanding the basis of antibiotic resistance: a platform for drug discovery</article-title>. <source>Microbiology</source>. <year>2014</year>;<volume>160</volume>:<fpage>2366</fpage>&#x2013;<lpage>2373</lpage>.<pub-id pub-id-type="pmid">25122880</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0044">
        <label>[44]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hait</surname><given-names>JM</given-names></name>, <name><surname>Tallent</surname><given-names>SM</given-names></name>, <name><surname>Bennett</surname><given-names>RW</given-names></name></person-group>
<article-title>Screening, detection, and serotyping methods for toxin genes and enterotoxins in Staphylococcus strains</article-title>. <source>J AOAC Int</source>. <year>2014</year>;<volume>97</volume>:<fpage>1078</fpage>&#x2013;<lpage>1083</lpage>.<pub-id pub-id-type="pmid">25145141</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0045">
        <label>[45]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duran</surname><given-names>N</given-names></name>, <name><surname>Ozer</surname><given-names>B</given-names></name>, <name><surname>Duran</surname><given-names>GG</given-names></name>, et al</person-group>
<article-title>Antibiotic resistance genes &amp; susceptibility patterns in staphylococci</article-title>. <source>Indian J Med Res</source>. <year>2012</year>;<volume>135</volume>:<fpage>389</fpage>&#x2013;<lpage>396</lpage>.<pub-id pub-id-type="pmid">22561627</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0046">
        <label>[46]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x2019;Costa</surname><given-names>VM</given-names></name>, <name><surname>King</surname><given-names>CE</given-names></name>, <name><surname>Kalan</surname><given-names>L</given-names></name>, et al</person-group>
<article-title>Antibiotic resistance is ancient</article-title>. <source>Nature</source>. <year>2011</year>;<volume>477</volume>:<fpage>457</fpage>&#x2013;<lpage>461</lpage>.<pub-id pub-id-type="pmid">21881561</pub-id></mixed-citation>
      </ref>
      <ref id="CIT0047">
        <label>[47]</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>J</given-names></name>, <name><surname>Waglechner</surname><given-names>N</given-names></name>, <name><surname>Wright</surname><given-names>G</given-names></name></person-group>
<article-title>The prehistory of antibiotic resistance</article-title>. <source>Cold Spring Harb Perspect Med</source>. <year>2016</year>;<volume>6</volume>:<page-range>pii: a025197</page-range>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Chem Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Chem Sci</journal-id>
      <journal-title-group>
        <journal-title>Chemical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2041-6520</issn>
      <issn pub-type="epub">2041-6539</issn>
      <publisher>
        <publisher-name>Royal Society of Chemistry</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28959396</article-id>
      <article-id pub-id-type="pmc">5605771</article-id>
      <article-id pub-id-type="publisher-id">c7sc00658f</article-id>
      <article-id pub-id-type="doi">10.1039/c7sc00658f</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Chemistry</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Metalloradical activation of &#x3B1;-formyldiazoacetates for the catalytic asymmetric radical cyclopropanation of alkenes<xref ref-type="fn" rid="fn1">&#x2020;</xref>
<fn id="fn1"><p>&#x2020;Electronic supplementary information (ESI) available. CCDC <uri xlink:type="simple" xlink:href="http://dx.doi.org/1532256">1532256</uri>. For ESI and crystallographic data in CIF or other electronic format see DOI: <uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1039/c7sc00658f">10.1039/c7sc00658f</uri>
<supplementary-material content-type="local-data" id="S1"><media xlink:href="SC-008-C7SC00658F-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="S2"><media xlink:href="SC-008-C7SC00658F-s002.cif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material>
</p></fn>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Xue</given-names>
          </name>
          <xref ref-type="aff" rid="affb">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Yong</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0532-3530</contrib-id>
          <xref ref-type="aff" rid="affa">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Xin</given-names>
          </name>
          <xref ref-type="aff" rid="affb">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wojtas</surname>
            <given-names>Lukasz</given-names>
          </name>
          <xref ref-type="aff" rid="affb">b</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Zhang</surname>
            <given-names>X. Peter</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7574-8409</contrib-id>
          <xref ref-type="aff" rid="affa">a</xref>
          <xref ref-type="aff" rid="affb">b</xref>
        </contrib>
      </contrib-group>
      <aff id="affa">
<label>a</label> Department of Chemistry , Merkert Chemistry Center , Boston College , Chestnut Hill , Massachusetts 02467 , USA . Email: <email>peter.zhang@bc.edu</email>
</aff>
      <aff id="affb">
<label>b</label> Department of Chemistry , University of South Florida , Tampa , FL 33620 , USA </aff>
      <pub-date pub-type="ppub">
        <day>1</day>
        <month>6</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <issue>6</issue>
      <fpage>4347</fpage>
      <lpage>4351</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>2</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>3</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>This journal is &#xA9; The Royal Society of Chemistry 2017</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="toc">
        <p>
<graphic xlink:href="c7sc00658f-ga.jpg" id="ga" position="float" orientation="portrait"/>For the first time, &#x3B1;-formyldiazoacetates (FDA), have been successfully applied for asymmetric olefin cyclopropanation <italic>via</italic> Co(<sc>ii</sc>)-based metalloradical catalysis.</p>
      </abstract>
      <abstract>
        <p>For the first time, &#x3B1;-formyldiazoacetates have been successfully applied for the asymmetric cyclopropanation of alkenes <italic>via</italic> Co(<sc>ii</sc>)-based metalloradical catalysis. The cobalt(<sc>ii</sc>) complex of the <italic>D</italic>
<sub>2</sub>-symmetric chiral amidoporphyrin [Co(3,5-Di<sup><italic>t</italic></sup>Bu-ChenPhyrin)] is an effective metalloradical catalyst that can activate &#x3B1;-formyldiazoacetates to cyclopropanate both aromatic and aliphatic olefins with varied electronic properties, affording the synthetically useful 1,1-cyclopropaneformylesters in high yields with both high diastereo- and enantioselectivity.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Radical reactions have been increasingly exploited as attractive tools in modern organic synthesis as they exhibit a number of unique features, including tolerance of functional groups.<sup><xref rid="cit1" ref-type="bibr">1</xref></sup> To address the existing challenges such as the control of enantioselectivity,<sup><xref rid="cit2" ref-type="bibr">2</xref></sup> metalloradical catalysis (MRC) has rendered a fundamentally new approach that enables the catalytic generation of metal-stabilized organic radicals as well as the selective control of their subsequent radical reactions.<sup><xref rid="cit3" ref-type="bibr">3</xref>,<xref rid="cit4" ref-type="bibr">4</xref></sup> As stable metalloradicals, cobalt(<sc>ii</sc>) complexes of the <italic>D</italic>
<sub>2</sub>-symmetric chiral amidoporphyrins [Co(<italic>D</italic>
<sub>2</sub>-Por*)] have emerged as a class of effective catalysts for asymmetric olefin cyclopropanation through a distinct radical process involving the catalytic generation of &#x3B1;-metalloalkyl radicals as the key intermediates (<xref ref-type="fig" rid="sch1">Scheme 1</xref>: <bold>A</bold>).<sup><xref rid="cit5" ref-type="bibr">5</xref></sup> It has been suggested that the unusual capability of [Co(<italic>D</italic>
<sub>2</sub>-Por*)] in activating acceptor/acceptor-substituted diazo reagents as well as regulating the reactivity and selectivity of the radical processes is further enhanced by the postulated double hydrogen-bonding interactions between the amide N&#x2013;H donors on the amidoporphyrin ligand and the two acceptors on the C-centered radical moiety (<xref ref-type="fig" rid="sch1">Scheme 1</xref>).<sup><xref rid="cit5e" ref-type="bibr">5e</xref>,<xref rid="cit5g" ref-type="bibr">g</xref>,<xref rid="cit5h" ref-type="bibr">h</xref></sup> Considering the demonstrated functional group tolerance of Co(<sc>ii</sc>)-based metalloradical catalysis (Co(<sc>ii</sc>)-MRC),<sup><xref rid="cit5d" ref-type="bibr">5d</xref>,<xref rid="cit5e" ref-type="bibr">e</xref>,<xref rid="cit5j" ref-type="bibr">j</xref>&#x2013;<xref rid="cit5l" ref-type="bibr">l</xref></sup> we were attracted to the possibility of accessing a new type of &#x3B1;-metalloalkyl radical bearing both &#x3B1;-formyl and &#x3B1;-alkoxycarbonyl functionalities from the metalloradical activation of &#x3B1;-formyldiazoacetates (FDA).<sup><xref rid="cit6" ref-type="bibr">6</xref></sup> Despite the fact that free &#x3B1;-formylalkyl radicals are scarce and prone to H-atom abstraction because of the weak aldehydic C&#x2013;H bonds,<sup><xref rid="cit7" ref-type="bibr">7</xref></sup> we reasoned that this type of &#x3B1;-metalloalkyl radical might be accessible on the basis of the combined effects of metal stabilization, double H-bonding interaction, and protection by the well-defined cavity of the ligand system (<xref ref-type="fig" rid="sch1">Scheme 1</xref>: <bold>A</bold>). Assuming that the &#x3B1;-formyl-&#x3B1;-alkoxycarbonyl-&#x3B1;-Co(<sc>iii</sc>)-alkyl radicals (<bold>A</bold>) are capable of undergoing stereoselective radical addition with olefins, followed by the effective 3-<italic>exo</italic>-tet radical cyclization<sup><xref rid="cit8" ref-type="bibr">8</xref></sup> of the corresponding &#x3B3;-Co(<sc>iii</sc>)-alkyl radicals (<bold>B</bold>), we anticipated the potential development of a new catalytic process for the asymmetric synthesis of optically active cyclopropanes bearing both aldehyde and ester functionalities, which would be valuable for stereoselective organic synthesis (<xref ref-type="fig" rid="sch1">Scheme 1</xref>).<sup><xref rid="cit9" ref-type="bibr">9</xref></sup>
</p>
      <fig id="sch1" fig-type="scheme" orientation="portrait" position="float">
        <label>Scheme 1</label>
        <caption>
          <title>Working proposal for the radical cyclopropanation of alkenes with FDA <italic>via</italic> Co(<sc>ii</sc>)-MRC.</title>
        </caption>
        <graphic xlink:href="c7sc00658f-s1"/>
      </fig>
      <p>The catalytic asymmetric cyclopropanation of alkenes with diazo reagents represents the most general approach for the stereoselective synthesis of optically active cyclopropanes.<sup><xref rid="cit10" ref-type="bibr">10</xref></sup> While a number of diazo reagents have been successfully employed, there is no previous report of a catalytic system that is effective for asymmetric olefin cyclopropanation with &#x3B1;-formyldiazoacetates (FDAs). The development of this catalytic process apparently confronts the formidable challenges associated with the inherent low reactivity of the acceptor/acceptor-substituted diazo reagents and the incompatibility of the aldehyde functionality with existing catalytic systems.<sup><xref rid="cit11" ref-type="bibr">11</xref></sup> Recently, Fokin and coworkers developed a Rh<sub>2</sub>-catalyzed system for a highly asymmetric cyclopropanation with <italic>N</italic>-sulfonyl-1,2,3-triazoles for the production of cyclopropyl imines, which could be subsequently transformed into the corresponding formyl cyclopropane derivatives.<sup><xref rid="cit12" ref-type="bibr">12</xref></sup> While this offers a valuable alternative for the preparation of optically active formyl cyclopropanes, the direct synthesis <italic>via</italic> asymmetric cyclopropanation with &#x3B1;-formyl diazo reagents is an appealing process that remains to be developed. As a new application of Co(<sc>ii</sc>)-MRC, we herein wish to report the first catalytic system based on [Co(<italic>D</italic>
<sub>2</sub>-Por*)] that is highly effective in activating FDA for asymmetric cyclopropanation. This asymmetric radical process is generally applicable for a broad scope of alkenes, offering a direct method for the high-yielding synthesis of 1,1-cyclopropaneformylesters with excellent control of the diastereo- and enantioselectivity. The products can be readily transformed into other chiral 1,1-bifunctionalized cyclopropanes and chiral dihydrofurans.</p>
    </sec>
    <sec>
      <title>Results and discussion</title>
      <p>Initial experiments were carried out with styrene as the model substrate to examine the suitability of FDA for the catalytic radical cyclopropanation by Co(<sc>ii</sc>)-MRC (<xref ref-type="table" rid="tab1">Table 1</xref>). While [Rh<sub>2</sub>(OAc)<sub>4</sub>] was indeed incompatible (entry 1), [Co(TPP)] only produced trace amounts of the corresponding cyclopropane from ethyl &#x3B1;-formyldiazoacetate (EFDA) (entry 2). Remarkably, when the Co(<sc>ii</sc>) complex of the <italic>D</italic>
<sub>2h</sub>-symmetric achiral amidoporphyrin [Co(<bold>P1</bold>)]<sup><xref rid="cit13" ref-type="bibr">13</xref></sup> was used as the catalyst, the reaction proceeded successfully to form the desired (<italic>E</italic>)-1,1-cyclopropaneformylester in a 46% yield (entry 3). The dramatic difference in the catalytic activity between [Co(TPP)] and [Co(<bold>P1</bold>)] is in alignment with the hypothesized role of the double H-bonding interaction in activating EFDA and stabilizing the resulting intermediate <bold>A</bold> (<xref ref-type="fig" rid="sch1">Scheme 1</xref>). By switching to [Co(<bold>P2</bold>)],<sup><xref rid="cit14" ref-type="bibr">14</xref></sup> the reactivity was further enhanced with the observation of a significant level of enantioselectivity (entry 4). Of the solvents examined, toluene was proven to be the medium of choice (entries 4&#x2013;8). Lowering the reaction temperature further increased the enantioselectivity, but decreased the yield (entries 8&#x2013;10). The diastereoselectivity was greatly improved when the bulkier <italic>tert</italic>-butyl &#x3B1;-formyldiazoacetate (<italic>t</italic>-BFDA) was used, affording cyclopropane <bold>1a</bold> in a 78% yield with 95&#x2009;:&#x2009;5 dr and 96% ee (entry 11). The product yield could be further improved to 84% by increasing the catalyst loading to 5 mol% while maintaining the high level of diastereo- and enantioselectivity (entry 12).</p>
      <table-wrap id="tab1" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <title>The catalytic asymmetric cyclopropanation of styrene with FDA<xref ref-type="fn" rid="tab1fna">
<sup><italic>a</italic></sup>
</xref>
</title>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
            <col span="1"/>
          </colgroup>
          <thead>
            <tr>
              <td colspan="8" rowspan="1">
<inline-graphic xlink:href="c7sc00658f-u1.jpg" id="ugr1"/>
<hr/>
</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Entry</td>
              <td rowspan="1" colspan="1">Catalyst</td>
              <td rowspan="1" colspan="1">R</td>
              <td rowspan="1" colspan="1">Solvent</td>
              <td rowspan="1" colspan="1">Temp. (&#xB0;C)</td>
              <td rowspan="1" colspan="1">Yield<xref ref-type="table-fn" rid="tab1fnb">
<sup><italic>b</italic></sup>
</xref> (%)</td>
              <td rowspan="1" colspan="1">(<italic>E</italic>)&#x2009;:&#x2009;(<italic>Z</italic>)</td>
              <td rowspan="1" colspan="1">ee<xref ref-type="table-fn" rid="tab1fnc">
<sup><italic>c</italic></sup>
</xref> (%)</td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">[Rh<sub>2</sub>(OAc)<sub>4</sub>]</td>
              <td rowspan="1" colspan="1">Et</td>
              <td rowspan="1" colspan="1">DCM</td>
              <td rowspan="1" colspan="1">60</td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">&#x2014;</td>
              <td rowspan="1" colspan="1">&#x2014;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">[Co(TPP)]</td>
              <td rowspan="1" colspan="1">Et</td>
              <td rowspan="1" colspan="1">DCM</td>
              <td rowspan="1" colspan="1">60</td>
              <td rowspan="1" colspan="1">&lt;10<xref ref-type="table-fn" rid="tab1fnd">
<sup><italic>d</italic></sup>
</xref>
</td>
              <td rowspan="1" colspan="1">&#x2014;</td>
              <td rowspan="1" colspan="1">&#x2014;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">[Co(<bold>P1</bold>)]</td>
              <td rowspan="1" colspan="1">Et</td>
              <td rowspan="1" colspan="1">DCM</td>
              <td rowspan="1" colspan="1">60</td>
              <td rowspan="1" colspan="1">46</td>
              <td rowspan="1" colspan="1">84&#x2009;:&#x2009;16</td>
              <td rowspan="1" colspan="1">&#x2014;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">4</td>
              <td rowspan="1" colspan="1">[Co(<bold>P2</bold>)]</td>
              <td rowspan="1" colspan="1">Et</td>
              <td rowspan="1" colspan="1">DCM</td>
              <td rowspan="1" colspan="1">60</td>
              <td rowspan="1" colspan="1">81</td>
              <td rowspan="1" colspan="1">80&#x2009;:&#x2009;20</td>
              <td rowspan="1" colspan="1">81</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">5</td>
              <td rowspan="1" colspan="1">[Co(<bold>P2</bold>)]</td>
              <td rowspan="1" colspan="1">Et</td>
              <td rowspan="1" colspan="1">EtOAc</td>
              <td rowspan="1" colspan="1">60</td>
              <td rowspan="1" colspan="1">81</td>
              <td rowspan="1" colspan="1">80&#x2009;:&#x2009;20</td>
              <td rowspan="1" colspan="1">81</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">6</td>
              <td rowspan="1" colspan="1">[Co(<bold>P2</bold>)]</td>
              <td rowspan="1" colspan="1">Et</td>
              <td rowspan="1" colspan="1">PhCl</td>
              <td rowspan="1" colspan="1">60</td>
              <td rowspan="1" colspan="1">73</td>
              <td rowspan="1" colspan="1">82&#x2009;:&#x2009;18</td>
              <td rowspan="1" colspan="1">83</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">7</td>
              <td rowspan="1" colspan="1">[Co(<bold>P2</bold>)]</td>
              <td rowspan="1" colspan="1">Et</td>
              <td rowspan="1" colspan="1">Hexanes</td>
              <td rowspan="1" colspan="1">60</td>
              <td rowspan="1" colspan="1">73</td>
              <td rowspan="1" colspan="1">80&#x2009;:&#x2009;20</td>
              <td rowspan="1" colspan="1">82</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">8</td>
              <td rowspan="1" colspan="1">[Co(<bold>P2</bold>)]</td>
              <td rowspan="1" colspan="1">Et</td>
              <td rowspan="1" colspan="1">Toluene</td>
              <td rowspan="1" colspan="1">60</td>
              <td rowspan="1" colspan="1">86</td>
              <td rowspan="1" colspan="1">85&#x2009;:&#x2009;15</td>
              <td rowspan="1" colspan="1">86</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">9</td>
              <td rowspan="1" colspan="1">[Co(<bold>P2</bold>)]</td>
              <td rowspan="1" colspan="1">Et</td>
              <td rowspan="1" colspan="1">Toluene</td>
              <td rowspan="1" colspan="1">40</td>
              <td rowspan="1" colspan="1">73</td>
              <td rowspan="1" colspan="1">86&#x2009;:&#x2009;14</td>
              <td rowspan="1" colspan="1">90</td>
            </tr>
            <tr>
